Query 041249
Match_columns 789
No_of_seqs 512 out of 3890
Neff 9.1
Searched_HMMs 46136
Date Fri Mar 29 05:15:06 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/041249.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/041249hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 PLN00113 leucine-rich repeat r 100.0 1.3E-61 2.9E-66 597.2 38.8 520 2-575 409-951 (968)
2 KOG1187 Serine/threonine prote 100.0 1.5E-49 3.3E-54 426.9 22.1 284 256-572 61-349 (361)
3 PLN00113 leucine-rich repeat r 100.0 3.3E-48 7.1E-53 478.2 27.0 455 1-789 122-588 (968)
4 KOG0192 Tyrosine kinase specif 100.0 2.9E-41 6.4E-46 359.8 15.5 258 268-574 39-302 (362)
5 KOG0595 Serine/threonine-prote 100.0 8.6E-41 1.9E-45 340.4 14.5 200 269-489 9-216 (429)
6 KOG0581 Mitogen-activated prot 100.0 1.7E-39 3.8E-44 328.5 15.8 255 271-572 80-336 (364)
7 KOG0197 Tyrosine kinases [Sign 100.0 1.7E-39 3.7E-44 344.0 13.3 249 273-572 209-458 (468)
8 KOG1026 Nerve growth factor re 100.0 2.1E-39 4.5E-44 359.4 11.0 269 269-577 485-764 (774)
9 KOG0598 Ribosomal protein S6 k 100.0 2.9E-38 6.2E-43 319.7 15.0 201 268-488 23-226 (357)
10 KOG0591 NIMA (never in mitosis 100.0 3.6E-39 7.7E-44 311.9 4.0 254 270-565 19-275 (375)
11 KOG0575 Polo-like serine/threo 100.0 1.5E-37 3.3E-42 331.9 16.1 200 270-489 18-220 (592)
12 KOG0615 Serine/threonine prote 100.0 2E-37 4.4E-42 315.0 11.7 254 270-572 172-438 (475)
13 KOG0592 3-phosphoinositide-dep 100.0 8.9E-38 1.9E-42 327.9 9.2 205 267-489 70-289 (604)
14 KOG4194 Membrane glycoprotein 100.0 1.6E-38 3.5E-43 333.9 3.4 205 575-781 241-448 (873)
15 KOG0193 Serine/threonine prote 100.0 2.4E-37 5.2E-42 328.4 8.0 262 260-570 382-648 (678)
16 KOG4194 Membrane glycoprotein 100.0 3.3E-37 7.1E-42 324.1 7.3 216 572-787 214-431 (873)
17 KOG0472 Leucine-rich repeat pr 100.0 4.6E-39 9.9E-44 324.7 -8.6 178 3-188 120-308 (565)
18 KOG0616 cAMP-dependent protein 100.0 1.2E-35 2.5E-40 290.1 13.8 198 270-490 44-244 (355)
19 KOG0578 p21-activated serine/t 100.0 1E-35 2.2E-40 315.5 14.5 252 270-572 273-524 (550)
20 KOG4721 Serine/threonine prote 100.0 1.1E-36 2.5E-41 318.6 6.0 244 271-575 125-368 (904)
21 KOG0198 MEKK and related serin 100.0 7.1E-36 1.5E-40 308.6 11.2 259 270-573 17-278 (313)
22 KOG1095 Protein tyrosine kinas 100.0 7E-36 1.5E-40 343.3 12.4 261 269-572 691-958 (1025)
23 KOG0196 Tyrosine kinase, EPH ( 100.0 5E-37 1.1E-41 332.9 2.4 258 270-576 629-892 (996)
24 KOG0593 Predicted protein kina 100.0 8.3E-36 1.8E-40 291.4 10.2 273 271-570 3-283 (396)
25 KOG0600 Cdc2-related protein k 100.0 2.8E-35 6.1E-40 306.7 14.3 204 269-489 116-322 (560)
26 KOG0659 Cdk activating kinase 100.0 1.3E-34 2.9E-39 278.7 15.2 273 270-570 2-280 (318)
27 KOG0582 Ste20-like serine/thre 100.0 1.7E-34 3.7E-39 296.5 16.2 263 268-569 24-291 (516)
28 KOG0597 Serine-threonine prote 100.0 1.3E-34 2.9E-39 303.6 12.7 210 270-505 2-213 (808)
29 KOG0583 Serine/threonine prote 100.0 3.6E-34 7.9E-39 308.5 16.4 247 268-569 15-273 (370)
30 cd05102 PTKc_VEGFR3 Catalytic 100.0 1.6E-34 3.4E-39 313.9 13.5 268 267-572 4-331 (338)
31 KOG0580 Serine/threonine prote 100.0 1.3E-34 2.7E-39 275.0 10.4 203 269-491 21-226 (281)
32 KOG1094 Discoidin domain recep 100.0 9.7E-35 2.1E-39 305.7 10.2 260 271-572 539-801 (807)
33 KOG0201 Serine/threonine prote 100.0 3.2E-35 6.9E-40 301.9 5.6 249 270-570 13-262 (467)
34 KOG0605 NDR and related serine 100.0 7.4E-34 1.6E-38 299.0 14.9 205 268-490 139-391 (550)
35 cd05096 PTKc_DDR1 Catalytic do 100.0 1.4E-33 3E-38 301.7 16.8 267 270-569 5-299 (304)
36 KOG2345 Serine/threonine prote 100.0 6.4E-35 1.4E-39 278.1 5.3 268 267-570 18-295 (302)
37 KOG0661 MAPK related serine/th 100.0 2.6E-34 5.6E-39 297.4 9.9 274 270-572 10-292 (538)
38 cd05631 STKc_GRK4 Catalytic do 100.0 1.8E-33 4E-38 297.8 16.6 200 271-489 1-203 (285)
39 KOG0194 Protein tyrosine kinas 100.0 3.4E-34 7.4E-39 309.0 10.8 260 266-576 153-421 (474)
40 cd07859 STKc_TDY_MAPK_plant Ca 100.0 1.9E-33 4.2E-38 305.4 15.9 204 272-489 2-210 (338)
41 cd05612 STKc_PRKX_like Catalyt 100.0 1.6E-33 3.4E-38 299.2 14.0 197 270-489 1-200 (291)
42 PHA02988 hypothetical protein; 100.0 4.6E-33 1E-37 294.2 17.2 257 257-570 12-274 (283)
43 cd05106 PTKc_CSF-1R Catalytic 100.0 1.7E-33 3.6E-38 309.2 14.1 264 269-571 37-368 (374)
44 PTZ00263 protein kinase A cata 100.0 2.2E-33 4.8E-38 303.4 14.7 196 270-488 18-216 (329)
45 cd05628 STKc_NDR1 Catalytic do 100.0 4E-33 8.6E-38 305.7 16.1 202 270-489 1-238 (363)
46 cd05571 STKc_PKB Catalytic dom 100.0 4.2E-33 9E-38 300.5 15.7 194 276-489 1-197 (323)
47 cd05585 STKc_YPK1_like Catalyt 100.0 6E-33 1.3E-37 297.8 16.6 191 278-488 1-194 (312)
48 cd05104 PTKc_Kit Catalytic dom 100.0 4E-33 8.7E-38 306.5 14.9 263 269-570 34-369 (375)
49 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 3.8E-33 8.3E-38 302.3 14.5 197 270-489 1-200 (333)
50 KOG0663 Protein kinase PITSLRE 100.0 2.9E-33 6.2E-38 277.3 12.0 202 270-489 76-280 (419)
51 cd05595 STKc_PKB_beta Catalyti 100.0 8E-33 1.7E-37 298.2 16.5 194 276-489 1-197 (323)
52 cd05048 PTKc_Ror Catalytic Dom 100.0 1.2E-32 2.7E-37 291.2 17.1 263 270-572 5-280 (283)
53 KOG0472 Leucine-rich repeat pr 100.0 2E-36 4.3E-41 305.7 -11.5 222 556-785 253-541 (565)
54 cd07848 STKc_CDKL5 Catalytic d 100.0 8.9E-33 1.9E-37 292.9 15.7 201 270-489 1-203 (287)
55 cd05108 PTKc_EGFR Catalytic do 100.0 7.6E-33 1.6E-37 297.7 14.5 252 270-571 7-264 (316)
56 KOG0585 Ca2+/calmodulin-depend 100.0 9.7E-33 2.1E-37 285.2 14.5 205 269-489 96-321 (576)
57 KOG2052 Activin A type IB rece 100.0 2.2E-32 4.9E-37 280.7 16.9 256 271-564 212-492 (513)
58 cd05629 STKc_NDR_like_fungal C 100.0 9E-33 1.9E-37 304.6 15.0 202 270-489 1-250 (377)
59 KOG3653 Transforming growth fa 100.0 1.9E-32 4.2E-37 283.3 16.1 200 271-487 211-424 (534)
60 cd05593 STKc_PKB_gamma Catalyt 100.0 2.1E-32 4.5E-37 295.5 17.0 194 276-489 1-197 (328)
61 KOG0444 Cytoskeletal regulator 100.0 2.3E-35 5E-40 311.5 -6.0 359 2-761 12-375 (1255)
62 KOG0584 Serine/threonine prote 100.0 1.1E-33 2.4E-38 302.9 6.7 226 274-518 44-274 (632)
63 cd05599 STKc_NDR_like Catalyti 100.0 1.1E-32 2.3E-37 302.7 14.7 202 270-489 1-241 (364)
64 cd06649 PKc_MEK2 Catalytic dom 100.0 3.8E-32 8.3E-37 294.0 18.6 200 269-489 4-204 (331)
65 KOG4278 Protein tyrosine kinas 100.0 2.5E-33 5.4E-38 295.8 8.9 263 262-574 259-522 (1157)
66 cd05626 STKc_LATS2 Catalytic d 100.0 1.6E-32 3.6E-37 302.7 15.9 201 271-489 2-250 (381)
67 cd07862 STKc_CDK6 Catalytic do 100.0 3.2E-32 6.8E-37 289.2 17.5 204 271-489 2-211 (290)
68 PTZ00426 cAMP-dependent protei 100.0 1.2E-32 2.6E-37 298.3 14.5 198 269-489 29-230 (340)
69 cd05064 PTKc_EphR_A10 Catalyti 100.0 1.1E-32 2.4E-37 288.7 13.7 252 269-570 4-260 (266)
70 cd05592 STKc_nPKC_theta_delta 100.0 2.7E-32 5.9E-37 293.1 16.9 194 276-489 1-198 (316)
71 PF07714 Pkinase_Tyr: Protein 100.0 4.1E-33 8.8E-38 290.8 10.1 246 275-568 4-255 (259)
72 KOG0694 Serine/threonine prote 100.0 1.3E-32 2.7E-37 297.5 14.0 201 268-489 366-570 (694)
73 cd05062 PTKc_IGF-1R Catalytic 100.0 2.2E-32 4.8E-37 288.3 15.6 263 267-569 3-272 (277)
74 KOG0588 Serine/threonine prote 100.0 1.3E-32 2.8E-37 294.8 13.7 197 271-488 13-213 (786)
75 cd07869 STKc_PFTAIRE1 Catalyti 100.0 2.4E-32 5.3E-37 292.0 15.9 201 269-489 4-206 (303)
76 PTZ00267 NIMA-related protein 100.0 1.9E-32 4.2E-37 310.2 15.6 253 271-569 68-321 (478)
77 KOG1989 ARK protein kinase fam 100.0 6E-33 1.3E-37 309.8 11.0 211 270-489 37-260 (738)
78 PTZ00283 serine/threonine prot 100.0 1.8E-32 4E-37 310.4 15.2 266 265-571 27-297 (496)
79 cd07871 STKc_PCTAIRE3 Catalyti 100.0 3.8E-32 8.3E-37 288.2 16.6 200 270-489 5-206 (288)
80 cd05591 STKc_nPKC_epsilon Cata 100.0 3E-32 6.4E-37 293.6 15.8 194 276-489 1-198 (321)
81 cd05621 STKc_ROCK2 Catalytic d 100.0 1.9E-32 4.2E-37 300.1 14.3 207 263-489 36-249 (370)
82 KOG0611 Predicted serine/threo 100.0 1.5E-32 3.2E-37 277.3 12.1 198 271-489 54-255 (668)
83 cd05587 STKc_cPKC Catalytic do 100.0 5.2E-32 1.1E-36 292.2 17.1 199 271-489 1-203 (324)
84 cd05618 STKc_aPKC_iota Catalyt 100.0 5.1E-32 1.1E-36 292.6 17.0 194 276-489 1-198 (329)
85 cd05148 PTKc_Srm_Brk Catalytic 100.0 1.9E-32 4.1E-37 286.0 13.2 255 267-572 3-258 (261)
86 PLN00034 mitogen-activated pro 100.0 5.7E-32 1.2E-36 295.4 17.5 250 270-572 74-329 (353)
87 cd05590 STKc_nPKC_eta Catalyti 100.0 4.1E-32 8.8E-37 292.3 16.1 194 276-489 1-198 (320)
88 cd06650 PKc_MEK1 Catalytic dom 100.0 6.9E-32 1.5E-36 292.1 17.7 201 268-489 3-204 (333)
89 cd05111 PTK_HER3 Pseudokinase 100.0 3.3E-32 7.1E-37 287.3 14.8 251 270-570 7-263 (279)
90 cd05616 STKc_cPKC_beta Catalyt 100.0 4.8E-32 1E-36 292.3 16.4 199 271-489 1-203 (323)
91 cd05573 STKc_ROCK_NDR_like Cat 100.0 2.6E-32 5.5E-37 298.1 14.3 202 270-489 1-232 (350)
92 cd05625 STKc_LATS1 Catalytic d 100.0 3.5E-32 7.6E-37 300.4 15.3 201 271-489 2-250 (382)
93 cd05594 STKc_PKB_alpha Catalyt 100.0 2.6E-32 5.6E-37 294.6 13.9 194 276-489 1-198 (325)
94 KOG0660 Mitogen-activated prot 100.0 2.3E-32 4.9E-37 275.8 12.3 281 268-571 20-310 (359)
95 cd05598 STKc_LATS Catalytic do 100.0 2.6E-32 5.5E-37 300.9 14.0 202 270-489 1-246 (376)
96 cd05588 STKc_aPKC Catalytic do 100.0 7.2E-32 1.6E-36 291.6 17.1 194 276-489 1-198 (329)
97 cd05622 STKc_ROCK1 Catalytic d 100.0 3.4E-32 7.3E-37 298.5 14.8 208 262-489 35-249 (371)
98 cd05589 STKc_PKN Catalytic dom 100.0 6.6E-32 1.4E-36 291.4 16.7 197 272-489 1-203 (324)
99 cd05033 PTKc_EphR Catalytic do 100.0 6.8E-32 1.5E-36 282.8 16.3 255 269-572 3-262 (266)
100 cd05584 STKc_p70S6K Catalytic 100.0 6.5E-32 1.4E-36 291.2 16.5 194 276-489 2-202 (323)
101 cd05605 STKc_GRK4_like Catalyt 100.0 5.2E-32 1.1E-36 286.7 15.4 200 271-489 1-203 (285)
102 cd05052 PTKc_Abl Catalytic dom 100.0 7.1E-32 1.5E-36 282.2 16.0 254 269-572 5-259 (263)
103 cd05619 STKc_nPKC_theta Cataly 100.0 9.2E-32 2E-36 288.9 17.2 194 276-489 1-198 (316)
104 cd05105 PTKc_PDGFR_alpha Catal 100.0 3.2E-32 6.9E-37 300.2 13.9 267 268-573 35-395 (400)
105 cd05575 STKc_SGK Catalytic dom 100.0 7.5E-32 1.6E-36 290.8 16.3 193 276-488 1-197 (323)
106 cd05608 STKc_GRK1 Catalytic do 100.0 8.3E-32 1.8E-36 284.4 16.3 196 278-489 1-199 (280)
107 cd05054 PTKc_VEGFR Catalytic d 100.0 3.3E-32 7.1E-37 294.9 13.6 268 268-573 5-331 (337)
108 cd05093 PTKc_TrkB Catalytic do 100.0 8.2E-32 1.8E-36 285.7 16.3 266 269-574 4-278 (288)
109 cd05090 PTKc_Ror1 Catalytic do 100.0 7.2E-32 1.6E-36 285.3 15.7 262 270-571 5-279 (283)
110 cd05601 STKc_CRIK Catalytic do 100.0 3.3E-32 7.1E-37 294.6 13.4 202 270-489 1-211 (330)
111 cd05072 PTKc_Lyn Catalytic dom 100.0 5.6E-32 1.2E-36 282.5 14.4 254 268-572 4-258 (261)
112 KOG1025 Epidermal growth facto 100.0 3.9E-33 8.5E-38 303.5 5.7 255 272-576 698-958 (1177)
113 cd05620 STKc_nPKC_delta Cataly 100.0 1.1E-31 2.4E-36 288.4 16.9 194 276-489 1-198 (316)
114 cd05036 PTKc_ALK_LTK Catalytic 100.0 8.6E-32 1.9E-36 283.8 15.6 260 268-570 4-273 (277)
115 cd05627 STKc_NDR2 Catalytic do 100.0 3.8E-32 8.3E-37 297.6 13.2 202 270-489 1-238 (360)
116 cd05596 STKc_ROCK Catalytic do 100.0 4.3E-32 9.3E-37 297.7 13.6 205 265-489 38-249 (370)
117 cd05607 STKc_GRK7 Catalytic do 100.0 2.3E-31 4.9E-36 280.6 18.5 244 278-568 1-247 (277)
118 cd08529 STKc_FA2-like Catalyti 100.0 1.2E-31 2.7E-36 278.9 16.3 250 271-570 1-252 (256)
119 cd05068 PTKc_Frk_like Catalyti 100.0 1.1E-31 2.5E-36 280.2 16.0 254 268-572 4-258 (261)
120 cd05615 STKc_cPKC_alpha Cataly 100.0 1E-31 2.3E-36 289.5 16.0 199 271-489 1-203 (323)
121 cd05049 PTKc_Trk Catalytic dom 100.0 8.8E-32 1.9E-36 284.1 15.1 261 269-569 4-275 (280)
122 cd05084 PTKc_Fes Catalytic dom 100.0 9.5E-32 2.1E-36 279.2 15.1 245 276-569 1-247 (252)
123 cd05035 PTKc_Axl_like Catalyti 100.0 1.9E-31 4.1E-36 280.3 17.3 261 272-571 1-268 (273)
124 cd06624 STKc_ASK Catalytic dom 100.0 1.2E-31 2.6E-36 281.3 15.6 258 264-570 2-264 (268)
125 KOG4250 TANK binding protein k 100.0 4.3E-32 9.4E-37 294.1 12.5 206 272-490 15-227 (732)
126 cd05094 PTKc_TrkC Catalytic do 100.0 1.5E-31 3.4E-36 284.0 16.7 266 270-575 5-282 (291)
127 cd05603 STKc_SGK2 Catalytic do 100.0 1.6E-31 3.5E-36 288.0 16.9 194 276-489 1-198 (321)
128 cd05570 STKc_PKC Catalytic dom 100.0 1.4E-31 3.1E-36 287.9 16.4 194 276-489 1-198 (318)
129 cd05091 PTKc_Ror2 Catalytic do 100.0 1.2E-31 2.6E-36 283.6 15.5 263 270-572 5-280 (283)
130 cd05045 PTKc_RET Catalytic dom 100.0 8.4E-32 1.8E-36 285.9 14.4 263 271-573 1-284 (290)
131 cd05617 STKc_aPKC_zeta Catalyt 100.0 1.6E-31 3.6E-36 288.5 16.8 194 276-489 1-198 (327)
132 KOG0589 Serine/threonine prote 100.0 4.5E-32 9.8E-37 286.9 12.0 253 270-571 4-258 (426)
133 cd05109 PTKc_HER2 Catalytic do 100.0 1.1E-31 2.3E-36 283.4 14.9 252 269-570 6-263 (279)
134 cd05114 PTKc_Tec_Rlk Catalytic 100.0 1.4E-31 2.9E-36 278.8 15.3 248 270-569 4-252 (256)
135 KOG0594 Protein kinase PCTAIRE 100.0 8.4E-32 1.8E-36 273.0 13.3 209 270-490 11-224 (323)
136 PRK13184 pknD serine/threonine 100.0 7.6E-32 1.6E-36 312.8 14.7 212 270-489 2-233 (932)
137 cd05614 STKc_MSK2_N N-terminal 100.0 1.3E-31 2.8E-36 290.2 15.6 200 271-489 1-209 (332)
138 cd05602 STKc_SGK1 Catalytic do 100.0 1.8E-31 4E-36 288.0 16.6 193 276-488 1-197 (325)
139 cd08228 STKc_Nek6 Catalytic do 100.0 1.4E-31 3.1E-36 280.4 15.3 258 270-572 2-262 (267)
140 cd06625 STKc_MEKK3_like Cataly 100.0 1.9E-31 4E-36 278.8 16.1 251 270-569 2-258 (263)
141 KOG4257 Focal adhesion tyrosin 100.0 2.9E-32 6.2E-37 288.5 9.5 254 270-574 389-648 (974)
142 KOG0574 STE20-like serine/thre 100.0 1.7E-33 3.8E-38 274.0 0.2 199 270-489 33-231 (502)
143 cd05055 PTKc_PDGFR Catalytic d 100.0 1.4E-31 3E-36 285.8 14.9 255 269-570 34-296 (302)
144 cd05597 STKc_DMPK_like Catalyt 100.0 1.8E-31 3.8E-36 288.8 15.7 201 270-488 1-209 (331)
145 cd05632 STKc_GRK5 Catalytic do 100.0 2.3E-31 4.9E-36 281.8 16.2 199 272-489 2-203 (285)
146 KOG0658 Glycogen synthase kina 100.0 1.5E-32 3.2E-37 277.6 6.7 201 272-489 26-228 (364)
147 cd05032 PTKc_InsR_like Catalyt 100.0 2.4E-31 5.2E-36 280.3 16.1 261 269-569 5-272 (277)
148 cd05075 PTKc_Axl Catalytic dom 100.0 3.5E-31 7.5E-36 278.3 17.3 260 272-570 1-266 (272)
149 cd05624 STKc_MRCK_beta Catalyt 100.0 1.3E-31 2.9E-36 289.7 14.4 201 270-488 1-209 (331)
150 cd06637 STKc_TNIK Catalytic do 100.0 1.9E-31 4.1E-36 280.3 15.1 259 267-570 3-268 (272)
151 cd06654 STKc_PAK1 Catalytic do 100.0 1.6E-31 3.4E-36 284.6 14.6 250 270-570 20-269 (296)
152 KOG4279 Serine/threonine prote 100.0 1.5E-32 3.3E-37 293.3 6.7 194 277-489 582-780 (1226)
153 cd05053 PTKc_FGFR Catalytic do 100.0 1.9E-31 4.2E-36 283.6 15.1 268 265-572 7-288 (293)
154 PHA03212 serine/threonine kina 100.0 2.7E-31 5.9E-36 292.7 16.8 195 269-489 91-285 (391)
155 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 1.8E-31 3.8E-36 282.4 14.6 266 272-572 6-278 (283)
156 cd05582 STKc_RSK_N N-terminal 100.0 1.1E-31 2.4E-36 288.8 13.0 194 276-489 2-200 (318)
157 cd05092 PTKc_TrkA Catalytic do 100.0 2.4E-31 5.1E-36 280.9 15.2 262 269-570 4-276 (280)
158 cd05061 PTKc_InsR Catalytic do 100.0 2.7E-31 5.8E-36 281.7 15.5 264 267-570 3-273 (288)
159 cd06646 STKc_MAP4K5 Catalytic 100.0 2.4E-31 5.2E-36 278.7 14.9 199 270-488 9-210 (267)
160 cd05623 STKc_MRCK_alpha Cataly 100.0 2.3E-31 5E-36 288.0 15.2 201 270-488 1-209 (332)
161 cd05630 STKc_GRK6 Catalytic do 100.0 2.3E-31 5E-36 281.7 14.8 200 271-489 1-203 (285)
162 cd05113 PTKc_Btk_Bmx Catalytic 100.0 2.3E-31 5E-36 277.1 14.3 248 270-569 4-252 (256)
163 cd07863 STKc_CDK4 Catalytic do 100.0 4.9E-31 1.1E-35 279.7 16.9 204 271-489 1-209 (288)
164 KOG0986 G protein-coupled rece 100.0 6.5E-32 1.4E-36 277.2 9.6 202 269-489 184-388 (591)
165 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 2.3E-31 4.9E-36 281.7 14.0 273 270-573 4-281 (284)
166 cd05043 PTK_Ryk Pseudokinase d 100.0 2E-31 4.2E-36 281.5 13.5 266 267-573 3-274 (280)
167 cd05116 PTKc_Syk Catalytic dom 100.0 4.8E-31 1E-35 274.9 16.1 246 277-573 2-253 (257)
168 cd05107 PTKc_PDGFR_beta Cataly 100.0 2.1E-31 4.5E-36 293.6 13.6 269 264-571 31-395 (401)
169 cd05604 STKc_SGK3 Catalytic do 100.0 3.8E-31 8.2E-36 285.6 15.2 193 276-488 1-197 (325)
170 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 5.9E-31 1.3E-35 275.6 16.2 257 270-571 2-261 (267)
171 cd05063 PTKc_EphR_A2 Catalytic 100.0 3.1E-31 6.8E-36 278.1 14.0 255 268-571 3-263 (268)
172 cd06651 STKc_MEKK3 Catalytic d 100.0 7.9E-31 1.7E-35 274.8 17.0 204 270-489 2-211 (266)
173 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 5.6E-31 1.2E-35 274.8 15.6 250 269-570 5-255 (260)
174 cd05115 PTKc_Zap-70 Catalytic 100.0 6.2E-31 1.3E-35 274.0 15.9 245 277-571 2-251 (257)
175 cd07853 STKc_NLK Catalytic dom 100.0 4.7E-31 1E-35 290.3 15.7 204 271-489 1-207 (372)
176 cd05101 PTKc_FGFR2 Catalytic d 100.0 5.6E-31 1.2E-35 281.6 15.9 268 267-574 12-295 (304)
177 cd05060 PTKc_Syk_like Catalyti 100.0 6.2E-31 1.4E-35 274.0 15.8 246 276-572 1-252 (257)
178 cd05095 PTKc_DDR2 Catalytic do 100.0 8.1E-31 1.8E-35 279.2 16.9 268 270-570 5-292 (296)
179 cd08229 STKc_Nek7 Catalytic do 100.0 3.3E-31 7.1E-36 277.7 13.6 258 270-572 2-262 (267)
180 cd05050 PTKc_Musk Catalytic do 100.0 6.2E-31 1.3E-35 279.0 15.8 262 268-569 3-283 (288)
181 cd06645 STKc_MAP4K3 Catalytic 100.0 3.8E-31 8.3E-36 277.2 14.0 199 270-488 9-210 (267)
182 cd05059 PTKc_Tec_like Catalyti 100.0 4.3E-31 9.3E-36 275.1 14.3 248 270-569 4-252 (256)
183 cd05051 PTKc_DDR Catalytic dom 100.0 9.7E-31 2.1E-35 278.6 17.2 268 269-569 4-291 (296)
184 cd06615 PKc_MEK Catalytic doma 100.0 1.4E-30 3.1E-35 278.9 18.4 198 270-489 1-200 (308)
185 cd06656 STKc_PAK3 Catalytic do 100.0 4E-31 8.6E-36 281.7 14.1 251 270-571 19-269 (297)
186 KOG0610 Putative serine/threon 100.0 4.8E-31 1E-35 269.2 13.9 204 270-489 77-337 (459)
187 cd06619 PKc_MKK5 Catalytic dom 100.0 2E-30 4.3E-35 273.7 19.2 195 270-490 1-196 (279)
188 cd06639 STKc_myosinIIIB Cataly 100.0 6.9E-31 1.5E-35 279.0 15.7 269 260-570 12-286 (291)
189 cd05097 PTKc_DDR_like Catalyti 100.0 1E-30 2.2E-35 278.4 16.8 267 270-569 5-290 (295)
190 cd07872 STKc_PCTAIRE2 Catalyti 100.0 8.4E-31 1.8E-35 280.9 16.3 200 270-489 6-207 (309)
191 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 1.8E-30 3.8E-35 272.6 18.2 201 276-489 1-212 (269)
192 cd06638 STKc_myosinIIIA Cataly 100.0 9.8E-31 2.1E-35 277.1 16.3 270 259-570 7-282 (286)
193 PTZ00036 glycogen synthase kin 100.0 3.5E-31 7.6E-36 296.5 13.4 205 268-489 64-273 (440)
194 cd06612 STKc_MST1_2 Catalytic 100.0 5.6E-31 1.2E-35 273.9 14.1 250 270-570 3-252 (256)
195 cd05089 PTKc_Tie1 Catalytic do 100.0 1.2E-30 2.7E-35 277.9 16.7 260 270-572 2-272 (297)
196 cd08223 STKc_Nek4 Catalytic do 100.0 1.7E-30 3.7E-35 270.6 17.4 252 271-571 1-254 (257)
197 cd05103 PTKc_VEGFR2 Catalytic 100.0 6.2E-31 1.3E-35 286.0 14.5 266 269-572 6-336 (343)
198 cd05065 PTKc_EphR_B Catalytic 100.0 6.5E-31 1.4E-35 275.8 14.2 251 270-569 4-262 (269)
199 cd06655 STKc_PAK2 Catalytic do 100.0 5.8E-31 1.3E-35 280.2 13.9 199 270-489 19-217 (296)
200 cd08219 STKc_Nek3 Catalytic do 100.0 1.3E-30 2.7E-35 271.3 16.1 248 271-568 1-249 (255)
201 KOG0599 Phosphorylase kinase g 100.0 6.6E-32 1.4E-36 260.1 5.9 253 270-572 17-284 (411)
202 cd05066 PTKc_EphR_A Catalytic 100.0 8.7E-31 1.9E-35 274.6 14.6 253 269-570 3-261 (267)
203 PTZ00266 NIMA-related protein 100.0 7E-31 1.5E-35 305.9 15.2 263 263-569 6-293 (1021)
204 cd05110 PTKc_HER4 Catalytic do 100.0 7.5E-31 1.6E-35 280.4 14.3 255 269-573 6-266 (303)
205 PHA03207 serine/threonine kina 100.0 1.1E-30 2.3E-35 289.2 15.9 198 269-490 91-290 (392)
206 cd05099 PTKc_FGFR4 Catalytic d 100.0 1E-30 2.2E-35 280.9 15.4 266 268-573 10-291 (314)
207 cd05039 PTKc_Csk_like Catalyti 100.0 1.3E-30 2.7E-35 271.5 15.5 246 269-570 5-251 (256)
208 cd08221 STKc_Nek9 Catalytic do 100.0 3.3E-30 7.1E-35 268.3 18.6 249 271-569 1-251 (256)
209 cd05088 PTKc_Tie2 Catalytic do 100.0 1.2E-30 2.6E-35 278.8 15.5 260 269-571 6-276 (303)
210 cd05082 PTKc_Csk Catalytic dom 100.0 1.9E-30 4.1E-35 270.2 16.6 246 269-570 5-251 (256)
211 cd00192 PTKc Catalytic domain 100.0 2.3E-30 5E-35 269.9 17.2 253 276-569 1-258 (262)
212 KOG0033 Ca2+/calmodulin-depend 100.0 2.3E-32 4.9E-37 259.5 1.8 200 269-489 10-214 (355)
213 cd05071 PTKc_Src Catalytic dom 100.0 1E-30 2.2E-35 273.3 14.5 252 269-572 5-257 (262)
214 cd05067 PTKc_Lck_Blk Catalytic 100.0 1.3E-30 2.9E-35 272.0 15.3 251 268-570 4-255 (260)
215 cd06611 STKc_SLK_like Catalyti 100.0 1.3E-30 2.9E-35 275.2 15.5 253 269-570 4-261 (280)
216 cd06643 STKc_SLK Catalytic dom 100.0 1.3E-30 2.8E-35 275.6 15.4 251 272-571 7-262 (282)
217 cd05098 PTKc_FGFR1 Catalytic d 100.0 9E-31 1.9E-35 280.4 14.3 266 269-574 17-298 (307)
218 cd06609 STKc_MST3_like Catalyt 100.0 1.9E-30 4.2E-35 273.0 16.4 249 270-570 1-250 (274)
219 cd05057 PTKc_EGFR_like Catalyt 100.0 1.4E-30 3E-35 274.9 15.3 254 269-572 6-265 (279)
220 cd05042 PTKc_Aatyk Catalytic d 100.0 2.6E-30 5.6E-35 271.3 17.1 201 276-489 1-212 (269)
221 cd06644 STKc_STK10_LOK Catalyt 100.0 4.3E-30 9.2E-35 273.1 19.0 252 270-570 12-268 (292)
222 cd05100 PTKc_FGFR3 Catalytic d 100.0 1.7E-30 3.7E-35 281.6 16.2 266 267-572 9-290 (334)
223 cd06629 STKc_MAPKKK_Bck1_like 100.0 3.2E-30 6.8E-35 271.1 17.7 255 271-570 2-268 (272)
224 cd07878 STKc_p38beta_MAPK11 Ca 100.0 2.6E-30 5.7E-35 281.3 17.7 202 268-489 13-218 (343)
225 KOG0444 Cytoskeletal regulator 100.0 3.2E-33 6.9E-38 295.4 -5.3 355 2-756 37-394 (1255)
226 cd06628 STKc_MAPKKK_Byr2_like 100.0 2.9E-30 6.2E-35 270.6 16.6 200 272-489 2-214 (267)
227 PHA03209 serine/threonine kina 100.0 1.1E-30 2.3E-35 285.6 13.8 194 267-487 63-256 (357)
228 cd07861 STKc_CDK1_euk Catalyti 100.0 3E-30 6.6E-35 273.1 16.7 201 271-489 1-204 (285)
229 cd06613 STKc_MAP4K3_like Catal 100.0 5.4E-30 1.2E-34 267.6 18.3 253 270-569 3-258 (262)
230 cd05040 PTKc_Ack_like Catalyti 100.0 2.1E-30 4.6E-35 269.9 15.3 247 276-570 1-253 (257)
231 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 1.1E-30 2.3E-35 276.5 13.1 258 271-570 5-278 (284)
232 cd05058 PTKc_Met_Ron Catalytic 100.0 2.2E-30 4.7E-35 270.7 15.3 248 276-571 1-255 (262)
233 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 1.2E-30 2.6E-35 276.0 13.4 268 270-573 4-281 (284)
234 cd05085 PTKc_Fer Catalytic dom 100.0 3.3E-30 7.1E-35 267.3 16.4 243 276-569 1-245 (250)
235 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 3E-30 6.5E-35 273.1 16.2 256 270-573 5-268 (284)
236 cd05069 PTKc_Yes Catalytic dom 100.0 2.3E-30 4.9E-35 270.3 15.1 249 270-570 6-255 (260)
237 cd06642 STKc_STK25-YSK1 Cataly 100.0 1.4E-30 3E-35 274.6 13.6 247 272-571 6-253 (277)
238 cd07874 STKc_JNK3 Catalytic do 100.0 9.5E-31 2.1E-35 286.2 12.7 202 269-489 16-220 (355)
239 cd08218 STKc_Nek1 Catalytic do 100.0 3.5E-30 7.7E-35 268.1 16.5 250 271-570 1-252 (256)
240 cd06636 STKc_MAP4K4_6 Catalyti 100.0 2.8E-30 6E-35 273.1 15.9 266 259-569 5-277 (282)
241 cd06632 STKc_MEKK1_plant Catal 100.0 3.3E-30 7.2E-35 268.4 16.2 198 271-489 1-204 (258)
242 cd05047 PTKc_Tie Catalytic dom 100.0 4E-30 8.8E-35 270.0 16.8 253 276-571 1-264 (270)
243 cd08227 PK_STRAD_alpha Pseudok 100.0 2.9E-30 6.4E-35 278.9 16.2 199 275-489 3-212 (327)
244 cd05586 STKc_Sck1_like Catalyt 100.0 1.1E-30 2.3E-35 282.7 12.7 192 278-489 1-199 (330)
245 cd06631 STKc_YSK4 Catalytic do 100.0 3E-30 6.6E-35 270.1 15.7 200 271-489 1-210 (265)
246 KOG0577 Serine/threonine prote 100.0 2E-31 4.4E-36 280.5 6.7 193 272-488 28-226 (948)
247 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 2.8E-30 6.2E-35 273.6 15.6 253 270-570 1-261 (286)
248 cd07875 STKc_JNK1 Catalytic do 100.0 1.5E-30 3.3E-35 285.5 13.9 202 269-489 23-227 (364)
249 cd07870 STKc_PFTAIRE2 Catalyti 100.0 3.1E-30 6.7E-35 274.1 15.8 203 268-490 3-207 (291)
250 cd05034 PTKc_Src_like Catalyti 100.0 2.4E-30 5.1E-35 270.2 14.6 252 268-570 4-256 (261)
251 PHA03211 serine/threonine kina 100.0 2E-30 4.4E-35 289.2 15.0 196 269-488 168-363 (461)
252 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 2.4E-30 5.2E-35 272.2 14.7 235 277-568 2-269 (274)
253 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 3.7E-30 7.9E-35 269.0 15.9 236 276-568 1-257 (262)
254 cd07849 STKc_ERK1_2_like Catal 100.0 3E-30 6.5E-35 280.0 15.8 281 269-571 4-292 (336)
255 cd06630 STKc_MEKK1 Catalytic d 100.0 5.1E-30 1.1E-34 268.7 17.0 254 271-570 1-263 (268)
256 cd06640 STKc_MST4 Catalytic do 100.0 5.8E-30 1.3E-34 269.9 17.3 248 271-571 5-253 (277)
257 PTZ00284 protein kinase; Provi 100.0 3.1E-30 6.8E-35 292.0 16.3 203 263-489 122-347 (467)
258 cd06617 PKc_MKK3_6 Catalytic d 100.0 3E-30 6.6E-35 272.8 15.2 253 270-570 1-260 (283)
259 cd07873 STKc_PCTAIRE1 Catalyti 100.0 3.7E-30 8.1E-35 274.8 15.8 200 270-489 6-207 (301)
260 cd06652 STKc_MEKK2 Catalytic d 100.0 6.2E-30 1.3E-34 267.8 17.1 204 270-489 2-211 (265)
261 cd05044 PTKc_c-ros Catalytic d 100.0 3.8E-30 8.2E-35 270.0 15.1 251 276-569 1-264 (269)
262 cd07847 STKc_CDKL1_4 Catalytic 100.0 6.3E-30 1.4E-34 270.8 17.0 200 270-489 1-203 (286)
263 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 9.8E-30 2.1E-34 269.6 18.3 263 270-572 1-267 (287)
264 cd06610 STKc_OSR1_SPAK Catalyt 100.0 8.5E-30 1.8E-34 266.8 17.6 259 270-570 1-263 (267)
265 cd05086 PTKc_Aatyk2 Catalytic 100.0 1.4E-29 2.9E-34 265.7 19.0 199 276-488 1-210 (268)
266 cd05056 PTKc_FAK Catalytic dom 100.0 3.6E-30 7.9E-35 270.3 14.6 253 269-572 5-262 (270)
267 cd08217 STKc_Nek2 Catalytic do 100.0 5.8E-30 1.3E-34 267.5 16.0 258 271-571 1-262 (265)
268 PF00069 Pkinase: Protein kina 100.0 1.7E-30 3.7E-35 270.9 11.9 253 272-570 1-256 (260)
269 cd05073 PTKc_Hck Catalytic dom 100.0 5.2E-30 1.1E-34 267.6 15.4 249 269-569 5-254 (260)
270 cd06605 PKc_MAPKK Catalytic do 100.0 4.3E-30 9.3E-35 268.8 14.8 254 270-570 1-256 (265)
271 cd08220 STKc_Nek8 Catalytic do 100.0 9.5E-30 2.1E-34 264.7 17.3 249 271-570 1-252 (256)
272 cd06647 STKc_PAK_I Catalytic d 100.0 3.6E-30 7.8E-35 273.7 14.1 200 269-489 18-217 (293)
273 cd05041 PTKc_Fes_like Catalyti 100.0 6.7E-30 1.5E-34 265.1 15.8 244 276-569 1-246 (251)
274 cd05609 STKc_MAST Catalytic do 100.0 9.1E-30 2E-34 272.3 17.2 249 270-566 1-265 (305)
275 cd06658 STKc_PAK5 Catalytic do 100.0 4.3E-30 9.3E-35 272.9 14.6 197 271-488 23-219 (292)
276 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 2.1E-30 4.6E-35 270.2 11.1 237 276-569 1-254 (258)
277 cd06623 PKc_MAPKK_plant_like C 100.0 1.2E-29 2.7E-34 265.0 16.9 253 270-570 1-255 (264)
278 KOG0199 ACK and related non-re 100.0 1.1E-30 2.3E-35 280.1 8.9 247 273-568 113-365 (1039)
279 cd06608 STKc_myosinIII_like Ca 100.0 9.3E-30 2E-34 267.6 15.9 262 267-570 3-271 (275)
280 cd05578 STKc_Yank1 Catalytic d 100.0 5.4E-30 1.2E-34 267.0 13.8 199 271-490 1-202 (258)
281 cd06653 STKc_MEKK3_like_1 Cata 100.0 1.3E-29 2.8E-34 265.2 16.7 204 270-489 2-211 (264)
282 cd05574 STKc_phototropin_like 100.0 6.5E-30 1.4E-34 275.0 14.7 204 270-489 1-234 (316)
283 cd06626 STKc_MEKK4 Catalytic d 100.0 2E-29 4.3E-34 263.6 18.0 201 271-489 1-208 (264)
284 cd07876 STKc_JNK2 Catalytic do 100.0 1.1E-29 2.3E-34 278.2 16.7 202 269-489 20-224 (359)
285 PHA03390 pk1 serine/threonine- 100.0 2E-29 4.3E-34 264.2 17.8 250 261-568 5-259 (267)
286 cd07844 STKc_PCTAIRE_like Cata 100.0 1.1E-29 2.4E-34 269.8 15.9 200 270-489 5-206 (291)
287 cd08225 STKc_Nek5 Catalytic do 100.0 1.2E-29 2.6E-34 264.1 15.8 250 271-570 1-253 (257)
288 cd05074 PTKc_Tyro3 Catalytic d 100.0 1.9E-29 4.1E-34 265.2 17.4 261 272-571 1-268 (273)
289 KOG0032 Ca2+/calmodulin-depend 100.0 1E-29 2.3E-34 273.6 15.6 200 269-490 34-241 (382)
290 smart00219 TyrKc Tyrosine kina 100.0 1.8E-29 3.9E-34 262.8 16.8 248 272-568 1-254 (258)
291 cd07839 STKc_CDK5 Catalytic do 100.0 6E-30 1.3E-34 270.7 13.5 198 271-488 1-201 (284)
292 cd08528 STKc_Nek10 Catalytic d 100.0 1.9E-29 4.2E-34 264.6 17.1 252 271-570 1-265 (269)
293 cd06659 STKc_PAK6 Catalytic do 100.0 8.1E-30 1.8E-34 271.5 14.5 196 272-488 23-218 (297)
294 cd05580 STKc_PKA Catalytic dom 100.0 1.6E-29 3.6E-34 268.3 16.5 197 270-489 1-200 (290)
295 cd07867 STKc_CDC2L6 Catalytic 100.0 2.1E-29 4.5E-34 271.2 17.5 206 275-490 6-219 (317)
296 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 1.1E-29 2.4E-34 264.7 14.8 189 276-489 1-209 (259)
297 cd07846 STKc_CDKL2_3 Catalytic 100.0 6.2E-30 1.4E-34 270.9 13.1 199 270-488 1-202 (286)
298 cd05046 PTK_CCK4 Pseudokinase 100.0 1.2E-29 2.6E-34 267.1 15.2 259 270-569 5-270 (275)
299 cd05633 STKc_GRK3 Catalytic do 100.0 1.4E-29 3.1E-34 267.1 15.7 192 277-490 1-199 (279)
300 cd05112 PTKc_Itk Catalytic dom 100.0 9.8E-30 2.1E-34 264.7 14.3 249 269-569 3-252 (256)
301 cd07855 STKc_ERK5 Catalytic do 100.0 1.4E-29 3.1E-34 274.5 15.9 284 269-570 4-293 (334)
302 cd06648 STKc_PAK_II Catalytic 100.0 3.1E-29 6.7E-34 265.5 17.9 248 271-569 20-267 (285)
303 cd06917 STKc_NAK1_like Catalyt 100.0 3.9E-29 8.5E-34 263.5 18.1 248 271-570 2-254 (277)
304 cd05083 PTKc_Chk Catalytic dom 100.0 2E-29 4.4E-34 262.1 15.6 242 270-569 6-248 (254)
305 cd07860 STKc_CDK2_3 Catalytic 100.0 1.3E-29 2.7E-34 268.3 14.3 200 271-489 1-203 (284)
306 cd07833 STKc_CDKL Catalytic do 100.0 1.5E-29 3.3E-34 268.1 14.8 201 270-489 1-204 (288)
307 cd06641 STKc_MST3 Catalytic do 100.0 2.5E-29 5.3E-34 265.1 16.1 248 271-571 5-253 (277)
308 KOG0690 Serine/threonine prote 100.0 3.8E-30 8.2E-35 253.4 8.9 201 270-490 168-371 (516)
309 cd07868 STKc_CDK8 Catalytic do 100.0 3.9E-29 8.4E-34 269.1 17.7 206 275-490 6-219 (317)
310 KOG0612 Rho-associated, coiled 100.0 2.1E-30 4.6E-35 292.2 7.9 208 262-488 67-282 (1317)
311 cd06635 STKc_TAO1 Catalytic do 100.0 3.4E-29 7.4E-34 269.4 17.0 248 271-573 26-279 (317)
312 cd06614 STKc_PAK Catalytic dom 100.0 3.8E-29 8.2E-34 265.0 17.1 253 267-569 16-268 (286)
313 cd06607 STKc_TAO Catalytic dom 100.0 4.6E-29 1E-33 267.2 17.9 247 270-571 15-267 (307)
314 cd07841 STKc_CDK7 Catalytic do 100.0 4.2E-29 9E-34 266.3 16.7 198 271-488 1-204 (298)
315 cd06606 STKc_MAPKKK Catalytic 100.0 3.6E-29 7.8E-34 260.3 15.5 203 271-489 1-205 (260)
316 cd07858 STKc_TEY_MAPK_plant Ca 100.0 3.3E-29 7.1E-34 271.9 15.8 205 269-489 4-211 (337)
317 cd05577 STKc_GRK Catalytic dom 100.0 4E-29 8.6E-34 263.5 15.8 193 278-489 1-196 (277)
318 cd07832 STKc_CCRK Catalytic do 100.0 4.6E-29 9.9E-34 264.2 16.3 199 271-488 1-202 (286)
319 cd06616 PKc_MKK4 Catalytic dom 100.0 2.8E-29 6E-34 266.3 14.3 258 270-571 4-267 (288)
320 KOG0618 Serine/threonine phosp 100.0 2.1E-31 4.6E-36 295.0 -2.0 227 549-783 258-487 (1081)
321 KOG0596 Dual specificity; seri 100.0 1.7E-29 3.8E-34 265.5 12.3 253 269-571 360-627 (677)
322 cd06657 STKc_PAK4 Catalytic do 100.0 5.3E-29 1.2E-33 264.5 16.3 245 275-570 25-269 (292)
323 cd05572 STKc_cGK_PKG Catalytic 100.0 5.2E-29 1.1E-33 260.3 15.9 192 278-490 1-195 (262)
324 KOG1024 Receptor-like protein 100.0 4.4E-30 9.6E-35 258.9 7.4 272 262-574 276-554 (563)
325 cd05122 PKc_STE Catalytic doma 100.0 1.3E-28 2.8E-33 255.0 18.7 198 271-488 1-198 (253)
326 cd07852 STKc_MAPK15 Catalytic 100.0 3.4E-29 7.4E-34 271.9 14.9 203 269-489 6-215 (337)
327 cd07842 STKc_CDK8_like Catalyt 100.0 5.5E-29 1.2E-33 267.6 16.2 208 271-490 1-219 (316)
328 cd07843 STKc_CDC2L1 Catalytic 100.0 4.5E-29 9.8E-34 265.4 15.2 202 270-489 5-209 (293)
329 KOG0667 Dual-specificity tyros 100.0 3.6E-29 7.8E-34 271.2 14.1 195 271-488 187-389 (586)
330 cd05606 STKc_beta_ARK Catalyti 100.0 8.5E-29 1.8E-33 261.1 16.7 192 277-490 1-199 (278)
331 cd07835 STKc_CDK1_like Catalyt 100.0 6.9E-29 1.5E-33 262.5 15.9 199 272-489 1-202 (283)
332 cd07840 STKc_CDK9_like Catalyt 100.0 9.3E-29 2E-33 261.8 16.8 201 272-489 1-204 (287)
333 cd08530 STKc_CNK2-like Catalyt 100.0 8.3E-29 1.8E-33 257.5 15.5 252 271-572 1-254 (256)
334 cd07865 STKc_CDK9 Catalytic do 100.0 8.1E-29 1.8E-33 265.5 15.8 207 270-489 12-226 (310)
335 cd07836 STKc_Pho85 Catalytic d 100.0 9.3E-29 2E-33 261.6 15.9 202 271-490 1-204 (284)
336 PHA02882 putative serine/threo 100.0 5.4E-29 1.2E-33 264.8 14.1 261 269-569 11-290 (294)
337 KOG0200 Fibroblast/platelet-de 100.0 4E-29 8.7E-34 288.3 14.1 271 264-574 290-578 (609)
338 KOG0586 Serine/threonine prote 100.0 3.1E-29 6.6E-34 268.7 12.1 203 267-490 53-258 (596)
339 cd07837 STKc_CdkB_plant Cataly 100.0 9.4E-29 2E-33 263.1 15.6 209 270-489 1-214 (295)
340 cd07879 STKc_p38delta_MAPK13 C 100.0 1.4E-28 3E-33 267.5 17.1 208 261-489 2-217 (342)
341 cd05611 STKc_Rim15_like Cataly 100.0 1.5E-28 3.3E-33 256.5 16.7 238 276-566 2-243 (260)
342 cd08215 STKc_Nek Catalytic dom 100.0 2.2E-28 4.7E-33 254.4 17.7 252 271-570 1-254 (258)
343 cd07845 STKc_CDK10 Catalytic d 100.0 1.5E-28 3.3E-33 263.4 16.2 203 269-489 6-211 (309)
344 cd06618 PKc_MKK7 Catalytic dom 100.0 1.1E-28 2.4E-33 262.8 14.9 253 269-571 14-273 (296)
345 cd07831 STKc_MOK Catalytic dom 100.0 2E-28 4.3E-33 258.8 16.7 272 272-570 1-278 (282)
346 KOG4645 MAPKKK (MAP kinase kin 100.0 2.3E-30 5.1E-35 295.5 1.9 203 270-490 1235-1444(1509)
347 cd07834 STKc_MAPK Catalytic do 100.0 1.6E-28 3.5E-33 265.8 16.1 205 271-489 1-209 (330)
348 KOG0607 MAP kinase-interacting 100.0 4.5E-29 9.9E-34 245.5 10.5 207 261-490 74-294 (463)
349 KOG4717 Serine/threonine prote 100.0 5.8E-29 1.3E-33 258.1 11.6 201 270-490 18-222 (864)
350 cd07850 STKc_JNK Catalytic dom 100.0 1.2E-28 2.6E-33 269.3 14.8 202 269-489 15-219 (353)
351 cd07838 STKc_CDK4_6_like Catal 100.0 3E-28 6.6E-33 257.9 17.5 203 272-489 1-208 (287)
352 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 1.7E-28 3.7E-33 265.0 15.5 202 264-489 4-208 (328)
353 cd05579 STKc_MAST_like Catalyt 100.0 2.2E-28 4.7E-33 255.6 15.4 193 278-488 1-202 (265)
354 cd05118 STKc_CMGC Catalytic do 100.0 3.2E-28 6.9E-33 257.2 16.5 275 272-570 1-279 (283)
355 cd05581 STKc_PDK1 Catalytic do 100.0 1.7E-28 3.8E-33 258.7 14.4 202 270-489 1-224 (280)
356 cd07864 STKc_CDK12 Catalytic d 100.0 3.9E-28 8.4E-33 259.3 17.2 210 266-489 3-220 (302)
357 cd07877 STKc_p38alpha_MAPK14 C 100.0 3.3E-28 7.2E-33 264.8 16.8 209 261-489 8-220 (345)
358 cd06634 STKc_TAO2 Catalytic do 100.0 1.7E-28 3.7E-33 262.9 14.2 248 270-572 15-268 (308)
359 PLN00009 cyclin-dependent kina 100.0 2.6E-28 5.6E-33 259.7 15.5 201 270-489 2-206 (294)
360 cd06627 STKc_Cdc7_like Catalyt 100.0 4.3E-28 9.3E-33 251.8 16.8 198 271-488 1-200 (254)
361 cd05613 STKc_MSK1_N N-terminal 100.0 4.1E-28 9E-33 257.6 16.8 199 271-488 1-209 (290)
362 KOG0579 Ste20-like serine/thre 100.0 1.5E-29 3.4E-34 267.7 5.4 199 271-488 33-236 (1187)
363 cd07857 STKc_MPK1 Catalytic do 100.0 3.5E-28 7.6E-33 263.3 16.0 204 271-489 1-212 (332)
364 cd08226 PK_STRAD_beta Pseudoki 100.0 3.3E-28 7.3E-33 263.0 15.5 199 276-490 4-213 (328)
365 cd07830 STKc_MAK_like Catalyti 100.0 4.3E-28 9.4E-33 256.3 16.0 198 272-489 1-201 (283)
366 cd08216 PK_STRAD Pseudokinase 100.0 4.3E-28 9.3E-33 260.5 16.2 192 282-489 12-212 (314)
367 cd06633 STKc_TAO3 Catalytic do 100.0 9.1E-28 2E-32 257.8 18.6 193 272-488 23-221 (313)
368 cd07854 STKc_MAPK4_6 Catalytic 100.0 3.7E-28 8E-33 264.2 14.6 205 270-489 5-221 (342)
369 KOG0984 Mitogen-activated prot 100.0 9.5E-29 2.1E-33 229.5 8.4 221 265-502 41-267 (282)
370 PTZ00024 cyclin-dependent prot 100.0 6.9E-28 1.5E-32 261.4 16.2 201 270-489 8-236 (335)
371 KOG0666 Cyclin C-dependent kin 100.0 6.7E-29 1.5E-33 243.7 7.0 207 270-489 24-242 (438)
372 cd05583 STKc_MSK_N N-terminal 100.0 6.2E-28 1.3E-32 255.9 14.8 199 271-488 1-209 (288)
373 KOG4236 Serine/threonine prote 99.9 9.9E-29 2.1E-33 257.0 7.5 194 275-488 569-767 (888)
374 cd07866 STKc_BUR1 Catalytic do 99.9 6.5E-28 1.4E-32 258.7 14.0 208 269-489 7-229 (311)
375 PHA03210 serine/threonine kina 99.9 4.8E-28 1E-32 275.3 13.1 204 269-487 147-368 (501)
376 cd07851 STKc_p38 Catalytic dom 99.9 7.3E-28 1.6E-32 261.9 14.0 202 268-489 13-218 (343)
377 cd08222 STKc_Nek11 Catalytic d 99.9 1.4E-27 3E-32 249.1 14.9 250 272-570 2-256 (260)
378 cd07829 STKc_CDK_like Catalyti 99.9 1.6E-27 3.5E-32 251.7 15.5 198 272-489 1-201 (282)
379 cd07880 STKc_p38gamma_MAPK12 C 99.9 2.1E-27 4.6E-32 258.2 16.8 203 267-489 12-218 (343)
380 cd05123 STKc_AGC Catalytic dom 99.9 2.7E-27 5.8E-32 245.3 15.9 192 278-489 1-195 (250)
381 KOG0983 Mitogen-activated prot 99.9 2.3E-28 5E-33 235.9 7.2 250 272-570 94-348 (391)
382 KOG0604 MAP kinase-activated p 99.9 3.4E-28 7.4E-33 237.8 8.3 203 268-490 59-266 (400)
383 KOG1006 Mitogen-activated prot 99.9 1.7E-29 3.7E-34 243.0 -1.6 253 274-568 68-324 (361)
384 KOG0618 Serine/threonine phosp 99.9 2E-30 4.4E-35 287.3 -9.2 224 555-786 241-466 (1081)
385 KOG0662 Cyclin-dependent kinas 99.9 2E-27 4.3E-32 215.6 10.0 198 271-488 3-204 (292)
386 KOG0587 Traf2- and Nck-interac 99.9 2.9E-27 6.4E-32 261.3 13.1 270 259-572 8-283 (953)
387 KOG1035 eIF-2alpha kinase GCN2 99.9 7.6E-28 1.6E-32 274.0 8.3 259 267-568 476-868 (1351)
388 cd05610 STKc_MASTL Catalytic d 99.9 4.8E-27 1E-31 275.3 15.4 146 270-433 4-152 (669)
389 KOG0696 Serine/threonine prote 99.9 6.6E-28 1.4E-32 244.3 7.0 203 267-489 346-552 (683)
390 KOG0603 Ribosomal protein S6 k 99.9 2E-27 4.3E-32 256.3 10.0 243 269-573 321-565 (612)
391 cd05576 STKc_RPK118_like Catal 99.9 9E-27 2E-31 239.5 14.4 180 281-488 4-183 (237)
392 KOG1151 Tousled-like protein k 99.9 2.3E-27 5E-32 242.2 9.4 204 271-489 464-686 (775)
393 KOG1027 Serine/threonine prote 99.9 1.1E-27 2.4E-32 263.5 5.6 269 272-592 511-788 (903)
394 KOG0608 Warts/lats-like serine 99.9 6.1E-27 1.3E-31 248.6 8.9 213 270-500 629-886 (1034)
395 KOG1152 Signal transduction se 99.9 9E-27 2E-31 245.7 8.7 197 270-488 561-770 (772)
396 PLN03224 probable serine/threo 99.9 1.7E-25 3.8E-30 249.0 18.5 217 268-488 143-434 (507)
397 PLN03225 Serine/threonine-prot 99.9 7.3E-26 1.6E-30 258.8 15.6 213 268-488 130-380 (566)
398 KOG0614 cGMP-dependent protein 99.9 4E-27 8.6E-32 244.7 3.6 200 270-490 420-622 (732)
399 smart00220 S_TKc Serine/Threon 99.9 1.2E-25 2.5E-30 231.2 13.9 238 282-569 1-239 (244)
400 KOG0669 Cyclin T-dependent kin 99.9 2.6E-27 5.7E-32 226.0 1.4 207 270-489 17-231 (376)
401 KOG0668 Casein kinase II, alph 99.9 2.6E-26 5.6E-31 216.3 7.8 207 268-502 36-245 (338)
402 KOG0695 Serine/threonine prote 99.9 7.2E-26 1.6E-30 223.9 11.2 212 270-501 250-467 (593)
403 smart00221 STYKc Protein kinas 99.9 6.4E-25 1.4E-29 223.2 16.8 199 272-489 1-202 (225)
404 KOG0664 Nemo-like MAPK-related 99.9 1.9E-26 4.2E-31 222.2 0.7 203 271-488 54-259 (449)
405 KOG0671 LAMMER dual specificit 99.9 3.4E-25 7.4E-30 224.5 7.1 199 269-490 88-312 (415)
406 KOG1345 Serine/threonine kinas 99.9 1.4E-24 2.9E-29 209.8 6.7 209 270-502 24-240 (378)
407 KOG0576 Mitogen-activated prot 99.9 2.9E-24 6.3E-29 230.6 3.3 199 269-487 14-215 (829)
408 KOG4237 Extracellular matrix p 99.9 1.7E-24 3.8E-29 219.5 -0.8 198 575-782 270-498 (498)
409 cd00180 PKc Catalytic domain o 99.9 4.8E-22 1E-26 199.2 16.3 184 278-480 1-187 (215)
410 KOG0665 Jun-N-terminal kinase 99.9 5.1E-23 1.1E-27 204.0 6.6 210 271-504 18-230 (369)
411 KOG1290 Serine/threonine prote 99.9 3.7E-22 8.1E-27 207.7 11.6 136 270-418 78-221 (590)
412 KOG1167 Serine/threonine prote 99.9 2.8E-22 6E-27 206.4 10.1 210 269-501 35-292 (418)
413 PLN03210 Resistant to P. syrin 99.9 8.6E-21 1.9E-25 235.1 24.3 172 579-759 725-904 (1153)
414 PRK15387 E3 ubiquitin-protein 99.9 3.9E-21 8.4E-26 221.3 16.1 123 580-719 343-465 (788)
415 PRK09188 serine/threonine prot 99.9 3.1E-21 6.8E-26 206.2 13.9 176 268-471 16-210 (365)
416 PRK15387 E3 ubiquitin-protein 99.9 6.5E-21 1.4E-25 219.5 17.5 140 583-743 326-465 (788)
417 PLN03210 Resistant to P. syrin 99.9 3.8E-20 8.3E-25 229.4 24.3 131 599-735 774-905 (1153)
418 KOG0670 U4/U6-associated splic 99.8 6.1E-22 1.3E-26 206.8 4.7 200 269-489 431-637 (752)
419 KOG4237 Extracellular matrix p 99.8 1E-22 2.2E-27 206.7 -3.9 230 556-786 68-360 (498)
420 PLN00181 protein SPA1-RELATED; 99.8 7.7E-21 1.7E-25 228.7 7.9 153 323-488 28-216 (793)
421 KOG0617 Ras suppressor protein 99.8 3.8E-22 8.3E-27 180.2 -4.2 164 601-771 31-195 (264)
422 smart00750 KIND kinase non-cat 99.8 3.2E-20 7E-25 181.4 8.1 165 357-571 1-165 (176)
423 KOG1164 Casein kinase (serine/ 99.8 4E-19 8.6E-24 190.8 13.7 202 271-489 19-239 (322)
424 KOG0617 Ras suppressor protein 99.8 5.2E-21 1.1E-25 172.9 -3.8 183 572-761 26-212 (264)
425 KOG1163 Casein kinase (serine/ 99.8 3.5E-19 7.7E-24 169.8 6.7 202 269-490 14-224 (341)
426 KOG1165 Casein kinase (serine/ 99.8 1.2E-18 2.5E-23 173.7 10.4 200 270-489 28-238 (449)
427 KOG0195 Integrin-linked kinase 99.8 1.5E-19 3.2E-24 174.8 2.4 243 277-573 197-444 (448)
428 PRK10359 lipopolysaccharide co 99.8 8.3E-19 1.8E-23 174.2 7.5 174 269-480 30-215 (232)
429 cd05147 RIO1_euk RIO kinase fa 99.7 3.9E-18 8.4E-23 167.8 10.2 142 275-438 2-170 (190)
430 COG0515 SPS1 Serine/threonine 99.7 1.5E-17 3.3E-22 178.8 15.4 200 272-489 2-213 (384)
431 cd05145 RIO1_like RIO kinase f 99.7 3.3E-17 7.2E-22 161.8 12.2 142 275-438 2-170 (190)
432 PRK15370 E3 ubiquitin-protein 99.7 3.4E-17 7.4E-22 190.2 13.3 202 556-785 179-380 (754)
433 PRK15370 E3 ubiquitin-protein 99.7 1.4E-17 3E-22 193.5 8.8 206 556-785 200-428 (754)
434 PRK12274 serine/threonine prot 99.7 7E-17 1.5E-21 156.8 11.5 190 272-492 4-212 (218)
435 PRK10345 hypothetical protein; 99.7 3.3E-16 7.2E-21 155.4 11.9 142 272-434 4-159 (210)
436 cd00116 LRR_RI Leucine-rich re 99.7 3.1E-18 6.8E-23 184.3 -2.9 230 557-786 25-292 (319)
437 KOG0590 Checkpoint kinase and 99.7 4E-17 8.6E-22 186.3 4.2 202 273-493 321-531 (601)
438 KOG1166 Mitotic checkpoint ser 99.6 2E-16 4.2E-21 183.7 8.8 202 263-486 691-902 (974)
439 cd00116 LRR_RI Leucine-rich re 99.6 1.5E-17 3.2E-22 179.1 -1.6 235 549-784 45-319 (319)
440 KOG1023 Natriuretic peptide re 99.6 3.6E-16 7.7E-21 170.1 9.0 216 321-576 1-225 (484)
441 smart00090 RIO RIO-like kinase 99.6 3.8E-15 8.2E-20 151.7 11.1 146 271-438 29-201 (237)
442 cd05144 RIO2_C RIO kinase fami 99.6 6.9E-15 1.5E-19 146.5 12.1 149 262-439 7-179 (198)
443 KOG0603 Ribosomal protein S6 k 99.6 3.5E-16 7.7E-21 169.7 2.4 187 277-489 1-193 (612)
444 KOG1240 Protein kinase contain 99.6 7E-16 1.5E-20 175.2 4.8 197 271-488 24-240 (1431)
445 KOG0532 Leucine-rich repeat (L 99.6 1.1E-16 2.4E-21 170.0 -2.4 184 577-771 73-256 (722)
446 PF14531 Kinase-like: Kinase-l 99.6 2.5E-15 5.4E-20 153.9 7.0 206 273-490 15-253 (288)
447 PRK09605 bifunctional UGMP fam 99.6 1.6E-14 3.5E-19 165.8 13.2 147 260-435 323-477 (535)
448 PRK14879 serine/threonine prot 99.6 1.6E-14 3.5E-19 145.5 11.2 135 276-435 2-144 (211)
449 KOG0532 Leucine-rich repeat (L 99.5 2.6E-16 5.6E-21 167.3 -4.1 194 583-787 54-249 (722)
450 TIGR03724 arch_bud32 Kae1-asso 99.5 4.2E-14 9.2E-19 141.1 10.3 131 277-435 1-139 (199)
451 KOG4158 BRPK/PTEN-induced prot 99.5 5.4E-14 1.2E-18 143.6 9.3 150 325-489 274-459 (598)
452 COG4886 Leucine-rich repeat (L 99.5 2.5E-14 5.4E-19 158.7 6.5 196 583-788 97-293 (394)
453 KOG1033 eIF-2alpha kinase PEK/ 99.5 2E-14 4.4E-19 153.3 3.1 130 346-488 330-464 (516)
454 PLN03150 hypothetical protein; 99.5 2.3E-13 5.1E-18 157.9 11.6 111 71-194 420-532 (623)
455 KOG0606 Microtubule-associated 99.4 5.8E-14 1.3E-18 159.8 5.6 167 269-490 82-261 (1205)
456 cd05119 RIO RIO kinase family, 99.4 5.9E-13 1.3E-17 131.4 9.9 138 275-437 2-166 (187)
457 cd05120 APH_ChoK_like Aminogly 99.4 1.4E-12 3E-17 123.4 11.6 136 274-435 2-139 (155)
458 COG4886 Leucine-rich repeat (L 99.4 1.2E-13 2.5E-18 153.4 4.7 186 574-768 111-297 (394)
459 PRK01723 3-deoxy-D-manno-octul 99.4 5.7E-12 1.2E-16 128.7 12.7 141 275-436 36-193 (239)
460 KOG0590 Checkpoint kinase and 99.3 2.9E-13 6.2E-18 154.8 3.1 218 270-503 20-246 (601)
461 PLN03150 hypothetical protein; 99.3 3.4E-12 7.4E-17 148.2 8.8 107 22-128 419-526 (623)
462 KOG1259 Nischarin, modulator o 99.3 4.3E-13 9.2E-18 132.3 -0.1 132 649-787 282-414 (490)
463 PF14580 LRR_9: Leucine-rich r 99.3 2.9E-12 6.4E-17 122.3 4.0 137 610-754 4-146 (175)
464 PF14580 LRR_9: Leucine-rich r 99.3 3.9E-12 8.5E-17 121.4 4.8 121 604-729 20-146 (175)
465 KOG0531 Protein phosphatase 1, 99.2 2E-12 4.4E-17 143.7 -0.4 197 574-784 90-289 (414)
466 KOG1259 Nischarin, modulator o 99.2 2.4E-12 5.3E-17 127.0 -1.0 131 625-763 282-414 (490)
467 KOG3207 Beta-tubulin folding c 99.1 4E-12 8.7E-17 132.0 -1.1 186 574-762 141-340 (505)
468 KOG1266 Protein kinase [Signal 99.1 4.9E-11 1.1E-15 119.7 6.5 161 319-486 119-281 (458)
469 TIGR01982 UbiB 2-polyprenylphe 99.1 1.2E-10 2.6E-15 129.4 10.2 144 275-438 122-310 (437)
470 KOG0531 Protein phosphatase 1, 99.1 3.8E-12 8.3E-17 141.5 -3.0 197 577-786 70-269 (414)
471 KOG1909 Ran GTPase-activating 99.1 1.5E-11 3.1E-16 124.8 -1.5 244 541-784 16-310 (382)
472 KOG3207 Beta-tubulin folding c 99.0 2.2E-11 4.7E-16 126.7 -1.1 209 576-787 118-341 (505)
473 cd05151 ChoK Choline Kinase (C 99.0 9E-10 2E-14 106.6 10.0 131 275-434 3-136 (170)
474 PRK04750 ubiB putative ubiquin 99.0 1.5E-09 3.2E-14 122.0 9.2 148 270-438 120-317 (537)
475 KOG1243 Protein kinase [Genera 99.0 3.6E-09 7.9E-14 116.7 11.8 170 288-483 30-199 (690)
476 KOG1909 Ran GTPase-activating 98.9 5.8E-11 1.3E-15 120.4 -2.4 217 569-786 20-284 (382)
477 PF13855 LRR_8: Leucine rich r 98.9 8.3E-10 1.8E-14 86.7 3.8 57 677-733 3-59 (61)
478 KOG0601 Cyclin-dependent kinas 98.9 1.8E-09 4E-14 118.1 7.4 199 271-488 115-328 (524)
479 PF13855 LRR_8: Leucine rich r 98.9 1.2E-09 2.5E-14 85.9 4.0 59 652-710 2-60 (61)
480 cd05146 RIO3_euk RIO kinase fa 98.9 1.7E-08 3.8E-13 98.4 11.4 141 275-439 2-178 (197)
481 KOG1859 Leucine-rich repeat pr 98.8 8.3E-11 1.8E-15 128.9 -9.1 206 544-761 76-292 (1096)
482 KOG0601 Cyclin-dependent kinas 98.8 4.2E-09 9.2E-14 115.3 3.9 208 257-486 251-465 (524)
483 KOG4579 Leucine-rich repeat (L 98.7 2E-10 4.3E-15 101.1 -5.6 137 628-770 28-168 (177)
484 COG3642 Mn2+-dependent serine/ 98.7 5E-08 1.1E-12 91.8 9.4 130 276-435 2-141 (204)
485 KOG1859 Leucine-rich repeat pr 98.7 1.4E-10 3E-15 127.2 -9.8 197 577-786 85-293 (1096)
486 cd05154 ACAD10_11_like Acyl-Co 98.7 1.6E-07 3.5E-12 95.1 12.3 146 275-434 3-206 (223)
487 KOG3087 Serine/threonine prote 98.7 9.8E-08 2.1E-12 89.2 9.1 144 274-435 11-166 (229)
488 KOG3741 Poly(A) ribonuclease s 98.6 2.4E-07 5.3E-12 99.2 12.5 181 283-486 289-475 (655)
489 KOG0606 Microtubule-associated 98.5 7.7E-08 1.7E-12 110.9 3.2 206 267-490 801-1038(1205)
490 PF01163 RIO1: RIO1 family; I 98.5 8.7E-07 1.9E-11 86.3 9.9 128 285-438 1-159 (188)
491 PRK15123 lipopolysaccharide co 98.5 2.1E-06 4.5E-11 88.8 13.2 146 276-434 28-194 (268)
492 KOG4579 Leucine-rich repeat (L 98.4 3.7E-09 8.1E-14 93.2 -6.0 105 580-688 28-136 (177)
493 KOG2982 Uncharacterized conser 98.4 4.6E-08 9.9E-13 97.3 0.0 63 700-762 200-263 (418)
494 KOG4658 Apoptotic ATPase [Sign 98.4 1.3E-07 2.8E-12 112.7 3.6 109 552-661 542-652 (889)
495 KOG4658 Apoptotic ATPase [Sign 98.3 3.2E-07 6.9E-12 109.4 2.0 129 577-706 543-675 (889)
496 COG5238 RNA1 Ran GTPase-activa 98.2 2.9E-07 6.3E-12 90.5 0.7 185 600-785 89-316 (388)
497 COG4248 Uncharacterized protei 98.2 1.8E-05 3.8E-10 83.1 13.0 202 273-490 14-225 (637)
498 KOG2982 Uncharacterized conser 98.2 4.4E-07 9.4E-12 90.5 0.9 202 578-786 44-263 (418)
499 KOG1644 U2-associated snRNP A' 98.1 6.1E-06 1.3E-10 78.3 6.3 102 629-732 44-149 (233)
500 PF13306 LRR_5: Leucine rich r 98.0 1.3E-05 2.7E-10 73.5 7.6 105 622-731 7-111 (129)
No 1
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=1.3e-61 Score=597.17 Aligned_cols=520 Identities=28% Similarity=0.434 Sum_probs=391.7
Q ss_pred EEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcC
Q 041249 2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQF 81 (789)
Q Consensus 2 l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 81 (789)
|+|++|+++|.+|+.+..++.|+.|++++|.+++.+|..+..+++|+.|+|++|++.+.+|..+ .+++|+.|+|++|++
T Consensus 409 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l 487 (968)
T PLN00113 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQF 487 (968)
T ss_pred EECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCcc
Confidence 4555566655566666666666666666666666666555566666666666666666666544 346788888888888
Q ss_pred CCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCc-----------cceeecCCcccCCCchhhh
Q 041249 82 RGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQG-----------LTILDLSRNKLSGEIPEFL 150 (789)
Q Consensus 82 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~-----------l~~l~ls~N~l~~~~p~~~ 150 (789)
++.+|..|..+++|++|+|++|++++.+|..+..+++|++|+|++|++.+ |+.|||++|+++|.+|..+
T Consensus 488 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 567 (968)
T PLN00113 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567 (968)
T ss_pred CCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhH
Confidence 88888889999999999999999999999999999999999999998753 8899999999999999999
Q ss_pred cCcccccEEecccCCCCCCCCCcccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHHHH
Q 041249 151 VGLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLA 230 (789)
Q Consensus 151 ~~~~~l~~l~ls~N~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~v~ 230 (789)
..+++|+.|++++|++++.+|..+.+.......+.||+.+|++.+....+.|..... ... +.+++++++++++++
T Consensus 568 ~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~---~~~--~~~~~~~~~~~~~~~ 642 (968)
T PLN00113 568 GNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK---TPS--WWFYITCTLGAFLVL 642 (968)
T ss_pred hcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc---cce--eeeehhHHHHHHHHH
Confidence 999999999999999999999988888888889999999998776555566643211 111 222333333333333
Q ss_pred HHHHHHHHHHHHhcccCCCC---Cc-------cc-cccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEE
Q 041249 231 LTLSISFLCWVRKRKEQSNP---NS-------LI-NSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVT 299 (789)
Q Consensus 231 ~~~~~~~~~~~~~~k~~~~~---~~-------~~-~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~va 299 (789)
+++++++++++++++.+... .. +. .....+++.++. ..|...+.||+|+||.||+|++..+++.||
T Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~va 719 (968)
T PLN00113 643 ALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFV 719 (968)
T ss_pred HHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEE
Confidence 33333333444332211110 00 00 112234555544 457788999999999999999988899999
Q ss_pred EEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCC
Q 041249 300 VKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL 379 (789)
Q Consensus 300 vK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l 379 (789)
||.++.... ....|++.+++++||||++++|+|.... ..++||||+++|+|.++++ .+
T Consensus 720 vK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~-----~~~lv~Ey~~~g~L~~~l~-------------~l 777 (968)
T PLN00113 720 VKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEK-----GAYLIHEYIEGKNLSEVLR-------------NL 777 (968)
T ss_pred EEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCC-----CCEEEEeCCCCCcHHHHHh-------------cC
Confidence 999864332 2235688999999999999999997765 7899999999999999983 36
Q ss_pred CHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccC
Q 041249 380 NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYG 459 (789)
Q Consensus 380 ~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 459 (789)
+|.++..|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+...... ....++..|+|||+.
T Consensus 778 ~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~ 850 (968)
T PLN00113 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETR 850 (968)
T ss_pred CHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccc
Confidence 899999999999999999998777789999999999999999988875 5554433211 123578999999999
Q ss_pred CCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc-hhhhccCCcccChhhHHHhhhhhhhhhhhc
Q 041249 460 LGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH-VMDIVDSTLLNDVEDLAIISNQRQRQIRVN 538 (789)
Q Consensus 460 ~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 538 (789)
....++.|+|||||||++|||+||+.||+..+......+.|++...... ..+.+|+.+.....
T Consensus 851 ~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 914 (968)
T PLN00113 851 ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS---------------- 914 (968)
T ss_pred cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC----------------
Confidence 9999999999999999999999999999876667778889988776544 55567776643211
Q ss_pred hhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249 539 NIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI 575 (789)
Q Consensus 539 ~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l 575 (789)
...++..++.+++..|++.+|.+||++.++...+..+
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 1224556778999999999999999999886655443
No 2
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-49 Score=426.94 Aligned_cols=284 Identities=36% Similarity=0.599 Sum_probs=245.6
Q ss_pred ccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeee
Q 041249 256 SLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTA 335 (789)
Q Consensus 256 ~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 335 (789)
....|++.|+..||++|+..+.||+|+||+||+|... +++.||||++........++|..|++++++++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 5678999999999999999999999999999999998 459999998865543314569999999999999999999999
Q ss_pred eccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCc
Q 041249 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN 415 (789)
Q Consensus 336 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~N 415 (789)
|.+.. ..+++|||||++|+|.++++.. ... .++|.+|++||.++|+||+|||+.+.++||||||||+|
T Consensus 140 C~e~~----~~~~LVYEym~nGsL~d~L~~~-------~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 140 CLEGG----EHRLLVYEYMPNGSLEDHLHGK-------KGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred EecCC----ceEEEEEEccCCCCHHHHhCCC-------CCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 98765 1489999999999999999865 111 78999999999999999999999999999999999999
Q ss_pred eecCCCCceeeCcccccccCCC-CCCccceeee-cccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccc-c
Q 041249 416 ILLDEEMVSHVGDFGLARFLPP-THVQTSSIGV-KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMF-E 492 (789)
Q Consensus 416 ill~~~~~~kl~Dfgla~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~-~ 492 (789)
||+|+++++||+|||+|+..+. ... .... .||.+|+|||+...+..++|+|||||||+|.|++||+.|.+... .
T Consensus 208 ILLD~~~~aKlsDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~ 284 (361)
T KOG1187|consen 208 ILLDEDFNAKLSDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR 284 (361)
T ss_pred eeECCCCCEEccCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence 9999999999999999977765 221 1112 79999999999999999999999999999999999999998654 4
Q ss_pred CCccHHHHHHHhCCCc-hhhhccCCcc-cChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 493 GDMNLHNFARMALPDH-VMDIVDSTLL-NDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 493 ~~~~~~~~~~~~~~~~-~~~~~d~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
+...++.|++..+.+. +.+++|+.+. +.+. ..++..++..++..|.+.++..||.|.++..
T Consensus 285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~-----------------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 285 GELSLVEWAKPLLEEGKLREIVDPRLKEGEYP-----------------DEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred ccccHHHHHHHHHHCcchhheeCCCccCCCCC-----------------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 5567999998888875 9999999987 3321 1146677899999999999999999998754
Q ss_pred cc
Q 041249 571 IL 572 (789)
Q Consensus 571 ~l 572 (789)
.+
T Consensus 348 ~L 349 (361)
T KOG1187|consen 348 EL 349 (361)
T ss_pred HH
Confidence 44
No 3
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=3.3e-48 Score=478.21 Aligned_cols=455 Identities=31% Similarity=0.481 Sum_probs=322.8
Q ss_pred CEEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249 1 ILALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ 80 (789)
Q Consensus 1 ~l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 80 (789)
+|||++|+++|.+|. +.+++|++|+|++|.+++.+|..++.+++|++|+|++|.+++.+|..++++++|++|+|++|+
T Consensus 122 ~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 199 (968)
T PLN00113 122 YLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199 (968)
T ss_pred EEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCC
Confidence 489999999999996 468999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCC-----------ccceeecCCcccCCCchhh
Q 041249 81 FRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQ-----------GLTILDLSRNKLSGEIPEF 149 (789)
Q Consensus 81 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~-----------~l~~l~ls~N~l~~~~p~~ 149 (789)
+++.+|..++.+++|++|+|++|++++.+|..++++++|++|++++|++. .|+.|++++|++++.+|..
T Consensus 200 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 279 (968)
T PLN00113 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279 (968)
T ss_pred CcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchh
Confidence 99999999999999999999999999999999999999999999999764 3899999999999999999
Q ss_pred hcCcccccEEecccCCCCCCCCCc-ccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHH
Q 041249 150 LVGLKVIENLNLSYNDLEGMVPTE-GVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMG 228 (789)
Q Consensus 150 ~~~~~~l~~l~ls~N~~~~~~~~~-~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~ 228 (789)
+..+++|+.|++++|.+++.+|.. ...+.+..+.+.+|..... .+.
T Consensus 280 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~-~~~-------------------------------- 326 (968)
T PLN00113 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK-IPV-------------------------------- 326 (968)
T ss_pred HhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCc-CCh--------------------------------
Confidence 999999999999999999887764 3345555555555532100 000
Q ss_pred HHHHHHHHHHHHHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc
Q 041249 229 LALTLSISFLCWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH 308 (789)
Q Consensus 229 v~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~ 308 (789)
T Consensus 327 -------------------------------------------------------------------------------- 326 (968)
T PLN00113 327 -------------------------------------------------------------------------------- 326 (968)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHH
Q 041249 309 RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIA 388 (789)
Q Consensus 309 ~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~ 388 (789)
.+..+ +++..+ .. ..+
T Consensus 327 --------~~~~l-----~~L~~L-~L----------------------------~~n---------------------- 342 (968)
T PLN00113 327 --------ALTSL-----PRLQVL-QL----------------------------WSN---------------------- 342 (968)
T ss_pred --------hHhcC-----CCCCEE-EC----------------------------cCC----------------------
Confidence 00000 000000 00 000
Q ss_pred HHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccc
Q 041249 389 IDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNG 468 (789)
Q Consensus 389 ~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~ 468 (789)
. +
T Consensus 343 -------------~---l-------------------------------------------------------------- 344 (968)
T PLN00113 343 -------------K---F-------------------------------------------------------------- 344 (968)
T ss_pred -------------C---C--------------------------------------------------------------
Confidence 0 0
Q ss_pred cchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHH
Q 041249 469 DVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISML 548 (789)
Q Consensus 469 DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 548 (789)
+|..|
T Consensus 345 -------------~~~~p-------------------------------------------------------------- 349 (968)
T PLN00113 345 -------------SGEIP-------------------------------------------------------------- 349 (968)
T ss_pred -------------cCcCC--------------------------------------------------------------
Confidence 00000
Q ss_pred hhccccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCC
Q 041249 549 RIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSN 628 (789)
Q Consensus 549 ~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~ 628 (789)
.....+.+++.+++..+.+....+..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++.+|..|..+++
T Consensus 350 ~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~ 429 (968)
T PLN00113 350 KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429 (968)
T ss_pred hHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCC
Confidence 00001123344444555555455555566666666666666666666666666666666666666666666666666666
Q ss_pred CcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccC
Q 041249 629 LIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGV 708 (789)
Q Consensus 629 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 708 (789)
|+.|++++|++++.+|..+..+++|+.|+|++|++.+..|..+ ..++|+.|+|++|++++..|..|.++++|+.|+|++
T Consensus 430 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 508 (968)
T PLN00113 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE 508 (968)
T ss_pred CCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcC
Confidence 6666666666666666666666666666666666666666544 346666666666666666666666666666666666
Q ss_pred ccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccC
Q 041249 709 NRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEV 788 (789)
Q Consensus 709 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 788 (789)
|++++.+|..+..+++|+.|+|++|.+++.+|..+. .+++|+.|+|++|++++.+|..+..+++|+.|++++|+++|.+
T Consensus 509 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~ 587 (968)
T PLN00113 509 NKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS-EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587 (968)
T ss_pred CcceeeCChHHcCccCCCEEECCCCcccccCChhHh-CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeC
Confidence 666666666666666666666666666666666554 6666666666666666666666666666666666666666665
Q ss_pred C
Q 041249 789 P 789 (789)
Q Consensus 789 P 789 (789)
|
T Consensus 588 p 588 (968)
T PLN00113 588 P 588 (968)
T ss_pred C
Confidence 5
No 4
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-41 Score=359.83 Aligned_cols=258 Identities=31% Similarity=0.424 Sum_probs=205.0
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceE-EEEEEeccccchh--hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTT-VTVKVFNLHHHRA--SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
..+++...+.||.|+||+||+|.|+ |+. ||||.+....... .+.|.+|+.++.+++|||||+++|+|.....
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~--- 113 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG--- 113 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---
Confidence 3344555667999999999999998 555 9999997653322 5689999999999999999999999976531
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-c
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-V 423 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~ 423 (789)
..++|||||++|+|.++++.. ....+++..++.|+.|||+||.|||+.+. ||||||||+|||++.++ +
T Consensus 114 -~~~iVtEy~~~GsL~~~l~~~--------~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~ 182 (362)
T KOG0192|consen 114 -SLCIVTEYMPGGSLSVLLHKK--------RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKT 182 (362)
T ss_pred -ceEEEEEeCCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCE
Confidence 479999999999999999753 34789999999999999999999998864 99999999999999998 9
Q ss_pred eeeCcccccccCCCCCCccceeeecccccccCcccCC--CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249 424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL--GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~ 501 (789)
+||+|||+++...... ...+...||..|||||.+. ..+|+.|+|||||||++|||+||+.||..... .+.+
T Consensus 183 ~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~ 255 (362)
T KOG0192|consen 183 LKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVA 255 (362)
T ss_pred EEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHH
Confidence 9999999999876543 2233467999999999999 56899999999999999999999999984322 1111
Q ss_pred HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249 502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH 574 (789)
Q Consensus 502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~ 574 (789)
... .....+ ......|...+..++..||+.++..||+..+....+..
T Consensus 256 ~~v--------~~~~~R------------------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~ 302 (362)
T KOG0192|consen 256 SAV--------VVGGLR------------------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES 302 (362)
T ss_pred HHH--------HhcCCC------------------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence 110 000011 00111366677788889999999999999887554443
No 5
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=8.6e-41 Score=340.42 Aligned_cols=200 Identities=31% Similarity=0.518 Sum_probs=182.4
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
-.+|...+.||+|.|++||+|.++.++..||||.+... .....+-+..|+.+++.++|||||++++.+...+ .
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~-----~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD-----F 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-----e
Confidence 36888888999999999999999999999999999766 4555677899999999999999999999998877 9
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-----
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE----- 421 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~----- 421 (789)
.|+|||||.+|+|.+|++.. +.+++.+...++.|+|.||++||+.+ ||||||||+|||++..
T Consensus 84 i~lVMEyC~gGDLs~yi~~~----------~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~ 150 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRR----------GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDT 150 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCC
Confidence 99999999999999999765 57899999999999999999999998 9999999999999865
Q ss_pred -CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 422 -MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 422 -~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
-.+||+|||+|+.+.+.. .....+|++.|||||++...+|+.|+|+||.|+++||+++|+.||+.
T Consensus 151 ~~~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 151 SPVLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CceEEecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 467999999999998665 23346799999999999999999999999999999999999999983
No 6
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-39 Score=328.54 Aligned_cols=255 Identities=23% Similarity=0.276 Sum_probs=208.8
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
+......||+|..|+||++.++.+++-+|+|++... .....+++.+|++++++.+||+||++||.|.... . ...+
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~---~-~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG---E-EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC---c-eEEe
Confidence 445678999999999999999999999999999655 4455789999999999999999999999998654 1 4899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeCc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||.+|+|+.++... +++++...-+|+.+|++||.|||+ .+ ||||||||+|||++..+++||+|
T Consensus 156 ~mEYMDgGSLd~~~k~~----------g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRV----------GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred ehhhcCCCCHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecc
Confidence 99999999999999644 668999999999999999999996 66 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
||.++.+-... .....||..|||||-+.+..|+.++||||||++++|+.+|+-|+....+...+..+.......+.
T Consensus 223 FGVS~~lvnS~----a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 223 FGVSGILVNSI----ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP 298 (364)
T ss_pred ccccHHhhhhh----cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence 99999876652 34467999999999999999999999999999999999999999754222223322222111110
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.|.+.. ..|..++...+..|.+.++-.|++..+...++
T Consensus 299 -----pP~lP~---------------------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 299 -----PPRLPE---------------------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred -----CCCCCc---------------------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 111110 03666777889999999999999998765543
No 7
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-39 Score=344.00 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=203.7
Q ss_pred CCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
...+.||+|-||+||.|.|+ +...||+|.++... -....|.+|+++|.+|+|+|||+++|+|...+ ..+||||
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVtE 281 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVTE 281 (468)
T ss_pred HHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEEE
Confidence 34578999999999999998 55699999997653 23467889999999999999999999998765 7899999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA 432 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 432 (789)
||+.|+|.++++.. .+..+...+.+.++.|||+||+||++++ +|||||.++|||++++..+||+|||+|
T Consensus 282 ~m~~GsLl~yLr~~--------~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTR--------EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred ecccCcHHHHhhhc--------CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccc
Confidence 99999999999753 4678899999999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhh
Q 041249 433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMD 511 (789)
Q Consensus 433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (789)
+...++.. .......-...|+|||.+..++++.|||||||||+||||+| |+.|+.. +...+.++
T Consensus 351 r~~~d~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-----msn~ev~~--------- 415 (468)
T KOG0197|consen 351 RLIGDDEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-----MSNEEVLE--------- 415 (468)
T ss_pred cccCCCce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-----CCHHHHHH---------
Confidence 95444432 12222223457999999999999999999999999999999 9999862 22222222
Q ss_pred hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 512 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.++...+ ......|+..+.+++..||+.++-+||+.......+
T Consensus 416 ~le~GyR------------------lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l 458 (468)
T KOG0197|consen 416 LLERGYR------------------LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVL 458 (468)
T ss_pred HHhccCc------------------CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHH
Confidence 2222222 223346888999999999999999999998654433
No 8
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=2.1e-39 Score=359.44 Aligned_cols=269 Identities=24% Similarity=0.354 Sum_probs=220.2
Q ss_pred hcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 342 (789)
..+....+.||+|.||+||+|... .....||||.++..... .+.+|++|+++++.++|||||+++|.|.+.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~-- 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD-- 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC--
Confidence 446667789999999999999974 23567999999988766 6889999999999999999999999999877
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCC----CCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKA----PRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill 418 (789)
..++|+|||..|||.+||...+-....... +..++..+.+.||.|||.||+||-++. +|||||-.+|+|+
T Consensus 563 ---P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV 636 (774)
T KOG1026|consen 563 ---PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV 636 (774)
T ss_pred ---eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence 899999999999999999865433332222 334999999999999999999999887 9999999999999
Q ss_pred CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL 497 (789)
Q Consensus 419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~ 497 (789)
+++..+||+|||+++..-..+.........-..+|||||.+..+++|++||||||||||||+++ |+.|++....+ ..
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--EV 714 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--EV 714 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--HH
Confidence 9999999999999998766654433323344579999999999999999999999999999998 99999854322 11
Q ss_pred HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccccC
Q 041249 498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGN 577 (789)
Q Consensus 498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~~ 577 (789)
++.++ +..+ .....+|+.++.+++..||+..+.+||+.+++...+..+..
T Consensus 715 Ie~i~-----------~g~l-------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 IECIR-----------AGQL-------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHH-----------cCCc-------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 22211 1111 12234799999999999999999999999998777665544
No 9
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-38 Score=319.69 Aligned_cols=201 Identities=29% Similarity=0.373 Sum_probs=183.4
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
..++|...++||+|+||+||.++-+++++.+|+|+++.. .....+...+|..++.+++||.||+++..|+...
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~---- 98 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE---- 98 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC----
Confidence 457999999999999999999999999999999999654 3345678999999999999999999999999877
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..++|+||+.+|.|..++.+. ..+++..+.-++.+|+.||.|||+.+ ||||||||+|||+|++|++
T Consensus 99 -kLylVld~~~GGeLf~hL~~e----------g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi 164 (357)
T KOG0598|consen 99 -KLYLVLDYLNGGELFYHLQRE----------GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHI 164 (357)
T ss_pred -eEEEEEeccCCccHHHHHHhc----------CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcE
Confidence 899999999999999999765 67899999999999999999999998 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
+|+|||+++..-.... .+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||.
T Consensus 165 ~LtDFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred EEeccccchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 9999999996544432 2334789999999999999999999999999999999999999998
No 10
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.6e-39 Score=311.88 Aligned_cols=254 Identities=23% Similarity=0.301 Sum_probs=204.0
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
.+|.+.++||.|.||+||+++...+|..||.|.+... .....+.+.+|+.+++.++|||||++++.....+ ..-.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~---~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED---NEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc---chhh
Confidence 3577788999999999999999999999999998744 4445678999999999999999999998533222 2237
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCC-CCceecCCCCCceecCCCCceee
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQ-PITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.+||||+..|+|...++..+ ...+.+++.++.+++.|++.||.++|+..+ ..|+||||||.||++++.+.+||
T Consensus 96 nivmE~c~~GDLsqmIk~~K------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFK------KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred HHHHHhhcccCHHHHHHHHH------hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 89999999999999997652 345789999999999999999999998432 24999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
+|||+++++...... .....||+-||+||.+....|+.|+||||+||++|||+.-++||.. .++.+..+..-.
T Consensus 170 GDfGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-----~n~~~L~~KI~q 242 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-----DNLLSLCKKIEQ 242 (375)
T ss_pred ccchhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-----ccHHHHHHHHHc
Confidence 999999998766532 3346799999999999999999999999999999999999999973 255555443322
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESL 565 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~ 565 (789)
-....+.| .-....+.+++..|..+++-.||+.
T Consensus 243 gd~~~~p~--------------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 243 GDYPPLPD--------------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCCCCcH--------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 11111111 1233455577788888999999874
No 11
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.5e-37 Score=331.95 Aligned_cols=200 Identities=28% Similarity=0.397 Sum_probs=182.9
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
..|...++||+|||+.+|.++..++|+.||+|++... +....+...+||++.+.++|||||+++++|.+.. +
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~-----n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN-----N 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-----c
Confidence 4688999999999999999999889999999999653 4455677899999999999999999999998877 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.|+|.|+|.+|+|.++++.+ +.+++.++..+..||+.||.|||+.+ |+|||||-.|+|+++++++||
T Consensus 93 VYivLELC~~~sL~el~Krr----------k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKI 159 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRR----------KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKI 159 (592)
T ss_pred eEEEEEecCCccHHHHHHhc----------CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEe
Confidence 99999999999999999744 78999999999999999999999998 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||+|.....++.. ....+||+.|+|||++.....+..+||||+|||||-|++|++||+.
T Consensus 160 gDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 160 GDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred cccceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 999999998765432 3347899999999999988899999999999999999999999973
No 12
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2e-37 Score=315.03 Aligned_cols=254 Identities=20% Similarity=0.223 Sum_probs=200.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 342 (789)
+-|-..+.+|+|+||.|-+|..+.+++.||||+++..... ......+|+++|++++|||||++.+++...+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d-- 249 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD-- 249 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC--
Confidence 4566789999999999999999999999999999644211 2234579999999999999999999998877
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE- 421 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~- 421 (789)
..||||||+.+|+|.+++-.. +.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+
T Consensus 250 ---s~YmVlE~v~GGeLfd~vv~n----------k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~ 313 (475)
T KOG0615|consen 250 ---SSYMVLEYVEGGELFDKVVAN----------KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDA 313 (475)
T ss_pred ---ceEEEEEEecCccHHHHHHhc----------cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCC
Confidence 679999999999999999665 44555566889999999999999999 9999999999999766
Q ss_pred --CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC--c-CccccchhhHHHHHHHHHhcCCCCccccCCcc
Q 041249 422 --MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--V-STNGDVYSYGILMLELIIRKKPSDIMFEGDMN 496 (789)
Q Consensus 422 --~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~ 496 (789)
..+||+|||+|+...... .+...+||+.|.|||++.+.. + ..|+||||+|||||-+++|..||.+......-
T Consensus 314 e~~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl 390 (475)
T KOG0615|consen 314 EDCLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL 390 (475)
T ss_pred cceEEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence 788999999999987443 344578999999999998754 3 34889999999999999999999865443222
Q ss_pred HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
..+..+..++.. .. ...+-..+..+++.+...++|-.|++..++..++
T Consensus 391 ~eQI~~G~y~f~------------p~----------------~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 391 KEQILKGRYAFG------------PL----------------QWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred HHHHhcCccccc------------Ch----------------hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 233322222211 00 0112234556788889999999999999886544
No 13
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=8.9e-38 Score=327.90 Aligned_cols=205 Identities=24% Similarity=0.420 Sum_probs=183.5
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 342 (789)
+...||..++.||+|+|++|++|+...+++++|||++... +....+....|-.+|.+| .||.|++++..|++..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-- 147 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-- 147 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--
Confidence 3457899999999999999999999999999999998543 334456677888999999 8999999999999877
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM 422 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~ 422 (789)
..|+|+||+++|+|.+++++. ..|++.....++++|+.||+|||+.| ||||||||+|||+|.++
T Consensus 148 ---sLYFvLe~A~nGdll~~i~K~----------Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 148 ---SLYFVLEYAPNGDLLDLIKKY----------GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDG 211 (604)
T ss_pred ---ceEEEEEecCCCcHHHHHHHh----------CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCC
Confidence 899999999999999999865 67899999999999999999999999 99999999999999999
Q ss_pred ceeeCcccccccCCCCCCc---------cce--eeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 423 VSHVGDFGLARFLPPTHVQ---------TSS--IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++||+|||.|+.+++.... ... ....||..|.+||++.++..++.+|||+|||++|+|+.|++||.+
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 9999999999998765421 111 347799999999999999999999999999999999999999964
No 14
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-38 Score=333.94 Aligned_cols=205 Identities=19% Similarity=0.203 Sum_probs=187.5
Q ss_pred ccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCc
Q 041249 575 IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIE 654 (789)
Q Consensus 575 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 654 (789)
|..|++|+.|.|..|.|+..-.+.|..+.++++|+|+.|+++..-.+.+.+++.|+.|+||+|.|..+.++.+...++|+
T Consensus 241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~ 320 (873)
T KOG4194|consen 241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK 320 (873)
T ss_pred hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence 55788889999999999988888999999999999999999988888899999999999999999988899999899999
Q ss_pred EEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCC---ccccCCCCccEEEcc
Q 041249 655 VLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVP---SSIFNISSIAEFDVG 731 (789)
Q Consensus 655 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls 731 (789)
+|+|++|+|+...+++|..+..|++|+|++|+|+.....+|..+++|++|||++|.|+..+. ..|.+|++|+.|+|.
T Consensus 321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~ 400 (873)
T KOG4194|consen 321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLT 400 (873)
T ss_pred eEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeec
Confidence 99999999998889999999999999999999998888899999999999999999986553 568889999999999
Q ss_pred CCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccC
Q 041249 732 ENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALN 781 (789)
Q Consensus 732 ~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 781 (789)
+|+|. .||...|.++++|++|||.+|.|..+-|.+|..+ .|++|.+..
T Consensus 401 gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 401 GNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred Cceee-ecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 99998 9999999999999999999999998999999999 888888754
No 15
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-37 Score=328.42 Aligned_cols=262 Identities=27% Similarity=0.373 Sum_probs=208.4
Q ss_pred ccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeec
Q 041249 260 LSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACS 337 (789)
Q Consensus 260 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 337 (789)
.+..++++-.+.+...+.||+|.||+||+|.|. -.||||+++... .+..+.|+.|++++++-+|.||+-++|+|.
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 344666667777788899999999999999997 469999997663 445688999999999999999999999998
Q ss_pred cCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417 (789)
Q Consensus 338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil 417 (789)
... .+||..||++-+|..+++-. ...|+..+.++||.|||+||.|||.++ |||||||+.|||
T Consensus 459 ~p~------~AIiTqwCeGsSLY~hlHv~---------etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIF 520 (678)
T KOG0193|consen 459 NPP------LAIITQWCEGSSLYTHLHVQ---------ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIF 520 (678)
T ss_pred CCc------eeeeehhccCchhhhhccch---------hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceE
Confidence 654 49999999999999999854 367889999999999999999999998 999999999999
Q ss_pred cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCccccCC
Q 041249 418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494 (789)
Q Consensus 418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~ 494 (789)
+.+++++||+|||++....--..........|..-|||||++.. .+|++.+||||||+|+|||++|.-||.....+.
T Consensus 521 l~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq 600 (678)
T KOG0193|consen 521 LHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ 600 (678)
T ss_pred EccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence 99999999999999986553332222333458889999998764 569999999999999999999999997332210
Q ss_pred ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.+.. ..++ ..-|.+ ......|..+|.++...|+..++.+||.......
T Consensus 601 -----Iifm-VGrG---~l~pd~-------------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 601 -----IIFM-VGRG---YLMPDL-------------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -----eEEE-eccc---ccCccc-------------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 0000 0000 000000 1122368889999999999999999999887643
No 16
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-37 Score=324.13 Aligned_cols=216 Identities=18% Similarity=0.157 Sum_probs=201.0
Q ss_pred cccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCC
Q 041249 572 LPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLS 651 (789)
Q Consensus 572 l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 651 (789)
...|++|++|+.|+|..|+|.-+---.|.+|++|+.|.|..|.|+..-.++|..|.++++|+|+.|+++..-.+++.+++
T Consensus 214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt 293 (873)
T KOG4194|consen 214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT 293 (873)
T ss_pred HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence 34577899999999999999944456799999999999999999988899999999999999999999988899999999
Q ss_pred CCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEcc
Q 041249 652 KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVG 731 (789)
Q Consensus 652 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 731 (789)
+|+.|+|++|.|..+.++++.-+++|++|+|+.|+|+...+++|..|..|++|+|++|+|+.....+|..+++|++|||+
T Consensus 294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 99999999999999999999999999999999999998888999999999999999999998888999999999999999
Q ss_pred CCcccccCCcc--cccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCccc
Q 041249 732 ENKIQGNIPLD--YGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE 787 (789)
Q Consensus 732 ~N~l~~~ip~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 787 (789)
+|.|+..|.+. .|.+|+.|+.|+|.+|+|..+...+|.++..|+.|||.+|.|-..
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSI 431 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASI 431 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceee
Confidence 99999877653 667899999999999999988889999999999999999988653
No 17
>KOG0472 consensus Leucine-rich repeat protein [Function unknown]
Probab=100.00 E-value=4.6e-39 Score=324.75 Aligned_cols=178 Identities=30% Similarity=0.478 Sum_probs=123.1
Q ss_pred EcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCC
Q 041249 3 ALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFR 82 (789)
Q Consensus 3 ~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 82 (789)
|+++|++. .+|++++.+-.+..|+..+|+++ +.|+.+..+.+|..+++.+|.++ .+|+..-.++.|++||..+|.|+
T Consensus 120 ~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~ 196 (565)
T KOG0472|consen 120 DCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE 196 (565)
T ss_pred hcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh
Confidence 34444444 44444444444444444444444 44444444445555555555554 33333334666777777777775
Q ss_pred CCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCC-----------ccceeecCCcccCCCchhhhc
Q 041249 83 GSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQ-----------GLTILDLSRNKLSGEIPEFLV 151 (789)
Q Consensus 83 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~-----------~l~~l~ls~N~l~~~~p~~~~ 151 (789)
.+|++++.+.+|+.|+|.+|+|. .+| +|.+|+.|++|+++.|++. ++.+|||.+|+++ ++|+.++
T Consensus 197 -tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c 272 (565)
T KOG0472|consen 197 -TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC 272 (565)
T ss_pred -cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHH
Confidence 78888888888888888888887 677 6888888888888888663 3778999999999 7999999
Q ss_pred CcccccEEecccCCCCCCCCCcccccCCccccccCCC
Q 041249 152 GLKVIENLNLSYNDLEGMVPTEGVFKNASAISVLGNN 188 (789)
Q Consensus 152 ~~~~l~~l~ls~N~~~~~~~~~~~~~~~~~~~~~~n~ 188 (789)
-+++|++||+|+|.|++.+++.|.. .+..+.+.|||
T Consensus 273 lLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP 308 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP 308 (565)
T ss_pred HhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence 9999999999999999998887655 55555666664
No 18
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-35 Score=290.11 Aligned_cols=198 Identities=25% Similarity=0.339 Sum_probs=181.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.+|.|+||.|..++.+.++..+|+|+++... ....+...+|..+++.+.||.++++++.|.+.. .
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-----~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-----N 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-----e
Confidence 57888999999999999999999999999999997553 333456788999999999999999999998877 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||.++|-|..++++. +++++.....+|+||+.|++|||+.+ |++||+||+|||+|.+|++||
T Consensus 119 lymvmeyv~GGElFS~Lrk~----------~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKS----------GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred EEEEEeccCCccHHHHHHhc----------CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEE
Confidence 99999999999999999765 68999999999999999999999998 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
+|||.|+..... +-..+||+.|+|||.+....|...+|.|||||++|||+.|.+||.+.
T Consensus 186 tDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 186 TDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred EeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 999999987654 34578999999999999999999999999999999999999999843
No 19
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1e-35 Score=315.53 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=208.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
..|+....||+|..|.||.|....+++.||||++....+...+-..+|+.+|+..+|+|||.++..+...+ ..|.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-----eLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-----ELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-----eeEE
Confidence 46778889999999999999999999999999999988888888999999999999999999999988776 8999
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|||||++|+|.+.+... .+++.++..|+.++++||+|||.++ |+|||||++|||++.++.+||+||
T Consensus 348 VMEym~ggsLTDvVt~~-----------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-----------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred EEeecCCCchhhhhhcc-----------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeee
Confidence 99999999999998654 5899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 509 (789)
|++..+..... ......||+.|||||+.....|++|+||||+|++++||+-|++||-. +. .+..... ...++.
T Consensus 414 GFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E~-PlrAlyL-Ia~ng~ 486 (550)
T KOG0578|consen 414 GFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---EN-PLRALYL-IATNGT 486 (550)
T ss_pred eeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---CC-hHHHHHH-HhhcCC
Confidence 99998876653 23346799999999999999999999999999999999999999862 11 1111111 111111
Q ss_pred hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.++-.+ ..-...+.+...+|.+.+...|++..+...++
T Consensus 487 P~lk~~-------------------------~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 487 PKLKNP-------------------------EKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred CCcCCc-------------------------cccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 111111 11123444667789999999999998775543
No 20
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-36 Score=318.64 Aligned_cols=244 Identities=21% Similarity=0.323 Sum_probs=197.8
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
.....+-+|.|+.|.||.|+++ ++.||||.++.- -+.+|..|++|+|+||+.+.|+|.... -.|||
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsP-----cyCIi 190 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSP-----CYCII 190 (904)
T ss_pred HhhhhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCc-----eeEEe
Confidence 3445678999999999999997 889999987533 245788999999999999999998766 78999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 430 (789)
||||..|-|.+.++.. +.++......|..+||.||.|||.+. |||||||+-||||+.+..+||+|||
T Consensus 191 MEfCa~GqL~~VLka~----------~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAG----------RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred eeccccccHHHHHhcc----------CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEecccc
Confidence 9999999999999754 67888899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchh
Q 041249 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVM 510 (789)
Q Consensus 431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 510 (789)
-++...+.. ....+.||..|||||++.+.++++|+||||||||||||+||..||.+.... . ..|.-+
T Consensus 258 TS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----A---IIwGVG-- 324 (904)
T KOG4721|consen 258 TSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----A---IIWGVG-- 324 (904)
T ss_pred chHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----e---eEEecc--
Confidence 999887653 234578999999999999999999999999999999999999999732111 0 011100
Q ss_pred hhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249 511 DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI 575 (789)
Q Consensus 511 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l 575 (789)
.- .+-.-...+|..-+.=++-.|++..+-+||+...+..+++.+
T Consensus 325 ---sN------------------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 325 ---SN------------------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ---CC------------------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 00 000112234555555667789999999999998876655433
No 21
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.1e-36 Score=308.62 Aligned_cols=259 Identities=27% Similarity=0.369 Sum_probs=200.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
.++...+.||+|.||.||.+....+|...|||..........+.+.+|+.+|++++|||||+++|...... ....++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~---~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE---NDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc---CeeeEe
Confidence 46777899999999999999999889999999997764444677999999999999999999999744332 125889
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCceeeCc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSHVGD 428 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~D 428 (789)
.|||+++|+|.+++... .+ .+++..+..+..||++||+|||+++ |||+||||+|||++. ++.+||+|
T Consensus 94 ~mEy~~~GsL~~~~~~~--------g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRY--------GG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred eeeccCCCcHHHHHHHc--------CC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEecc
Confidence 99999999999999765 33 7999999999999999999999998 999999999999999 79999999
Q ss_pred ccccccCCCCC-CccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 429 FGLARFLPPTH-VQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 429 fgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
||.++...... .........||+.|||||+...+. ...++|||||||++.||+||+.||....+.. ....+....
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~---~~~~~ig~~ 238 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA---EALLLIGRE 238 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH---HHHHHHhcc
Confidence 99998776411 122233577999999999998654 4469999999999999999999998531111 111111111
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
...+.+.+. ......+....|...++..||+..+...++-
T Consensus 239 ~~~P~ip~~---------------------------ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 239 DSLPEIPDS---------------------------LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCCCCcc---------------------------cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111111111 1122336677899999999999988755543
No 22
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7e-36 Score=343.34 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=207.7
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCc-----eEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGR-----TTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 342 (789)
.++-...+.||+|.||+||+|++..-. ..||||.++.. +.+...+|.+|..+|++++|||||+++|+|....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~-- 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG-- 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC--
Confidence 345556789999999999999996443 34999998655 4566789999999999999999999999998755
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM 422 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~ 422 (789)
..++++|||.+|+|..|+++.+... .....++....+.++.|||+|+.||+++. +|||||.++|+|+++..
T Consensus 769 ---~~~i~leyM~gGDL~sflr~~r~~~---~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r 839 (1025)
T KOG1095|consen 769 ---PPLILLEYMEGGDLLSFLRESRPAP---FQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERR 839 (1025)
T ss_pred ---CcEEEehhcccCcHHHHHHhccccc---CCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccC
Confidence 7899999999999999998763222 23677899999999999999999999887 99999999999999999
Q ss_pred ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHH
Q 041249 423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFA 501 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 501 (789)
.+||+|||+|+.+.............-...|||||.+.++.++.|+|||||||++||++| |..||..... ...+..+.
T Consensus 840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-~~v~~~~~ 918 (1025)
T KOG1095|consen 840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-FEVLLDVL 918 (1025)
T ss_pred cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-HHHHHHHH
Confidence 999999999995544432211111123358999999999999999999999999999999 9999863211 00111111
Q ss_pred HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
+. + |......|...+.+++..||+.++-+||+........
T Consensus 919 ~g--------------------------g-----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~ 958 (1025)
T KOG1095|consen 919 EG--------------------------G-----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQD 958 (1025)
T ss_pred hC--------------------------C-----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhh
Confidence 10 0 2334557889999999999999999999998775533
No 23
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=5e-37 Score=332.94 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=212.5
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCc---eEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGR---TTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
....++++||.|.||+||.|.++-.+ ..||||.++... ....++|..|+.+|.++.||||+++-|+.....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~----- 703 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK----- 703 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-----
Confidence 45567899999999999999997554 569999998664 445678999999999999999999999987655
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..+||.|||++|+|+.||+.+ + ..+++.+..-++++||.||.||-+++ +|||||.++|||++.+..+|
T Consensus 704 PvMIiTEyMENGsLDsFLR~~--------D-GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCK 771 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN--------D-GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCK 771 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc--------C-CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEE
Confidence 789999999999999999765 3 45999999999999999999999998 99999999999999999999
Q ss_pred eCcccccccCCCCC-CccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249 426 VGDFGLARFLPPTH-VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 426 l~Dfgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 503 (789)
++|||+++.+.++. ....+.+-.-..+|.|||.+.-.++|..+|||||||||||.++ |+.||.+... .+
T Consensus 772 VsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----Qd---- 842 (996)
T KOG0196|consen 772 VSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QD---- 842 (996)
T ss_pred eccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----HH----
Confidence 99999999886665 2223333344578999999999999999999999999999886 9999874321 11
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIG 576 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~ 576 (789)
+...+...+ |....+.|...+.+++..||+.+.-.||........++.+.
T Consensus 843 -----VIkaIe~gy------------------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 843 -----VIKAIEQGY------------------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred -----HHHHHHhcc------------------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 111111111 12345689999999999999999999999988876665443
No 24
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=8.3e-36 Score=291.43 Aligned_cols=273 Identities=21% Similarity=0.265 Sum_probs=203.2
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.|....++|+|+||.||+++.+++|+.||||.+... .....+...+||++++.++|+|+|.++.+|.... ..+
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-----klh 77 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-----KLH 77 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc-----eeE
Confidence 466677899999999999999999999999999644 3344677899999999999999999999986543 889
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+...-|.++= ..+..++.....+++.|+++|+.|+|.++ ++||||||+|||++..+.+||+|
T Consensus 78 LVFE~~dhTvL~eLe----------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCD 144 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELE----------RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCD 144 (396)
T ss_pred EEeeecchHHHHHHH----------hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEecc
Confidence 999999986555543 23466889999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH--HHhC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA--RMAL 505 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~--~~~~ 505 (789)
||.|+.+..... ..+....|..|+|||.+.+ -+|+..+||||.||++.||++|.+-|. +..++.+.. +..+
T Consensus 145 FGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P----G~SDiDQLy~I~ktL 218 (396)
T KOG0593|consen 145 FGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP----GRSDIDQLYLIRKTL 218 (396)
T ss_pred chhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC----CcchHHHHHHHHHHH
Confidence 999999884332 2233457899999999988 579999999999999999999998875 334444443 3332
Q ss_pred CC---chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 506 PD---HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 506 ~~---~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.+ ....+.........-. +..+......-.....-...+++++-.|.+.+|.+|.++.....
T Consensus 219 G~L~prhq~iF~~N~~F~Gv~---lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 219 GNLIPRHQSIFSSNPFFHGVR---LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cccCHHHHHHhccCCceeeee---cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 1111111110000000 00000000001112233457788999999999999999987644
No 25
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.8e-35 Score=306.72 Aligned_cols=204 Identities=28% Similarity=0.388 Sum_probs=180.2
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
.+.|...+.||+|+||.||+|+...+++.||+|.++.+. ........+||.+|+++.||||+++.+...+.. ...
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---SGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---Cce
Confidence 356777889999999999999999999999999998775 455677899999999999999999999987652 237
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.|+|+|||+. +|.-++.. .+-.|+..++..++.|++.||+|+|+.+ |+|||||.+|||||.++.+||
T Consensus 193 iYlVFeYMdh-DL~GLl~~---------p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSS---------PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred EEEEEecccc-hhhhhhcC---------CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEe
Confidence 8999999997 78877753 3567999999999999999999999999 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||+|+++....... .+...-|..|+|||++.+.. |+...|+||.|||+.||++|++.|..
T Consensus 260 aDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G 322 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG 322 (560)
T ss_pred ccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC
Confidence 9999999988776443 34455799999999999865 99999999999999999999999864
No 26
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=1.3e-34 Score=278.67 Aligned_cols=273 Identities=23% Similarity=0.304 Sum_probs=205.6
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch--hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
+.|...+.+|+|.||.||+|++..+++.||||.++..... ......+||..++.++|+||+.++++|...+ ..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-----~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-----NL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-----ce
Confidence 3577788999999999999999999999999999766333 3567889999999999999999999998876 88
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
.+|+|||+. +|+..++.. ...++...+..++.++.+|++|||.+. |+||||||.|+|++.++.+|++
T Consensus 77 ~lVfEfm~t-dLe~vIkd~---------~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiA 143 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDK---------NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIA 143 (318)
T ss_pred EEEEEeccc-cHHHHhccc---------ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEee
Confidence 999999996 899988654 567899999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC-
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL- 505 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~- 505 (789)
|||+|+.+.+...... ...-|..|+|||.+.+.+ |+..+||||.||++.||+-|.+-|. ++.++.+......
T Consensus 144 DFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~If~~ 217 (318)
T KOG0659|consen 144 DFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKIFRA 217 (318)
T ss_pred cccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHHHHH
Confidence 9999999987764322 225788999999999865 9999999999999999999986654 4556666544331
Q ss_pred -CCchhhh-ccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 506 -PDHVMDI-VDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 506 -~~~~~~~-~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.-...+. -+-.-..++-++...... ........+.....++........|..|-++.+...
T Consensus 218 LGTP~~~~WP~~~~lpdY~~~~~~P~~----~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 218 LGTPTPDQWPEMTSLPDYVKIQQFPKP----PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred cCCCCcccCccccccccHHHHhcCCCC----ccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 1111111 010111111111111000 001122233444567777777777777777776643
No 27
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-34 Score=296.46 Aligned_cols=263 Identities=21% Similarity=0.229 Sum_probs=210.0
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
..++|...+.||.|..++||+|.....+..||||++..++-. ..+.+.+|+..|+.++||||++++..|.... .
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-----~ 98 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-----E 98 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----e
Confidence 457889999999999999999999989999999999877443 3589999999999999999999999998776 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.|+||.||..|++.++++.. .+..+++..+..|.+++++||.|||.+| .||||+|+.||||+.+|.+||
T Consensus 99 LWvVmpfMa~GS~ldIik~~--------~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkL 167 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTY--------YPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKL 167 (516)
T ss_pred eEEeehhhcCCcHHHHHHHH--------ccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEE
Confidence 99999999999999999765 4556999999999999999999999998 999999999999999999999
Q ss_pred CcccccccCCCCCCccce--eeecccccccCcccC-CC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHH
Q 041249 427 GDFGLARFLPPTHVQTSS--IGVKGSIGYIAPEYG-LG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~--~~~~gt~~y~aPE~~-~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~ 502 (789)
+|||.+..+.+....... ....||+.|||||.+ .. ..|+.|+||||||++..||.+|..||..+..- +..-
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----kvLl 242 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----KVLL 242 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----HHHH
Confidence 999998888766532222 345799999999994 33 35999999999999999999999999843221 1111
Q ss_pred HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
..+........ ... +..+........+.+++..|.+-++-.||+.....
T Consensus 243 ~tLqn~pp~~~-t~~-----------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 243 LTLQNDPPTLL-TSG-----------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred HHhcCCCCCcc-ccc-----------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 11111100000 000 01122234455777889999999999999998664
No 28
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=1.3e-34 Score=303.59 Aligned_cols=210 Identities=30% Similarity=0.434 Sum_probs=185.1
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++|...+.||+|.||.||||+-+.+.+.||+|.+..... ...+.+.+|++++++++||||+.++.+|.... +.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~-----~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA-----HL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-----eE
Confidence 467788899999999999999999999999999965533 34577999999999999999999999987665 89
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
|+|.||+.+ +|..++.. +..+++..+..+++|+..||.|||+.. |.|||+||.|||++..+++|++
T Consensus 77 ~vVte~a~g-~L~~il~~----------d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~Klc 142 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQ----------DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLC 142 (808)
T ss_pred EEEehhhhh-hHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeec
Confidence 999999997 99999964 478999999999999999999999988 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 505 (789)
|||+|+.+.... ...+.+.||+-|||||...+..|+..+|.||+||++||+.+|++||.. .++.+.++...
T Consensus 143 dFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~ 213 (808)
T KOG0597|consen 143 DFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSIL 213 (808)
T ss_pred hhhhhhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHh
Confidence 999999887644 234567899999999999999999999999999999999999999972 34455555443
No 29
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.6e-34 Score=308.54 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=201.0
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc----cc-hhhHHHHHHHHHHhcCC-CCccceeeeeeccCCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH----HH-RASRSFIAECRALRSIR-HRNLVKVFTACSGVDY 341 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 341 (789)
....|...+.||+|+||.|+.|....+++.||+|++... .. ...+...+|+.++++++ ||||++++.++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 456899999999999999999999989999999987543 12 23556778999999998 999999999998776
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE 421 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~ 421 (789)
..++||||+.+|+|.+++... .++.+.+...++.|++.|++|+|+.+ |+||||||+||+++.+
T Consensus 94 ----~~~ivmEy~~gGdL~~~i~~~----------g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~ 156 (370)
T KOG0583|consen 94 ----KIYIVMEYCSGGDLFDYIVNK----------GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGN 156 (370)
T ss_pred ----eEEEEEEecCCccHHHHHHHc----------CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCC
Confidence 799999999999999999643 67788999999999999999999998 9999999999999999
Q ss_pred -CceeeCcccccccCC-CCCCccceeeecccccccCcccCCCCC-cC-ccccchhhHHHHHHHHHhcCCCCccccCCccH
Q 041249 422 -MVSHVGDFGLARFLP-PTHVQTSSIGVKGSIGYIAPEYGLGSE-VS-TNGDVYSYGILMLELIIRKKPSDIMFEGDMNL 497 (789)
Q Consensus 422 -~~~kl~Dfgla~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~ 497 (789)
+++||+|||++.... .+. .....+||+.|+|||.+.+.. |+ .++||||+||+||.|++|+.||++ .+.
T Consensus 157 ~~~~Kl~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~ 228 (370)
T KOG0583|consen 157 EGNLKLSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNV 228 (370)
T ss_pred CCCEEEeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccH
Confidence 999999999999884 222 234567999999999999877 85 779999999999999999999984 233
Q ss_pred HHHHHHhCCCc--hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 498 HNFARMALPDH--VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 498 ~~~~~~~~~~~--~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
....+...... +.+.++ ......+..+|...++..|.+...+.
T Consensus 229 ~~l~~ki~~~~~~~p~~~~-----------------------------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 229 PNLYRKIRKGEFKIPSYLL-----------------------------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHHHHhcCCccCCCCcC-----------------------------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 33333321111 111111 23344667788888888888888775
No 30
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=1.6e-34 Score=313.93 Aligned_cols=268 Identities=22% Similarity=0.270 Sum_probs=200.7
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccC
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGV 339 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 339 (789)
.+.++|...+.||+|+||.||+|.+. .+++.||||+++.... .....+.+|++++.++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34678999999999999999999852 3456899999875432 3356789999999999 899999999988643
Q ss_pred CCCCCceEEEEeeccCCCChhhhccCCCCCc-------------------------------------------------
Q 041249 340 DYQGNDFKALVYEFMQNGSLEEWLYPVNRED------------------------------------------------- 370 (789)
Q Consensus 340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------------------------------------------------- 370 (789)
. ...++||||+++|+|.+++.......
T Consensus 84 ~----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 84 N----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred C----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 2 25789999999999999986531100
Q ss_pred ---cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeee
Q 041249 371 ---EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447 (789)
Q Consensus 371 ---~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 447 (789)
........+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..............
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence 00001245888999999999999999999888 999999999999999999999999999876543322222234
Q ss_pred cccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHH
Q 041249 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAI 526 (789)
Q Consensus 448 ~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 526 (789)
.++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+........ .+..
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~--------~~~~--------- 298 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGT--------RMRA--------- 298 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcCC--------CCCC---------
Confidence 46678999999999999999999999999999997 99998742211 11111111000 0000
Q ss_pred hhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 527 ISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
...+...+.+++..|++.++..||+...+...+
T Consensus 299 -------------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l 331 (338)
T cd05102 299 -------------PENATPEIYRIMLACWQGDPKERPTFSALVEIL 331 (338)
T ss_pred -------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 012334567889999999999999998775433
No 31
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.3e-34 Score=275.00 Aligned_cols=203 Identities=23% Similarity=0.353 Sum_probs=182.5
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
-++|..++.||+|-||.||.|+.+.++-.||+|++... .....+++++|+++-+.++||||+++|+++.+..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~----- 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK----- 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-----
Confidence 36899999999999999999999999999999998544 3445688999999999999999999999998877
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..|+++||..+|.+...+... ....+++.....+..|+|.|+.|+|..+ ++||||||+|+|++-++..|
T Consensus 96 riyLilEya~~gel~k~L~~~--------~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEG--------RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred eeEEEEEecCCchHHHHHHhc--------ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCee
Confidence 899999999999999999743 4467888899999999999999999877 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMF 491 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~ 491 (789)
++|||.+-..+... ....+||+-|.|||+..+...+.++|+|++||..||+++|.+||+...
T Consensus 165 iAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 165 IADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred ccCCCceeecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 99999998776333 234679999999999999999999999999999999999999998543
No 32
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=9.7e-35 Score=305.66 Aligned_cols=260 Identities=22% Similarity=0.330 Sum_probs=206.8
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh-hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
...+.++||+|-||+|+.+... ++..||||+++...... ..+|.+|+++|.+++||||++++|+|...+ ..++
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Picm 612 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLCM 612 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chHH
Confidence 4457889999999999999997 57999999998876555 489999999999999999999999998877 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
++|||++|+|.+|+... ....+....-..|+.|||.||+||.+.. +||||+.++|+|++.++++||+||
T Consensus 613 I~EYmEnGDLnqFl~ah--------eapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAH--------ELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred HHHHHhcCcHHHHHHhc--------cCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCc
Confidence 99999999999999765 2223455667789999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH--hcCCCCccccCCccHHHHHHHhCCC
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII--RKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt--G~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
|+++.+-............-..+|||+|.+..+++++++|||+|||++||+++ ...||+...++ ..++-....++.
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~ 759 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRD 759 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCC
Confidence 99997766554332233344579999999999999999999999999999865 88998743222 122222222221
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
. -+..+ .....-|...+.+++..|++.+...||+.......+
T Consensus 760 ~--------~~~~~---------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 760 Q--------GRQVV---------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred C--------Cccee---------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 1 11000 112235778888999999999999999998765443
No 33
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-35 Score=301.94 Aligned_cols=249 Identities=24% Similarity=0.273 Sum_probs=206.6
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.-|+..+.||.|.||.||+|.+..+++.||+|++...... ......+|+.+++.++++||.++||.+.... ..|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cHH
Confidence 4577789999999999999999999999999999877544 4678999999999999999999999987766 899
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
++|||+.+|++.+.+... ..+.+..+.-|.+++..|+.|+|+++ .+|||||+.||++..++.+|++|
T Consensus 88 iiMey~~gGsv~~lL~~~----------~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~D 154 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSG----------NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLAD 154 (467)
T ss_pred HHHHHhcCcchhhhhccC----------CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEe
Confidence 999999999999999654 44577788889999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
||.+..+...... .....||+.|||||++....|+.|+||||+|++.+||++|.+|+.... |.+
T Consensus 155 fgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h--------------Pmr 218 (467)
T KOG0201|consen 155 FGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH--------------PMR 218 (467)
T ss_pred cceeeeeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC--------------cce
Confidence 9999887655432 245679999999999998889999999999999999999999997321 222
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
+.-.+.+.-. +.....+...+.+.+..|.+.+|-+||+......
T Consensus 219 vlflIpk~~P------------------P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 219 VLFLIPKSAP------------------PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred EEEeccCCCC------------------CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1111221111 1112255666778899999999999999986643
No 34
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=7.4e-34 Score=298.96 Aligned_cols=205 Identities=23% Similarity=0.343 Sum_probs=180.4
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
..++|.....||+|+||+||.|+-+.+|+.+|+|+++.. ........+.|-++|....+|.||++|..|++.+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~---- 214 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE---- 214 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC----
Confidence 458999999999999999999999999999999999755 3444567888999999999999999999999888
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..|+||||+++|++..+|... ..|++.....++.+++.|++-+|..| +|||||||+|+|||..|++
T Consensus 215 -~LYLiMEylPGGD~mTLL~~~----------~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 215 -YLYLIMEYLPGGDMMTLLMRK----------DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred -eeEEEEEecCCccHHHHHHhc----------CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCE
Confidence 899999999999999999755 67899999999999999999999998 9999999999999999999
Q ss_pred eeCcccccccCCCCC----------------------Cc-----------------------cceeeecccccccCcccC
Q 041249 425 HVGDFGLARFLPPTH----------------------VQ-----------------------TSSIGVKGSIGYIAPEYG 459 (789)
Q Consensus 425 kl~Dfgla~~~~~~~----------------------~~-----------------------~~~~~~~gt~~y~aPE~~ 459 (789)
||+|||++.-+...+ .. .......||+-|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 999999986432100 00 001123499999999999
Q ss_pred CCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 460 LGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 460 ~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
.+..|+..+|.||+|||||||++|-+||...
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~ 391 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSE 391 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999999999843
No 35
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=1.4e-33 Score=301.72 Aligned_cols=267 Identities=20% Similarity=0.311 Sum_probs=199.2
Q ss_pred cCCCCCCcccccCCccEEEEEEcC----------------CceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCcccee
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDE----------------GRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKV 332 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l 332 (789)
++|...+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999998642 345799999876533 335679999999999999999999
Q ss_pred eeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccc---------cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCC
Q 041249 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEV---------DKAPRNLNLLQRLNIAIDVASALDYLHHDCQ 403 (789)
Q Consensus 333 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~ 403 (789)
++++.... ..++||||+.+|+|.+++......... ......+++.++..++.|++.||+|||+.+
T Consensus 85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 158 (304)
T cd05096 85 LGVCVDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN- 158 (304)
T ss_pred EEEEecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence 99987655 789999999999999998653211110 112345788999999999999999999988
Q ss_pred CCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-
Q 041249 404 PITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII- 482 (789)
Q Consensus 404 ~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt- 482 (789)
|+||||||+||++++++.+||+|||+++...............++..|+|||+...+.++.++||||||+++|||++
T Consensus 159 --ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 --FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred --ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 99999999999999999999999999987654432222223345788999999988899999999999999999987
Q ss_pred -hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEec
Q 041249 483 -RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILD 561 (789)
Q Consensus 483 -G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~ 561 (789)
|..||.... .......+............ ......|...+.+++..|++.++.+
T Consensus 237 ~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 237 CKEQPYGELT--DEQVIENAGEFFRDQGRQVY-----------------------LFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred cCCCCCCcCC--HHHHHHHHHHHhhhcccccc-----------------------ccCCCCCCHHHHHHHHHHccCCchh
Confidence 556765321 11122222111111000000 0011134456778999999999999
Q ss_pred cCcccccc
Q 041249 562 LESLKLAG 569 (789)
Q Consensus 562 l~s~~~~~ 569 (789)
||+...+.
T Consensus 292 RPs~~~i~ 299 (304)
T cd05096 292 RPSFSDIH 299 (304)
T ss_pred CcCHHHHH
Confidence 99998764
No 36
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=6.4e-35 Score=278.13 Aligned_cols=268 Identities=18% Similarity=0.185 Sum_probs=214.2
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
+..+.|.+.+.+|+|||+.||.++.-.+++.+|+|++..+..++.+...+|++..++++|||++++++++.....++...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45678999999999999999999998899999999999888888899999999999999999999999987776667778
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.|++++|...|+|.+.+... ...+..+++.+.+.|+.+|++||++||... ++++||||||.||++.+.+.+++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~------k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERL------KIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred EEEEeehhccccHHHHHHHH------hhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEE
Confidence 99999999999999999655 234567899999999999999999999985 57999999999999999999999
Q ss_pred CcccccccCCCCCC-------ccceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCccccCCcc
Q 041249 427 GDFGLARFLPPTHV-------QTSSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN 496 (789)
Q Consensus 427 ~Dfgla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~ 496 (789)
.|||.+...+-... -..+....-|.+|+|||...- ...++++|||||||++|+|+.|..||+..++.+.+
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 99999886652210 111222347889999998753 45799999999999999999999999854442222
Q ss_pred HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
+.-. +..+.+. +|. .......+.+++.+|.+++|..||+..+...
T Consensus 251 laLA-----------v~n~q~s----------------~P~--~~~yse~l~~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 251 LALA-----------VQNAQIS----------------IPN--SSRYSEALHQLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred EEEe-----------eeccccc----------------cCC--CCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1111 1111110 000 1113456778899999999999999877643
No 37
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-34 Score=297.38 Aligned_cols=274 Identities=23% Similarity=0.240 Sum_probs=208.4
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 347 (789)
+.|...+.||.|+||.||+|+-.+++..||||.++..- .-....-.+|+..+++++ ||||+++..++.+.+ +..
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~L 85 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RIL 85 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ceE
Confidence 46677889999999999999999999999999986553 233445678999999998 999999999987654 379
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++|||||.. +|.++++.+ .+.|++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+
T Consensus 86 ~fVfE~Md~-NLYqLmK~R---------~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKia 152 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDR---------NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIA 152 (538)
T ss_pred eeeHHhhhh-hHHHHHhhc---------CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEec
Confidence 999999997 899999754 578999999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCC-CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh--
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA-- 504 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~-- 504 (789)
|||+||........ +....|..|+|||++. .+.|+.+.||||+|||++|+.+-++-|.. ...+.+..+..
T Consensus 153 DFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG----~sE~Dqi~KIc~V 225 (538)
T KOG0661|consen 153 DFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG----ASEIDQIYKICEV 225 (538)
T ss_pred ccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC----CcHHHHHHHHHHH
Confidence 99999988766533 2345889999999875 56799999999999999999999887753 33344444433
Q ss_pred CCCchhhhccCCcccChhhHHHhhhhhhhhhh----hchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIR----VNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
++....+.++... .+......+.++.. .....++..+.++++..|...++..||+..+...++
T Consensus 226 LGtP~~~~~~eg~-----~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 226 LGTPDKDSWPEGY-----NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hCCCccccchhHH-----HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1111111111100 00000000000000 112334667777888999999999999998876543
No 38
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=1.8e-33 Score=297.79 Aligned_cols=200 Identities=25% Similarity=0.378 Sum_probs=173.6
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
.|...+.||+|+||+||+|....+++.||+|.+.... ......+.+|++++++++|++|+++++++...+ ..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-----~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-----AL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-----eE
Confidence 3677889999999999999999899999999986442 223346788999999999999999999987655 79
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++|+||+.+|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNM--------GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHhh--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEe
Confidence 9999999999999887543 2245889999999999999999999888 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||++........ .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 145 DLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred eCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 9999987643321 2234689999999999999999999999999999999999999974
No 39
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-34 Score=308.98 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=203.8
Q ss_pred HHhhcCCCCCCcccccCCccEEEEEEcCCce---E-EEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeecc
Q 041249 266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRT---T-VTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSG 338 (789)
Q Consensus 266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~---~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 338 (789)
+..-++....+.||+|.||+||+|.+...+. . ||||..+.. ......+|.+|+++|..++|||||++||++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3344555666999999999999999975422 3 899999853 35567889999999999999999999999987
Q ss_pred CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249 339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418 (789)
Q Consensus 339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill 418 (789)
.. ..++|||+|.+|+|.+++... +..++..+++.++.+.|.||+|||..+ ++||||-++|+|+
T Consensus 233 ~~-----Pl~ivmEl~~gGsL~~~L~k~---------~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~ 295 (474)
T KOG0194|consen 233 EE-----PLMLVMELCNGGSLDDYLKKN---------KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLY 295 (474)
T ss_pred CC-----ccEEEEEecCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHhee
Confidence 76 789999999999999999865 236899999999999999999999988 9999999999999
Q ss_pred CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL 497 (789)
Q Consensus 419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~ 497 (789)
+.++.+||+|||+++........ .....-...|+|||++..+.|++++|||||||++||+.+ |..||..... ...
T Consensus 296 ~~~~~vKISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v 371 (474)
T KOG0194|consen 296 SKKGVVKISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEV 371 (474)
T ss_pred cCCCeEEeCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--HHH
Confidence 99999999999998876411110 001124468999999999999999999999999999998 8989873211 122
Q ss_pred HHHH-HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccccc
Q 041249 498 HNFA-RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIG 576 (789)
Q Consensus 498 ~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~ 576 (789)
..++ ...++... .......+..+...|+..++-+|+++..+...+..+.
T Consensus 372 ~~kI~~~~~r~~~------------------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 372 KAKIVKNGYRMPI------------------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred HHHHHhcCccCCC------------------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 2222 11111110 0123445557777999999999999998876665544
No 40
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=1.9e-33 Score=305.39 Aligned_cols=204 Identities=24% Similarity=0.301 Sum_probs=171.7
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
|...+.||+|+||.||+|....+++.||||.+... .......+.+|++++++++||||+++++++...........++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 67788999999999999999989999999998643 2233456889999999999999999999886554333346899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 82 v~e~~~-~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 82 VFELME-SDLHQVIKAN----------DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred EEecCC-CCHHHHHHhc----------ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccC
Confidence 999996 6898888543 45899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCC-ccceeeecccccccCcccCCC--CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 430 GLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 430 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+++....... ........|+..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 99986543321 112234568999999998765 6789999999999999999999999963
No 41
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=1.6e-33 Score=299.21 Aligned_cols=197 Identities=26% Similarity=0.372 Sum_probs=173.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||.||+|....+++.||+|++.... ......+.+|++++++++||||+++++++.+.. .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR-----F 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-----e
Confidence 47888999999999999999999899999999986432 233456889999999999999999998876654 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+|+|.+++... ..+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl 142 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNS----------GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKL 142 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEE
Confidence 89999999999999998643 46888999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||+++...... ....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 143 TDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred EecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999998764322 234589999999999888899999999999999999999999963
No 42
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=4.6e-33 Score=294.17 Aligned_cols=257 Identities=19% Similarity=0.269 Sum_probs=197.7
Q ss_pred cccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh---hHHHHHHHHHHhcCCCCccceee
Q 041249 257 LLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA---SRSFIAECRALRSIRHRNLVKVF 333 (789)
Q Consensus 257 ~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~ 333 (789)
...++..++ +......||+|+++.||+|.+ +++.||||+++...... .+.+.+|++++++++||||++++
T Consensus 12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred ceecCHHHc-----CCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 445555555 233346899999999999998 48999999997553332 46788999999999999999999
Q ss_pred eeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCC
Q 041249 334 TACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLK 412 (789)
Q Consensus 334 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk 412 (789)
|++.+.. .+....++||||+.+|+|.+++... +.+++.....++.|++.||+|||.. + ++|||||
T Consensus 85 g~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlk 150 (283)
T PHA02988 85 GFIIDIV-DDLPRLSLILEYCTRGYLREVLDKE----------KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLT 150 (283)
T ss_pred eeEEecc-cCCCceEEEEEeCCCCcHHHHHhhC----------CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCC
Confidence 9986521 1223679999999999999999643 4688999999999999999999974 5 7899999
Q ss_pred CCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC--CCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 413 PSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 413 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
|+||++++++.+|++|||+++...... ....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 151 p~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 151 SVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred hhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999998764332 12347889999999876 67999999999999999999999999732
Q ss_pred ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
...++........ ..+.+ ...|...+.+++..|++.++..||+...+..
T Consensus 226 -----~~~~~~~~i~~~~----~~~~~----------------------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 226 -----TTKEIYDLIINKN----NSLKL----------------------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -----CHHHHHHHHHhcC----CCCCC----------------------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1122211111000 00000 1134456778889999999999999987743
No 43
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=1.7e-33 Score=309.20 Aligned_cols=264 Identities=21% Similarity=0.324 Sum_probs=199.0
Q ss_pred hcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGVDY 341 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 341 (789)
-++|...+.||+|+||.||+|.+.. +++.||+|+++.... .....+.+|+++++.+ +|+||++++++|....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~- 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG- 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC-
Confidence 3578899999999999999998643 345799999975433 3346688999999999 8999999999987765
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCC----------------------------------------------------
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNRE---------------------------------------------------- 369 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------- 369 (789)
..++||||+.+|+|.+++......
T Consensus 116 ----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 116 ----PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred ----CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 789999999999999988542100
Q ss_pred --------ccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCc
Q 041249 370 --------DEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQ 441 (789)
Q Consensus 370 --------~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 441 (789)
.........+++.++..|+.|++.||+|||+.+ ++||||||+||++++++++||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 001112345889999999999999999999888 999999999999999999999999999876544322
Q ss_pred cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccC
Q 041249 442 TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLND 520 (789)
Q Consensus 442 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 520 (789)
.......++..|+|||++....++.++|||||||++|||++ |+.||.....+. .+........... .+.
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~-----~~~---- 338 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMS-----RPD---- 338 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCcc-----CCC----
Confidence 22222335678999999998899999999999999999997 999997432211 1111111110000 000
Q ss_pred hhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 521 VEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
.....+.+++..|++.++.+||+...+...
T Consensus 339 ---------------------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 339 ---------------------FAPPEIYSIMKMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred ---------------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112346678889999999999999877544
No 44
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=2.2e-33 Score=303.37 Aligned_cols=196 Identities=24% Similarity=0.323 Sum_probs=174.5
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN-----R 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-----E
Confidence 57888999999999999999999899999999986432 233467889999999999999999999987765 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 159 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKA----------GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKV 159 (329)
T ss_pred EEEEEcCCCCChHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEE
Confidence 99999999999999998643 45788889999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
+|||+++...... ....|++.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 160 ~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 160 TDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred eeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence 9999998765432 23468999999999998889999999999999999999999996
No 45
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=4e-33 Score=305.67 Aligned_cols=202 Identities=25% Similarity=0.325 Sum_probs=175.1
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||+||+|....+++.||+|+++... ......+..|++++.+++|++|+++++.+.+.. .
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-----~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-----N 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----e
Confidence 47889999999999999999999889999999996432 223456888999999999999999999987765 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL 142 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKK----------DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKL 142 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEE
Confidence 99999999999999998643 46889999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCc---------------------------------cceeeecccccccCcccCCCCCcCccccchhh
Q 041249 427 GDFGLARFLPPTHVQ---------------------------------TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSY 473 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sf 473 (789)
+|||+++........ .......||..|+|||++.+..++.++|||||
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 999999865422100 00123469999999999998899999999999
Q ss_pred HHHHHHHHHhcCCCCc
Q 041249 474 GILMLELIIRKKPSDI 489 (789)
Q Consensus 474 Gvvl~elltG~~P~~~ 489 (789)
||++|||++|+.||..
T Consensus 223 Gvil~ell~G~~Pf~~ 238 (363)
T cd05628 223 GVIMYEMLIGYPPFCS 238 (363)
T ss_pred HHHHHHHHhCCCCCCC
Confidence 9999999999999963
No 46
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=4.2e-33 Score=300.48 Aligned_cols=194 Identities=24% Similarity=0.284 Sum_probs=169.3
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
+.||+|+||.||++....+++.||+|+++... ......+..|++++++++||||+++++++...+ ..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD-----RLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC-----EEEEEEe
Confidence 46999999999999999899999999987542 233456788999999999999999999987765 8999999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA 432 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 432 (789)
|+.+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a 142 (323)
T cd05571 76 YANGGELFFHLSRE----------RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence 99999999988643 46889999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 143 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred cccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 75432221 12345699999999999998999999999999999999999999963
No 47
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=6e-33 Score=297.78 Aligned_cols=191 Identities=25% Similarity=0.312 Sum_probs=167.7
Q ss_pred ccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
||+|+||.||+|....+++.||+|+++.. .......+..|++++.+++||||+++++++.... ..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-----KLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC-----eEEEEEcCC
Confidence 69999999999999989999999998643 2334566888999999999999999999987655 889999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 76 ~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 76 NGGELFHHLQRE----------GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred CCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 999999998643 45889999999999999999999888 99999999999999999999999999986
Q ss_pred CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 143 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 143 NMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred CccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence 433221 1234568999999999999899999999999999999999999996
No 48
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=4e-33 Score=306.47 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=199.4
Q ss_pred hcCCCCCCcccccCCccEEEEEE-----cCCceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVL-----DEGRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDY 341 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 341 (789)
.++|...+.||+|+||.||+|++ ..++..||||+++... ....+.+.+|++++..+ +||||++++++|...+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~- 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG- 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence 45788899999999999999975 2356789999987543 33456788999999999 8999999999997766
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCcc--------------------------------------------------
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNREDE-------------------------------------------------- 371 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------- 371 (789)
..++||||+++|+|.+++........
T Consensus 113 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 113 ----PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ----cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 78999999999999999865321000
Q ss_pred ---------------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCC
Q 041249 372 ---------------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436 (789)
Q Consensus 372 ---------------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 436 (789)
.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0011235889999999999999999999888 9999999999999999999999999998765
Q ss_pred CCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhccC
Q 041249 437 PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDS 515 (789)
Q Consensus 437 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 515 (789)
............++..|+|||.+....++.++|||||||++|||++ |..||.....+ ..+..++....... .+
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~-----~~ 339 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRML-----SP 339 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccCC-----CC
Confidence 4432222222335667999999999999999999999999999998 88898643211 12222222111100 00
Q ss_pred CcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 516 TLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.....++.+++..|++.++-.||++..+..
T Consensus 340 -------------------------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 340 -------------------------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred -------------------------CCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 011234668889999999999999987743
No 49
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=3.8e-33 Score=302.28 Aligned_cols=197 Identities=24% Similarity=0.327 Sum_probs=174.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||.||+|.+..+++.||+|+++... ......+..|++++..++||||+++++++.... .
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-----Y 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-----E
Confidence 36888999999999999999999889999999996542 233466888999999999999999999987765 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNL----------GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEE
Confidence 99999999999999998543 46788999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||++..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 200 (333)
T cd05600 143 TDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200 (333)
T ss_pred EeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence 99999986544 12235689999999999988999999999999999999999999973
No 50
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=2.9e-33 Score=277.32 Aligned_cols=202 Identities=26% Similarity=0.358 Sum_probs=176.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh--hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
+.|.+.+.|++|+||.||+|+++.+++.||+|.++...... .-...+||.++.+.+|||||.+-.+..... .+..
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---ccee
Confidence 56778899999999999999999999999999998765322 334678999999999999999988876654 3468
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
|+||||++. +|...+.. .++++...+...+..|+++|++|||+.+ |+|||||++|+|+.+.|.+||+
T Consensus 153 y~VMe~~Eh-DLksl~d~---------m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMET---------MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred eeeHHHHHh-hHHHHHHh---------ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEec
Confidence 999999997 88888854 4578999999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||+|+.+..... ..+...-|..|+|||.+.+.+ |++..|+||+|||+.|++++++-|..
T Consensus 220 DFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G 280 (419)
T KOG0663|consen 220 DFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG 280 (419)
T ss_pred ccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence 9999999876642 234556789999999998865 99999999999999999999988863
No 51
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=8e-33 Score=298.17 Aligned_cols=194 Identities=24% Similarity=0.294 Sum_probs=168.8
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
+.||+|+||.||++....+++.||+|+++... ......+..|++++++++||||+++++++...+ ..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----RLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----EEEEEEe
Confidence 46999999999999999899999999997542 233456778999999999999999999987665 8999999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA 432 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 432 (789)
|+.+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 76 YANGGELFFHLSRE----------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred CCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHh
Confidence 99999999888543 46889999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 143 KEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred ccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 76432221 12235689999999999999999999999999999999999999963
No 52
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=1.2e-32 Score=291.18 Aligned_cols=263 Identities=21% Similarity=0.354 Sum_probs=203.9
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCc-----eEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGR-----TTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
++|...+.||+|+||.||+|.....+ ..||+|.++.... .....+.+|++.+++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--- 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ--- 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC---
Confidence 47888999999999999999986444 6899999865433 33567899999999999999999999987655
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccc------cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEV------DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil 417 (789)
..+++|||+.+|+|.+++.......+. ......+++.++..++.|++.||+|||+.+ ++|+||||+||+
T Consensus 82 --~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil 156 (283)
T cd05048 82 --PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCL 156 (283)
T ss_pred --ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEE
Confidence 789999999999999999754221110 111256889999999999999999999988 999999999999
Q ss_pred cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCcc
Q 041249 418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMN 496 (789)
Q Consensus 418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~ 496 (789)
+++++.+||+|||+++...............++..|+|||.+..+.++.++|||||||++|||++ |..||...... .
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~ 234 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--E 234 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999987654432222333456788999999998999999999999999999998 99998743211 1
Q ss_pred HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
+...++..... . ....+..++.+++..|++.++..||+..++...+
T Consensus 235 ~~~~i~~~~~~---~---------------------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 235 VIEMIRSRQLL---P---------------------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred HHHHHHcCCcC---C---------------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 11111111000 0 0113456677899999999999999998875544
No 53
>KOG0472 consensus Leucine-rich repeat protein [Function unknown]
Probab=100.00 E-value=2e-36 Score=305.74 Aligned_cols=222 Identities=23% Similarity=0.363 Sum_probs=167.6
Q ss_pred eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccC-----------------
Q 041249 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGE----------------- 618 (789)
Q Consensus 556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~----------------- 618 (789)
++..+|+.++++. ..|+.+.-+++|+.||+++|.|+ ..|.+++++ .|+.|-+.+|.+.++
T Consensus 253 ~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLr 329 (565)
T KOG0472|consen 253 SLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLR 329 (565)
T ss_pred cceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHH
Confidence 3445666667665 66888888999999999999999 577778888 899998888877520
Q ss_pred ---------------------CCccC---cCCCCCcEEEcccCCCCCCCCc-ccCCCC--CCcEEEccCCCCC-------
Q 041249 619 ---------------------IPVNL---SSCSNLIRIGLAKNQLMGKIPS-DFGSLS--KIEVLSLGFNNLI------- 664 (789)
Q Consensus 619 ---------------------~p~~~---~~l~~L~~L~l~~N~l~~~~~~-~~~~l~--~L~~L~L~~N~l~------- 664 (789)
.+..| ..+.+.++|++++-+++ .+|+ .|.... -.+..+++.|++.
T Consensus 330 s~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~ 408 (565)
T KOG0472|consen 330 SKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLV 408 (565)
T ss_pred HhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhhhhhhhH
Confidence 11111 12345666666666666 3333 232211 1444555555442
Q ss_pred ----------------ccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEE
Q 041249 665 ----------------GSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEF 728 (789)
Q Consensus 665 ----------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 728 (789)
+.+|..++.+++|..|+|++|-+. .+|..++.+..|+.||+|+|++. .+|..+..+..++.+
T Consensus 409 ~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtl 486 (565)
T KOG0472|consen 409 ELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETL 486 (565)
T ss_pred HHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHH
Confidence 255666778889999999999987 78888999999999999999998 888888888888888
Q ss_pred EccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCc
Q 041249 729 DVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785 (789)
Q Consensus 729 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 785 (789)
-.++|++. .+|.+-..+|.+|+.|||.+|.|. .+|..+++|++|++|++++|+|.
T Consensus 487 las~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 487 LASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred Hhcccccc-ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 88889997 777773338999999999999999 78999999999999999999998
No 54
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=8.9e-33 Score=292.90 Aligned_cols=201 Identities=23% Similarity=0.327 Sum_probs=172.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++|...+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-----KL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC-----EE
Confidence 46888999999999999999999899999999986542 233567889999999999999999999987655 88
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++||||+.++.+..+... ...+++..+..++.|++.||+|||..+ ++||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~ 142 (287)
T cd07848 76 YLVFEYVEKNMLELLEEM----------PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLC 142 (287)
T ss_pred EEEEecCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 999999998877655421 245889999999999999999999888 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||++......... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 143 DFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred eccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 99999876543321 12234588999999999988899999999999999999999999974
No 55
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=7.6e-33 Score=297.68 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=197.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCce----EEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRT----TVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
.+|+..+.||+|+||.||+|.+..+++ .||+|.++... ....+.+..|+.+++.++||||++++|+|...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 578999999999999999999865554 48999986543 34456789999999999999999999998653
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..++|+||+..|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREH---------KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhc---------cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcE
Confidence 467999999999999998653 245788999999999999999999888 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 503 (789)
||+|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||+.... ..+..+...
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~~~~~~~~ 226 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEK 226 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhC
Confidence 9999999998765443222223335678999999999999999999999999999998 9999863211 011111110
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
... . .....|...+.+++..|++.++-.||+.......
T Consensus 227 ~~~----------~--------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 227 GER----------L--------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCC----------C--------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 0 0011234456688899999999999999877543
No 56
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=9.7e-33 Score=285.20 Aligned_cols=205 Identities=23% Similarity=0.340 Sum_probs=172.5
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch--------------hhHHHHHHHHHHhcCCCCccceeee
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------------ASRSFIAECRALRSIRHRNLVKVFT 334 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~l~~ 334 (789)
-+.|...+.||+|.||.|-+|....+++.||||++...... ..+...+||++|++++|||||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 46899999999999999999999999999999998543111 1247889999999999999999999
Q ss_pred eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS 414 (789)
Q Consensus 335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~ 414 (789)
+..+.. ....|||+|||..|.+...= .....++..+..+|+.++..||+|||.++ ||||||||+
T Consensus 176 vLDDP~---s~~~YlVley~s~G~v~w~p----------~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPs 239 (576)
T KOG0585|consen 176 VLDDPE---SDKLYLVLEYCSKGEVKWCP----------PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPS 239 (576)
T ss_pred eecCcc---cCceEEEEEeccCCccccCC----------CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchh
Confidence 876543 44799999999998765422 22233999999999999999999999999 999999999
Q ss_pred ceecCCCCceeeCcccccccCCCCC---CccceeeecccccccCcccCCCCC----cCccccchhhHHHHHHHHHhcCCC
Q 041249 415 NILLDEEMVSHVGDFGLARFLPPTH---VQTSSIGVKGSIGYIAPEYGLGSE----VSTNGDVYSYGILMLELIIRKKPS 487 (789)
Q Consensus 415 Nill~~~~~~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DV~sfGvvl~elltG~~P~ 487 (789)
|+|++.++++||+|||.+...+... .........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||
T Consensus 240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 9999999999999999999775433 223344567999999999987743 467899999999999999999999
Q ss_pred Cc
Q 041249 488 DI 489 (789)
Q Consensus 488 ~~ 489 (789)
-+
T Consensus 320 ~~ 321 (576)
T KOG0585|consen 320 FD 321 (576)
T ss_pred cc
Confidence 63
No 57
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-32 Score=280.74 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=194.1
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhc--CCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRS--IRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.....+.||+|.||+||+|.|+ |+.||||+|... +.+.+.+|.++... ++|+||+.+++.-.... ..-...|
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEE
Confidence 4556789999999999999998 999999999532 33445555555554 59999999998743222 2223589
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-----CCCCceecCCCCCceecCCCCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-----CQPITTHCDLKPSNILLDEEMV 423 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~ivH~dlk~~Nill~~~~~ 423 (789)
+|.+|.+.|+|.+|+... .++....++++.-+|.||+|||.. |.|.|+|||||+.|||+..++.
T Consensus 286 LvTdYHe~GSL~DyL~r~-----------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN-----------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred EeeecccCCcHHHHHhhc-----------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 999999999999999754 688899999999999999999964 6788999999999999999999
Q ss_pred eeeCcccccccCCCCC--CccceeeecccccccCcccCCCCC------cCccccchhhHHHHHHHHHh----------cC
Q 041249 424 SHVGDFGLARFLPPTH--VQTSSIGVKGSIGYIAPEYGLGSE------VSTNGDVYSYGILMLELIIR----------KK 485 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~------~~~k~DV~sfGvvl~elltG----------~~ 485 (789)
+-|+|+|+|-...... .........||.+|||||++...- .-..+||||||.|+||+..+ +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 9999999999887664 233444567999999999987532 23469999999999999654 35
Q ss_pred CCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCc
Q 041249 486 PSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLES 564 (789)
Q Consensus 486 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s 564 (789)
||++....+.++.+..+ ..+....+++...+|...+++..+.+++..||...+..|-+
T Consensus 435 Pyyd~Vp~DPs~eeMrk---------------------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRK---------------------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT 492 (513)
T ss_pred CcccCCCCCCCHHHHhc---------------------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH
Confidence 66554444444443322 22222333444446666788899999999999977755433
No 58
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=9e-33 Score=304.57 Aligned_cols=202 Identities=23% Similarity=0.298 Sum_probs=173.0
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||+||++....+++.||||++.... ......+..|+++++.++||||+++++++.... .
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-----Y 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----e
Confidence 47888999999999999999999999999999985432 233456888999999999999999999988765 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+++|+|.+++... +.+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~----------~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl 142 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKY----------DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKL 142 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEE
Confidence 99999999999999998643 46788889999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCc---------------------------------------------cceeeecccccccCcccCCC
Q 041249 427 GDFGLARFLPPTHVQ---------------------------------------------TSSIGVKGSIGYIAPEYGLG 461 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~ 461 (789)
+|||+++........ .......||..|+|||++..
T Consensus 143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (377)
T cd05629 143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222 (377)
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence 999999643211000 00012458999999999988
Q ss_pred CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 462 SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 462 ~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
..++.++|||||||++|||++|+.||..
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 223 QGYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred CCCCCceeeEecchhhhhhhcCCCCCCC
Confidence 8899999999999999999999999963
No 59
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-32 Score=283.31 Aligned_cols=200 Identities=31% Similarity=0.440 Sum_probs=167.4
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHh--cCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALR--SIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.....++||+|+||.||+|++. ++.||||++... ....|..|-++.+ .++|+||++++++-....-. ....+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-cccee
Confidence 3444578999999999999997 699999999643 3445666666555 45899999999986554433 44789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC------CCCceecCCCCCceecCCCC
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC------QPITTHCDLKPSNILLDEEM 422 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------~~~ivH~dlk~~Nill~~~~ 422 (789)
+|+||.+.|+|.+|+... .++|....+|+.-+++||+|||+.- .|+|+|||||++|||+..++
T Consensus 285 LVt~fh~kGsL~dyL~~n-----------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-----------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred EEeeeccCCcHHHHHHhc-----------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 999999999999999754 6899999999999999999999864 56799999999999999999
Q ss_pred ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC------cCccccchhhHHHHHHHHHhcCCC
Q 041249 423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE------VSTNGDVYSYGILMLELIIRKKPS 487 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~k~DV~sfGvvl~elltG~~P~ 487 (789)
++.|+|||+|..+.+.......-+..||.+|||||++.+.. .=.+.||||+|.|||||+++..-+
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99999999999999887666566688999999999987643 123699999999999999986555
No 60
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=2.1e-32 Score=295.54 Aligned_cols=194 Identities=24% Similarity=0.310 Sum_probs=169.0
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
+.||+|+||.||++....+++.||+|++... .......+..|+++++.++||||+++++++...+ ..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD-----RLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----EEEEEEe
Confidence 4689999999999999989999999999644 2233467888999999999999999999987665 8999999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA 432 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 432 (789)
|+.+|+|..++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 76 y~~~g~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~ 142 (328)
T cd05593 76 YVNGGELFFHLSRE----------RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLC 142 (328)
T ss_pred CCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCC
Confidence 99999999888543 46889999999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 143 KEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred ccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 76432221 12235689999999999988999999999999999999999999963
No 61
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]
Probab=100.00 E-value=2.3e-35 Score=311.53 Aligned_cols=359 Identities=23% Similarity=0.363 Sum_probs=297.2
Q ss_pred EEcCCCCCC-ccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCc
Q 041249 2 LALDSNRLS-GNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQ 80 (789)
Q Consensus 2 l~l~~n~~~-~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 80 (789)
+|+++|.|+ +.+|..+..++++++|.|..-+|. .+|+.++.|.+|++|.+++|++. .+-..+..|+.|+.+++..|+
T Consensus 12 vDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~ 89 (1255)
T KOG0444|consen 12 VDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNN 89 (1255)
T ss_pred ccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccc
Confidence 589999999 589999999999999999999999 99999999999999999999999 666789999999999999999
Q ss_pred CC-CCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhh-hcCcccccE
Q 041249 81 FR-GSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEF-LVGLKVIEN 158 (789)
Q Consensus 81 l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~-~~~~~~l~~ 158 (789)
|. .-+|..+.++..|+.||||+|+++ +.|..+..-+++-+|+||+|+ |. .||.. +-++.-|-+
T Consensus 90 LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~-------------Ie-tIPn~lfinLtDLLf 154 (1255)
T KOG0444|consen 90 LKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNN-------------IE-TIPNSLFINLTDLLF 154 (1255)
T ss_pred cccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCc-------------cc-cCCchHHHhhHhHhh
Confidence 96 458999999999999999999999 889888777776665555554 55 44433 556777888
Q ss_pred EecccCCCCCCCCCcccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHHHHHHHHHHHH
Q 041249 159 LNLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFL 238 (789)
Q Consensus 159 l~ls~N~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~v~~~~~~~~~ 238 (789)
||||+|++...||..-.+..++.+.+.+||.
T Consensus 155 LDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL------------------------------------------------- 185 (1255)
T KOG0444|consen 155 LDLSNNRLEMLPPQIRRLSMLQTLKLSNNPL------------------------------------------------- 185 (1255)
T ss_pred hccccchhhhcCHHHHHHhhhhhhhcCCChh-------------------------------------------------
Confidence 8888888876655321010011000000000
Q ss_pred HHHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHH
Q 041249 239 CWVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAEC 318 (789)
Q Consensus 239 ~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~ 318 (789)
T Consensus 186 -------------------------------------------------------------------------------- 185 (1255)
T KOG0444|consen 186 -------------------------------------------------------------------------------- 185 (1255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 041249 319 RALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYL 398 (789)
Q Consensus 319 ~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L 398 (789)
T Consensus 186 -------------------------------------------------------------------------------- 185 (1255)
T KOG0444|consen 186 -------------------------------------------------------------------------------- 185 (1255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHH
Q 041249 399 HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILML 478 (789)
Q Consensus 399 H~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ 478 (789)
T Consensus 186 -------------------------------------------------------------------------------- 185 (1255)
T KOG0444|consen 186 -------------------------------------------------------------------------------- 185 (1255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceee
Q 041249 479 ELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVT 558 (789)
Q Consensus 479 elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~ 558 (789)
T Consensus 186 -------------------------------------------------------------------------------- 185 (1255)
T KOG0444|consen 186 -------------------------------------------------------------------------------- 185 (1255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred EeccCcccccccccccccCccccchhcccCCccc-ccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccC
Q 041249 559 ILDLESLKLAGSILPHIGNLSFLKILNLENNSFT-HEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKN 637 (789)
Q Consensus 559 ~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N 637 (789)
....+..+..+++|++|.+++.+-+ ..+|.++..+.+|..+|||.|.+. .+|..+.++++|+.|+||+|
T Consensus 186 ---------~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N 255 (1255)
T KOG0444|consen 186 ---------NHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGN 255 (1255)
T ss_pred ---------hHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcC
Confidence 0000111234567788888886543 358889999999999999999999 89999999999999999999
Q ss_pred CCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCcc-CCccccCCCCCCeeeccCccccccCC
Q 041249 638 QLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGS-IPFTLSKLKNLVILYLGVNRLSGIVP 716 (789)
Q Consensus 638 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p 716 (789)
+|+ .+........+|++|+||.|+++ .+|.++.++++|+.|++.+|+++-. +|+.++.|.+|+++..++|.+. ..|
T Consensus 256 ~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVP 332 (1255)
T KOG0444|consen 256 KIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVP 332 (1255)
T ss_pred cee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCc
Confidence 999 56556777889999999999999 8999999999999999999998733 7899999999999999999998 999
Q ss_pred ccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccc
Q 041249 717 SSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT 761 (789)
Q Consensus 717 ~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~ 761 (789)
+.+..+.+|+.|.|++|.+- ++|..+. -++.|+.|||..|.=-
T Consensus 333 EglcRC~kL~kL~L~~NrLi-TLPeaIH-lL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 333 EGLCRCVKLQKLKLDHNRLI-TLPEAIH-LLPDLKVLDLRENPNL 375 (1255)
T ss_pred hhhhhhHHHHHhccccccee-echhhhh-hcCCcceeeccCCcCc
Confidence 99999999999999999998 9999998 7999999999999844
No 62
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.1e-33 Score=302.92 Aligned_cols=226 Identities=24% Similarity=0.398 Sum_probs=189.0
Q ss_pred CCCcccccCCccEEEEEEcCCceEEEEEEeccc----cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 274 SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH----HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 274 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
...+||+|.|-+||+|.+..+|-+||=-.++.. .....++|..|+++|+.|+||||+++|.+..+.. +...-+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~ 120 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINF 120 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeee
Confidence 356899999999999999988888875443322 3334578999999999999999999999876654 235778
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-CceeeCc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGD 428 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~D 428 (789)
|.|.|..|+|+.|.++. +..+......|++||++||.|||++ .|||+|||||..|||++.+ |.+||+|
T Consensus 121 iTEL~TSGtLr~Y~kk~----------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKH----------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred eeecccCCcHHHHHHHh----------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecc
Confidence 99999999999999765 6678889999999999999999998 6899999999999999754 8999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
+|+|.....+.. ..+.||+.|||||+.. ..|++.+||||||+.|+||+|+..||.........|.......-|..
T Consensus 190 LGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 190 LGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred hhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 999999876652 2478999999999877 78999999999999999999999999876666666666666556666
Q ss_pred hhhhccCCcc
Q 041249 509 VMDIVDSTLL 518 (789)
Q Consensus 509 ~~~~~d~~~~ 518 (789)
+..+-||.++
T Consensus 265 l~kV~dPevr 274 (632)
T KOG0584|consen 265 LSKVKDPEVR 274 (632)
T ss_pred hhccCCHHHH
Confidence 6667676654
No 63
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=99.98 E-value=1.1e-32 Score=302.69 Aligned_cols=202 Identities=24% Similarity=0.342 Sum_probs=174.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||+||+|....+++.||||+++... ......+..|++++..++||||+++++++.... .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-----Y 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----e
Confidence 47889999999999999999999899999999996432 233456788999999999999999999988766 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 142 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKK----------DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKL 142 (364)
T ss_pred EEEEECCCCCcHHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEE
Confidence 99999999999999998643 45899999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCcc------------------------------------ceeeecccccccCcccCCCCCcCccccc
Q 041249 427 GDFGLARFLPPTHVQT------------------------------------SSIGVKGSIGYIAPEYGLGSEVSTNGDV 470 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV 470 (789)
+|||+++......... ......||+.|+|||++....++.++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 222 (364)
T cd05599 143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222 (364)
T ss_pred eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence 9999987654321100 0012358999999999998899999999
Q ss_pred hhhHHHHHHHHHhcCCCCc
Q 041249 471 YSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 471 ~sfGvvl~elltG~~P~~~ 489 (789)
|||||++|||++|+.||..
T Consensus 223 wSlG~il~el~~G~~Pf~~ 241 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCS 241 (364)
T ss_pred ecchhHHHHhhcCCCCCCC
Confidence 9999999999999999973
No 64
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=99.98 E-value=3.8e-32 Score=294.04 Aligned_cols=200 Identities=25% Similarity=0.341 Sum_probs=176.2
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
-++|...+.||+|+||.||++....++..||+|.+..... .....+.+|++++++++||||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----EE
Confidence 4689999999999999999999998999999999976532 33567999999999999999999999987655 78
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+||+++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~ 146 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEA----------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLC 146 (331)
T ss_pred EEEeecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEc
Confidence 9999999999999998643 45788999999999999999999752 39999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||++....... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 147 Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 147 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999998664432 2234589999999999988999999999999999999999999964
No 65
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=99.98 E-value=2.5e-33 Score=295.75 Aligned_cols=263 Identities=23% Similarity=0.366 Sum_probs=217.2
Q ss_pred HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249 262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY 341 (789)
Q Consensus 262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 341 (789)
+.+++....+.....+||.|-||+||.|.|+.-...||||.++.+... ..+|.+|+++|+.++|||+|+++|+|....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~Ep- 336 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEP- 336 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCC-
Confidence 356666667778888999999999999999988999999999765443 568999999999999999999999998776
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE 421 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~ 421 (789)
..|||.|||..|+|.+|++++ ....++....+.+|.||+.||+||.... +|||||.++|+|++++
T Consensus 337 ----PFYIiTEfM~yGNLLdYLRec--------nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEn 401 (1157)
T KOG4278|consen 337 ----PFYIITEFMCYGNLLDYLREC--------NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGEN 401 (1157)
T ss_pred ----CeEEEEecccCccHHHHHHHh--------chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhcccccc
Confidence 789999999999999999887 3445677788999999999999999888 9999999999999999
Q ss_pred CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHH
Q 041249 422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNF 500 (789)
Q Consensus 422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~ 500 (789)
..+|++|||+++++..+.... ..+..=...|.|||.+.-..++.|+|||+|||+|||+.| |-.||.. .++.+.
T Consensus 402 hiVKvADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-----idlSqV 475 (1157)
T KOG4278|consen 402 HIVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-----IDLSQV 475 (1157)
T ss_pred ceEEeeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-----ccHHHH
Confidence 999999999999987654221 112222357999999999999999999999999999998 9999862 223322
Q ss_pred HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249 501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH 574 (789)
Q Consensus 501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~ 574 (789)
.+.+...++ -+....|...+.+++..||+..+-|||+..++....+.
T Consensus 476 ---------Y~LLEkgyR------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 476 ---------YGLLEKGYR------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ---------HHHHhcccc------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 233333333 22345899999999999999999999999887654443
No 66
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=99.98 E-value=1.6e-32 Score=302.71 Aligned_cols=201 Identities=22% Similarity=0.307 Sum_probs=172.7
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
.|...+.||+|+||+||+|....+++.||+|++.... ......+..|++++++++|+||+++++++.+.+ ..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-----NL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-----EE
Confidence 5778899999999999999999899999999996442 233467889999999999999999999998765 89
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||..+ |+||||||+|||++.++++||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~ 143 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRM----------EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLT 143 (381)
T ss_pred EEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEe
Confidence 9999999999999998643 45788899999999999999999888 9999999999999999999999
Q ss_pred cccccccCCCCCC---------------------------------------------ccceeeecccccccCcccCCCC
Q 041249 428 DFGLARFLPPTHV---------------------------------------------QTSSIGVKGSIGYIAPEYGLGS 462 (789)
Q Consensus 428 Dfgla~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 462 (789)
|||+++....... ........||..|+|||.+...
T Consensus 144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (381)
T cd05626 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223 (381)
T ss_pred eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence 9999764321100 0001124699999999999888
Q ss_pred CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 463 EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 463 ~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
.++.++|||||||++|||++|+.||..
T Consensus 224 ~~~~~~DiwSlG~il~elltG~~Pf~~ 250 (381)
T cd05626 224 GYTQLCDWWSVGVILFEMLVGQPPFLA 250 (381)
T ss_pred CCCCccceeehhhHHHHHHhCCCCCcC
Confidence 899999999999999999999999974
No 67
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=99.98 E-value=3.2e-32 Score=289.16 Aligned_cols=204 Identities=28% Similarity=0.387 Sum_probs=168.9
Q ss_pred CCCCCCcccccCCccEEEEEEc-CCceEEEEEEeccccc--hhhHHHHHHHHHHhcC---CCCccceeeeeeccCCCCCC
Q 041249 271 GFSSANLIGTGSFGSVYKGVLD-EGRTTVTVKVFNLHHH--RASRSFIAECRALRSI---RHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~~ 344 (789)
+|...+.||+|+||+||+|... .+++.||+|.++.... .....+.+|+++++.+ +||||++++++|........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888999999999999999985 3578899999865432 2234566677776665 69999999999865443334
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
...++|+||+. ++|.+++... ....+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV--------PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCE
Confidence 46899999997 6899888643 2345889999999999999999999988 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+|||.++...... ......|+..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus 150 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 150 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred EEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 999999998765432 22345689999999999888999999999999999999999999974
No 68
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=99.98 E-value=1.2e-32 Score=298.32 Aligned_cols=198 Identities=25% Similarity=0.378 Sum_probs=173.6
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCc-eEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGR-TTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
-++|...+.||+|+||.||+|.+..++ ..||+|++... .......+..|+++++.++||||+++++++....
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~---- 104 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES---- 104 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC----
Confidence 357888999999999999999976554 68999998643 2233456888999999999999999999997765
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..++||||+.+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++
T Consensus 105 -~~~lv~Ey~~~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 105 -YLYLVLEFVIGGEFFTFLRRN----------KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred -EEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCE
Confidence 899999999999999998644 46889999999999999999999988 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 171 kL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 171 KMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred EEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 999999998764322 235689999999999988899999999999999999999999973
No 69
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=99.98 E-value=1.1e-32 Score=288.73 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=196.4
Q ss_pred hcCCCCCCcccccCCccEEEEEEc---CCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
.++|...+.||+|+||.||+|++. ..+..||+|+++.... .....+.+|++.+.+++||||+++++++...+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 79 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN---- 79 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC----
Confidence 457888999999999999999875 3467899999876532 33567899999999999999999999987655
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~ 146 (266)
T cd05064 80 -TMMIVTEYMSNGALDSFLRKH---------EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVC 146 (266)
T ss_pred -CcEEEEEeCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcE
Confidence 789999999999999998643 246899999999999999999999888 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 503 (789)
|++|||.+......... ......++..|+|||.+....++.++|||||||++||+++ |+.||...... .....+..
T Consensus 147 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~ 223 (266)
T cd05064 147 KISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVED 223 (266)
T ss_pred EECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHC
Confidence 99999987664332211 1112335678999999999999999999999999999875 99999632111 11111110
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
... .. ....+...+.+++..|++.++..||+......
T Consensus 224 ~~~--------~~----------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 224 GFR--------LP----------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCC--------CC----------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 000 00 01134456778889999999999999876643
No 70
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=99.98 E-value=2.7e-32 Score=293.11 Aligned_cols=194 Identities=24% Similarity=0.359 Sum_probs=165.3
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||+||+|....+++.||+|+++... ......+..|..++... .||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE-----HLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence 46999999999999999889999999997542 22334455666777654 8999999999987655 899999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+++|+|..++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~gg~L~~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~ 142 (316)
T cd05592 76 EYLNGGDLMFHIQSS----------GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGM 142 (316)
T ss_pred cCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcC
Confidence 999999999988543 46888999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 143 CKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred CeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence 98654332 122345689999999999988999999999999999999999999973
No 71
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=99.98 E-value=4.1e-33 Score=290.77 Aligned_cols=246 Identities=29% Similarity=0.438 Sum_probs=189.3
Q ss_pred CCcccccCCccEEEEEEc----CCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 275 ANLIGTGSFGSVYKGVLD----EGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
.+.||.|.||.||+|.+. ..+..|+||+++.... ...+.+.+|++.+++++||||++++|+|.... ..++
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~~l 78 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PLFL 78 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----cccc
Confidence 468999999999999998 4578899999966533 34788999999999999999999999998554 6899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||++.|+|.+++... ....+++.++..|+.|+|.||+|||+.+ ++|++|+++||+++.++.+||+||
T Consensus 79 v~e~~~~g~L~~~L~~~--------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f 147 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSK--------NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDF 147 (259)
T ss_dssp EEE--TTEBHHHHHHHT--------CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEEST
T ss_pred ccccccccccccccccc--------cccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 99999999999999754 3467899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
|++....................|+|||.+....++.++||||||+++||+++ |+.||... +..++........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~~~~~ 222 (259)
T PF07714_consen 148 GLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKLKQGQ 222 (259)
T ss_dssp TTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHHHTTE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccccccc
Confidence 99988743332222223446789999999999999999999999999999999 78888632 1122211111100
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA 568 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~ 568 (789)
.. .....+...+.+++..|++.+|.+||++...
T Consensus 223 ~~---------------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i 255 (259)
T PF07714_consen 223 RL---------------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEI 255 (259)
T ss_dssp ET---------------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred cc---------------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00 0111344567789999999999999998765
No 72
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.98 E-value=1.3e-32 Score=297.54 Aligned_cols=201 Identities=24% Similarity=0.347 Sum_probs=176.4
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 343 (789)
.-++|....+||+|.||.|+.+..+.+++.+|||+++.. ...+.+....|-+++... +||.++.++..++..+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~--- 442 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE--- 442 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC---
Confidence 447899999999999999999999999999999999755 334455666777777666 6999999999998877
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV 423 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 423 (789)
+.++||||..+|++..+.+ .+.+++..+..||++|+.||+|||+++ |||||||-+|||+|.+|+
T Consensus 443 --~l~fvmey~~Ggdm~~~~~-----------~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 443 --HLFFVMEYVAGGDLMHHIH-----------TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred --eEEEEEEecCCCcEEEEEe-----------cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCc
Confidence 9999999999999544443 357899999999999999999999999 999999999999999999
Q ss_pred eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+||+|||+++.--... ..+...+||+.|||||++.+..|+..+|.|||||+||||++|..||..
T Consensus 507 ~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 507 VKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred EEecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999754222 245568899999999999999999999999999999999999999974
No 73
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=99.98 E-value=2.2e-32 Score=288.28 Aligned_cols=263 Identities=21% Similarity=0.326 Sum_probs=199.1
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVD 340 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 340 (789)
.++++|+..+.||+|+||.||+|.+. ..+..||+|++.... ......+.+|+++++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45788999999999999999999875 235779999986432 234556889999999999999999999987655
Q ss_pred CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE 420 (789)
Q Consensus 341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~ 420 (789)
..++||||+++|+|.+++...+...........+++.++..++.|++.||+|||+.+ ++||||||+||++++
T Consensus 83 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~ 154 (277)
T cd05062 83 -----PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 154 (277)
T ss_pred -----CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcC
Confidence 789999999999999998654211111112345688899999999999999999887 999999999999999
Q ss_pred CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHH
Q 041249 421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHN 499 (789)
Q Consensus 421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~ 499 (789)
++.+|++|||+++...............++..|+|||++..+.++.++|||||||++|||++ |+.||.... ...
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----~~~ 229 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----NEQ 229 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHH
Confidence 99999999999986654332211222345778999999998889999999999999999999 788886321 111
Q ss_pred HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
..+........+ ....+...+.+++..|.+.++.+||+.....
T Consensus 230 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 272 (277)
T cd05062 230 VLRFVMEGGLLD---------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272 (277)
T ss_pred HHHHHHcCCcCC---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 111111100000 0112344567889999999999999887663
No 74
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.98 E-value=1.3e-32 Score=294.83 Aligned_cols=197 Identities=25% Similarity=0.366 Sum_probs=176.9
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
-|.-++.||+|+.|.|..|++..+|+.+|||++... .......++.||.+|+-+.|||++++|++..... +.
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~-----~l 87 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ-----HL 87 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-----eE
Confidence 466788999999999999999999999999999655 3334567899999999999999999999865544 99
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
|+|.||+++|-|.+++-.. ..+++.+..+++.||..|+.|+|..+ |+|||+||+|+|+|+++.+||+
T Consensus 88 ylvlEyv~gGELFdylv~k----------G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIA 154 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRK----------GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIA 154 (786)
T ss_pred EEEEEecCCchhHHHHHhh----------CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeee
Confidence 9999999999999999654 67899999999999999999999998 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
|||+|....++.. ...-+|++.|.|||++.+.+| +.++||||.|||||.|+||+.||+
T Consensus 155 DFGMAsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd 213 (786)
T KOG0588|consen 155 DFGMASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD 213 (786)
T ss_pred ccceeecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence 9999998877652 223569999999999999998 578999999999999999999998
No 75
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=99.98 E-value=2.4e-32 Score=291.96 Aligned_cols=201 Identities=25% Similarity=0.388 Sum_probs=170.8
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
.++|...+.||+|+||.||+|....+++.||+|+++.... .....+.+|+++++.++||||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-----TL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC-----eE
Confidence 4789999999999999999999998899999999865432 23456788999999999999999999987655 79
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++||||+. +++.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 79 ~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~ 145 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKH---------PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLA 145 (303)
T ss_pred EEEEECCC-cCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEC
Confidence 99999996 6787777532 245788899999999999999999988 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||+++....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 146 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 146 DFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999876543221 1223457899999998765 4589999999999999999999999974
No 76
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=99.98 E-value=1.9e-32 Score=310.17 Aligned_cols=253 Identities=19% Similarity=0.203 Sum_probs=200.3
Q ss_pred CCCCCCcccccCCccEEEEEEcCC-ceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEG-RTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
.|...+.||.|++|.||+|....+ ++.||+|.+..........+..|+++++.++||||+++++++...+ ..++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-----KLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-----EEEE
Confidence 377889999999999999998766 7889999876555555667888999999999999999999998766 8999
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+.+|+|.+++.... .....+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 143 v~E~~~gg~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRL------KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred EEECCCCCCHHHHHHHHH------hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeC
Confidence 999999999999885431 12346889999999999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 509 (789)
|+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||... +............
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~-----~~~~~~~~~~~~~- 287 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP-----SQREIMQQVLYGK- 287 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhCC-
Confidence 9998775543322233456999999999999989999999999999999999999999632 1122221111100
Q ss_pred hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
.++. ...+...+.+++..|++.++-.|++.....
T Consensus 288 ---~~~~-----------------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 288 ---YDPF-----------------------PCPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred ---CCCC-----------------------CccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 0000 001223456778889999999999987664
No 77
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=99.98 E-value=6e-33 Score=309.85 Aligned_cols=211 Identities=21% Similarity=0.279 Sum_probs=176.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeee-eccCCCCC-Cce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTA-CSGVDYQG-NDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~~~~~~-~~~ 346 (789)
-..++.+.|.+|||+.||.|+....+..||+|++-.......+.+.+||++|++|+ |+|||.|++. .......+ ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 34556789999999999999999777999999998777788899999999999996 9999999994 33322223 356
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
..+.||||.+|.|-+++..+ -..+|++.++++|+.|+|+|+++||.. .+||+|||||.+||||+.+++.||
T Consensus 117 vllLmEyC~gg~Lvd~mn~R--------lq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTR--------LQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred EEeehhhccCCcHHHHHHHH--------HhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence 78999999999999999754 224499999999999999999999987 688999999999999999999999
Q ss_pred CcccccccCCCCCCc-------cceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQ-------TSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||||.|...-..... ........|+.|+|||++. +..+++|+||||+||+||-|+....||+.
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence 999988755433210 1111244899999999864 45689999999999999999999999984
No 78
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=99.98 E-value=1.8e-32 Score=310.43 Aligned_cols=266 Identities=21% Similarity=0.245 Sum_probs=206.8
Q ss_pred HHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249 265 LHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 342 (789)
.....++|...+.||+|+||+||+|....+++.||||+++... ......+.+|+..+..++|+||+++...+...+..
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3345679999999999999999999998899999999986542 33456788999999999999999988776543311
Q ss_pred ---CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249 343 ---GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD 419 (789)
Q Consensus 343 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~ 419 (789)
.....++||||+.+|+|.+++... ......+++..+..++.|++.||.|||+.+ |+||||||+||+++
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~------~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~ 177 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSR------AKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLC 177 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHh------hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEe
Confidence 112368999999999999998643 123356899999999999999999999887 99999999999999
Q ss_pred CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHH
Q 041249 420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN 499 (789)
Q Consensus 420 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~ 499 (789)
.++.+||+|||+++...............||..|+|||++....++.++|||||||++|||++|+.||... ....
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~~ 252 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NMEE 252 (496)
T ss_pred CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHHH
Confidence 99999999999998776543333333456999999999999999999999999999999999999999632 2222
Q ss_pred HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
++........ .... ..+...+.+++..|++.++-.||+......+
T Consensus 253 ~~~~~~~~~~-~~~~--------------------------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 VMHKTLAGRY-DPLP--------------------------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHhcCCC-CCCC--------------------------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 2222211100 0000 1223456678889999999999999876544
No 79
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=99.98 E-value=3.8e-32 Score=288.19 Aligned_cols=200 Identities=24% Similarity=0.378 Sum_probs=170.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||.|+||.||+|....+++.||+|.++.... .....+.+|++++++++||||+++++++.... ..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER-----CLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC-----eEE
Confidence 568889999999999999999998999999999875432 33456789999999999999999999987654 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+. |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~D 146 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNC---------GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLAD 146 (288)
T ss_pred EEEeCCC-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECc
Confidence 9999998 4898887543 245788899999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+++....... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 147 fG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 147 FGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred CcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999986543321 1223457899999998865 5689999999999999999999999964
No 80
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=99.98 E-value=3e-32 Score=293.65 Aligned_cols=194 Identities=27% Similarity=0.338 Sum_probs=167.4
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||.||+|....+++.||+|+++... ......+..|++++..+ +||||+++++++.... ..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~-----~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD-----RLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----eEEEEE
Confidence 46999999999999999889999999986542 23345677888888876 7999999999987665 789999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~ 142 (321)
T cd05591 76 EYVNGGDLMFQIQRS----------RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGM 142 (321)
T ss_pred eCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeeccc
Confidence 999999999888543 46889999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++....... ......|+..|+|||++....++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 143 CKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred ceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence 876433221 12235689999999999988999999999999999999999999973
No 81
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=99.98 E-value=1.9e-32 Score=300.13 Aligned_cols=207 Identities=22% Similarity=0.317 Sum_probs=176.8
Q ss_pred HHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccC
Q 041249 263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGV 339 (789)
Q Consensus 263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 339 (789)
.++....++|...+.||+|+||.||++....+++.||+|++... .......+.+|+++++.++||||+++++++...
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34445668999999999999999999999989999999998642 223345688999999999999999999998765
Q ss_pred CCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249 340 DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD 419 (789)
Q Consensus 340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~ 419 (789)
. ..++||||+++|+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 116 ~-----~~~lv~Ey~~gg~L~~~l~~~-----------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~ 176 (370)
T cd05621 116 K-----YLYMVMEYMPGGDLVNLMSNY-----------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLD 176 (370)
T ss_pred C-----EEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEC
Confidence 5 899999999999999998532 4788899999999999999999988 99999999999999
Q ss_pred CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC----CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS----EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 420 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
.++.+||+|||++......... ......||..|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus 177 ~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 177 KHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred CCCCEEEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 9999999999999876543321 12245699999999998653 378999999999999999999999973
No 82
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=99.98 E-value=1.5e-32 Score=277.30 Aligned_cols=198 Identities=23% Similarity=0.363 Sum_probs=178.7
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
.|.+.+.+|+|.||.|-+|..+..|+.||||.++.. ..++.-.+++||++|+.++||||+.+|.+|...+ ..
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd-----KI 128 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD-----KI 128 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc-----eE
Confidence 455667899999999999999889999999999755 3344556889999999999999999999987766 89
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
.+||||..+|.|.+|+.++ +.+++.+..++++||..|+.|+|.+. +||||||-+|||+|+++++||+
T Consensus 129 vivMEYaS~GeLYDYiSer----------~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIA 195 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISER----------GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIA 195 (668)
T ss_pred EEEEEecCCccHHHHHHHh----------ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeee
Confidence 9999999999999999765 78999999999999999999999888 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||++.++.... ..+.++|++-|.+||+..+.+| .+.+|-||+||+||-|+.|.-||+.
T Consensus 196 DFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 196 DFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred ccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 999999987765 3345779999999999998887 6889999999999999999999974
No 83
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=99.98 E-value=5.2e-32 Score=292.17 Aligned_cols=199 Identities=23% Similarity=0.299 Sum_probs=170.2
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCC-ccceeeeeeccCCCCCCce
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHR-NLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~~~~ 346 (789)
+|...+.||+|+||.||+|....+++.||+|+++.. .......+..|++++..+.|+ +|+++++++...+ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-----R 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----E
Confidence 577889999999999999999988999999998644 223456678899999999765 5778888776655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+|+|.+++... ..+++..+..++.|++.||+|||..+ |+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQV----------GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEE
Confidence 99999999999999988643 45788999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 143 ADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred eecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 99999875432221 23345689999999999998999999999999999999999999973
No 84
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=99.98 E-value=5.1e-32 Score=292.60 Aligned_cols=194 Identities=25% Similarity=0.319 Sum_probs=167.8
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||.||+|....+++.||+|+++.. .......+..|+.++.++ +||||+++++++.... ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-----RLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-----EEEEEE
Confidence 4799999999999999989999999999754 223345677888888877 8999999999987665 899999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~~~L~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~ 142 (329)
T cd05618 76 EYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 999999999888543 46899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 143 CKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 876432221 12335689999999999999999999999999999999999999963
No 85
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=99.98 E-value=1.9e-32 Score=286.03 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=205.5
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++..+|...+.||.|+||.||+|.+.. ++.||+|.+..........+..|+++++.++|+||+++++++.... .
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 76 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-----P 76 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-----C
Confidence 456789999999999999999999985 8999999998766656778999999999999999999999987665 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+++|+|.+++... .+..+++.++..++.|++.|++|||+.+ ++|+||||+||++++++.+|+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl 145 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSP--------EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKV 145 (261)
T ss_pred eEEEEeecccCCHHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEE
Confidence 89999999999999999754 3456899999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMAL 505 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 505 (789)
+|||.+......... .....++..|+|||......++.++||||||+++|+|++ |+.||.... .......+....
T Consensus 146 ~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~ 221 (261)
T cd05148 146 ADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQITAGY 221 (261)
T ss_pred ccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHHhCC
Confidence 999999877544321 113345678999999988889999999999999999998 899986321 111111111100
Q ss_pred CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.. .....+...+.+++..|++.++.+||+.......+
T Consensus 222 ~~------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 222 RM------------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred cC------------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 00 00113345677889999999999999998765433
No 86
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=99.98 E-value=5.7e-32 Score=295.44 Aligned_cols=250 Identities=24% Similarity=0.284 Sum_probs=190.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||+|+||+||+|.+..+++.||||++..... .....+.+|++++++++|+||+++++++.... ..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-----EIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-----eEE
Confidence 456667899999999999999998899999999865433 33567899999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+.+|+|.... ..++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 149 lv~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~D 211 (353)
T PLN00034 149 VLLEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIAD 211 (353)
T ss_pred EEEecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcc
Confidence 999999999886532 2356678899999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 503 (789)
||+++....... ......||..|+|||++.. ...+.++|||||||++|||++|+.||.....+ ........
T Consensus 212 fG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~ 287 (353)
T PLN00034 212 FGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCA 287 (353)
T ss_pred cccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHH
Confidence 999987653321 1223468999999998743 22457899999999999999999999732111 11111111
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
..... .+. ....+..++.+++..|++.++.+|++..++..++
T Consensus 288 ~~~~~-----~~~----------------------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 288 ICMSQ-----PPE----------------------APATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred HhccC-----CCC----------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 10000 000 0112234566788899999999999998775543
No 87
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=99.98 E-value=4.1e-32 Score=292.29 Aligned_cols=194 Identities=26% Similarity=0.344 Sum_probs=167.3
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||+||+|....+++.||+|+++.. .......+..|++++... +||||+++++++...+ ..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-----~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD-----RLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-----EEEEEE
Confidence 4699999999999999989999999998643 223345677888888877 7999999999987665 789999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 76 Ey~~~g~L~~~i~~~----------~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~ 142 (320)
T cd05590 76 EFVNGGDLMFHIQKS----------RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM 142 (320)
T ss_pred cCCCCchHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCC
Confidence 999999999988643 46889999999999999999999888 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (320)
T cd05590 143 CKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198 (320)
T ss_pred CeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 876432221 12335689999999999988999999999999999999999999973
No 88
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=99.98 E-value=6.9e-32 Score=292.11 Aligned_cols=201 Identities=24% Similarity=0.344 Sum_probs=175.7
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
..++|...+.||+|+||.||++.+..+++.+|+|.+.... ......+.+|++++++++|+||++++++|.... .
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~ 77 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----E 77 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-----E
Confidence 3478999999999999999999999899999999987653 234567899999999999999999999998765 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+|+|.+++... ..+++.....++.|++.||+|||+.+ .++||||||+||+++.++.+||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL 145 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKA----------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKL 145 (333)
T ss_pred EEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEE
Confidence 99999999999999998643 45788899999999999999999742 2999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||++....... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 146 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 146 CDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred eeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999987654332 1234588999999999888899999999999999999999999974
No 89
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=99.98 E-value=3.3e-32 Score=287.34 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=194.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCce----EEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRT----TVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
++|...+.||+|+||+||+|.+..+++ .|++|.+..... ....++..|+..++++.||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~----- 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA----- 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-----
Confidence 578888999999999999999976665 477788754322 2345778888899999999999999987532
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..++++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 82 -~~~~i~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVRQH---------RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIV 148 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcE
Confidence 467899999999999999643 246899999999999999999999887 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 503 (789)
||+|||.++...+...........++..|+|||....+.++.++|||||||++||+++ |+.||..... ..+.+++..
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~ 226 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEK 226 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHC
Confidence 9999999987655443222334557789999999998999999999999999999998 9999863211 111222211
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.... ..+ ..|...+.+++..|+..++-.||+..+...
T Consensus 227 ~~~~-----~~~-------------------------~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 GERL-----AQP-------------------------QICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCcC-----CCC-------------------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1000 000 012334557788999999999999987643
No 90
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=99.98 E-value=4.8e-32 Score=292.29 Aligned_cols=199 Identities=23% Similarity=0.301 Sum_probs=170.4
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCce
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 346 (789)
+|...+.||+|+||.||+|....+++.||+|+++... .........|.+++..+ .|++|+++++++...+ .
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD-----R 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-----E
Confidence 5788899999999999999999889999999987542 22334566788888777 5899999998887655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL 142 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQV----------GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEE
Confidence 99999999999999988643 45788999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||+++....... ......||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 143 ~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 143 ADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred ccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 99999876433221 12345689999999999999999999999999999999999999973
No 91
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=99.98 E-value=2.6e-32 Score=298.10 Aligned_cols=202 Identities=25% Similarity=0.333 Sum_probs=176.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||+||+|....+++.||||+++... ......+..|++++..++|+||+++++++.... .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-----H 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-----e
Confidence 46888999999999999999999899999999986442 234567889999999999999999999887655 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+|+|.+++... ..+++..+..++.|++.||+|||..+ |+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL 142 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK----------DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKL 142 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEe
Confidence 99999999999999998643 46889999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCC---------------------------CccceeeecccccccCcccCCCCCcCccccchhhHHHHHH
Q 041249 427 GDFGLARFLPPTH---------------------------VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLE 479 (789)
Q Consensus 427 ~Dfgla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~e 479 (789)
+|||++....... .........||..|+|||++.+..++.++|||||||++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 222 (350)
T cd05573 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222 (350)
T ss_pred ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence 9999998765433 0111223568999999999999999999999999999999
Q ss_pred HHHhcCCCCc
Q 041249 480 LIIRKKPSDI 489 (789)
Q Consensus 480 lltG~~P~~~ 489 (789)
|++|+.||..
T Consensus 223 ll~g~~Pf~~ 232 (350)
T cd05573 223 MLYGFPPFYS 232 (350)
T ss_pred hccCCCCCCC
Confidence 9999999974
No 92
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=99.98 E-value=3.5e-32 Score=300.41 Aligned_cols=201 Identities=21% Similarity=0.298 Sum_probs=171.8
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
.|...+.||+|+||+||+|....+++.||+|++.... ......+.+|+++++.++|+||+++++.+...+ ..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-----~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----NL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-----EE
Confidence 5778899999999999999999899999999986432 233467889999999999999999999998765 89
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++||||+++|+|.+++... ..+++.....++.|++.||+|||+.+ ||||||||+|||++.++++||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~ 143 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRM----------GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLT 143 (382)
T ss_pred EEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEe
Confidence 9999999999999998643 45788889999999999999999988 9999999999999999999999
Q ss_pred cccccccCCCCCC---------------------------------------------ccceeeecccccccCcccCCCC
Q 041249 428 DFGLARFLPPTHV---------------------------------------------QTSSIGVKGSIGYIAPEYGLGS 462 (789)
Q Consensus 428 Dfgla~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 462 (789)
|||++........ ........||..|+|||++.+.
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (382)
T cd05625 144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223 (382)
T ss_pred ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence 9999753321000 0001124589999999999988
Q ss_pred CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 463 EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 463 ~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
.++.++|||||||++|||++|+.||..
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 224 GYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred CCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 999999999999999999999999973
No 93
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=99.98 E-value=2.6e-32 Score=294.63 Aligned_cols=194 Identities=24% Similarity=0.293 Sum_probs=167.9
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
+.||+|+||.||++....+++.||+|+++... ......+..|++++..++||||+++++++...+ ..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~-----~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----RLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC-----EEEEEEe
Confidence 46899999999999999899999999996542 233456788999999999999999999887665 8999999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
|+.+|+|.+++... ..+++.++..++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~ 142 (325)
T cd05594 76 YANGGELFFHLSRE----------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGL 142 (325)
T ss_pred CCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCC
Confidence 99999999888543 468999999999999999999997 66 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 143 CKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred CeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence 875432221 12234689999999999998999999999999999999999999963
No 94
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=2.3e-32 Score=275.76 Aligned_cols=281 Identities=21% Similarity=0.212 Sum_probs=211.4
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEec--cccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFN--LHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
....|...+.||+|+||.|..+....+++.||||.+. .......++..+|++.++.++|+||+.+++++.....+..+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456666889999999999999999999999999997 55666788899999999999999999999999875555666
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++|+|+|+ -+|...++.. +.++.....-+..|+++||.|+|+.+ |+|||+||+|++++.+-..|
T Consensus 100 DvYiV~elMe-tDL~~iik~~----------~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lK 165 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQ----------QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLK 165 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcC----------ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEE
Confidence 8999999996 4899988654 55888999999999999999999999 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHH--HH
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF--AR 502 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~--~~ 502 (789)
++|||+|+...........+....|..|.|||.+.. ..|+...||||.||++.||++|++-|.. ...+.+. +.
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG----~d~v~Ql~lI~ 241 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG----KDYVHQLQLIL 241 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC----CchHHHHHHHH
Confidence 999999999875433334455668999999998865 5699999999999999999999998852 2222222 11
Q ss_pred HhCCCc----hhhhccCCcccChhhHHHhhhh-hhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 503 MALPDH----VMDIVDSTLLNDVEDLAIISNQ-RQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 503 ~~~~~~----~~~~~d~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
...+-. +..+-....+. ...+.+ ..+..+.....+.....+++..++...+|.+|.+..++..+
T Consensus 242 ~~lGtP~~e~l~~i~s~~ar~-----yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 242 ELLGTPSEEDLQKIRSEKARP-----YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhcCCCCHHHHHHhccHHHHH-----HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 112111 11111011100 000000 11112222333455566677778888888888888877544
No 95
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=99.97 E-value=2.6e-32 Score=300.94 Aligned_cols=202 Identities=22% Similarity=0.296 Sum_probs=172.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
.+|...+.||+|+||.||+|....+++.||||++.... ......+..|++++.+++|+||+++++.+.... .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-----N 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----E
Confidence 36888999999999999999999899999999986432 223456888999999999999999999987655 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRL----------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEE
Confidence 99999999999999998643 45788888999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCC-----------------------------------------ccceeeecccccccCcccCCCCCcC
Q 041249 427 GDFGLARFLPPTHV-----------------------------------------QTSSIGVKGSIGYIAPEYGLGSEVS 465 (789)
Q Consensus 427 ~Dfgla~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 465 (789)
+|||++........ ........||..|+|||++....++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 99999753321000 0001134699999999999988999
Q ss_pred ccccchhhHHHHHHHHHhcCCCCc
Q 041249 466 TNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 466 ~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
.++|||||||++|||++|+.||..
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~ 246 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLA 246 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCC
Confidence 999999999999999999999974
No 96
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=99.97 E-value=7.2e-32 Score=291.56 Aligned_cols=194 Identities=25% Similarity=0.328 Sum_probs=168.3
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||.||+|....+++.||+|+++... ....+.+..|+.++.++ +||||+++++++.... ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~-----~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES-----RLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-----EEEEEE
Confidence 46899999999999999899999999997542 23345688899999998 7999999999987665 789999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~~~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~ 142 (329)
T cd05588 76 EFVSGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGM 142 (329)
T ss_pred eCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcc
Confidence 999999999888543 46899999999999999999999888 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 143 CKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 87532222 122345689999999999998999999999999999999999999974
No 97
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=99.97 E-value=3.4e-32 Score=298.50 Aligned_cols=208 Identities=22% Similarity=0.305 Sum_probs=178.4
Q ss_pred HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeecc
Q 041249 262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSG 338 (789)
Q Consensus 262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 338 (789)
+.++..+.++|...+.||+|+||.||++....+++.||+|++... .......+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 456667789999999999999999999999999999999998643 22334567889999999999999999999876
Q ss_pred CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249 339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418 (789)
Q Consensus 339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill 418 (789)
.. ..++||||+++|+|.+++... .++...+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 115 ~~-----~~~lv~Ey~~gg~L~~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll 175 (371)
T cd05622 115 DR-----YLYMVMEYMPGGDLVNLMSNY-----------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLL 175 (371)
T ss_pred CC-----EEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEE
Confidence 55 899999999999999998532 4788889999999999999999988 9999999999999
Q ss_pred CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC----CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS----EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+.++++||+|||+++........ ......||+.|+|||++... .++.++|||||||++|||++|+.||..
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 99999999999999876543321 12345699999999998653 378999999999999999999999973
No 98
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=99.97 E-value=6.6e-32 Score=291.37 Aligned_cols=197 Identities=24% Similarity=0.336 Sum_probs=167.1
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHH---hcCCCCccceeeeeeccCCCCCCc
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRAL---RSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
|...+.||+|+||.||+|.+..+++.||||+++... ....+.+..|++++ +.++||||+++++++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~----- 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED----- 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-----
Confidence 566789999999999999999899999999996442 22234566666554 5678999999999987665
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++||||+.+|+|..++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+|
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-----------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEE
Confidence 89999999999999988743 35899999999999999999999988 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+|||+++....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 142 L~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 142 IADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred eCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 999999875432221 12345689999999999988999999999999999999999999963
No 99
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=99.97 E-value=6.8e-32 Score=282.80 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=200.1
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
.++|+..+.||+|+||.||+|.+..+ ...||||.++.... .....+..|+..+++++||||+++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 78 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR---- 78 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC----
Confidence 46799999999999999999998643 46899999875433 34567899999999999999999999987655
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..++||||+.+|+|.+++... ...+++.++..++.|++.|++|||+.+ |+|+||||+||++++++.+
T Consensus 79 -~~~iv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 79 -PVMIITEYMENGSLDKFLREN---------DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVC 145 (266)
T ss_pred -ceEEEEEcCCCCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCE
Confidence 789999999999999998643 236899999999999999999999887 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 503 (789)
|++|||++................++..|+|||......++.++||||||+++|||++ |..||..... ..+...+..
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~ 223 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKAVED 223 (266)
T ss_pred EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHHHHHc
Confidence 9999999998763332222223345678999999998899999999999999999998 9999863211 111111111
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.... + ....+...+.+++..|++.++-.||+...+...+
T Consensus 224 ~~~~-------~-----------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 224 GYRL-------P-----------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred CCCC-------C-----------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1000 0 0112334567889999999999999988774433
No 100
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=99.97 E-value=6.5e-32 Score=291.17 Aligned_cols=194 Identities=24% Similarity=0.306 Sum_probs=165.9
Q ss_pred CcccccCCccEEEEEEc---CCceEEEEEEecccc----chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 276 NLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHH----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+.||+|+||.||++... .+++.||+|+++... ......+..|+++++.++||||+++++++.... ..+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-----KLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-----eEE
Confidence 57999999999999874 468899999986432 223456788999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+.+|+|.+++... ..+.+..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D 143 (323)
T cd05584 77 LILEYLSGGELFMHLERE----------GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTD 143 (323)
T ss_pred EEEeCCCCchHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEee
Confidence 999999999999998643 45778888999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+++....... ......|+..|+|||++....++.++|||||||++|||++|+.||..
T Consensus 144 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 144 FGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred CcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 999875433221 12234689999999999988899999999999999999999999973
No 101
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=99.97 E-value=5.2e-32 Score=286.67 Aligned_cols=200 Identities=26% Similarity=0.376 Sum_probs=173.0
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
+|...+.||+|+||+||++....+++.||+|.+.... ......+.+|++++++++||||+++++.+...+ ..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-----AL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-----eE
Confidence 4777889999999999999998889999999986432 222345778999999999999999999987655 89
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++||||+.+|+|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~ 144 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNM--------GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEeccCCCcHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEe
Confidence 9999999999999887543 2346899999999999999999999988 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||++........ .....|+..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus 145 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 145 DLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred eCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence 9999987643321 1234688999999999888899999999999999999999999974
No 102
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=99.97 E-value=7.1e-32 Score=282.15 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=200.4
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
..+|...+.||+|++|.||+|.+...++.||+|.+... ......+.+|++.+++++|+||+++++++.... ..+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 78 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFY 78 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-----CcE
Confidence 35678889999999999999999988999999998643 333567889999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+.+++|.+++... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 79 lv~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~d 147 (263)
T cd05052 79 IITEFMTYGNLLDYLREC--------NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 147 (263)
T ss_pred EEEEeCCCCcHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCC
Confidence 999999999999998654 2356899999999999999999999887 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
||.+......... ......++..|+|||......++.++|||||||++|||++ |..||... +...+.+.....
T Consensus 148 f~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~~~~~ 221 (263)
T cd05052 148 FGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELLEKG 221 (263)
T ss_pred Cccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHCC
Confidence 9999876543311 1112234568999999988899999999999999999998 99998632 112221111100
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.... ....+...+.+++.+|++.++-+||+.......+
T Consensus 222 ---------~~~~------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 259 (263)
T cd05052 222 ---------YRME------------------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAF 259 (263)
T ss_pred ---------CCCC------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 0000 0112344567888999999999999998775433
No 103
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=99.97 E-value=9.2e-32 Score=288.88 Aligned_cols=194 Identities=25% Similarity=0.393 Sum_probs=166.3
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||+||+|.+..+++.||+|+++... ......+..|.+++... +||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-----NLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-----EEEEEE
Confidence 46899999999999999889999999987542 23344566777888764 8999999999987765 789999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 76 ey~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05619 76 EYLNGGDLMFHIQSC----------HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGM 142 (316)
T ss_pred eCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCc
Confidence 999999999998643 45788999999999999999999888 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 143 CKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred ceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 875432221 12345689999999999988999999999999999999999999973
No 104
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=99.97 E-value=3.2e-32 Score=300.24 Aligned_cols=267 Identities=22% Similarity=0.307 Sum_probs=201.5
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccc-hhhHHHHHHHHHHhcCC-CCccceeeeeeccCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHH-RASRSFIAECRALRSIR-HRNLVKVFTACSGVD 340 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 340 (789)
..++|...+.||+|+||.||+|++.. .+..||||+++.... ...+.+..|+++++++. ||||++++++|....
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35688899999999999999999742 235799999975433 33467899999999995 999999999997655
Q ss_pred CCCCceEEEEeeccCCCChhhhccCCCCCcc-------------------------------------------------
Q 041249 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDE------------------------------------------------- 371 (789)
Q Consensus 341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------------------------- 371 (789)
..++||||+++|+|.+++........
T Consensus 115 -----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 115 -----PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred -----ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 78999999999999998865311000
Q ss_pred -------------------------------------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249 372 -------------------------------------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS 414 (789)
Q Consensus 372 -------------------------------------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~ 414 (789)
.......+++.++..++.|++.||+|||+.+ ++||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH
Confidence 0011245889999999999999999999988 999999999
Q ss_pred ceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccC
Q 041249 415 NILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEG 493 (789)
Q Consensus 415 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~ 493 (789)
||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....+
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99999999999999999987654432222233446788999999998899999999999999999997 99998632211
Q ss_pred CccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 494 DMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
. .+...++.... + .....+...+.+++..|++.++.+||+...+...+.
T Consensus 347 ~-~~~~~~~~~~~--------~----------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 347 S-TFYNKIKSGYR--------M----------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred H-HHHHHHhcCCC--------C----------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 0 01111110000 0 001123455678899999999999999887655443
No 105
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=99.97 E-value=7.5e-32 Score=290.80 Aligned_cols=193 Identities=27% Similarity=0.336 Sum_probs=163.6
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHH-HHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECR-ALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||+||+|....+++.||+|++.... ......+..|.. +++.++||||+++++++.... ..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~-----~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD-----KLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-----EEEEEE
Confidence 46999999999999999899999999986432 222334444444 567889999999999987655 789999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~ 142 (323)
T cd05575 76 DYVNGGELFFHLQRE----------RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGL 142 (323)
T ss_pred cCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCC
Confidence 999999999988643 46788999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 197 (323)
T cd05575 143 CKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (323)
T ss_pred CcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCC
Confidence 875432221 2234568999999999999899999999999999999999999996
No 106
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=99.97 E-value=8.3e-32 Score=284.37 Aligned_cols=196 Identities=26% Similarity=0.367 Sum_probs=168.0
Q ss_pred ccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
||+|+||+||++....+++.||+|.+..... .....+..|++++++++|+||+++.+++.... ..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT-----DLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC-----eEEEEEeCC
Confidence 6999999999999998999999999864322 22356778999999999999999998886654 789999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
++|+|..++.... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+..
T Consensus 76 ~~g~L~~~~~~~~------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 76 NGGDLRYHIYNVD------EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred CCCCHHHHHHhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 9999998875431 12356899999999999999999999888 99999999999999999999999999987
Q ss_pred CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
....... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 147 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 147 LKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred cCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 6543321 2235689999999999999999999999999999999999999974
No 107
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=99.97 E-value=3.3e-32 Score=294.87 Aligned_cols=268 Identities=21% Similarity=0.249 Sum_probs=200.9
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGVD 340 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 340 (789)
..+.|...+.||+|+||.||+|.... +++.||+|+++... ....+.+..|++++.++ +|+||++++++|...+
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 34678899999999999999997532 35789999987543 23345678899999999 8999999999886543
Q ss_pred CCCCceEEEEeeccCCCChhhhccCCCCCc--------------------------------------------------
Q 041249 341 YQGNDFKALVYEFMQNGSLEEWLYPVNRED-------------------------------------------------- 370 (789)
Q Consensus 341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------------------------- 370 (789)
...++++||+++|+|.+++......-
T Consensus 85 ----~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 85 ----GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ----CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 26789999999999999986431100
Q ss_pred -cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecc
Q 041249 371 -EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG 449 (789)
Q Consensus 371 -~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g 449 (789)
........+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.............+
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 00001236899999999999999999999888 99999999999999999999999999987754433222333456
Q ss_pred cccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhh
Q 041249 450 SIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIIS 528 (789)
Q Consensus 450 t~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 528 (789)
+..|+|||++.+..++.++|||||||++|||++ |+.||...... ..+....+..... .
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~----~---------------- 296 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKEGTRM----R---------------- 296 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhccCCC----C----------------
Confidence 778999999999999999999999999999998 99998642211 1111111110000 0
Q ss_pred hhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 529 NQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
....+..++.+++..|++.++.+||+..++...+.
T Consensus 297 ----------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~ 331 (337)
T cd05054 297 ----------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILG 331 (337)
T ss_pred ----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 01123345678899999999999999988755443
No 108
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=99.97 E-value=8.2e-32 Score=285.69 Aligned_cols=266 Identities=23% Similarity=0.343 Sum_probs=203.5
Q ss_pred hcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
.++|...+.||.|+||.||++... .++..+|+|.++.........+..|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD--- 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC---
Confidence 467889999999999999999852 345679999987666566678999999999999999999999987655
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCcc---ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDE---VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE 420 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~ 420 (789)
..++|+||+.+|+|.+++...+.... .......+++.+++.++.|++.||+|||+.+ ++||||||+||++++
T Consensus 81 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~ 155 (288)
T cd05093 81 --PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGE 155 (288)
T ss_pred --ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEcc
Confidence 78999999999999999864421110 1122345899999999999999999999888 999999999999999
Q ss_pred CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHH
Q 041249 421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHN 499 (789)
Q Consensus 421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~ 499 (789)
++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||...... .+..
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~~~ 233 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIE 233 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH
Confidence 99999999999986654332222223335678999999988889999999999999999999 89998632211 1111
Q ss_pred HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249 500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH 574 (789)
Q Consensus 500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~ 574 (789)
.+.... ... ....+..++.+++..|++.++.+||+...+...+..
T Consensus 234 ~i~~~~---~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~ 278 (288)
T cd05093 234 CITQGR---VLQ---------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278 (288)
T ss_pred HHHcCC---cCC---------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 111000 000 001223457789999999999999999887544433
No 109
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=99.97 E-value=7.2e-32 Score=285.34 Aligned_cols=262 Identities=20% Similarity=0.296 Sum_probs=198.5
Q ss_pred cCCCCCCcccccCCccEEEEEEc----CCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLD----EGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
++|...+.||+|+||.||+|.+. ..++.|++|.+.... ......+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ---- 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Confidence 46778899999999999999863 356789999997443 233467889999999999999999999987655
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCc-------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNRED-------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil 417 (789)
..++||||+.+|+|.+++....... ........+++.+.+.++.|++.||+|||+.+ ++||||||+||+
T Consensus 81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nil 156 (283)
T cd05090 81 -PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL 156 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEE
Confidence 7899999999999999985331110 00111345889999999999999999999888 999999999999
Q ss_pred cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCcc
Q 041249 418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMN 496 (789)
Q Consensus 418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~ 496 (789)
+++++.+|++|||+++...............++..|+|||++....++.++|||||||++|||++ |..||.... ...
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~ 234 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQE 234 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHH
Confidence 99999999999999987654432222233445678999999988889999999999999999998 999986321 111
Q ss_pred HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
+...+....... ....+...+.+++..|++.++..||+...+...
T Consensus 235 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 235 VIEMVRKRQLLP------------------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHHcCCcCC------------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 111111110000 001233456678889999999999998876443
No 110
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=99.97 E-value=3.3e-32 Score=294.63 Aligned_cols=202 Identities=23% Similarity=0.264 Sum_probs=174.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||+||++....+++.||+|+++... ......+.+|+++++.++|+||+++++++.... .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-----~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-----N 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----e
Confidence 47888999999999999999999899999999997542 234567889999999999999999999887655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL 143 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRY---------EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKL 143 (330)
T ss_pred EEEEECCCCCCCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEe
Confidence 89999999999999998643 246889999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCC------CCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL------GSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||++......... ......||..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 144 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 144 ADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred ccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 999999876544322 222346899999999986 45688999999999999999999999963
No 111
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=99.97 E-value=5.6e-32 Score=282.55 Aligned_cols=254 Identities=22% Similarity=0.397 Sum_probs=199.5
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
..++|...+.||+|++|.||+|... +++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+.... ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 76 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-----PI 76 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-----Cc
Confidence 3467889999999999999999976 66789999976433 23567899999999999999999999887654 78
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++++||+.+|+|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|++
T Consensus 77 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~ 145 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSD--------EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIA 145 (261)
T ss_pred EEEEecCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEEC
Confidence 9999999999999998643 2456788999999999999999999887 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
|||.+......... ......++..|+|||+...+.++.++|||||||++|||++ |+.||.... .......+....+
T Consensus 146 dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~~ 222 (261)
T cd05072 146 DFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQRGYR 222 (261)
T ss_pred CCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHHHcCCC
Confidence 99999876543321 1122345678999999988889999999999999999998 999986321 1112222111111
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
. + ....+...+.+++.+|++.++-+||+.......+
T Consensus 223 ~-------~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 223 M-------P-----------------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred C-------C-----------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 0 0 0012234566889999999999999998775443
No 112
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=99.97 E-value=3.9e-33 Score=303.53 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=209.6
Q ss_pred CCCCCcccccCCccEEEEEEcCCc----eEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGR----TTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
....++||+|+||+||+|.|-..+ -+||||++... ..+...++.+|+-.|++++|||+++++|+|... .
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------T 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------h
Confidence 345679999999999999995444 35899998654 445578899999999999999999999999865 3
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
..||.+||+.|.|.++++.. ...+-....+.|..|||+||.|||.+. +|||||-++|||+..-.++|+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~h---------r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvki 839 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREH---------RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKI 839 (1177)
T ss_pred HHHHHHhcccchHHHHHHHh---------hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEE
Confidence 78999999999999999764 356778889999999999999999887 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMAL 505 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 505 (789)
.|||+++...++..+.......-.+.|||-|.+....|+.++|||||||++||++| |..|++...-+
T Consensus 840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------ 907 (1177)
T KOG1025|consen 840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------ 907 (1177)
T ss_pred EecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------
Confidence 99999999998887665555556678999999999999999999999999999998 99999732110
Q ss_pred CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccccc
Q 041249 506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIG 576 (789)
Q Consensus 506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~ 576 (789)
.+.+.+...- |....+.|...+..++.+||..+...||..++.......+.
T Consensus 908 --eI~dlle~ge------------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 908 --EIPDLLEKGE------------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred --HhhHHHhccc------------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 1122211111 12234578889999999999999999999988765544443
No 113
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=99.97 E-value=1.1e-31 Score=288.41 Aligned_cols=194 Identities=24% Similarity=0.350 Sum_probs=166.2
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||.||+|.+..+++.||+|.++... .........|+.++... +||||+++++++...+ ..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE-----HLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-----EEEEEE
Confidence 46999999999999999899999999996542 23345567777887755 8999999999987655 899999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 76 E~~~~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05620 76 EFLNGGDLMFHIQDK----------GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGM 142 (316)
T ss_pred CCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCC
Confidence 999999999988543 46788999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~ 198 (316)
T cd05620 143 CKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred CeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 87543222 122345689999999999999999999999999999999999999963
No 114
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=99.97 E-value=8.6e-32 Score=283.82 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=199.1
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY 341 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 341 (789)
++++|...+.||+|++|.||+|.+.. .+..||+|.+.... ......+..|+.++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL- 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence 56789999999999999999999986 67889999986543 333467899999999999999999999887655
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE 421 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~ 421 (789)
..++||||+.+|+|.+++...+... .....+++.+++.++.||+.||+|||+.+ ++||||||+||+++.+
T Consensus 83 ----~~~lv~e~~~g~~L~~~i~~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~ 152 (277)
T cd05036 83 ----PRFILLELMAGGDLKSFLRENRPRP---ERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCK 152 (277)
T ss_pred ----CcEEEEecCCCCCHHHHHHHhCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEecc
Confidence 6799999999999999987552111 12346899999999999999999999988 9999999999999865
Q ss_pred C---ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249 422 M---VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL 497 (789)
Q Consensus 422 ~---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~ 497 (789)
+ .+|++|||.++................+..|+|||++.+..+++++|||||||++|||++ |+.||+....
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~----- 227 (277)
T cd05036 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----- 227 (277)
T ss_pred CCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 4 689999999987643322111112233568999999999999999999999999999997 9999863211
Q ss_pred HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.............+ ....+...+.+++..|++.++.+||+...+..
T Consensus 228 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~ 273 (277)
T cd05036 228 QEVMEFVTGGGRLD---------------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273 (277)
T ss_pred HHHHHHHHcCCcCC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11111111100000 01123345678889999999999999987643
No 115
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=99.97 E-value=3.8e-32 Score=297.60 Aligned_cols=202 Identities=26% Similarity=0.328 Sum_probs=174.4
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||.||++....+++.||+|+++.. .......+..|++++..++|++|+++++.+.... .
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-----N 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence 4788899999999999999999989999999998643 2233467888999999999999999999987665 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++++||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL 142 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKK----------DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKL 142 (360)
T ss_pred EEEEEeCCCCccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEE
Confidence 99999999999999998643 46889999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCc---------------------------------cceeeecccccccCcccCCCCCcCccccchhh
Q 041249 427 GDFGLARFLPPTHVQ---------------------------------TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSY 473 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sf 473 (789)
+|||+++........ .......||..|+|||++.+..++.++|||||
T Consensus 143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 999998755322100 00113468999999999999899999999999
Q ss_pred HHHHHHHHHhcCCCCc
Q 041249 474 GILMLELIIRKKPSDI 489 (789)
Q Consensus 474 Gvvl~elltG~~P~~~ 489 (789)
||++|||++|+.||..
T Consensus 223 Gvilyel~tG~~Pf~~ 238 (360)
T cd05627 223 GVIMYEMLIGYPPFCS 238 (360)
T ss_pred cceeeecccCCCCCCC
Confidence 9999999999999963
No 116
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=99.97 E-value=4.3e-32 Score=297.73 Aligned_cols=205 Identities=22% Similarity=0.306 Sum_probs=174.7
Q ss_pred HHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249 265 LHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY 341 (789)
Q Consensus 265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 341 (789)
.....++|...+.||+|+||.||++....+++.||+|+++.. .......+..|+.+++.++||||+++++++....
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~- 116 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK- 116 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 344567899999999999999999999989999999998643 2233456788999999999999999999887655
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE 421 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~ 421 (789)
..++||||+++|+|.+++.. ..++...+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 117 ----~~~lv~Ey~~gg~L~~~l~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~ 178 (370)
T cd05596 117 ----YLYMVMEYMPGGDLVNLMSN-----------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS 178 (370)
T ss_pred ----EEEEEEcCCCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCC
Confidence 89999999999999998853 24678888999999999999999988 9999999999999999
Q ss_pred CceeeCcccccccCCCCCCccceeeecccccccCcccCCCC----CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS----EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+.+||+|||.+......... ......||+.|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus 179 ~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 179 GHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred CCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 99999999999876543211 12235689999999987653 478999999999999999999999973
No 117
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=99.97 E-value=2.3e-31 Score=280.58 Aligned_cols=244 Identities=20% Similarity=0.243 Sum_probs=190.5
Q ss_pred ccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
||+|+||+||++....+++.||+|.+.... ......+..|++++++++||||+++++++.... ..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~-----~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT-----HLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC-----eEEEEEecC
Confidence 699999999999999899999999986432 222345667999999999999999999887655 789999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
.+|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 76 ~g~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 76 NGGDLKYHIYNV--------GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred CCCCHHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 999999888543 2345889999999999999999999888 99999999999999999999999999987
Q ss_pred CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhcc
Q 041249 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVD 514 (789)
Q Consensus 435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d 514 (789)
...... .....|+..|+|||++.+..++.++|||||||++|||++|+.||....+. .......+......
T Consensus 145 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~------ 214 (277)
T cd05607 145 LKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE------ 214 (277)
T ss_pred cCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc------
Confidence 654321 22346889999999999888999999999999999999999999643211 11122222111110
Q ss_pred CCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249 515 STLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA 568 (789)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~ 568 (789)
+... ......++.+++..|.+.++..|++..+.
T Consensus 215 --~~~~-------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~ 247 (277)
T cd05607 215 --VKFE-------------------HQNFTEESKDICRLFLAKKPEDRLGSREK 247 (277)
T ss_pred --cccc-------------------cccCCHHHHHHHHHHhccCHhhCCCCccc
Confidence 0000 00123345688889999999999998654
No 118
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=99.97 E-value=1.2e-31 Score=278.93 Aligned_cols=250 Identities=21% Similarity=0.268 Sum_probs=200.4
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||+|++|.||+|....+++.|++|.+... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-----KLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-----EEE
Confidence 577788999999999999999989999999998643 3445678999999999999999999999987655 889
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+.+++|.+++... ....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+|++|
T Consensus 76 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~d 144 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ--------RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGD 144 (256)
T ss_pred EEEEeCCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcc
Confidence 999999999999998643 2356889999999999999999999887 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
||.++........ .....|+..|+|||+..+..++.++|||||||++|||++|+.||..... ....+......
T Consensus 145 f~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~ 217 (256)
T cd08529 145 LGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKIIRGV 217 (256)
T ss_pred cccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC
Confidence 9998876544321 2234578899999999999999999999999999999999999963221 11111110000
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
... +. ......+.+++.+|++.++.+||++.....
T Consensus 218 ~~~-----~~----------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 218 FPP-----VS----------------------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCC-----Cc----------------------cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 000 00 022345668888999999999999876643
No 119
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=99.97 E-value=1.1e-31 Score=280.24 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=198.7
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
..++|...+.||+|++|.||+|.+. +++.||+|.++... ...+.+.+|++++++++|+||+++++++.... ..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 76 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-----PI 76 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCC-----Ce
Confidence 4567888999999999999999986 56789999986543 23567889999999999999999999987655 78
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++||||+.+++|.+++... .+..+++.++..++.|++.|+.|||+.+ ++||||||+||++++++.+||+
T Consensus 77 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~ 145 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGG--------AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVA 145 (261)
T ss_pred eeeeecccCCcHHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEEC
Confidence 9999999999999998654 2456899999999999999999999888 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
|||+++........ .......+..|+|||+.....++.++||||||+++|||++ |+.||..... ......+.....
T Consensus 146 dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~ 222 (261)
T cd05068 146 DFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQQVDQGYR 222 (261)
T ss_pred CcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCC
Confidence 99999887643211 1112223457999999998899999999999999999999 9999863211 011111110000
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
. .....+...+.+++.+|++.++.+||+.......+
T Consensus 223 --------~----------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 223 --------M----------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred --------C----------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 0 00112334567888999999999999998765433
No 120
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=99.97 E-value=1e-31 Score=289.50 Aligned_cols=199 Identities=24% Similarity=0.319 Sum_probs=169.9
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCce
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 346 (789)
+|...+.||+|+||+||+|....+++.||+|+++... ......+..|++++..+. |++|+++.+++...+ .
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD-----R 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-----E
Confidence 4777889999999999999999899999999986442 233456778888998885 577778888876655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~----------~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQV----------GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEE
Confidence 89999999999999998643 46899999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||+++....... ......||..|+|||++....++.++|||||||++|||++|+.||..
T Consensus 143 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 143 ADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred eccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 99999886433321 12235589999999999988899999999999999999999999974
No 121
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=99.97 E-value=8.8e-32 Score=284.12 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=200.9
Q ss_pred hcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 342 (789)
.++|...+.||+|+||.||+|.... +++.||||.++..... ..+.+.+|++++++++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD-- 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC--
Confidence 4568888999999999999998753 3578999999765444 4578999999999999999999999987765
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCcc----ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDE----VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill 418 (789)
..++||||+++|+|.+++........ .......+++.++..++.|++.|++|||+.+ ++||||||+||++
T Consensus 82 ---~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili 155 (280)
T cd05049 82 ---PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLV 155 (280)
T ss_pred ---CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEE
Confidence 78999999999999999975421100 0123456899999999999999999999888 9999999999999
Q ss_pred CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL 497 (789)
Q Consensus 419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~ 497 (789)
+.++.+||+|||.++...............++..|+|||++....+++++|||||||++|||++ |+.||..... ...
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--~~~ 233 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--EEV 233 (280)
T ss_pred cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHH
Confidence 9999999999999986543332222223345678999999999999999999999999999999 9999863211 112
Q ss_pred HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
...++..... .. ...+...+.+++..|++.++..|++..++.
T Consensus 234 ~~~~~~~~~~----~~--------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 275 (280)
T cd05049 234 IECITQGRLL----QR--------------------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275 (280)
T ss_pred HHHHHcCCcC----CC--------------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 2222110000 00 002234566888999999999999887663
No 122
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=99.97 E-value=9.5e-32 Score=279.25 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=191.1
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|++++++++||||++++++|.... ..++|+||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-----CeEEEEeec
Confidence 46899999999999998889999999876443 334567999999999999999999999987655 789999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
.+++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+..
T Consensus 76 ~~~~L~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 76 QGGDFLTFLRTE---------GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred cCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcc
Confidence 999999998533 245789999999999999999999888 99999999999999999999999999886
Q ss_pred CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhc
Q 041249 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIV 513 (789)
Q Consensus 435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (789)
..............++..|+|||.+.++.++.++||||||+++|||++ |..||...... .......
T Consensus 144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~----------- 210 (252)
T cd05084 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIE----------- 210 (252)
T ss_pred cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHH-----------
Confidence 543321111111223467999999999899999999999999999998 88888632110 0111111
Q ss_pred cCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 514 DSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 514 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
..... .....+...+.+++.+|.+.++..||+...+.
T Consensus 211 -~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~ 247 (252)
T cd05084 211 -QGVRL------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVH 247 (252)
T ss_pred -cCCCC------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 00000 00112344567888999999999999998764
No 123
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=99.97 E-value=1.9e-31 Score=280.31 Aligned_cols=261 Identities=22% Similarity=0.357 Sum_probs=198.8
Q ss_pred CCCCCcccccCCccEEEEEEcCC---ceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND 345 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 345 (789)
|...+.||+|+||.||+|....+ +..||+|.++... ......+..|++.++.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 55678999999999999998643 3789999987543 3335678999999999999999999998866542 2233
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++++||+.+|+|..++..... ......+++.+...++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRL----GGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhc----cCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEE
Confidence 47999999999999999854311 123357899999999999999999999888 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHh
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMA 504 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 504 (789)
|+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||..... ....++....
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~~~ 231 (273)
T cd05035 154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRHG 231 (273)
T ss_pred ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC
Confidence 999999987765443222223345678999999988889999999999999999999 8888863211 1111111111
Q ss_pred CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
.. +. ....+..++.+++.+|++.++-+||+...+...
T Consensus 232 ~~--------~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 232 NR--------LK----------------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CC--------CC----------------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 00 011234466788889999999999998876443
No 124
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=99.97 E-value=1.2e-31 Score=281.29 Aligned_cols=258 Identities=19% Similarity=0.217 Sum_probs=201.2
Q ss_pred HHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 264 NLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
|++.+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++|+||+++++++....
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 78 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG--- 78 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC---
Confidence 45678889999999999999999999998889999999987776666778999999999999999999999987765
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCC--CHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNL--NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE- 420 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~- 420 (789)
..++|+||+.+++|.+++... ...+ ++..+..++.|++.||+|||+.+ ++||||||+||+++.
T Consensus 79 --~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~ 144 (268)
T cd06624 79 --FFKIFMEQVPGGSLSALLRSK---------WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTY 144 (268)
T ss_pred --EEEEEEecCCCCCHHHHHHHh---------cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCC
Confidence 789999999999999998643 1233 77888999999999999999887 999999999999986
Q ss_pred CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC--cCccccchhhHHHHHHHHHhcCCCCccccCCccHH
Q 041249 421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498 (789)
Q Consensus 421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~ 498 (789)
.+.+||+|||.+........ ......|+..|+|||+..... ++.++||||||+++|||++|+.||...... ...
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~--~~~ 220 (268)
T cd06624 145 SGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP--QAA 220 (268)
T ss_pred CCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh--hhh
Confidence 67999999999886643321 112235788999999987654 789999999999999999999998632111 111
Q ss_pred HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.+...... ..+.+ ...+...+.+++..|++.++-+||+..+...
T Consensus 221 ~~~~~~~~------~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 221 MFKVGMFK------IHPEI----------------------PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred Hhhhhhhc------cCCCC----------------------CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11100000 00000 0122334567788999999999999877644
No 125
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=99.97 E-value=4.3e-32 Score=294.10 Aligned_cols=206 Identities=29% Similarity=0.405 Sum_probs=177.6
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCC-CCCCceEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVD-YQGNDFKAL 349 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~l 349 (789)
|...+.||+|+||.||+|+.+.+|+.||||+++... ....+..-+|++++++++|+|||+++++-.... +.-.....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 345678999999999999999999999999997653 344667888999999999999999998854432 111446789
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC--CCC--cee
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD--EEM--VSH 425 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~k 425 (789)
|||||.+|+|+..+.+. .....|++.+.+.++.+++.||.|||.++ ||||||||.||++- .++ .-|
T Consensus 95 vmEyC~gGsL~~~L~~P-------EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-------ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred EEeecCCCcHHHHhcCc-------ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEe
Confidence 99999999999999765 45678999999999999999999999998 99999999999994 334 349
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
|+|||.|+.+++.. ......||..|.|||+... ..|+.-+|.|||||++|+.+||..||-..
T Consensus 165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999999998776 4567889999999999985 78999999999999999999999999743
No 126
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=99.97 E-value=1.5e-31 Score=284.02 Aligned_cols=266 Identities=23% Similarity=0.348 Sum_probs=204.3
Q ss_pred cCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
.+|...+.||+|+||.||+|.+. .+...|++|.++.......+.+.+|++.+++++|+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD---- 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC----
Confidence 45777889999999999999864 235679999987666666678999999999999999999999987655
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill 418 (789)
..++||||+.+++|.+++....... ........+++.+++.++.|++.|++|||+.+ ++||||||+||++
T Consensus 81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~ 156 (291)
T cd05094 81 -PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLV 156 (291)
T ss_pred -ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEE
Confidence 7899999999999999996542110 00112345899999999999999999999888 9999999999999
Q ss_pred CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL 497 (789)
Q Consensus 419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~ 497 (789)
+.++.+||+|||++................++..|+|||+.....++.++|||||||++|||+| |+.||...... ..
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~ 234 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EV 234 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987654432222233446788999999998899999999999999999999 99998632111 11
Q ss_pred HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccc
Q 041249 498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHI 575 (789)
Q Consensus 498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l 575 (789)
.+...... ..+ ....+...+.+++..|++.++..||+...+...+..+
T Consensus 235 ~~~~~~~~---~~~---------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 IECITQGR---VLE---------------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHhCCC---CCC---------------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11111000 000 0012334567899999999999999998886555443
No 127
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=99.97 E-value=1.6e-31 Score=288.00 Aligned_cols=194 Identities=26% Similarity=0.323 Sum_probs=163.5
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHH-HHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECR-ALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||.||+|+...+++.||+|++.... ......+..|+. +++.++||||+++++++...+ ..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~-----~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE-----KLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----EEEEEE
Confidence 46999999999999999899999999986432 222334555554 678889999999999887655 889999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+++|+|...+... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 142 (321)
T cd05603 76 DYVNGGELFFHLQRE----------RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGL 142 (321)
T ss_pred cCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCC
Confidence 999999998887543 45788889999999999999999888 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++...... .......|+..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 143 CKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred CccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 87542222 122345689999999999888899999999999999999999999963
No 128
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=99.97 E-value=1.4e-31 Score=287.90 Aligned_cols=194 Identities=24% Similarity=0.312 Sum_probs=167.1
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||+||+|.+..+++.||+|+++... ......+..|++++..+ +||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~-----~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD-----RLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence 46999999999999999889999999987442 23345677888888888 7999999999987655 899999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|+|..++... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~ 142 (318)
T cd05570 76 EYVNGGDLMFHIQRS----------GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGM 142 (318)
T ss_pred cCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCC
Confidence 999999999888543 46899999999999999999999888 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 143 CKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred CeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 875332221 12234589999999999999999999999999999999999999963
No 129
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=99.97 E-value=1.2e-31 Score=283.63 Aligned_cols=263 Identities=18% Similarity=0.242 Sum_probs=199.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
.+|...+.||+|+||.||+|.+.. .++.||+|+++..... ....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--- 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ--- 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC---
Confidence 346677899999999999999753 3578999999755433 3466889999999999999999999987665
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil 417 (789)
..++++||+.+++|.+++....... ........+++..+..++.|++.||+|+|+.+ ++||||||+||+
T Consensus 82 --~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil 156 (283)
T cd05091 82 --PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVL 156 (283)
T ss_pred --ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheE
Confidence 7899999999999999985321110 01112345889999999999999999999888 999999999999
Q ss_pred cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCcc
Q 041249 418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMN 496 (789)
Q Consensus 418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~ 496 (789)
+++++.+||+|||+++...............+++.|+|||.+..+.++.++||||||+++|||++ |..||....
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----- 231 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----- 231 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----
Confidence 99999999999999887654432222233446778999999988899999999999999999998 888886321
Q ss_pred HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
..++........... + ...|...+.+++..|++.++..||+...+...+
T Consensus 232 ~~~~~~~i~~~~~~~-----~----------------------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 232 NQDVIEMIRNRQVLP-----C----------------------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred HHHHHHHHHcCCcCC-----C----------------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 112222111111000 0 013445577889999999999999998775443
No 130
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=99.97 E-value=8.4e-32 Score=285.90 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=199.5
Q ss_pred CCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
+|...+.||+|+||.||+|.... +...|++|.+..... .....+..|++++++++||||+++++.|...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG---- 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC----
Confidence 46778999999999999998742 236799998865433 33467889999999999999999999987655
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCc--------------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecC
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNRED--------------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCD 410 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~d 410 (789)
..++|+||+.+|+|.+++....... ........+++.++..++.|++.||+|||+.+ ++|||
T Consensus 77 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~d 152 (290)
T cd05045 77 -PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRD 152 (290)
T ss_pred -CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhh
Confidence 6899999999999999986532111 01122356899999999999999999999888 99999
Q ss_pred CCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCc
Q 041249 411 LKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDI 489 (789)
Q Consensus 411 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~ 489 (789)
|||+||++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |+.||..
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999987654432222223345678999999988889999999999999999999 9999863
Q ss_pred cccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 490 MFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
... ..+.++.... .... ....+...+.+++..|++.++-.||+...+.
T Consensus 233 ~~~--~~~~~~~~~~------------~~~~------------------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 233 IAP--ERLFNLLKTG------------YRME------------------RPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred CCH--HHHHHHHhCC------------CCCC------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 211 1111111111 0000 0112334567888999999999999998875
Q ss_pred cccc
Q 041249 570 SILP 573 (789)
Q Consensus 570 ~~l~ 573 (789)
..+.
T Consensus 281 ~~l~ 284 (290)
T cd05045 281 KELE 284 (290)
T ss_pred HHHH
Confidence 4443
No 131
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=99.97 E-value=1.6e-31 Score=288.48 Aligned_cols=194 Identities=25% Similarity=0.315 Sum_probs=168.4
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||+||+|....+++.||+|+++... ....+.+..|+.++.++ +||+|+++++.+.... ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS-----RLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-----EEEEEE
Confidence 46999999999999999899999999997542 23345688899999888 6999999999887655 799999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+++|+|..++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (327)
T cd05617 76 EYVNGGDLMFHMQRQ----------RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGM 142 (327)
T ss_pred eCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEecccc
Confidence 999999999888543 46899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 143 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 143 CKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 87533222 112345689999999999999999999999999999999999999964
No 132
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.97 E-value=4.5e-32 Score=286.94 Aligned_cols=253 Identities=21% Similarity=0.246 Sum_probs=209.5
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++|...+.+|+|+||.++..+.+..++.+|+|.+..... ...+...+|+.++++++|||||.+.+.+.+.+ ...
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----QLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----ceE
Confidence 578888999999999999999999999999999986643 33457899999999999999999999987655 238
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
+|||+|+++|++.+.+... .+..+++.++..|+.|++.|+.|||... |+|||||++|||++.+..+||+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~--------k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLg 148 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQ--------KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLG 148 (426)
T ss_pred EEEEeecCCCCHHHHHHHH--------hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeec
Confidence 9999999999999999866 3577999999999999999999999776 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
|||+|+.+.+... ....+.||+-||+||.+.+.+|..|+||||+||++|||++-+++|.. .+....+....+.
T Consensus 149 DfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-----~~m~~Li~ki~~~ 221 (426)
T KOG0589|consen 149 DFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-----SNMSELILKINRG 221 (426)
T ss_pred chhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-----cchHHHHHHHhhc
Confidence 9999999987652 23357799999999999999999999999999999999999999973 2333333322221
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
..+|... ....++..++..|++..+-.||+.......
T Consensus 222 ----~~~Plp~-----------------------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 ----LYSPLPS-----------------------MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----cCCCCCc-----------------------cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1222221 223445577788899999999998877554
No 133
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=99.97 E-value=1.1e-31 Score=283.41 Aligned_cols=252 Identities=22% Similarity=0.331 Sum_probs=198.1
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCce----EEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRT----TVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
.++|...+.||+|+||+||+|.+..+++ .||+|+++... ......+..|+..++.+.|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence 4678889999999999999999876665 48999986543 33456788999999999999999999998642
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV 423 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 423 (789)
..++++||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 82 --~~~l~~~~~~~g~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 82 --TVQLVTQLMPYGCLLDYVREN---------KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNH 147 (279)
T ss_pred --CcEEEEEcCCCCCHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCc
Confidence 467999999999999998643 246899999999999999999999888 999999999999999999
Q ss_pred eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249 424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR 502 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 502 (789)
+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||+... ...+..++.
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~ 225 (279)
T cd05109 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLE 225 (279)
T ss_pred EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHH
Confidence 99999999987754432222222345678999999988899999999999999999998 899986321 112222222
Q ss_pred HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
...... ....+...+.+++..|++.++..||+......
T Consensus 226 ~~~~~~------------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 226 KGERLP------------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCCcCC------------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111000 01123445668888999999999999988743
No 134
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=99.97 E-value=1.4e-31 Score=278.83 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=193.9
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
++|+..+.||+|+||.||++.+. ++..+|+|.+.... .....+.+|++++++++||||+++++++.... ..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-----PLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC-----CEEE
Confidence 56888899999999999999987 56789999876332 23467889999999999999999999987655 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+|++||
T Consensus 77 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~ 144 (256)
T cd05114 77 VTEFMENGCLLNYLRQR---------QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCC
Confidence 99999999999998643 135789999999999999999999888 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
|.++........ ......++..|+|||......++.++||||||+++|||++ |+.||.... .......+.....
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i~~~~~-- 219 (256)
T cd05114 145 GMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMISRGFR-- 219 (256)
T ss_pred CCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCC--
Confidence 999876433211 1122335668999999988889999999999999999999 899986321 1111111111100
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
...+. .....+.+++.+|++.++..||+.....
T Consensus 220 ---~~~~~-------------------------~~~~~~~~li~~c~~~~p~~Rps~~~l~ 252 (256)
T cd05114 220 ---LYRPK-------------------------LASMTVYEVMYSCWHEKPEGRPTFAELL 252 (256)
T ss_pred ---CCCCC-------------------------CCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 00000 1123567889999999999999988763
No 135
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=99.97 E-value=8.4e-32 Score=273.01 Aligned_cols=209 Identities=26% Similarity=0.380 Sum_probs=176.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCc-cceeeeeeccCCC-CCCc
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRN-LVKVFTACSGVDY-QGND 345 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~-~~~~ 345 (789)
..|...++||+|+||+||+|+...+|+.||+|.++.... .......+|+.+++.++|+| |+++++++..... +...
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 456667889999999999999999999999999987755 24567789999999999999 9999999876542 3333
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++|+||+.. +|..++..... ....++...+..++.|++.||+|||+++ |+||||||+||++++.+.+|
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~------~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPK------KPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLK 160 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccc------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEe
Confidence 67899999986 99999976521 1145777899999999999999999998 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
|+|||+|+...-+... .+...+|..|+|||.+.+. .|++..||||+||++.||++++.-|...
T Consensus 161 laDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~ 224 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD 224 (323)
T ss_pred eeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC
Confidence 9999999977643321 3345689999999999987 5999999999999999999988887643
No 136
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=99.97 E-value=7.6e-32 Score=312.83 Aligned_cols=212 Identities=24% Similarity=0.356 Sum_probs=175.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~-----~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD-----P 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-----E
Confidence 46888999999999999999999889999999986542 223567899999999999999999999987655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccc-cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEV-DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
.++||||+++|+|.+++......... ......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEE
Confidence 89999999999999998643111111 112345678889999999999999999988 99999999999999999999
Q ss_pred eCcccccccCCCCCC----------------ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHV----------------QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999987622110 0011124589999999999999999999999999999999999999964
No 137
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=99.97 E-value=1.3e-31 Score=290.19 Aligned_cols=200 Identities=25% Similarity=0.326 Sum_probs=169.4
Q ss_pred CCCCCCcccccCCccEEEEEEc---CCceEEEEEEeccc----cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249 271 GFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLH----HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 342 (789)
+|...+.||+|+||.||++... .+++.||+|++... .....+.+..|++++..+ .|++|+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA-- 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence 5778899999999999998864 46889999998643 222345688899999999 5999999998887655
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM 422 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~ 422 (789)
..++||||+.+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 79 ---~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 79 ---KLHLILDYVSGGEMFTHLYQR----------DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEG 142 (332)
T ss_pred ---EEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCC
Confidence 789999999999999998643 46889999999999999999999988 99999999999999999
Q ss_pred ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
.+||+|||+++........ ......||..|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 143 ~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 9999999999865433321 122456999999999987654 78999999999999999999999964
No 138
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=99.97 E-value=1.8e-31 Score=288.02 Aligned_cols=193 Identities=26% Similarity=0.328 Sum_probs=162.7
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHH-HHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAEC-RALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||+||+|....+++.||+|++.... ......+..|. .+++.++|+||+++++++...+ ..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~-----~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-----KLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-----eEEEEE
Confidence 46999999999999999889999999986432 12223344444 4567889999999999987665 789999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~ 142 (325)
T cd05602 76 DYINGGELFYHLQRE----------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGL 142 (325)
T ss_pred eCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCC
Confidence 999999999988643 45778888899999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 143 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (325)
T cd05602 143 CKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred CcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCC
Confidence 875432221 1234568999999999999899999999999999999999999996
No 139
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=99.97 E-value=1.4e-31 Score=280.43 Aligned_cols=258 Identities=21% Similarity=0.286 Sum_probs=201.9
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||.||+|+...+++.||||.++.. .......+.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-----E 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-----e
Confidence 5788999999999999999999889999999987543 2333457889999999999999999999987655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++|+||+++|+|.+++... ......++...+..++.|++.||+|||+.+ ++|+||||+||+++.++.+++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l 147 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYF------KKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCcHHHHHHHh------hhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEE
Confidence 89999999999999888532 112345788999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
+|||.+........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... .....+......
T Consensus 148 ~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~~~~ 222 (267)
T cd08228 148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLFSLCQKIEQ 222 (267)
T ss_pred CccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc---ccHHHHHHHHhc
Confidence 99999987654332 1123458889999999988889999999999999999999999986321 122222221111
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.. .+.. ........+.+++.+|++.++..||+..++...+
T Consensus 223 ~~-----~~~~---------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 223 CD-----YPPL---------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred CC-----CCCC---------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 00 0000 0012234566888899999999999998875433
No 140
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=99.97 E-value=1.9e-31 Score=278.85 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=197.1
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-----hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-----RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
++|...+.||+|++|.||+|....+++.||+|.+..... .....+.+|++++++++||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE---- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----
Confidence 579999999999999999999988899999999864321 12356888999999999999999999987765
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+
T Consensus 78 -~~~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 78 -TLSIFMEYMPGGSVKDQLKAY----------GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNV 143 (263)
T ss_pred -eEEEEEEECCCCcHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 899999999999999988643 45788899999999999999999988 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccc-eeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249 425 HVGDFGLARFLPPTHVQTS-SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 503 (789)
||+|||+++.......... .....++..|+|||...+..++.++||||||+++|||++|+.||.... ......+.
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~ 219 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE----AMAAIFKI 219 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc----hHHHHHHH
Confidence 9999999987654321111 123457789999999999889999999999999999999999986321 11111111
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
..... .+.+ ...+...+.++...|++.++..||+.....
T Consensus 220 ~~~~~-----~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 258 (263)
T cd06625 220 ATQPT-----NPQL----------------------PSHVSPDARNFLRRTFVENAKKRPSAEELL 258 (263)
T ss_pred hccCC-----CCCC----------------------CccCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 10000 0000 012233456788899999999999877653
No 141
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=99.97 E-value=2.9e-32 Score=288.52 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=206.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcC----CceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDE----GRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
+.....++||.|-||.||+|.+.. ..-.||||+.+.+ .....+.|..|.-+|+.++||||++++|+|.+.
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~----- 463 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ----- 463 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-----
Confidence 444567789999999999999852 2346899999865 445577899999999999999999999999864
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..|+|||.++-|-|++|+..+ ...++..+...++.|++.||+|||+.. +|||||.++|||+....-+
T Consensus 464 -P~WivmEL~~~GELr~yLq~n---------k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQN---------KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCV 530 (974)
T ss_pred -ceeEEEecccchhHHHHHHhc---------cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCccee
Confidence 489999999999999999865 456888999999999999999999877 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 503 (789)
|++|||+++.+.++...... ...-...|||||.+.-.+++..+|||-|||.+||+++ |..||......
T Consensus 531 KLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------- 599 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------- 599 (974)
T ss_pred eecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------
Confidence 99999999999887754333 2223457999999999999999999999999999987 99999743221
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH 574 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~ 574 (789)
|++-. ....-|.....+|...+..++.+||..+|.+||........+..
T Consensus 600 -------DVI~~---------------iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 600 -------DVIGH---------------IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred -------ceEEE---------------ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 11100 00011123345899999999999999999999999877655443
No 142
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=99.97 E-value=1.7e-33 Score=274.00 Aligned_cols=199 Identities=25% Similarity=0.349 Sum_probs=177.6
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
+-|++.+++|+|+||.||+|.++++|+.||||.+... .+.+++.+|+.++.+...|++|++||.+.-.. ..|+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLWI 105 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLWI 105 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceEe
Confidence 3577788999999999999999999999999998543 45678999999999999999999999976555 8999
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|||||..|+..+.++.+ .+.+++.++..++.+.++||+|||... -+|||||+.|||++.++++||+||
T Consensus 106 VMEYCGAGSiSDI~R~R---------~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADF 173 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRAR---------RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADF 173 (502)
T ss_pred ehhhcCCCcHHHHHHHh---------cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhc
Confidence 99999999999998654 478999999999999999999999776 899999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|.|..+.+... ....+.||+.|||||++..-.|+.++||||+|++..||.-|++||.+
T Consensus 174 GVAGQLTDTMA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 174 GVAGQLTDTMA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred cccchhhhhHH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 99887654432 12346799999999999999999999999999999999999999974
No 143
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=99.97 E-value=1.4e-31 Score=285.79 Aligned_cols=255 Identities=21% Similarity=0.287 Sum_probs=197.4
Q ss_pred hcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDY 341 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 341 (789)
.++|...+.||+|+||.||+|.+. ..+..||+|.++... ....+.+.+|+++++++ +|+||+++++++....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG- 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC-
Confidence 467999999999999999999862 345689999987543 33356789999999999 7999999999987665
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE 421 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~ 421 (789)
..++||||+.+|+|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++++
T Consensus 113 ----~~~lv~e~~~~~~L~~~i~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~ 177 (302)
T cd05055 113 ----PILVITEYCCYGDLLNFLRRK--------RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHG 177 (302)
T ss_pred ----ceEEEEEcCCCCcHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCC
Confidence 789999999999999998643 1234899999999999999999999887 9999999999999999
Q ss_pred CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHH
Q 041249 422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNF 500 (789)
Q Consensus 422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~ 500 (789)
+.+|++|||.++...............++..|+|||.+....++.++|||||||++|||++ |+.||...... ..+...
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~~ 256 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKL 256 (302)
T ss_pred CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHHH
Confidence 9999999999987654432222222345678999999999999999999999999999998 99998632111 111111
Q ss_pred HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
....++.. . .......+.+++.+|++.++.+||+..++..
T Consensus 257 ~~~~~~~~--------~----------------------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 257 IKEGYRMA--------Q----------------------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHcCCcCC--------C----------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11110000 0 0011234667888999999999999987744
No 144
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=99.97 E-value=1.8e-31 Score=288.77 Aligned_cols=201 Identities=24% Similarity=0.293 Sum_probs=172.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||+||++....+++.||+|+++.. .......+.+|+.++..++|+||+++++++.... .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN-----N 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-----e
Confidence 4788899999999999999999988999999998642 2233456889999999999999999999987665 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl 143 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRL 143 (331)
T ss_pred EEEEEecCCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEE
Confidence 99999999999999998542 246888999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
+|||++......... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 144 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 144 ADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 999998766543321 1122458999999999863 457899999999999999999999996
No 145
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=99.97 E-value=2.3e-31 Score=281.78 Aligned_cols=199 Identities=26% Similarity=0.372 Sum_probs=172.4
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
|+..+.||+|+||+||+|.+..+++.||+|.+.... ......+..|++++++++|++|+++.+.+...+ ..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-----ALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-----EEE
Confidence 666789999999999999999899999999986442 223455788999999999999999998887655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+.+|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~D 145 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNM--------GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISD 145 (285)
T ss_pred EEEEeccCccHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEec
Confidence 999999999999888543 2346899999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||++........ .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 146 fg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 146 LGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred CCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 999976543321 1234689999999999988999999999999999999999999973
No 146
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=99.97 E-value=1.5e-32 Score=277.61 Aligned_cols=201 Identities=29% Similarity=0.397 Sum_probs=169.0
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
|...+++|.|+||.||+|...++++.||||....+.. .--.|+++|+++.|||||++..+|......+.-...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 4557899999999999999999999999999854433 334689999999999999999888765533223467899
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-CceeeCccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVGDFG 430 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg 430 (789)
|||+. +|.+.++.. ....+.++...+.-+..|+.+||+|||+.+ |+||||||+|+|+|.+ +.+||+|||
T Consensus 102 eymP~-tL~~~~r~~------~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHY------TRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HhchH-HHHHHHHHH------hhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCC
Confidence 99996 888888642 123467888889999999999999999988 9999999999999987 889999999
Q ss_pred ccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
.|+.+...... ....-|..|+|||.+.+.+ |+.+.||||.|||+.||+-|++-|..
T Consensus 172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 99998777643 2344678899999999865 99999999999999999999998863
No 147
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=99.97 E-value=2.4e-31 Score=280.34 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=200.1
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCC-----ceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEG-----RTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 342 (789)
.++|...+.||+|+||.||+|.+... +..||+|.+.... ......+.+|+++++.++|+||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ-- 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC--
Confidence 46788899999999999999998643 4789999986443 233567889999999999999999999987655
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM 422 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~ 422 (789)
..++||||+.+|+|.+++.......+.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 83 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~ 156 (277)
T cd05032 83 ---PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDL 156 (277)
T ss_pred ---CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCC
Confidence 789999999999999999754221111122345789999999999999999999887 99999999999999999
Q ss_pred ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHH
Q 041249 423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFA 501 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 501 (789)
.+||+|||+++...............++..|+|||....+.++.++|||||||++||+++ |+.||.... ...+..+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~~~~~ 234 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--NEEVLKFV 234 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--HHHHHHHH
Confidence 999999999987654432222223346788999999988889999999999999999998 999986321 11111111
Q ss_pred HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
. ...... . ...+...+.+++..|++.++-.||+.....
T Consensus 235 ~---~~~~~~-----~----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 272 (277)
T cd05032 235 I---DGGHLD-----L----------------------PENCPDKLLELMRMCWQYNPKMRPTFLEIV 272 (277)
T ss_pred h---cCCCCC-----C----------------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 1 000000 0 012345677889999999999999887653
No 148
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=99.97 E-value=3.5e-31 Score=278.32 Aligned_cols=260 Identities=23% Similarity=0.373 Sum_probs=195.5
Q ss_pred CCCCCcccccCCccEEEEEEcCCce--EEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCce
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRT--TVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGNDF 346 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~~ 346 (789)
|...+.||+|+||.||+|++..++. .||+|.++.. .......+..|++.++.++|+||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999976654 6999998654 23445678899999999999999999998754321 22235
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++++||+.+|+|.+++..... ......+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRL----GDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcc----cCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEE
Confidence 7899999999999988753311 123356899999999999999999999887 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMAL 505 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 505 (789)
+|||+++...............++..|+|||......++.++||||||+++|||++ |+.||.... ...+...++..
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~- 230 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIYDYLRQG- 230 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHcC-
Confidence 99999987754432211222346678999999998899999999999999999999 788886321 11111111110
Q ss_pred CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.... ....+...+.+++..|++.++.+||+......
T Consensus 231 --~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 231 --NRLK---------------------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred --CCCC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0000 00123344668889999999999999887643
No 149
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=99.97 E-value=1.3e-31 Score=289.66 Aligned_cols=201 Identities=22% Similarity=0.292 Sum_probs=173.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||+||++....+++.||+|++... .......+.+|+.++..++|++|+++++++...+ .
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~-----~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN-----Y 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence 4788899999999999999999989999999998642 2233456888999999999999999999987665 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~---------~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl 143 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRL 143 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEE
Confidence 99999999999999999642 245788899999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
+|||+++........ ......|+..|+|||++.. +.++.++|||||||++|||++|+.||.
T Consensus 144 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 144 ADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 999999876543321 1223469999999998865 568899999999999999999999996
No 150
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=99.97 E-value=1.9e-31 Score=280.29 Aligned_cols=259 Identities=20% Similarity=0.246 Sum_probs=199.8
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCC-C
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQG-N 344 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~-~ 344 (789)
.+++.|+..+.||+|+||+||+|.+..+++.||+|.+.... .....+..|++++.++ +|+||+++++++......+ .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46778899999999999999999999889999999986543 3345788999999999 7999999999987644322 2
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
...++||||+.+|+|.+++... ....+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--------~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT--------KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCE
Confidence 3689999999999999998643 2346889999999999999999999988 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHH
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN 499 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~ 499 (789)
||+|||++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||+.... ...
T Consensus 151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~ 224 (272)
T cd06637 151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRA 224 (272)
T ss_pred EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHH
Confidence 9999999886543221 123356889999999886 34588899999999999999999999963211 111
Q ss_pred HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
..... ........+ ..+...+.++..+|++.++.+||+...+..
T Consensus 225 ~~~~~-~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 225 LFLIP-RNPAPRLKS--------------------------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHh-cCCCCCCCC--------------------------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11100 000000000 112334567888999999999999876643
No 151
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=99.97 E-value=1.6e-31 Score=284.63 Aligned_cols=250 Identities=20% Similarity=0.265 Sum_probs=199.0
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
.+|...+.||+|++|.||+|....+++.||+|.+..........+..|+++++.++|+|++++++.+.... ..++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-----~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-----EEEE
Confidence 57888899999999999999998889999999998766666678999999999999999999999987655 8999
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 95 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~df 160 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 160 (296)
T ss_pred eecccCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECcc
Confidence 9999999999998843 24788899999999999999999888 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 509 (789)
|.+......... .....|+..|+|||......++.++|||||||++|||++|+.||..... ...+.. ......
T Consensus 161 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~-~~~~~~ 233 (296)
T cd06654 161 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYL-IATNGT 233 (296)
T ss_pred ccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHH-HhcCCC
Confidence 998876543311 1234588899999999888899999999999999999999999963221 111111 000000
Q ss_pred hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.....+ ......+.+++.+|+..++..||+......
T Consensus 234 ~~~~~~-------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PELQNP-------------------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCc-------------------------cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000000 011234557778999999999999876644
No 152
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=1.5e-32 Score=293.28 Aligned_cols=194 Identities=24% Similarity=0.374 Sum_probs=172.6
Q ss_pred cccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCC
Q 041249 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQN 356 (789)
Q Consensus 277 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~ 356 (789)
++|+|.||+||-|++..+...+|||-+.....+..+-+.+||+..+.++|.|||+++|.|.+.. +.-|.||..++
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-----f~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-----FFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-----eEEEEeecCCC
Confidence 7999999999999999999999999998777777888999999999999999999999987655 88899999999
Q ss_pred CChhhhccCCCCCccccCCCCCC--CHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCceeeCcccccc
Q 041249 357 GSLEEWLYPVNREDEVDKAPRNL--NLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSHVGDFGLAR 433 (789)
Q Consensus 357 g~L~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~ 433 (789)
|+|..++... +.++ ++.++-.+.+||++||.|||... |||||||-.|||++. .|.+||+|||-++
T Consensus 657 GSLSsLLrsk---------WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsK 724 (1226)
T KOG4279|consen 657 GSLSSLLRSK---------WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSK 724 (1226)
T ss_pred CcHHHHHHhc---------cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccch
Confidence 9999999754 4555 78889999999999999999888 999999999999975 5788999999998
Q ss_pred cCCCCCCccceeeecccccccCcccCCCCC--cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 434 FLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 434 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
.+.--.+ .+....||..|||||++..|+ |+..+|||||||++.||.||++||..
T Consensus 725 RLAginP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 725 RLAGINP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred hhccCCc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 7653332 234467999999999998876 89999999999999999999999973
No 153
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=99.97 E-value=1.9e-31 Score=283.58 Aligned_cols=268 Identities=20% Similarity=0.323 Sum_probs=203.6
Q ss_pred HHHhhcCCCCCCcccccCCccEEEEEEcCC-----ceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249 265 LHNATDGFSSANLIGTGSFGSVYKGVLDEG-----RTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACS 337 (789)
Q Consensus 265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 337 (789)
+..+.++|+..+.||+|+||.||++.+... ...||+|.+.... ......+.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 344567888899999999999999998643 3789999987542 23446688999999999 8999999999987
Q ss_pred cCCCCCCceEEEEeeccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL 411 (789)
Q Consensus 338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl 411 (789)
... ..+++|||+.+|+|.+++.......+ .......+++..++.++.|++.||+|||+.+ ++||||
T Consensus 87 ~~~-----~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dl 158 (293)
T cd05053 87 QEG-----PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDL 158 (293)
T ss_pred CCC-----CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 655 78999999999999999865311100 0123457899999999999999999999887 999999
Q ss_pred CCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcc
Q 041249 412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIM 490 (789)
Q Consensus 412 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~ 490 (789)
||+||++++++.+|++|||.++...............++..|+|||...+..++.++|||||||++||+++ |..||...
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999999999999997765432222222335678999999988899999999999999999997 99998632
Q ss_pred ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
...+..+..... .. ......+...+.+++..|++.++-.||+......
T Consensus 239 -----~~~~~~~~~~~~---------~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 239 -----PVEELFKLLKEG---------YR------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred -----CHHHHHHHHHcC---------Cc------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 111111111000 00 0001123446778999999999999999987754
Q ss_pred cc
Q 041249 571 IL 572 (789)
Q Consensus 571 ~l 572 (789)
.+
T Consensus 287 ~l 288 (293)
T cd05053 287 DL 288 (293)
T ss_pred HH
Confidence 43
No 154
>PHA03212 serine/threonine kinase US3; Provisional
Probab=99.97 E-value=2.7e-31 Score=292.68 Aligned_cols=195 Identities=24% Similarity=0.326 Sum_probs=168.7
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
..+|...+.||+|+||.||++....+++.||+|... ...+.+|++++++++||||+++++++.... ..+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNK-----FTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC-----eeE
Confidence 367999999999999999999999999999999743 235678999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+|++. ++|.+++... ..+++.+++.++.|++.||+|||+.+ ||||||||+||+++.++.+||+|
T Consensus 160 lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~D 225 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAK----------RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGD 225 (391)
T ss_pred EEEecCC-CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEe
Confidence 9999986 6888887533 45789999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+++....... .......||+.|+|||++....++.++|||||||++|||++|+.|+..
T Consensus 226 FG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 226 FGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred CCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 999976433221 112235699999999999988999999999999999999999988753
No 155
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=99.97 E-value=1.8e-31 Score=282.38 Aligned_cols=266 Identities=22% Similarity=0.311 Sum_probs=196.8
Q ss_pred CCCCCcccccCCccEEEEEE----cCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 272 FSSANLIGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
|...+.||+|+||+||.+.+ ..+++.||+|+++.... .....+.+|++++++++||||+++++++.... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG---GKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---Cce
Confidence 37788999999999988764 34578899999875532 34567889999999999999999999876532 235
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+|+|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l 148 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKI 148 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEE
Confidence 7999999999999999853 24899999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccc-eeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249 427 GDFGLARFLPPTHVQTS-SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 505 (789)
+|||+++.......... .....++..|+|||......++.++||||||+++|||++|+.|+............+.....
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05080 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM 228 (283)
T ss_pred eecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc
Confidence 99999987754332111 11223556799999998888999999999999999999999998643211111111100000
Q ss_pred CC-chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 506 PD-HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 506 ~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.. ...+..+..... .....+..++.+++..|++.++-+||+...+...+
T Consensus 229 ~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 229 TVVRLIELLERGMRL------------------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred chhhhhhhhhcCCCC------------------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 00 011111111100 00123456778899999999999999998775433
No 156
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=99.97 E-value=1.1e-31 Score=288.80 Aligned_cols=194 Identities=27% Similarity=0.326 Sum_probs=167.4
Q ss_pred CcccccCCccEEEEEE---cCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249 276 NLIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
+.||+|+||.||++.. ..+++.||+|+++.... .....+..|++++++++||||+++++++.... ..++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG-----KLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----EEEEE
Confidence 5799999999999876 34689999999965422 23455778999999999999999999987655 88999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 430 (789)
|||+.+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 77 ~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg 143 (318)
T cd05582 77 LDFLRGGDLFTRLSKE----------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 143 (318)
T ss_pred EcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeecc
Confidence 9999999999988543 46899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+++....... ......|+..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus 144 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 144 LSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred CCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 9886544321 22345689999999999888899999999999999999999999973
No 157
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=99.97 E-value=2.4e-31 Score=280.95 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=199.9
Q ss_pred hcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
..+|...+.||+|+||.||++... .++..+|+|.+..........+..|++.+++++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR--- 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC---
Confidence 356778899999999999999753 346789999987666666778999999999999999999999987655
Q ss_pred CceEEEEeeccCCCChhhhccCCCCC-----ccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNRE-----DEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill 418 (789)
..++|+||+.+|+|.+++...... .........+++.+++.++.|++.|++|||+.+ ++||||||+||++
T Consensus 81 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~ 155 (280)
T cd05092 81 --PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLV 155 (280)
T ss_pred --ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEE
Confidence 789999999999999998654211 001112246899999999999999999999888 9999999999999
Q ss_pred CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL 497 (789)
Q Consensus 419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~ 497 (789)
++++.+||+|||++................++..|+|||+.....++.++|||||||++|||++ |+.||..... ...
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~ 233 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TEA 233 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--HHH
Confidence 9999999999999986654332211222335678999999998899999999999999999998 8999863211 111
Q ss_pred HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
........+. .....+...+.+++..|++.+|.+||+...+..
T Consensus 234 ~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQGREL------------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHcCccC------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111100000 000123345668889999999999999887643
No 158
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=99.97 E-value=2.7e-31 Score=281.73 Aligned_cols=264 Identities=20% Similarity=0.308 Sum_probs=199.0
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVD 340 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 340 (789)
.++++|.+.+.||+|+||.||+|..+. .+..||+|.++... ......+.+|+..+++++||||+++++++....
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 467889999999999999999997652 35689999986443 233456788999999999999999999987655
Q ss_pred CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE 420 (789)
Q Consensus 341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~ 420 (789)
..++||||+.+|+|.+++................++..+..++.|++.||.|||+.+ ++||||||+||++++
T Consensus 83 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~ 154 (288)
T cd05061 83 -----PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAH 154 (288)
T ss_pred -----CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcC
Confidence 689999999999999999653211111122345677889999999999999999887 999999999999999
Q ss_pred CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHH
Q 041249 421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHN 499 (789)
Q Consensus 421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~ 499 (789)
++.+|++|||+++...............++..|+|||.+..+.++.++|||||||++|||++ |+.||.... ..+
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----~~~ 229 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----NEQ 229 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----HHH
Confidence 99999999999987654432222222335678999999998899999999999999999999 788886321 111
Q ss_pred HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
+........... ....+...+.+++..|.+.++..||+......
T Consensus 230 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 230 VLKFVMDGGYLD---------------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred HHHHHHcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 211111100000 00122346778899999999999999887643
No 159
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=99.97 E-value=2.4e-31 Score=278.74 Aligned_cols=199 Identities=24% Similarity=0.324 Sum_probs=173.5
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
++|...+.||+|+||.||+|....+++.||+|++..........+.+|+.++++++||||+++++++.... ..++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-----~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-----KLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-----EEEE
Confidence 57999999999999999999998889999999997665555667889999999999999999999987655 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||+.+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+|||++|+||+++.++.+|++||
T Consensus 84 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~df 150 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT----------GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADF 150 (267)
T ss_pred EEeCCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcC
Confidence 99999999999988533 45789999999999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
|.+........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||.
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 151 GVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred ccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 99987643321 112345888999999874 3457889999999999999999999985
No 160
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=99.97 E-value=2.3e-31 Score=288.03 Aligned_cols=201 Identities=23% Similarity=0.286 Sum_probs=172.2
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||+||++....+++.||+|++... .......+.+|+.++..++|++|+++++.+.... .
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-----N 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-----E
Confidence 4788899999999999999999988999999998532 2223455888999999999999999999987665 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~---------~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL 143 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKF---------EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRL 143 (332)
T ss_pred EEEEEeccCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEE
Confidence 99999999999999999642 245888899999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
+|||++......... ......||..|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 144 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 144 ADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred eecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 999998765433211 122346899999999886 3468999999999999999999999997
No 161
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=99.97 E-value=2.3e-31 Score=281.70 Aligned_cols=200 Identities=25% Similarity=0.390 Sum_probs=172.8
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
.|...+.||+|+||+||++.+..+++.||+|.+.... ......+.+|++++++++|++++++++.+...+ ..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-----AL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-----EE
Confidence 3677889999999999999999999999999986442 222356778999999999999999999987655 89
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++||||+.+|+|.+++... ....+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++++
T Consensus 76 ~lv~e~~~g~~L~~~l~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHM--------GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred EEEEEecCCCcHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEe
Confidence 9999999999999988543 2345889999999999999999999887 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||++........ .....|+..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus 145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 145 DLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred eccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 9999876543321 1234689999999999988999999999999999999999999974
No 162
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=99.97 E-value=2.3e-31 Score=277.14 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=193.6
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
++|...+.||+|++|.||.|.+. ++..||+|.++... .....+.+|++++.+++||||+++++++.... ..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-----PIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-----CcEE
Confidence 46778889999999999999886 45679999986433 23467899999999999999999999987655 6799
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+.+|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+|++||
T Consensus 77 v~e~~~~~~l~~~i~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~ 144 (256)
T cd05113 77 VTEYMSNGCLLNYLREH---------GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDF 144 (256)
T ss_pred EEEcCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCC
Confidence 99999999999998643 236899999999999999999999888 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
|.++........ ......++..|+|||......++.++|||||||++|||++ |+.||..... ......+......
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~- 220 (256)
T cd05113 145 GLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEKVSQGLRL- 220 (256)
T ss_pred ccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHhcCCCC-
Confidence 999876543311 1122345678999999988889999999999999999998 9999863211 1111111100000
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
+. .......+.+++..|++.++.+||+.....
T Consensus 221 ------~~-----------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll 252 (256)
T cd05113 221 ------YR-----------------------PHLASEKVYAIMYSCWHEKAEERPTFQQLL 252 (256)
T ss_pred ------CC-----------------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 00 001234566888899999999999987653
No 163
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=99.97 E-value=4.9e-31 Score=279.65 Aligned_cols=204 Identities=28% Similarity=0.406 Sum_probs=169.9
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcC---CCCccceeeeeeccCCCCCCc
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSI---RHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~~~ 345 (789)
.|...+.||+|+||+||+|....+++.||+|.++.... .....+.+|+++++++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 37778899999999999999999999999999875422 2234566777777665 699999999998765444445
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++|+||+. +++.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--------PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 6899999998 4888887543 2345899999999999999999999988 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+|||.++....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 149 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 149 LADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred ECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 999999987653321 1234578899999999988999999999999999999999999863
No 164
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=99.97 E-value=6.5e-32 Score=277.16 Aligned_cols=202 Identities=25% Similarity=0.353 Sum_probs=181.2
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
-+.|+.-++||+||||+||-++.+.+|+.+|.|.+... ..........|-+++.+++.+.||.+-..+...+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd----- 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD----- 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-----
Confidence 36788899999999999999999999999999998543 4445567888999999999999999977776665
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..|+|+..|.+|+|.-+++.. ....+++.....++++|+.||++||... ||+||+||+|||+|+.|+++
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~--------g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNH--------GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred ceEEEEEeecCCceeEEeecc--------CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeE
Confidence 899999999999999999765 4467999999999999999999999887 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+|+|+|..++..... .+..||.+|||||++.++.|+..+|.||+||++|||+.|+.||-.
T Consensus 328 ISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred eeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 9999999999877643 345799999999999999999999999999999999999999963
No 165
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=99.97 E-value=2.3e-31 Score=281.69 Aligned_cols=273 Identities=25% Similarity=0.322 Sum_probs=200.3
Q ss_pred cCCCCCCcccccCCccEEEEEE----cCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 270 DGFSSANLIGTGSFGSVYKGVL----DEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
.+|...+.||+|+||.||++.+ ..+++.||+|.+........+.+.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence 4678889999999999999985 3468899999987666666678999999999999999999999875432 23
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++|+||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH---------RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVK 148 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc---------CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEE
Confidence 579999999999999998643 235899999999999999999999888 99999999999999999999
Q ss_pred eCcccccccCCCCCCccce-eeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249 426 VGDFGLARFLPPTHVQTSS-IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 504 (789)
|+|||+++..+........ ....++..|+|||...+..++.++|||||||++|||++|..|+..... .+.+..
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~ 222 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRMM 222 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhhc
Confidence 9999999987654322111 112244569999999888899999999999999999999877642211 111100
Q ss_pred CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
............+. + .. ....+......+...+.+++..|++.++-.||+...+...++
T Consensus 223 ~~~~~~~~~~~~~~----~--~~----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05081 223 GNDKQGQMIVYHLI----E--LL----KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281 (284)
T ss_pred ccccccccchHHHH----H--HH----hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 00000000000000 0 00 000001111234556788999999999999999988755433
No 166
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=99.97 E-value=2e-31 Score=281.55 Aligned_cols=266 Identities=21% Similarity=0.352 Sum_probs=204.4
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcC----CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDE----GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY 341 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 341 (789)
...++|...+.||+|+||.||+|.+.. +++.|++|++.... ......+..|+..+++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~- 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG- 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence 346788899999999999999999975 36889999986543 334567889999999999999999999876532
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE 421 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~ 421 (789)
...++++||+..|+|.+++....... ...+..+++.++..++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 82 ---~~~~~~~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~ 153 (280)
T cd05043 82 ---EPPFVLYPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEE 153 (280)
T ss_pred ---CCCEEEEEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCC
Confidence 26789999999999999986541111 112357899999999999999999999887 9999999999999999
Q ss_pred CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHH
Q 041249 422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNF 500 (789)
Q Consensus 422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~ 500 (789)
+.+|++|||+++.+.+...........++..|+|||++....++.++||||||+++||+++ |+.||... ....+..+
T Consensus 154 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~ 231 (280)
T cd05043 154 LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAY 231 (280)
T ss_pred CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHH
Confidence 9999999999987654432222223346778999999988889999999999999999999 99999632 11122222
Q ss_pred HHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 501 ARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 501 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
....... .....+..++.+++..|++.++-.||+...+...+.
T Consensus 232 ~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 232 LKDGYRL------------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred HHcCCCC------------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 2211110 001123345678899999999999999988754433
No 167
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=99.97 E-value=4.8e-31 Score=274.90 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=190.8
Q ss_pred cccccCCccEEEEEEc--CCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 277 LIGTGSFGSVYKGVLD--EGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 277 ~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
.||+|+||.||+|.++ .+++.||+|+++.... ...+.+..|+.+++++.|+||+++++++... ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE------SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC------CcEEEEe
Confidence 5899999999999763 4578999999864432 3356789999999999999999999987532 4689999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA 432 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 432 (789)
|+++|+|.+++... ..+++..+..++.|++.||+|||..+ ++||||||+||++++++.+||+|||.+
T Consensus 76 ~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~ 142 (257)
T cd05116 76 LAELGPLNKFLQKN----------KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLS 142 (257)
T ss_pred cCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccc
Confidence 99999999998543 45789999999999999999999888 999999999999999999999999999
Q ss_pred ccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchh
Q 041249 433 RFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVM 510 (789)
Q Consensus 433 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 510 (789)
+......... ......++..|+|||.+....++.++|||||||++|||++ |+.||..... ......++.... .
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~~~---~ 217 (257)
T cd05116 143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGER---M 217 (257)
T ss_pred cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC---C
Confidence 8775443211 1112234578999999988889999999999999999998 9999974211 112222211100 0
Q ss_pred hhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 511 DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 511 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
+ . ...+...+.+++..|++.++-+||++..+...+.
T Consensus 218 ~-----~----------------------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 218 E-----C----------------------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253 (257)
T ss_pred C-----C----------------------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence 0 0 0123345668899999999999999988755444
No 168
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=99.97 E-value=2.1e-31 Score=293.59 Aligned_cols=269 Identities=19% Similarity=0.275 Sum_probs=201.6
Q ss_pred HHHHhhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccc-hhhHHHHHHHHHHhcCC-CCccceeeeee
Q 041249 264 NLHNATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHH-RASRSFIAECRALRSIR-HRNLVKVFTAC 336 (789)
Q Consensus 264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 336 (789)
+.....++|...+.||+|+||.||+|.+.. .++.||+|+++.... ...+.+..|++++.++. ||||++++++|
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 355566788899999999999999999752 356899999975432 23457889999999997 99999999999
Q ss_pred ccCCCCCCceEEEEeeccCCCChhhhccCCCCCc----------------------------------------------
Q 041249 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED---------------------------------------------- 370 (789)
Q Consensus 337 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------- 370 (789)
.... ..++|+||+.+|+|.++++..+...
T Consensus 111 ~~~~-----~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (401)
T cd05107 111 TKGG-----PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE 185 (401)
T ss_pred ccCC-----CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence 7755 7899999999999999997542100
Q ss_pred ------------------------------------------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCcee
Q 041249 371 ------------------------------------------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408 (789)
Q Consensus 371 ------------------------------------------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH 408 (789)
........+++.....++.|++.||+|||+.+ ++|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH 262 (401)
T cd05107 186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVH 262 (401)
T ss_pred ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCc
Confidence 00012245788889999999999999999887 999
Q ss_pred cCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCC
Q 041249 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPS 487 (789)
Q Consensus 409 ~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~ 487 (789)
|||||+||++++++.+|++|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||
T Consensus 263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999987643332111223346788999999998889999999999999999998 89998
Q ss_pred CccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccc
Q 041249 488 DIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKL 567 (789)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~ 567 (789)
....... .....+..... +. ....+...+.+++..|++.++-.||+...
T Consensus 343 ~~~~~~~-~~~~~~~~~~~--------~~----------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~e 391 (401)
T cd05107 343 PELPMNE-QFYNAIKRGYR--------MA----------------------KPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391 (401)
T ss_pred CCCCchH-HHHHHHHcCCC--------CC----------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 6321110 00111110000 00 00123345678888999999999999987
Q ss_pred cccc
Q 041249 568 AGSI 571 (789)
Q Consensus 568 ~~~~ 571 (789)
....
T Consensus 392 ll~~ 395 (401)
T cd05107 392 LVHL 395 (401)
T ss_pred HHHH
Confidence 7443
No 169
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=99.97 E-value=3.8e-31 Score=285.55 Aligned_cols=193 Identities=27% Similarity=0.336 Sum_probs=164.2
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHH-HHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECR-ALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||+||+|....+++.||+|++.... ......+..|.. +++.++||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~-----~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE-----KLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-----EEEEEE
Confidence 46999999999999999899999999986442 223344555554 567789999999999887655 899999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|+|..++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 76 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~ 142 (325)
T cd05604 76 DFVNGGELFFHLQRE----------RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGL 142 (325)
T ss_pred cCCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCC
Confidence 999999999888543 46889999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
++....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 143 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (325)
T cd05604 143 CKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred cccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCC
Confidence 875432221 1234568999999999999999999999999999999999999996
No 170
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=99.97 E-value=5.9e-31 Score=275.63 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=202.2
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|++|.||+|....+++.||+|.++.. .......+.+|++++++++|+|++++++++.... .
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~-----~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-----E 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-----e
Confidence 6788999999999999999999989999999998643 2233567899999999999999999999987655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+++|+|.+++... ......+++.++..++.+++.||+|||+.+ ++||||+|+||+++.++.+++
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l 147 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHF------KKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEecCCCCCHHHHHHHh------cccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEE
Confidence 89999999999999988543 122356889999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
+|||.+......... .....++..|+|||...+..++.++|||||||++|+|++|+.||... .....++......
T Consensus 148 ~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~ 222 (267)
T cd08224 148 GDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD---KMNLYSLCKKIEK 222 (267)
T ss_pred eccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC---CccHHHHHhhhhc
Confidence 999998876543321 22345888999999998888999999999999999999999998632 1222222211110
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
... .+ . ........+.+++..|++.++..||+...+...
T Consensus 223 ~~~----~~-~---------------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~ 261 (267)
T cd08224 223 CDY----PP-L---------------------PADHYSEELRDLVSRCINPDPEKRPDISYVLQV 261 (267)
T ss_pred CCC----CC-C---------------------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 000 00 0 001233456688889999999999999876443
No 171
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=99.97 E-value=3.1e-31 Score=278.05 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=198.1
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCce---EEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRT---TVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
.+++|+..+.||+|+||.||+|....+++ .+|+|.++... ......+..|++++++++|+|++++.+++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 79 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK--- 79 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC---
Confidence 35678889999999999999999875544 79999986542 334567899999999999999999999987665
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV 423 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 423 (789)
..++||||+.+++|.+++... ...+++.++..++.|++.|++|||+.+ ++|+||||+||+++.++.
T Consensus 80 --~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~ 145 (268)
T cd05063 80 --PAMIITEYMENGALDKYLRDH---------DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLE 145 (268)
T ss_pred --CcEEEEEcCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCc
Confidence 789999999999999998543 245899999999999999999999888 999999999999999999
Q ss_pred eeeCcccccccCCCCCCccce-eeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHH
Q 041249 424 SHVGDFGLARFLPPTHVQTSS-IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFA 501 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 501 (789)
+|++|||.+............ .....+..|+|||+.....++.++|||||||++||+++ |+.||..... ..+.
T Consensus 146 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~ 220 (268)
T cd05063 146 CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVM 220 (268)
T ss_pred EEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHH
Confidence 999999999876543322111 11223457999999988889999999999999999998 9999863211 1111
Q ss_pred HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
+..... .. ......+...+.+++..|++.++.+||++..+...
T Consensus 221 ~~i~~~---------~~------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 221 KAINDG---------FR------------------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHhcC---------CC------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111000 00 00011234556788999999999999999877443
No 172
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=99.97 E-value=7.9e-31 Score=274.75 Aligned_cols=204 Identities=23% Similarity=0.367 Sum_probs=173.1
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-----chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
.+|...+.||+|+||.||+|....+++.||+|.+.... ......+.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA---E 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC---C
Confidence 47899999999999999999998889999999986432 223456889999999999999999999876432 2
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
...++++||+++++|.+++... ..+++.....++.|++.||+|||+.+ ++||||+|+||+++.++.+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~ 145 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY----------GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNV 145 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence 3678999999999999998543 35788999999999999999999887 9999999999999999999
Q ss_pred eeCcccccccCCCCCC-ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 425 HVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+|||+++....... ........++..|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 9999999986643221 1112234588899999999888899999999999999999999999973
No 173
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=99.97 E-value=5.6e-31 Score=274.85 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=195.1
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.++|...+.||+|++|.||+|... ++..||+|.++.... ..+.+.+|++++++++|+|++++++++.. . ..+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~-----~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-E-----PIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-C-----CcE
Confidence 457888999999999999999887 667799999875433 34578999999999999999999988743 2 578
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
++|||+.+++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|++|
T Consensus 77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~d 145 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDG--------EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIAD 145 (260)
T ss_pred EEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCC
Confidence 999999999999998643 2346899999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
||.+......... ......++..|+|||.....+++.++||||||+++|||++ |+.||.... ............+.
T Consensus 146 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~ 222 (260)
T cd05070 146 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQVERGYRM 222 (260)
T ss_pred ceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCC
Confidence 9999876543311 1112335678999999988899999999999999999999 899986321 11111111110000
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
. ....+...+.+++.+|++.++..||+......
T Consensus 223 --------~----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 223 --------P----------------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred --------C----------------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 00123345778899999999999999876543
No 174
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=99.97 E-value=6.2e-31 Score=274.04 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=189.0
Q ss_pred cccccCCccEEEEEEc--CCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeec
Q 041249 277 LIGTGSFGSVYKGVLD--EGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEF 353 (789)
Q Consensus 277 ~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 353 (789)
.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|++++++++|+||+++++.+.. . ..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~-----~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-E-----ALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-C-----CeEEEEEe
Confidence 3899999999999875 4456799999875533 335679999999999999999999998753 2 57999999
Q ss_pred cCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccc
Q 041249 354 MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLAR 433 (789)
Q Consensus 354 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 433 (789)
+++|+|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+.
T Consensus 76 ~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 76 ASGGPLNKFLSGK---------KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred CCCCCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccc
Confidence 9999999998643 246899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhh
Q 041249 434 FLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMD 511 (789)
Q Consensus 434 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (789)
......... ......++..|+|||......++.++|||||||++||+++ |+.||..... ......+....+.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~---- 217 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEVMSFIEQGKRL---- 217 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHCCCCC----
Confidence 665443211 1112223568999999988889999999999999999996 9999863211 1111111111000
Q ss_pred hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 512 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
.....+..++.+++..|+..++-+||+...+...
T Consensus 218 --------------------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 218 --------------------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0011334566688999999999999998877443
No 175
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=99.97 E-value=4.7e-31 Score=290.34 Aligned_cols=204 Identities=24% Similarity=0.305 Sum_probs=171.2
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||+|+||.||++....+++.||||.+... .....+.+.+|+++++.++|+||+++++++...........+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 578899999999999999999889999999998643 223446788999999999999999999998765433333689
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+. ++|.+.+... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----------QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred EEeeccc-cCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecc
Confidence 9999997 5787777433 56899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+++........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 147 fg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 147 FGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred ccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 9999876543321 12234578899999998774 479999999999999999999999974
No 176
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=99.97 E-value=5.6e-31 Score=281.57 Aligned_cols=268 Identities=20% Similarity=0.328 Sum_probs=203.5
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEc-------CCceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLD-------EGRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACS 337 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 337 (789)
...++|...+.||+|+||.||+|++. ..+..||+|.+.... ....+.+..|+..++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34578889999999999999999852 234579999986442 34456789999999999 8999999999987
Q ss_pred cCCCCCCceEEEEeeccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL 411 (789)
Q Consensus 338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl 411 (789)
... ..++||||+.+|+|.+++........ .......+++.++..++.|++.||+|||+.+ ++||||
T Consensus 92 ~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dl 163 (304)
T cd05101 92 QDG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDL 163 (304)
T ss_pred cCC-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeeccc
Confidence 655 78999999999999999975421110 0112346889999999999999999999988 999999
Q ss_pred CCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcc
Q 041249 412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIM 490 (789)
Q Consensus 412 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~ 490 (789)
||+||++++++.+||+|||.++...............++..|+|||...+..++.++||||||+++|||++ |..||...
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987765443222233345678999999988889999999999999999998 78887522
Q ss_pred ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
....+.+........ .....+...+.+++..|++..+..||++..+..
T Consensus 244 -----~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 244 -----PVEELFKLLKEGHRM---------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred -----CHHHHHHHHHcCCcC---------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 222222211110000 001134456678888999999999999988755
Q ss_pred cccc
Q 041249 571 ILPH 574 (789)
Q Consensus 571 ~l~~ 574 (789)
.+..
T Consensus 292 ~l~~ 295 (304)
T cd05101 292 DLDR 295 (304)
T ss_pred HHHH
Confidence 4443
No 177
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=99.97 E-value=6.2e-31 Score=273.99 Aligned_cols=246 Identities=25% Similarity=0.335 Sum_probs=192.7
Q ss_pred CcccccCCccEEEEEEcCCc---eEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGR---TTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||.||+|.+...+ ..||+|.+..... ...+.+..|+++++++.|+||+++++++.. + ..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-----~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-E-----PLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-C-----ceEEEE
Confidence 47999999999999886544 7899999875543 345678999999999999999999998753 2 579999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|+|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~ 141 (257)
T cd05060 75 ELAPLGPLLKYLKKR----------REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGM 141 (257)
T ss_pred EeCCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccc
Confidence 999999999999654 36889999999999999999999888 99999999999999999999999999
Q ss_pred cccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCch
Q 041249 432 ARFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHV 509 (789)
Q Consensus 432 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 509 (789)
++......... ......++..|+|||......++.++||||||+++|||++ |+.||.... ...+..++....+..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~~~~~- 218 (257)
T cd05060 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESGERLP- 218 (257)
T ss_pred cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcCCcCC-
Confidence 98775443221 1112224568999999998899999999999999999998 999986321 112222222111100
Q ss_pred hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
....+...+.+++..|++.++..||+.......+
T Consensus 219 -----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 219 -----------------------------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred -----------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 0012334567889999999999999988775443
No 178
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=99.97 E-value=8.1e-31 Score=279.20 Aligned_cols=268 Identities=18% Similarity=0.284 Sum_probs=198.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcC----------------CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCcccee
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDE----------------GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKV 332 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l 332 (789)
++|+..+.||+|+||.||++.+.. ++..||+|+++... ......+.+|++.+++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 568889999999999999986542 34579999987553 3345678999999999999999999
Q ss_pred eeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCcc-ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDE-VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL 411 (789)
Q Consensus 333 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl 411 (789)
++++...+ ..++||||+.+|+|.+++........ .......+++.++..++.|++.||+|||+.+ ++|+||
T Consensus 85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl 156 (296)
T cd05095 85 LAVCITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDL 156 (296)
T ss_pred EEEEecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccC
Confidence 99987665 68999999999999999875422111 1223346888999999999999999999988 999999
Q ss_pred CCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH--hcCCCCc
Q 041249 412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII--RKKPSDI 489 (789)
Q Consensus 412 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt--G~~P~~~ 489 (789)
||+||+++.++.+|++|||.++.+.............++..|+|||....+.++.++|||||||++|||++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999987654432222222334678999999888899999999999999999998 6788763
Q ss_pred cccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 490 MFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
.... .........+.........+ ....|...+.+++..|++.++..||+...+.
T Consensus 237 ~~~~--~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 237 LSDE--QVIENTGEFFRDQGRQVYLP-----------------------KPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred cChH--HHHHHHHHHHhhccccccCC-----------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 2111 11110000000000000000 0112345677899999999999999988764
Q ss_pred c
Q 041249 570 S 570 (789)
Q Consensus 570 ~ 570 (789)
.
T Consensus 292 ~ 292 (296)
T cd05095 292 A 292 (296)
T ss_pred H
Confidence 3
No 179
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=99.97 E-value=3.3e-31 Score=277.69 Aligned_cols=258 Identities=20% Similarity=0.272 Sum_probs=201.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||.|++|.||+|....+++.||||.+... .......+.+|+++++.++|+||+++++++...+ .
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-----E 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-----e
Confidence 4678889999999999999999888999999987543 2233467889999999999999999999987655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.+++|||+++++|.+++... ......+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l 147 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHF------KKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred EEEEEEecCCCCHHHHHHHh------hccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEE
Confidence 89999999999999988632 112356899999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
+|||.+......... .....++..|+|||...+..++.++||||||+++|||++|..||..... ....+.+..
T Consensus 148 ~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~-- 220 (267)
T cd08229 148 GDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKI-- 220 (267)
T ss_pred CcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---hHHHHhhhh--
Confidence 999998876543321 1234588899999999888899999999999999999999999863211 111111111
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.....+... ...+...+.+++..|++.++..||++..+....
T Consensus 221 ---~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 221 ---EQCDYPPLP---------------------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred ---hcCCCCCCC---------------------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 000001010 012334566788899999999999998764433
No 180
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=99.97 E-value=6.2e-31 Score=278.96 Aligned_cols=262 Identities=24% Similarity=0.337 Sum_probs=199.9
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDY 341 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 341 (789)
..++|...+.||+|+||.||+|.... +++.||+|.+..... .....+..|+++++++.||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~- 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK- 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-
Confidence 45789999999999999999998742 578899999875432 33567899999999999999999999987765
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCcc------------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceec
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNREDE------------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHC 409 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~ 409 (789)
..++|+||+.+|+|.+++........ .......+++.+++.++.|++.||+|||..+ ++||
T Consensus 82 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~ 154 (288)
T cd05050 82 ----PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHR 154 (288)
T ss_pred ----ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 78999999999999999964321100 1122346889999999999999999999887 9999
Q ss_pred CCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCC
Q 041249 410 DLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSD 488 (789)
Q Consensus 410 dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~ 488 (789)
||||+||++++++.+|++|||.+.................+..|+|||......++.++|||||||++|||++ |..||.
T Consensus 155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999886543322111222234567999999988899999999999999999998 888885
Q ss_pred ccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249 489 IMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA 568 (789)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~ 568 (789)
.. ...++.+......... . ...+..++.+++.+|++.++..||+..++
T Consensus 235 ~~-----~~~~~~~~~~~~~~~~-----~----------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~el 282 (288)
T cd05050 235 GM-----AHEEVIYYVRDGNVLS-----C----------------------PDNCPLELYNLMRLCWSKLPSDRPSFASI 282 (288)
T ss_pred CC-----CHHHHHHHHhcCCCCC-----C----------------------CCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 22 1122222111110000 0 01234567788999999999999998876
Q ss_pred c
Q 041249 569 G 569 (789)
Q Consensus 569 ~ 569 (789)
.
T Consensus 283 ~ 283 (288)
T cd05050 283 N 283 (288)
T ss_pred H
Confidence 4
No 181
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=99.97 E-value=3.8e-31 Score=277.21 Aligned_cols=199 Identities=25% Similarity=0.331 Sum_probs=173.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
++|...+.||+|+||.||+|....+++.||+|.++.........+.+|+.+++.++||||+++++++...+ ..++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-----~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-----KLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----EEEE
Confidence 57778889999999999999998889999999997665555567889999999999999999999987665 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||+++++|.+++... ..+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 84 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~df 150 (267)
T cd06645 84 CMEFCGGGSLQDIYHVT----------GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADF 150 (267)
T ss_pred EEeccCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 99999999999998543 46889999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
|.+........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||.
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 151 GVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred eeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 99876543221 122346889999999874 4568999999999999999999999985
No 182
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=99.97 E-value=4.3e-31 Score=275.08 Aligned_cols=248 Identities=26% Similarity=0.356 Sum_probs=193.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
.+|+..+.||+|+||.||+|.++ ++..+|+|.+.... .....+.+|++++++++||||+++++++.... ..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR-----PIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-----ceEE
Confidence 46888999999999999999987 56789999985432 23456888999999999999999999987655 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||+++++|.+++... ...+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+|++||
T Consensus 77 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~df 144 (256)
T cd05059 77 VTEYMANGCLLNYLRER---------KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDF 144 (256)
T ss_pred EEecCCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCc
Confidence 99999999999998643 236899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
|.++........ ......++..|+|||......++.++||||||+++||+++ |+.||+..... .....+....+
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~-- 219 (256)
T cd05059 145 GLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGYR-- 219 (256)
T ss_pred ccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCCc--
Confidence 999876533211 1112234467999999998899999999999999999999 89998632111 11111110000
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
. .....+..++.+++..|++.++..||+...+.
T Consensus 220 ------~----------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l 252 (256)
T cd05059 220 ------L----------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLL 252 (256)
T ss_pred ------C----------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 0 00112345677899999999999999987653
No 183
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=99.97 E-value=9.7e-31 Score=278.57 Aligned_cols=268 Identities=21% Similarity=0.301 Sum_probs=200.6
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCc----------------eEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccce
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGR----------------TTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVK 331 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 331 (789)
..+|...+.||+|+||.||+|.....+ ..||+|.+.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 467889999999999999999876433 568999987553 334567899999999999999999
Q ss_pred eeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccc-cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecC
Q 041249 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEV-DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCD 410 (789)
Q Consensus 332 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~d 410 (789)
+++++.... ..++|+||+.+++|.+++......... ......+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 84 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~d 155 (296)
T cd05051 84 LLGVCTVDP-----PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRD 155 (296)
T ss_pred EEEEEecCC-----CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccc
Confidence 999987654 789999999999999998654211000 112346899999999999999999999888 99999
Q ss_pred CCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH--hcCCCC
Q 041249 411 LKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII--RKKPSD 488 (789)
Q Consensus 411 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt--G~~P~~ 488 (789)
|||+||+++.++.++++|||.++...............++..|+|||+.....++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999987654433222333456778999999988899999999999999999998 677775
Q ss_pred ccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249 489 IMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA 568 (789)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~ 568 (789)
... ...........+.........+ ....+..++.+++..|++.++..||+...+
T Consensus 236 ~~~--~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 236 HLT--DQQVIENAGHFFRDDGRQIYLP-----------------------RPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred CcC--hHHHHHHHHhccccccccccCC-----------------------CccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 321 1111111111111000000000 011233467789999999999999998876
Q ss_pred c
Q 041249 569 G 569 (789)
Q Consensus 569 ~ 569 (789)
.
T Consensus 291 ~ 291 (296)
T cd05051 291 H 291 (296)
T ss_pred H
Confidence 3
No 184
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=99.97 E-value=1.4e-30 Score=278.91 Aligned_cols=198 Identities=25% Similarity=0.343 Sum_probs=173.6
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||+|+||.||++.+..++..+|+|.+..... .....+.+|++++.+++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-----EIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----EEE
Confidence 478899999999999999999998899999999865432 33456889999999999999999999998766 899
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeC
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.+|++
T Consensus 76 lv~ey~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~ 142 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA----------GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLC 142 (308)
T ss_pred EEeeccCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEc
Confidence 999999999999998643 457889999999999999999997 45 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||++....... .....|+..|+|||...+..++.++||||||+++|||++|+.||..
T Consensus 143 dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 143 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred cCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 999987654332 1234588899999999888899999999999999999999999863
No 185
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=99.97 E-value=4e-31 Score=281.66 Aligned_cols=251 Identities=21% Similarity=0.248 Sum_probs=199.9
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
.+|...+.||+|++|.||+|....+++.||+|.+........+.+.+|+.+++.++|+||+++++++.... ..++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----EEEE
Confidence 57888999999999999999998889999999997766666677899999999999999999999987655 8899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+|++||
T Consensus 94 v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Df 159 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 159 (297)
T ss_pred eecccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcC
Confidence 9999999999998853 24788899999999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 509 (789)
|.+......... .....++..|+|||...+..++.++|||||||++|++++|+.||........... . ....
T Consensus 160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~----~~~~- 231 (297)
T cd06656 160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-I----ATNG- 231 (297)
T ss_pred ccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-e----ccCC-
Confidence 999876544321 1234578899999999988899999999999999999999999963211100000 0 0000
Q ss_pred hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
.+.+. ........+.+++.+|++.++..|++...+...
T Consensus 232 ----~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 232 ----TPELQ--------------------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ----CCCCC--------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 000112334577789999999999998877554
No 186
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=99.97 E-value=4.8e-31 Score=269.18 Aligned_cols=204 Identities=24% Similarity=0.324 Sum_probs=177.0
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
+.|...+.||.|.-|+||.+..+.++..+|+|++.... .....+...|-++|+.+.||.+..+|+.+.... .
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~-----~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK-----Y 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc-----e
Confidence 45666789999999999999999889999999996553 333456788999999999999999999998877 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.|+|||||++|+|..+.+.. .++.+++..+..++++|+.||+|||..| ||+|||||+|||+-++|++-|
T Consensus 152 ~cl~meyCpGGdL~~LrqkQ--------p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQ--------PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIML 220 (459)
T ss_pred eEEEEecCCCccHHHHHhhC--------CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEe
Confidence 99999999999999998766 6788999999999999999999999999 999999999999999999999
Q ss_pred CcccccccCCCCC---------------------------------C---------------------ccceeeeccccc
Q 041249 427 GDFGLARFLPPTH---------------------------------V---------------------QTSSIGVKGSIG 452 (789)
Q Consensus 427 ~Dfgla~~~~~~~---------------------------------~---------------------~~~~~~~~gt~~ 452 (789)
+||.++...+..- . ........||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 9999876432100 0 011223458999
Q ss_pred ccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 453 YIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 453 y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|.|||++.+..-+..+|.|+|||++|||+.|..||..
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG 337 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKG 337 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCC
Confidence 9999999999999999999999999999999999974
No 187
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=99.97 E-value=2e-30 Score=273.72 Aligned_cols=195 Identities=26% Similarity=0.365 Sum_probs=170.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||+|+||.||+|.+..+++.||+|.+... .......+..|++++++++||||+++++++.... ..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-----RIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-----EEE
Confidence 3677889999999999999999889999999998654 2334567889999999999999999999988765 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+++|++..+. .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 76 lv~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~d 138 (279)
T cd06619 76 ICTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCD 138 (279)
T ss_pred EEEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEee
Confidence 999999999886542 3577888999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
||++....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 139 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 139 FGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred CCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 99998664432 22346889999999999888999999999999999999999999753
No 188
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=99.97 E-value=6.9e-31 Score=279.01 Aligned_cols=269 Identities=24% Similarity=0.231 Sum_probs=206.3
Q ss_pred ccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeecc
Q 041249 260 LSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSG 338 (789)
Q Consensus 260 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 338 (789)
+++.++..++++|...+.||+|+||.||++....+++.+|+|++.... .....+.+|++++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 556778888999999999999999999999998899999999986432 2345678899999999 89999999999876
Q ss_pred CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249 339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418 (789)
Q Consensus 339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill 418 (789)
.+.......++|+||+.+|+|.+++... ......+++..+..++.|++.||+|||..+ ++||||||+||++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili 161 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGL------LICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILL 161 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHh------hhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEE
Confidence 5433334689999999999999988542 112356899999999999999999999887 9999999999999
Q ss_pred CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC-----CcCccccchhhHHHHHHHHHhcCCCCccccC
Q 041249 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-----EVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493 (789)
Q Consensus 419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DV~sfGvvl~elltG~~P~~~~~~~ 493 (789)
+.++.+||+|||.+......... .....|+..|+|||.+... .++.++|||||||++|||++|+.||......
T Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 162 TTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred cCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 99999999999998876543211 1234578899999987643 3689999999999999999999998632110
Q ss_pred CccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 494 DMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
..+..+.+.. ...+.+ .......+.+++.+|++.++..||+......
T Consensus 240 -~~~~~~~~~~----~~~~~~-------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 -KTLFKIPRNP----PPTLLH-------------------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -HHHHHHhcCC----CCCCCc-------------------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111111000 000000 0112235678889999999999999887644
No 189
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=99.97 E-value=1e-30 Score=278.38 Aligned_cols=267 Identities=19% Similarity=0.309 Sum_probs=196.5
Q ss_pred cCCCCCCcccccCCccEEEEEEcCC--------------ceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeee
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEG--------------RTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFT 334 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~ 334 (789)
++|...+.||+|+||.||++..... ...||+|.++... ......+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5788899999999999999987532 2358999987543 233467899999999999999999999
Q ss_pred eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCc--cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCC
Q 041249 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED--EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK 412 (789)
Q Consensus 335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk 412 (789)
++.... ..++||||+.+++|.+++....... ........+++.+++.++.|++.||+|||+.+ ++|||||
T Consensus 85 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlk 156 (295)
T cd05097 85 VCVSDD-----PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLA 156 (295)
T ss_pred EEcCCC-----ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccC
Confidence 987655 7899999999999999985431110 00111234788999999999999999999988 9999999
Q ss_pred CCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH--hcCCCCcc
Q 041249 413 PSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII--RKKPSDIM 490 (789)
Q Consensus 413 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt--G~~P~~~~ 490 (789)
|+||++++++.+|++|||++................++..|+|||....+.++.++|||||||++|||++ |..||...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999987654432222223345678999999988899999999999999999998 56677632
Q ss_pred ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
..+ .........+........ ......+...+.+++..|+..++-+||++..+.
T Consensus 237 ~~~--~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 237 SDE--QVIENTGEFFRNQGRQIY-----------------------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred ChH--HHHHHHHHhhhhcccccc-----------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 111 111111111100000000 000011234677899999999999999998763
No 190
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=99.97 E-value=8.4e-31 Score=280.90 Aligned_cols=200 Identities=24% Similarity=0.369 Sum_probs=170.0
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||+|+||+||+|+...+++.||+|.++.... .....+.+|++++++++||||+++++++...+ ..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-----SLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-----eEE
Confidence 578889999999999999999998899999999875432 33456788999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+.+ ++.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~D 147 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDC---------GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLAD 147 (309)
T ss_pred EEEeCCCC-CHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECc
Confidence 99999985 888877533 245788899999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||.++........ .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 148 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 148 FGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred cccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999865433211 123457889999998865 4689999999999999999999999964
No 191
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=99.97 E-value=1.8e-30 Score=272.58 Aligned_cols=201 Identities=25% Similarity=0.378 Sum_probs=163.4
Q ss_pred CcccccCCccEEEEEEcC--CceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 276 NLIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
+.||+|+||.||+|.+.. ++..+|+|.++.... .....+.+|++++++++||||+++++++.+.. ..++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-----PYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-----CcEEEEE
Confidence 368999999999998753 346799998865543 33457889999999999999999999987655 6899999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA 432 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 432 (789)
|+++|+|.+++.... .......++..+..++.|++.|++|||+.+ ++|+||||+||+++.++++|++|||.+
T Consensus 76 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 76 FCPLGDLKGYLRSCR-----KAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred CCCCCcHHHHHHHhh-----hcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccc
Confidence 999999999986531 012235677788899999999999999888 999999999999999999999999999
Q ss_pred ccCCCCCCccceeeecccccccCcccCCCC-------CcCccccchhhHHHHHHHHH-hcCCCCc
Q 041249 433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-------EVSTNGDVYSYGILMLELII-RKKPSDI 489 (789)
Q Consensus 433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~k~DV~sfGvvl~ellt-G~~P~~~ 489 (789)
................++..|+|||+.... .++.++||||||+++|||++ |+.||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 765443322222334577889999987542 35889999999999999996 9999964
No 192
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=99.97 E-value=9.8e-31 Score=277.08 Aligned_cols=270 Identities=21% Similarity=0.246 Sum_probs=205.9
Q ss_pred cccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249 259 NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACS 337 (789)
Q Consensus 259 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 337 (789)
.+.++.+.+++++|...+.||+|+||.||++....+++.+|+|.++... .....+..|+.+++++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 4566778889999999999999999999999999889999999986432 2345688899999999 6999999999986
Q ss_pred cCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417 (789)
Q Consensus 338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil 417 (789)
..........++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil 156 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFL------KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNIL 156 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhh------ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEE
Confidence 544334447899999999999999875320 12346788999999999999999999887 999999999999
Q ss_pred cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCCcccc
Q 041249 418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSDIMFE 492 (789)
Q Consensus 418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~ 492 (789)
++.++.+|++|||.+........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 157 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred ECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 99999999999999887654321 1223458899999998753 4478999999999999999999999863211
Q ss_pred CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
...+.+.. ........++. .+...+.+++.+|++.++-+||+...+..
T Consensus 235 ----~~~~~~~~-~~~~~~~~~~~-------------------------~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 235 ----MRALFKIP-RNPPPTLHQPE-------------------------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred ----hHHHhhcc-ccCCCcccCCC-------------------------CcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11111100 00000000110 12234567888999999999999877643
No 193
>PTZ00036 glycogen synthase kinase; Provisional
Probab=99.97 E-value=3.5e-31 Score=296.46 Aligned_cols=205 Identities=25% Similarity=0.366 Sum_probs=166.2
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC---CCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY---QGN 344 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~~~ 344 (789)
...+|...+.||+|+||.||+|....+++.||||.+.... ....+|+.+++.++||||+++++++..... ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999998889999999885332 234579999999999999999887654321 112
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-c
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-V 423 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~ 423 (789)
...++||||+++ ++.+++... ......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~------~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~ 209 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHY------ARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHT 209 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHH------hhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCc
Confidence 246799999985 676666432 123456899999999999999999999988 99999999999999665 7
Q ss_pred eeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+||+|||+|+....... .....||..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 210 vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 273 (440)
T PTZ00036 210 LKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273 (440)
T ss_pred eeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999987654332 1234578999999988664 689999999999999999999999964
No 194
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=99.97 E-value=5.6e-31 Score=273.94 Aligned_cols=250 Identities=24% Similarity=0.271 Sum_probs=199.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
++|...+.||+|++|.||+|.+..+++.|++|.++.... ...+.+|++.+++++|+||+++++++.... ..++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT-----DLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----cEEE
Confidence 678899999999999999999998889999999865533 678999999999999999999999987765 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
++||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+||
T Consensus 76 ~~e~~~~~~L~~~l~~~---------~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~df 143 (256)
T cd06612 76 VMEYCGAGSVSDIMKIT---------NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADF 143 (256)
T ss_pred EEecCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEccc
Confidence 99999999999998543 356899999999999999999999888 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 509 (789)
|.+........ ......++..|+|||++.+..++.++|||||||++|||++|+.||....... .... . ..
T Consensus 144 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~~~-~-~~-- 213 (256)
T cd06612 144 GVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AIFM-I-PN-- 213 (256)
T ss_pred ccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hhhh-h-cc--
Confidence 99987754431 1223447889999999988889999999999999999999999997421110 0000 0 00
Q ss_pred hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
...+... ........+.++...|++.+|..|++...+..
T Consensus 214 --~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 214 --KPPPTLS--------------------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --CCCCCCC--------------------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000000 00112234567788999999999999876643
No 195
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=99.97 E-value=1.2e-30 Score=277.94 Aligned_cols=260 Identities=21% Similarity=0.305 Sum_probs=196.2
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCce--EEEEEEeccc-cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRT--TVTVKVFNLH-HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 345 (789)
++|...+.||+|+||.||+|....++. .+++|.++.. .....+.+..|++++.++ +||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG----- 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-----
Confidence 678899999999999999999876654 4788888643 233456789999999999 7999999999987655
Q ss_pred eEEEEeeccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD 419 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~ 419 (789)
..++|+||+++|+|.+++........ .......+++.++..++.|++.||+|||+.+ ++||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEEC
Confidence 78999999999999999965421110 0112346899999999999999999999887 99999999999999
Q ss_pred CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHH
Q 041249 420 EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLH 498 (789)
Q Consensus 420 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~ 498 (789)
+++.+||+|||++........ ......+..|+|||+.....++.++|||||||++|||++ |..||... ...
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~-----~~~ 225 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-----TCA 225 (297)
T ss_pred CCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----CHH
Confidence 999999999999875322111 111123457999999988889999999999999999998 99998632 112
Q ss_pred HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
++...... .... .....+...+.+++..|++.++..||+...+...+
T Consensus 226 ~~~~~~~~---------~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 226 ELYEKLPQ---------GYRM------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred HHHHHHhc---------CCCC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 22111110 0000 00112334566888999999999999998875443
No 196
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=99.97 E-value=1.7e-30 Score=270.56 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=198.4
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||+|++|.||++....+++.||+|.+.... ....+.+.+|++++++++|+|++++.+.+...+ ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEE
Confidence 5778899999999999999999889999999986542 334567899999999999999999988764322 2578
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+++++|.+++... ....+++.++..++.+++.|++|||+.+ ++||||||+||+++.++.++|+|
T Consensus 77 lv~e~~~~~~l~~~l~~~--------~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~d 145 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ--------KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGD 145 (257)
T ss_pred EEecccCCCcHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEec
Confidence 999999999999998643 2346899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
||++........ ......++..|+|||...+..++.++||||||+++|||++|+.||+.. +............
T Consensus 146 f~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~~~~~~~~ 218 (257)
T cd08223 146 LGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLVYRIIEGK 218 (257)
T ss_pred ccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhcC
Confidence 999987643321 122345788999999999999999999999999999999999998632 1222221111100
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
. +.+ .......+.+++..|.+.++.+||+......+
T Consensus 219 ~-----~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 L-----PPM----------------------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred C-----CCC----------------------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000 01223456688899999999999998776443
No 197
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=99.97 E-value=6.2e-31 Score=285.99 Aligned_cols=266 Identities=22% Similarity=0.250 Sum_probs=196.5
Q ss_pred hcCCCCCCcccccCCccEEEEEEc-----CCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLD-----EGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGVDY 341 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 341 (789)
.++|...+.||+|+||.||+|.+. .+++.||||+++.... .....+.+|++++.++ +|+||++++++|....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-
Confidence 367999999999999999999853 3578899999975432 3346788999999999 6899999999886433
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCc---------------------------------------------------
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNRED--------------------------------------------------- 370 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------------------------------------------- 370 (789)
...++||||+.+|+|.+++.......
T Consensus 85 ---~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 85 ---GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred ---CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 25789999999999999986431100
Q ss_pred ------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccce
Q 041249 371 ------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSS 444 (789)
Q Consensus 371 ------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 444 (789)
........+++.++..++.|++.||+|||+.+ |+||||||+||++++++++|++|||++............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 00001235788999999999999999999888 999999999999999999999999999876443322222
Q ss_pred eeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhh
Q 041249 445 IGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVED 523 (789)
Q Consensus 445 ~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 523 (789)
....++..|+|||.+....++.++||||||+++|||++ |..||...... ......+.........
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~------------- 304 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRAP------------- 304 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhccCCCCCC-------------
Confidence 22345678999999988889999999999999999997 99998632111 0111111100000000
Q ss_pred HHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 524 LAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
......+.+++..|++.++..||+...+...+
T Consensus 305 -----------------~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 305 -----------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred -----------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 01123466788899999999999998875433
No 198
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=99.97 E-value=6.5e-31 Score=275.82 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=195.2
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCce---EEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRT---TVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
.+|...+.||+|+||.||+|.+..+++ .||||.++.. .......+..|++.++.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----- 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR----- 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-----
Confidence 357778999999999999999976554 6999998654 3334568999999999999999999999987655
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++|+||+.+|+|.+++... ...+++.++..++.|++.|++|||+.+ ++|+||||+||+++.++.+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~k 146 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQN---------DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCK 146 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEE
Confidence 789999999999999998643 245899999999999999999999888 99999999999999999999
Q ss_pred eCcccccccCCCCCCccc-eeeec--ccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHH
Q 041249 426 VGDFGLARFLPPTHVQTS-SIGVK--GSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFA 501 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~-~~~~~--gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~ 501 (789)
++|||.+........... ..... .+..|+|||+.....++.++|||||||++||+++ |..||.... ......++
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i 224 (269)
T cd05065 147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAI 224 (269)
T ss_pred ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHH
Confidence 999999887654332111 11111 2457999999999999999999999999999886 999986321 11222222
Q ss_pred HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
....+. .....+...+.+++..|++.++.+||+...+.
T Consensus 225 ~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 262 (269)
T cd05065 225 EQDYRL------------------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIV 262 (269)
T ss_pred HcCCcC------------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 111100 00113344566888899999999999998664
No 199
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=99.97 E-value=5.8e-31 Score=280.17 Aligned_cols=199 Identities=22% Similarity=0.364 Sum_probs=176.2
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
.+|...+.||.|++|.||+|....+++.|++|.+..........+.+|++.++.++||||+++++++.... ..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD-----ELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc-----eEEE
Confidence 46888899999999999999998899999999997666556678899999999999999999999987655 8999
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||+.+++|.+++.. ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+||
T Consensus 94 v~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-----------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred EEEecCCCcHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccC
Confidence 9999999999998843 24789999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|++......... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~ 217 (296)
T cd06655 160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (296)
T ss_pred ccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 998876543321 1234588899999999988899999999999999999999999964
No 200
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=99.97 E-value=1.3e-30 Score=271.32 Aligned_cols=248 Identities=19% Similarity=0.214 Sum_probs=197.0
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
+|...+.||+|+||.||++.+..+++.+|+|.++.. .....+.+.+|++++++++|+||+++.+.+.... ..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-----HLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEE
Confidence 467789999999999999999989999999998643 3334567889999999999999999999987665 8999
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||+++|++.+++... ....+++.....++.|++.||.|||+.+ ++|+||||+||++++++.++++||
T Consensus 76 v~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~df 144 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQ--------RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDF 144 (255)
T ss_pred EEeeCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEccc
Confidence 99999999999988543 2345788999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 509 (789)
|.+........ ......|+..|+|||......++.++||||||+++|+|++|+.||... +.............
T Consensus 145 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~~~~~~~~ 217 (255)
T cd08219 145 GSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLILKVCQGSY 217 (255)
T ss_pred Ccceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHHHHhcCCC
Confidence 99987654332 122345888999999998888999999999999999999999999732 11111111111100
Q ss_pred hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA 568 (789)
Q Consensus 510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~ 568 (789)
.. .. ......+.+++.+|++.+|..||+....
T Consensus 218 ~~-~~--------------------------~~~~~~~~~li~~~l~~~P~~Rp~~~~i 249 (255)
T cd08219 218 KP-LP--------------------------SHYSYELRSLIKQMFKRNPRSRPSATTI 249 (255)
T ss_pred CC-CC--------------------------cccCHHHHHHHHHHHhCCcccCCCHHHH
Confidence 00 00 0122345577889999999999988765
No 201
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=99.97 E-value=6.6e-32 Score=260.06 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=200.2
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch--------hhHHHHHHHHHHhcC-CCCccceeeeeeccCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------ASRSFIAECRALRSI-RHRNLVKVFTACSGVD 340 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 340 (789)
..|...+.+|.|..+.|.++..+.++++.|+|++...... -.++..+|+.+++++ .||+|+++.+.+....
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4677889999999999999999999999999998643211 135677899999999 6999999999988766
Q ss_pred CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE 420 (789)
Q Consensus 341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~ 420 (789)
+.++|+|.|+.|-|.+++.+. -.+++.+...|+.|+..|++|||... ||||||||+|||+++
T Consensus 97 -----F~FlVFdl~prGELFDyLts~----------VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILldd 158 (411)
T KOG0599|consen 97 -----FVFLVFDLMPRGELFDYLTSK----------VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDD 158 (411)
T ss_pred -----hhhhhhhhcccchHHHHhhhh----------eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecc
Confidence 899999999999999999654 56889999999999999999999988 999999999999999
Q ss_pred CCceeeCcccccccCCCCCCccceeeecccccccCcccCCC------CCcCccccchhhHHHHHHHHHhcCCCCccccCC
Q 041249 421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG------SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494 (789)
Q Consensus 421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~ 494 (789)
+.++||+|||.|..++++. .....+||++|.|||.+.. ..|+..+|+||.||+||-|+.|.+||.... .
T Consensus 159 n~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Q 233 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--Q 233 (411)
T ss_pred ccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--H
Confidence 9999999999999988776 3445789999999998754 248899999999999999999999996310 0
Q ss_pred ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
+-+... ++...+ +++..+..+......+++.+|.++++..|-+.++...++
T Consensus 234 mlMLR~-----------ImeGky----------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 234 MLMLRM-----------IMEGKY----------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHHHHH-----------HHhccc----------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 001111 111111 111122223334455777888888888887777665443
No 202
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=99.97 E-value=8.7e-31 Score=274.56 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=196.5
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCc---eEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGR---TTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
..+|...+.||+|+||.||+|.+..++ ..+|+|.++... ....+.+..|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 78 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK---- 78 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence 357888999999999999999986443 479999986543 334567899999999999999999999987654
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..++||||+++|+|.+++... ...+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 79 -~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 145 (267)
T cd05066 79 -PVMIVTEYMENGSLDAFLRKH---------DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVC 145 (267)
T ss_pred -ccEEEEEcCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeE
Confidence 789999999999999998643 245899999999999999999999888 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccc-eeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249 425 HVGDFGLARFLPPTHVQTS-SIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR 502 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 502 (789)
|++|||++........... .....++..|+|||+.....++.++||||||+++||+++ |+.||..... ......+.
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~ 223 (267)
T cd05066 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIE 223 (267)
T ss_pred EeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHh
Confidence 9999999988765432111 112223568999999998899999999999999999886 9999863211 11112111
Q ss_pred HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
..... + ....+...+.+++..|++.++..||++..+..
T Consensus 224 ~~~~~-------~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 224 EGYRL-------P-----------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCcC-------C-----------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 11000 0 00123345668888999999999999887643
No 203
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=99.97 E-value=7e-31 Score=305.87 Aligned_cols=263 Identities=20% Similarity=0.273 Sum_probs=200.3
Q ss_pred HHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249 263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVD 340 (789)
Q Consensus 263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 340 (789)
.+.....++|.+.+.||+|+||+||+|.+..+++.||+|.+... .......+..|+.+++.++||||+++++++....
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 33444567899999999999999999999989999999998644 2334567899999999999999999999875432
Q ss_pred CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCC----CCceecCCCCCce
Q 041249 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQ----PITTHCDLKPSNI 416 (789)
Q Consensus 341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~----~~ivH~dlk~~Ni 416 (789)
....++||||+.+|+|.+++.... .....+++..++.|+.||+.||+|||..+. .+||||||||+||
T Consensus 86 ---~~~lyIVMEY~~gGSL~~lL~k~~------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNI 156 (1021)
T PTZ00266 86 ---NQKLYILMEFCDAGDLSRNIQKCY------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNI 156 (1021)
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHe
Confidence 236899999999999999986431 123468999999999999999999998652 3499999999999
Q ss_pred ecCC-----------------CCceeeCcccccccCCCCCCccceeeecccccccCcccCCC--CCcCccccchhhHHHH
Q 041249 417 LLDE-----------------EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGILM 477 (789)
Q Consensus 417 ll~~-----------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGvvl 477 (789)
|++. ...+||+|||++........ .....||+.|+|||++.. ..+++++|||||||++
T Consensus 157 LL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL 233 (1021)
T PTZ00266 157 FLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233 (1021)
T ss_pred EeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence 9964 34589999999987654321 223468999999998854 4589999999999999
Q ss_pred HHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhcccccee
Q 041249 478 LELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKV 557 (789)
Q Consensus 478 ~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l 557 (789)
|||++|+.||... .....++...... +.+. .......+.+++..|++.
T Consensus 234 YELLTGk~PF~~~----~~~~qli~~lk~~-------p~lp---------------------i~~~S~eL~dLI~~~L~~ 281 (1021)
T PTZ00266 234 YELCSGKTPFHKA----NNFSQLISELKRG-------PDLP---------------------IKGKSKELNILIKNLLNL 281 (1021)
T ss_pred HHHHHCCCCCCcC----CcHHHHHHHHhcC-------CCCC---------------------cCCCCHHHHHHHHHHhcC
Confidence 9999999999632 1222222211110 0000 001123456788899999
Q ss_pred eEeccCcccccc
Q 041249 558 TILDLESLKLAG 569 (789)
Q Consensus 558 ~~l~l~s~~~~~ 569 (789)
++..||+.....
T Consensus 282 dPeeRPSa~QlL 293 (1021)
T PTZ00266 282 SAKERPSALQCL 293 (1021)
T ss_pred ChhHCcCHHHHh
Confidence 999999987764
No 204
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=99.97 E-value=7.5e-31 Score=280.41 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=197.8
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCce----EEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRT----TVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
.++|...+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.++++++||||++++|+|...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 4678889999999999999999876665 578888865433 2345788999999999999999999998643
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV 423 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 423 (789)
..++++||+++|++.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHEH---------KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNH 147 (303)
T ss_pred --CceeeehhcCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCc
Confidence 357899999999999998643 235788999999999999999999888 999999999999999999
Q ss_pred eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249 424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR 502 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 502 (789)
+||+|||+++...............++..|+|||+..+..++.++|||||||++||+++ |+.||.... .....++++
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~ 225 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLE 225 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH
Confidence 99999999987754443222333446778999999988889999999999999999998 999986321 111222222
Q ss_pred HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
..... .....+...+.+++..|+..++-.||+.......+.
T Consensus 226 ~~~~~------------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 226 KGERL------------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CCCCC------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11000 000123345668888999999999999988755443
No 205
>PHA03207 serine/threonine kinase US3; Provisional
Probab=99.97 E-value=1.1e-30 Score=289.20 Aligned_cols=198 Identities=24% Similarity=0.278 Sum_probs=169.6
Q ss_pred hcCCCCCCcccccCCccEEEEEEcC--CceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
...|...+.||+|+||.||++.... .++.||+|.+... ....+|++++++++||||+++++++.... .
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS-----T 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC-----E
Confidence 3578899999999999999998643 4678999987533 24568999999999999999999887655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++|||++. +++.+++.. ...+++.++..++.|++.||+|||+.+ ||||||||+|||++.++.+||
T Consensus 161 ~~lv~e~~~-~~l~~~l~~----------~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l 226 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDR----------SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVL 226 (392)
T ss_pred EEEEehhcC-CCHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEE
Confidence 899999987 688888732 256899999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
+|||++................||..|+|||++....++.++|||||||++|||++|+.||...
T Consensus 227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9999998766544333333466999999999999999999999999999999999999999643
No 206
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=99.97 E-value=1e-30 Score=280.88 Aligned_cols=266 Identities=22% Similarity=0.352 Sum_probs=199.3
Q ss_pred hhcCCCCCCcccccCCccEEEEEEc-------CCceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeecc
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLD-------EGRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSG 338 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 338 (789)
..++|...+.||+|+||.||+++.. .....||+|.++... ......+..|+++++++ +||||++++++|..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4467888999999999999999863 234679999987543 23456788999999999 69999999999876
Q ss_pred CCCCCCceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCC
Q 041249 339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK 412 (789)
Q Consensus 339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk 412 (789)
.. ..++|+||+.+|+|.+++....... ........+++.++..++.|++.||.|||+.+ ++|||||
T Consensus 90 ~~-----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlk 161 (314)
T cd05099 90 EG-----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLA 161 (314)
T ss_pred CC-----ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccc
Confidence 54 6899999999999999996542110 01112346899999999999999999999888 9999999
Q ss_pred CCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccc
Q 041249 413 PSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMF 491 (789)
Q Consensus 413 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~ 491 (789)
|+||++++++.+||+|||.++...............++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~- 240 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI- 240 (314)
T ss_pred ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC-
Confidence 9999999999999999999987654332211122234567999999988889999999999999999999 89998632
Q ss_pred cCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 492 EGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
...............+ ....+..++.+++.+|++.++-.||+.......
T Consensus 241 ----~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 241 ----PVEELFKLLREGHRMD---------------------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred ----CHHHHHHHHHcCCCCC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1111111110000000 011234456688899999999999998876543
Q ss_pred cc
Q 041249 572 LP 573 (789)
Q Consensus 572 l~ 573 (789)
+.
T Consensus 290 l~ 291 (314)
T cd05099 290 LD 291 (314)
T ss_pred HH
Confidence 33
No 207
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=99.97 E-value=1.3e-30 Score=271.50 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=197.0
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.++|...+.||.|++|.||+|... ++.||+|.++.... ..+.+..|+.++++++|+||+++++++.... ..+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN-----PLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC-----CeE
Confidence 468889999999999999999985 78999999976644 5678999999999999999999999987654 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.+||+|
T Consensus 77 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d 145 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSR--------GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSD 145 (256)
T ss_pred EEEEecCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcc
Confidence 999999999999998654 2236899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
||.++....... ...++..|+|||++..+.++.++||||||+++||+++ |+.||..... ..+..........
T Consensus 146 ~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~ 218 (256)
T cd05039 146 FGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVEKGYRM 218 (256)
T ss_pred cccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhcCCCC
Confidence 999987743321 2335568999999998899999999999999999997 9999863211 1111111111000
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
. ....+...+.+++..|++.++..||+......
T Consensus 219 ~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 E------------------------------APEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred C------------------------------CccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 00122345667888999999999999876643
No 208
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=99.97 E-value=3.3e-30 Score=268.33 Aligned_cols=249 Identities=19% Similarity=0.268 Sum_probs=199.1
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|+..+.||.|+||.||.+....+++.|++|.+... .....+.+.+|++++++++|+||+++++++.+.. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-----TLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-----eEE
Confidence 477889999999999999999989999999998654 3344567889999999999999999999987755 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
++|||+++|+|.+++... .+..+++.++..++.|++.|++|||+.+ ++|+||+|+||++++++.+|++|
T Consensus 76 ~~~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d 144 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--------KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGD 144 (256)
T ss_pred EEEEecCCCcHHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECc
Confidence 999999999999998643 2356899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
||.+........ ......++..|+|||...+..++.++||||||+++|||++|+.||+.. ...+.........
T Consensus 145 ~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~ 217 (256)
T cd08221 145 FGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-----NPLNLVVKIVQGN 217 (256)
T ss_pred CcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHHcCC
Confidence 999987654432 123355889999999998888999999999999999999999998632 1112211111110
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
.... ...+...+.+++..|++.++.+|++.....
T Consensus 218 ~~~~---------------------------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll 251 (256)
T cd08221 218 YTPV---------------------------VSVYSSELISLVHSLLQQDPEKRPTADEVL 251 (256)
T ss_pred CCCC---------------------------ccccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 0000 012234456778889999999999877653
No 209
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=99.97 E-value=1.2e-30 Score=278.83 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=195.4
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCce--EEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRT--TVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~ 344 (789)
.++|...+.||+|+||.||+|.+..++. .+++|.++... ......+.+|++++.++ +|+||+++++++....
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~---- 81 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG---- 81 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC----
Confidence 4678889999999999999999876665 45777765432 33456788999999999 8999999999987655
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccc------cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEV------DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill 418 (789)
..++|+||+++|+|.+++.......+. ......+++.++..++.|++.|++|||+.+ ++||||||+||++
T Consensus 82 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili 157 (303)
T cd05088 82 -YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILV 157 (303)
T ss_pred -CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEe
Confidence 789999999999999999754221110 112346899999999999999999999888 9999999999999
Q ss_pred CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccH
Q 041249 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNL 497 (789)
Q Consensus 419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~ 497 (789)
+.++.+||+|||++....... ......++..|+|||+.....++.++|||||||++|||+| |..||.....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 229 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----- 229 (303)
T ss_pred cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----
Confidence 999999999999986432111 1111224567999999988889999999999999999998 9999863211
Q ss_pred HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
.+..... +.. ... .....+...+.+++..|++.++..||+.......
T Consensus 230 ~~~~~~~-~~~--------~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 230 AELYEKL-PQG--------YRL------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHHHH-hcC--------CcC------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111111 000 000 0001223456688899999999999999876443
No 210
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=99.97 E-value=1.9e-30 Score=270.24 Aligned_cols=246 Identities=26% Similarity=0.352 Sum_probs=192.9
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
-++|...+.||+|+||.||++... ++.||+|.++... ..+.+..|+.++++++|+|++++++++.... ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~ 76 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY 76 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----CceE
Confidence 357888999999999999999875 7889999986432 3467899999999999999999999764332 2679
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+|++|
T Consensus 77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~d 145 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSR--------GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSD 145 (256)
T ss_pred EEEECCCCCcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecC
Confidence 999999999999998643 2345789999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
||.++....... ...++..|+|||+.....++.++||||||+++|||++ |+.||... ...+........
T Consensus 146 fg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~ 215 (256)
T cd05082 146 FGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKG 215 (256)
T ss_pred CccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcC
Confidence 999886543321 2234568999999988889999999999999999998 99998621 222222111000
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
...+ ....+...+.+++..|++.++.+||+......
T Consensus 216 ~~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 216 YKMD---------------------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCC---------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0000 00123445668888999999999999887643
No 211
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=99.97 E-value=2.3e-30 Score=269.92 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=198.5
Q ss_pred CcccccCCccEEEEEEcCC---ceEEEEEEeccccchh-hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||.||+|..... +..|++|.++...... .+.+.+|++.+..++|+|++++++++.... ..++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE-----PLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC-----ceEEEE
Confidence 4799999999999999865 8999999997664443 678999999999999999999999987644 789999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+++|.+++....... .......+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.+|++|||.
T Consensus 76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence 9999999999986531100 0011367899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchh
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVM 510 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 510 (789)
+................++..|+|||......++.++||||+|+++|||++ |+.||.... ...+.+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~~---- 225 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYLRKGYR---- 225 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC----
Confidence 998876543223334567889999999988899999999999999999999 699987431 1111111111000
Q ss_pred hhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 511 DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 511 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
......+..++.+++..|++.++.+||+.....
T Consensus 226 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~ 258 (262)
T cd00192 226 --------------------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELV 258 (262)
T ss_pred --------------------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHH
Confidence 001112345667888899999999999887653
No 212
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=99.97 E-value=2.3e-32 Score=259.53 Aligned_cols=200 Identities=25% Similarity=0.383 Sum_probs=174.1
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++.|+.-+.||+|.|+.||++....+|+.+|+|.++.. .....+.+.+|+++.+.++||||+++.....+.. .
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~-----~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc-----e
Confidence 46788888999999999999999999999999998644 4446678999999999999999999998877665 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---Cc
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---MV 423 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~---~~ 423 (789)
.++|+|+|.+|+|..-+-.+ ..+++...-++..||+.||.|+|+++ |||||+||+|+++..+ --
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R----------~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~ 151 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR----------EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAA 151 (355)
T ss_pred eEEEEecccchHHHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCc
Confidence 99999999999976655322 45677788899999999999999998 9999999999999532 35
Q ss_pred eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+||+|||+|...... ....+..||++|||||+....+|+..+|||+.||+||-|+.|..||.+
T Consensus 152 vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 152 VKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred eeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 699999999998833 245567899999999999999999999999999999999999999974
No 213
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=99.97 E-value=1e-30 Score=273.31 Aligned_cols=252 Identities=26% Similarity=0.422 Sum_probs=195.1
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.+.|...+.||+|+||.||+|.+.. ...||+|.++.... ....+..|++++++++|+||+++++.+.. . ..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~-----~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-----PIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC-CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-C-----CcE
Confidence 3568889999999999999999874 45699999875332 34578999999999999999999987643 2 468
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+.+|+|.+++... .+..+++..+..++.|+++||+|+|+.+ ++|+||||+||++++++.+||+|
T Consensus 77 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~d 145 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGE--------MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVAD 145 (262)
T ss_pred EEEEcCCCCcHHHHHhhc--------cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEecc
Confidence 999999999999999643 2346789999999999999999999887 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
||.++........ ......++..|+|||+.....++.++||||||+++|||++ |+.||..... .........
T Consensus 146 fg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-----~~~~~~~~~- 218 (262)
T cd05071 146 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVER- 218 (262)
T ss_pred CCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-----HHHHHHHhc-
Confidence 9999876544321 1122346678999999998999999999999999999999 8888863211 011110000
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
... ......+...+.+++..|++.++-.||+.......+
T Consensus 219 --------~~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l 257 (262)
T cd05071 219 --------GYR------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 257 (262)
T ss_pred --------CCC------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 000 000113445677899999999999999988765443
No 214
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=99.97 E-value=1.3e-30 Score=272.01 Aligned_cols=251 Identities=23% Similarity=0.392 Sum_probs=195.8
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
..++|...+.||+|+||.||+|..+ +++.||+|.+..... ....+..|++++++++|+||+++++++.. + ..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----~~ 75 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-E-----PI 75 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-C-----Cc
Confidence 3467888999999999999999976 678899999864433 34678899999999999999999988642 2 57
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++++||+.+|+|.+++... .+..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++++
T Consensus 76 ~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~ 144 (260)
T cd05067 76 YIITEYMENGSLVDFLKTP--------EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIA 144 (260)
T ss_pred EEEEEcCCCCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEc
Confidence 9999999999999998643 3356899999999999999999999888 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
|||.+......... ......++..|+|||++....++.++||||||+++||+++ |+.||.... ...+........+
T Consensus 145 dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~ 221 (260)
T cd05067 145 DFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNLERGYR 221 (260)
T ss_pred cCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHcCCC
Confidence 99999876533211 1122345678999999998899999999999999999999 999996321 1111111111100
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.. . ...+..++.+++.+|.+.++.+||+......
T Consensus 222 ~~--------~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 222 MP--------R----------------------PDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CC--------C----------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 0 0012345678888999999999999876643
No 215
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=99.97 E-value=1.3e-30 Score=275.20 Aligned_cols=253 Identities=22% Similarity=0.252 Sum_probs=199.1
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.++|.+.+.||.|++|.||+|.+..+++.||+|+++.......+.+..|++++++++|+||+++++++.... ..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN-----KLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-----eEE
Confidence 467888999999999999999998889999999998766666678999999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|
T Consensus 79 lv~e~~~~~~L~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 79 ILIEFCDGGALDSIMLEL---------ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred EEeeccCCCcHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEcc
Confidence 999999999999998543 246899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 503 (789)
||.+........ ......++..|+|||.+. ...++.++||||||+++|||++|+.||..... ......
T Consensus 147 ~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~~~~~~ 219 (280)
T cd06611 147 FGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----MRVLLK 219 (280)
T ss_pred Cccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----HHHHHH
Confidence 998876543322 123455889999999874 34478899999999999999999999863211 111111
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
..... .+.+. ....+...+.+++..|++.++..|++...+..
T Consensus 220 ~~~~~-----~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 220 ILKSE-----PPTLD--------------------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HhcCC-----CCCcC--------------------CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 10000 00000 00012234557788899999999999887644
No 216
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=99.97 E-value=1.3e-30 Score=275.60 Aligned_cols=251 Identities=22% Similarity=0.262 Sum_probs=195.4
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
|...+.||+|+||.||+|....++..+++|.+..........+..|+++++.++|||++++++++.... ..++|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-----EEEEEE
Confidence 456788999999999999999889999999997665556677899999999999999999999987655 789999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|++..++... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+|++|||+
T Consensus 82 e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~ 149 (282)
T cd06643 82 EFCAGGAVDAVMLEL---------ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGV 149 (282)
T ss_pred EecCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccc
Confidence 999999999887532 246899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
+........ ......++..|+|||++. ...++.++|||||||++|||++|+.||..... ........+...+
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~ 226 (282)
T cd06643 150 SAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPP 226 (282)
T ss_pred ccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-HHHHHHHhhcCCC
Confidence 876543221 122345889999999874 34578899999999999999999999863211 0011111110000
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
....+ ..+...+.+++..|++.++.+|++.......
T Consensus 227 ----~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 ----TLAQP-------------------------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CCCCc-------------------------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0122345678889999999999998766443
No 217
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=99.97 E-value=9e-31 Score=280.40 Aligned_cols=266 Identities=21% Similarity=0.336 Sum_probs=200.2
Q ss_pred hcCCCCCCcccccCCccEEEEEEcC-------CceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDE-------GRTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGV 339 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 339 (789)
.++|...+.||+|+||.||++.+.. ....+|+|.++... ......+..|++++.++ +|+||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4678999999999999999998742 23579999997543 33456788899999999 799999999998766
Q ss_pred CCCCCceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCC
Q 041249 340 DYQGNDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKP 413 (789)
Q Consensus 340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~ 413 (789)
. ..++||||+.+|+|.+++....... ........+++.+++.++.|++.||+|||+.+ ++||||||
T Consensus 97 ~-----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp 168 (307)
T cd05098 97 G-----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAA 168 (307)
T ss_pred C-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccH
Confidence 5 7899999999999999997542110 00112345899999999999999999999887 99999999
Q ss_pred CceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcccc
Q 041249 414 SNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFE 492 (789)
Q Consensus 414 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~ 492 (789)
+||++++++.+||+|||.++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-- 246 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-- 246 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--
Confidence 999999999999999999987654332111222234568999999988889999999999999999998 88888532
Q ss_pred CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
...+..+........ .....+..++.+++..|++.++-.||++..+...+
T Consensus 247 ---~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 247 ---PVEELFKLLKEGHRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred ---CHHHHHHHHHcCCCC---------------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 122222111000000 00112344566788899999999999998875544
Q ss_pred cc
Q 041249 573 PH 574 (789)
Q Consensus 573 ~~ 574 (789)
..
T Consensus 297 ~~ 298 (307)
T cd05098 297 DR 298 (307)
T ss_pred HH
Confidence 43
No 218
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=99.97 E-value=1.9e-30 Score=273.03 Aligned_cols=249 Identities=24% Similarity=0.272 Sum_probs=198.0
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||.|++|.||+|....+++.||+|++.... ......+.+|+++++.++|+||+++++++.+.. ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-----KLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-----eEE
Confidence 36778899999999999999999899999999987553 344567889999999999999999999987665 899
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+.+++|.+++.. ..+++.++..++.|++.|+.|||+.+ ++|+||+|+||++++++.++++|
T Consensus 76 ~v~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d 141 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP-----------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLAD 141 (274)
T ss_pred EEEEeeCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999853 26889999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
||.++....... ......++..|+|||++.+..++.++||||||+++|||++|+.||...... .....+....+
T Consensus 142 ~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~-- 215 (274)
T cd06609 142 FGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVLFLIPKNNP-- 215 (274)
T ss_pred cccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHHHHhhhcCC--
Confidence 999988765431 122345788999999999888999999999999999999999999632211 01110110100
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
+.+.. ..+...+.+++..|+..++.+|++......
T Consensus 216 ------~~~~~---------------------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 ------PSLEG---------------------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ------CCCcc---------------------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 01000 002234557778899999999998877644
No 219
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=99.97 E-value=1.4e-30 Score=274.90 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=196.7
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCce----EEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRT----TVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
.++|...+.||+|+||.||+|.+..+++ .||+|....... .....+.+|++.+++++|+||++++++|.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--- 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S--- 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C---
Confidence 3567888999999999999999875544 589998865543 345678899999999999999999999875 3
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV 423 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 423 (789)
..++|+||+.+|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 82 --~~~~v~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~ 147 (279)
T cd05057 82 --QVQLITQLMPLGCLLDYVRNH---------KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQH 147 (279)
T ss_pred --ceEEEEecCCCCcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCe
Confidence 689999999999999998643 235899999999999999999999887 999999999999999999
Q ss_pred eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249 424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR 502 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 502 (789)
+||+|||.++...............++..|+|||......++.++||||||+++||+++ |+.||+.... ..+.+.+.
T Consensus 148 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~ 225 (279)
T cd05057 148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLE 225 (279)
T ss_pred EEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHh
Confidence 99999999987764432222222234568999999988889999999999999999998 9999873211 11122211
Q ss_pred HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
..... .....+...+.+++..|+..++..||+.......+
T Consensus 226 ~~~~~------------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l 265 (279)
T cd05057 226 KGERL------------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265 (279)
T ss_pred CCCCC------------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 10000 00011234456778899999999999888764433
No 220
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=99.97 E-value=2.6e-30 Score=271.27 Aligned_cols=201 Identities=25% Similarity=0.341 Sum_probs=160.9
Q ss_pred CcccccCCccEEEEEEcC--CceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 276 NLIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
+.||+|+||.||+|.... ....+|+|.+.... ......+.+|++.++.++|+||+++++++.... ..++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-----~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-----PYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-----ceEEEEE
Confidence 358999999999997643 24578888876443 233567889999999999999999999987665 7899999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA 432 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 432 (789)
|+.+|+|.+++.... .......++.....++.|++.||+|||+.+ |+||||||+||++++++.+|++|||++
T Consensus 76 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 147 (269)
T cd05042 76 FCPLGDLKNYLRSNR-----GMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLA 147 (269)
T ss_pred eCCCCcHHHHHHhcc-----ccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccc
Confidence 999999999986541 111234567888999999999999999888 999999999999999999999999998
Q ss_pred ccCCCCCCccceeeecccccccCcccCCC-------CCcCccccchhhHHHHHHHHH-hcCCCCc
Q 041249 433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLG-------SEVSTNGDVYSYGILMLELII-RKKPSDI 489 (789)
Q Consensus 433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~sfGvvl~ellt-G~~P~~~ 489 (789)
................++..|+|||+... ..++.++|||||||++|||++ |..||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 76544332212223345678999998642 357889999999999999999 7888863
No 221
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=99.97 E-value=4.3e-30 Score=273.11 Aligned_cols=252 Identities=20% Similarity=0.222 Sum_probs=197.1
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
++|.+.+.||+|+||.||+|....+++.|++|.+........+.+..|+++++.++|+||+++++.+.... ..++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-----KLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-----eEEE
Confidence 57888999999999999999999889999999998766666778999999999999999999999987655 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+.++++..++... ...+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.+||+||
T Consensus 87 v~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~df 154 (292)
T cd06644 87 MIEFCPGGAVDAIMLEL---------DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADF 154 (292)
T ss_pred EEecCCCCcHHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccC
Confidence 99999999998887533 245899999999999999999999888 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 504 (789)
|.+........ ......++..|+|||++. ...++.++|||||||++|||++|+.||..... .......
T Consensus 155 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~ 227 (292)
T cd06644 155 GVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKI 227 (292)
T ss_pred ccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHH
Confidence 98876433221 122345788999999875 34578899999999999999999999863211 1111111
Q ss_pred CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.........+ ...+...+.+++..|++.++..||+...+..
T Consensus 228 ~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 228 AKSEPPTLSQ-------------------------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred hcCCCccCCC-------------------------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000 0012234557788899999999998876643
No 222
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=99.97 E-value=1.7e-30 Score=281.65 Aligned_cols=266 Identities=21% Similarity=0.328 Sum_probs=200.1
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCC-------ceEEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEG-------RTTVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACS 337 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 337 (789)
....+|...+.||+|+||.||+|.+... ...||+|.++... ....+.+.+|+++++++ +||||++++++|.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 3345788899999999999999986422 3468999887543 33456789999999999 8999999999987
Q ss_pred cCCCCCCceEEEEeeccCCCChhhhccCCCCCc------cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNRED------EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL 411 (789)
Q Consensus 338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl 411 (789)
... ..++++||+.+|+|.+++....... ........+++.+++.++.|++.||+|||..+ ++||||
T Consensus 89 ~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dl 160 (334)
T cd05100 89 QDG-----PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDL 160 (334)
T ss_pred cCC-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccc
Confidence 655 7899999999999999987541100 00112346889999999999999999999988 999999
Q ss_pred CCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCcc
Q 041249 412 KPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIM 490 (789)
Q Consensus 412 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~ 490 (789)
||+||++++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999987654332222222334567999999999899999999999999999998 88888632
Q ss_pred ccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 491 FEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
....+.+........+. ...+...+.+++..|++.++..||+..+...
T Consensus 241 -----~~~~~~~~~~~~~~~~~---------------------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~ 288 (334)
T cd05100 241 -----PVEELFKLLKEGHRMDK---------------------------PANCTHELYMIMRECWHAVPSQRPTFKQLVE 288 (334)
T ss_pred -----CHHHHHHHHHcCCCCCC---------------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 22222222111100000 1123345668889999999999999987754
Q ss_pred cc
Q 041249 571 IL 572 (789)
Q Consensus 571 ~l 572 (789)
.+
T Consensus 289 ~l 290 (334)
T cd05100 289 DL 290 (334)
T ss_pred HH
Confidence 43
No 223
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=99.97 E-value=3.2e-30 Score=271.07 Aligned_cols=255 Identities=18% Similarity=0.272 Sum_probs=195.2
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc----------hhhHHHHHHHHHHhcCCCCccceeeeeeccCC
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH----------RASRSFIAECRALRSIRHRNLVKVFTACSGVD 340 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 340 (789)
.|...+.||.|++|.||+|....+++.||+|.++.... ...+.+..|+.++++++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 36678899999999999999988899999998854211 11346788999999999999999999987655
Q ss_pred CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249 341 YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE 420 (789)
Q Consensus 341 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~ 420 (789)
..++|+||+.+|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.
T Consensus 82 -----~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~ 143 (272)
T cd06629 82 -----YLSIFLEYVPGGSIGSCLRTY----------GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDA 143 (272)
T ss_pred -----ceEEEEecCCCCcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcC
Confidence 789999999999999998643 46888999999999999999999887 999999999999999
Q ss_pred CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC--cCccccchhhHHHHHHHHHhcCCCCccccCCccHH
Q 041249 421 EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498 (789)
Q Consensus 421 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~ 498 (789)
++.+|++|||.+................|+..|+|||...... ++.++||||||+++||+++|+.||.... ...
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~ 219 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----AIA 219 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----hHH
Confidence 9999999999998765433222233456889999999987654 8999999999999999999999986211 111
Q ss_pred HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.+.. ..........++.. ..+....+.+++..|++.++..||++..+..
T Consensus 220 ~~~~-~~~~~~~~~~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 220 AMFK-LGNKRSAPPIPPDV----------------------SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHH-hhccccCCcCCccc----------------------cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111 11100000111111 0123345667788999999999999876644
No 224
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=99.97 E-value=2.6e-30 Score=281.30 Aligned_cols=202 Identities=25% Similarity=0.324 Sum_probs=170.1
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGN 344 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~ 344 (789)
..++|...+.||+|+||.||+|....+++.||||.+.... ......+.+|++++++++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999998889999999986432 2234567789999999999999999998754331 122
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-----------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCE
Confidence 3578999987 5788887742 35889999999999999999999988 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+|||+++...... ....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 158 RILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred EEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999998764332 23458899999999876 5689999999999999999999999963
No 225
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]
Probab=99.97 E-value=3.2e-33 Score=295.39 Aligned_cols=355 Identities=28% Similarity=0.402 Sum_probs=288.3
Q ss_pred EEcCCCCCCccCCcCccCCccCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCC-CCcccccCCCCCCEEEccCCc
Q 041249 2 LALDSNRLSGNIPPSIGNLKKLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSG-TIPPQLMGLTSLVALDLSRNQ 80 (789)
Q Consensus 2 l~l~~n~~~~~~p~~~~~l~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~ 80 (789)
|.|..-++. .+|++++.|.+|++|.+++|+|. .+-+.++.|+.|+.+++.+|++.. .+|+.+..+..|+.||||+|+
T Consensus 37 LkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNq 114 (1255)
T KOG0444|consen 37 LKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQ 114 (1255)
T ss_pred EEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhh
Confidence 445556666 89999999999999999999999 788889999999999999999973 488899999999999999999
Q ss_pred CCCCCcccccCCCCCCEEeccCCCCCCcCCcc-ccCCcccccccccCCCCCccceeecCCcccCCCchhhhcCcccccEE
Q 041249 81 FRGSFPTEVGNLINLETLTVSGNILQGEIPST-LGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFLVGLKVIENL 159 (789)
Q Consensus 81 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~~~~~~l~~l 159 (789)
|+ .+|..+-.-.++-+|+||+|+|. .||.. |-+++.|-. ||||+|++. .+|..+..+..|++|
T Consensus 115 L~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLf-------------LDLS~NrLe-~LPPQ~RRL~~LqtL 178 (1255)
T KOG0444|consen 115 LR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLF-------------LDLSNNRLE-MLPPQIRRLSMLQTL 178 (1255)
T ss_pred hh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhh-------------hccccchhh-hcCHHHHHHhhhhhh
Confidence 99 99999999999999999999998 67754 566655544 555556666 566678889999999
Q ss_pred ecccCCCCCCCCCcccccCCccccccCCCccccCCCcCCCCCCCCCCCcccccceeeeEeehhhHHHHHHHHHHHHHHHH
Q 041249 160 NLSYNDLEGMVPTEGVFKNASAISVLGNNKLCGGISEFKLPPCGLKKSTEWRLTFELKLVIAIVSGLMGLALTLSISFLC 239 (789)
Q Consensus 160 ~ls~N~~~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~v~~~~~~~~~~ 239 (789)
+||+|++...-- +.++ +.
T Consensus 179 ~Ls~NPL~hfQL-----rQLP--------------------sm------------------------------------- 196 (1255)
T KOG0444|consen 179 KLSNNPLNHFQL-----RQLP--------------------SM------------------------------------- 196 (1255)
T ss_pred hcCCChhhHHHH-----hcCc--------------------cc-------------------------------------
Confidence 999999864410 0000 00
Q ss_pred HHHhcccCCCCCccccccccccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHH
Q 041249 240 WVRKRKEQSNPNSLINSLLNLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECR 319 (789)
Q Consensus 240 ~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~ 319 (789)
T Consensus 197 -------------------------------------------------------------------------------- 196 (1255)
T KOG0444|consen 197 -------------------------------------------------------------------------------- 196 (1255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhh
Q 041249 320 ALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH 399 (789)
Q Consensus 320 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH 399 (789)
.+|+-||
T Consensus 197 -------------------------------------------------------------------------tsL~vLh 203 (1255)
T KOG0444|consen 197 -------------------------------------------------------------------------TSLSVLH 203 (1255)
T ss_pred -------------------------------------------------------------------------hhhhhhh
Confidence 0011122
Q ss_pred cCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHH
Q 041249 400 HDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLE 479 (789)
Q Consensus 400 ~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~e 479 (789)
-.+. ..|
T Consensus 204 ms~T--------------------------------------------qRT----------------------------- 210 (1255)
T KOG0444|consen 204 MSNT--------------------------------------------QRT----------------------------- 210 (1255)
T ss_pred cccc--------------------------------------------cch-----------------------------
Confidence 1110 000
Q ss_pred HHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeE
Q 041249 480 LIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTI 559 (789)
Q Consensus 480 lltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~ 559 (789)
T Consensus 211 -------------------------------------------------------------------------------- 210 (1255)
T KOG0444|consen 211 -------------------------------------------------------------------------------- 210 (1255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCC
Q 041249 560 LDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQL 639 (789)
Q Consensus 560 l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l 639 (789)
....|..+..+.+|..+|||.|.+. .+|+++..+.+|+.|+||+|+|+ .+....+...+|++|+||+|++
T Consensus 211 --------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQL 280 (1255)
T KOG0444|consen 211 --------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQL 280 (1255)
T ss_pred --------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchh
Confidence 0012334556889999999999999 89999999999999999999999 6667778889999999999999
Q ss_pred CCCCCcccCCCCCCcEEEccCCCCCc-cCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCcc
Q 041249 640 MGKIPSDFGSLSKIEVLSLGFNNLIG-SIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSS 718 (789)
Q Consensus 640 ~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 718 (789)
+ .+|+++..+++|+.|.+.+|+++- -+|+.++++.+|+.+..++|++. ..|+.++.|.+|+.|.|++|++. .+|++
T Consensus 281 t-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPea 357 (1255)
T KOG0444|consen 281 T-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEA 357 (1255)
T ss_pred c-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhh
Confidence 9 899999999999999999999862 36888999999999999999998 89999999999999999999999 89999
Q ss_pred ccCCCCccEEEccCCcccccCCcccccCCCCccEEEcc
Q 041249 719 IFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIG 756 (789)
Q Consensus 719 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~ 756 (789)
+.-++.|+.|||..|.-. ..|+.-...-+.|+.-+++
T Consensus 358 IHlL~~l~vLDlreNpnL-VMPPKP~da~~~lefYNID 394 (1255)
T KOG0444|consen 358 IHLLPDLKVLDLRENPNL-VMPPKPNDARKKLEFYNID 394 (1255)
T ss_pred hhhcCCcceeeccCCcCc-cCCCCcchhhhcceeeecc
Confidence 999999999999999976 5655432223456655444
No 226
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=99.97 E-value=2.9e-30 Score=270.56 Aligned_cols=200 Identities=26% Similarity=0.429 Sum_probs=171.6
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch---------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCC
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR---------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 342 (789)
|.....||+|++|.||+|....+++.||+|.+...... ..+.+..|++++++++||||+++++++....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD-- 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Confidence 66778999999999999999888999999988644221 1256888999999999999999999987655
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM 422 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~ 422 (789)
..++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++
T Consensus 80 ---~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~ 143 (267)
T cd06628 80 ---HLNIFLEYVPGGSVAALLNNY----------GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKG 143 (267)
T ss_pred ---ccEEEEEecCCCCHHHHHHhc----------cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCC
Confidence 789999999999999999543 45788899999999999999999888 99999999999999999
Q ss_pred ceeeCcccccccCCCCCCc----cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 423 VSHVGDFGLARFLPPTHVQ----TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
.+||+|||.++........ .......|+..|+|||.+....++.++|||||||++|+|++|+.||..
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 144 GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 9999999999877633211 111224578899999999988899999999999999999999999973
No 227
>PHA03209 serine/threonine kinase US3; Provisional
Probab=99.97 E-value=1.1e-30 Score=285.58 Aligned_cols=194 Identities=22% Similarity=0.344 Sum_probs=166.1
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
....+|...+.||+|+||.||+|....+++.||+|+.... ....|+.++++++|+||+++++++.... .
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~ 131 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA-----I 131 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC-----e
Confidence 3456899999999999999999999988999999985322 2356899999999999999999987765 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++|+|++. |++.+++... ...+++.++..|+.|++.||+|||..+ ||||||||+||+++.++.+||
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl 198 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKR---------SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCI 198 (357)
T ss_pred eEEEEEccC-CcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEE
Confidence 899999986 6888887533 356899999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS 487 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~ 487 (789)
+|||.++...... ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 199 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 199 GDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ecCccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999997543221 122456899999999999999999999999999999999965554
No 228
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=99.97 E-value=3e-30 Score=273.13 Aligned_cols=201 Identities=26% Similarity=0.358 Sum_probs=170.4
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||.|++|.||+|....+++.||+|.++... ......+.+|+.++.+++||||+++++++.... ..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-----RLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-----eEE
Confidence 5778899999999999999998889999999986543 223467889999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+. +++.+++... .....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 76 ~v~e~~~-~~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 144 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSL-------PKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLAD 144 (285)
T ss_pred EEEecCC-CCHHHHHhcC-------CCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECc
Confidence 9999998 6888888543 12356899999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||++........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 145 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 145 FGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred ccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999986543321 11223468899999987654 478999999999999999999999974
No 229
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=99.97 E-value=5.4e-30 Score=267.55 Aligned_cols=253 Identities=23% Similarity=0.261 Sum_probs=200.2
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
++|...+.||.|++|.||+|....+++.+++|++........+.+.+|++++++++||||+++++++.... ..++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD-----KLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC-----EEEE
Confidence 57888999999999999999998888999999998766666788999999999999999999999887655 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
+|||+.+++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+|++||
T Consensus 78 ~~e~~~~~~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~ 145 (262)
T cd06613 78 VMEYCGGGSLQDIYQVT---------RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADF 145 (262)
T ss_pred EEeCCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECcc
Confidence 99999999999988543 246889999999999999999999888 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCC---CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS---EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
|.+........ ......++..|+|||..... .++.++||||||+++|||++|+.||....... ......+...+
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-~~~~~~~~~~~ 222 (262)
T cd06613 146 GVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-ALFLISKSNFP 222 (262)
T ss_pred ccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCC
Confidence 99886654321 11234578899999998776 78999999999999999999999997422110 01111110000
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
.+.+. ........+.+++..|++.++..||+...+.
T Consensus 223 -------~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 258 (262)
T cd06613 223 -------PPKLK--------------------DKEKWSPVFHDFIKKCLTKDPKKRPTATKLL 258 (262)
T ss_pred -------Ccccc--------------------chhhhhHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00000 0112234566888999999999999987653
No 230
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=99.97 E-value=2.1e-30 Score=269.89 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=193.7
Q ss_pred CcccccCCccEEEEEEcC-Cc--eEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDE-GR--TTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|++|.||+|.+.. ++ ..||+|.++.... ...+.+..|++.+++++||||+++++++.. . ..++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-----~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H-----PLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C-----eEEEEE
Confidence 468999999999999864 33 3699999987655 567789999999999999999999999875 3 789999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|+|.+++... ....+++..+..++.|++.||+|||..+ ++|+||||+||+++.++.+||+|||.
T Consensus 75 e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 75 ELAPLGSLLDRLRKD--------ALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred EecCCCcHHHHHHhc--------ccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccc
Confidence 999999999998654 1146899999999999999999999888 99999999999999999999999999
Q ss_pred cccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCch
Q 041249 432 ARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHV 509 (789)
Q Consensus 432 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 509 (789)
++........ .......++..|+|||+.....++.++|||||||++|||++ |+.||.... ..+..+......
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~- 217 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-----GSQILKKIDKEG- 217 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhcC-
Confidence 9987654321 11223457789999999988899999999999999999999 999986321 111111111000
Q ss_pred hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.... ....+...+.+++..|++.++.+||+...+..
T Consensus 218 -----~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 218 -----ERLE--------------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -----CcCC--------------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0000 00112345668888999999999999887643
No 231
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=99.97 E-value=1.1e-30 Score=276.55 Aligned_cols=258 Identities=23% Similarity=0.342 Sum_probs=197.0
Q ss_pred CCCCCCcccccCCccEEEEEEc----CCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 271 GFSSANLIGTGSFGSVYKGVLD----EGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
.|.+.+.||+|+||.||.+.+. .+++.||+|.++... ......+.+|++++++++|||++++.+++.... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---GN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---CC
Confidence 4677899999999999999853 467899999987553 334567999999999999999999999886542 23
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++||||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~ 149 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRN---------KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVK 149 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEE
Confidence 579999999999999998543 235899999999999999999999888 99999999999999999999
Q ss_pred eCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccC----------C
Q 041249 426 VGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG----------D 494 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~----------~ 494 (789)
|+|||+++........ .......++..|+|||...+..++.++|||||||++|||++++.|....... .
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05079 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ 229 (284)
T ss_pred ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc
Confidence 9999999877544321 1122344677899999998888999999999999999999988775432110 0
Q ss_pred ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.....+.. ..... .+......+...+.+++..|.+.++.+||+......
T Consensus 230 ~~~~~~~~---------~~~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 230 MTVTRLVR---------VLEEG------------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred ccHHHHHH---------HHHcC------------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00000000 00000 001111234567889999999999999999887644
No 232
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=99.97 E-value=2.2e-30 Score=270.65 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=185.6
Q ss_pred CcccccCCccEEEEEEcC---CceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDE---GRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||.||+|.+.. ....||+|.+... .......+.+|+.+++.++||||+++++++...+ ...++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEE
Confidence 468999999999999753 3467999998543 3344567889999999999999999999875432 2578999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|+|.+++... ....++..++.++.|++.||+|||..+ ++||||||+||++++++.+|++|||+
T Consensus 77 e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 77 PYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred ecCCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccc
Confidence 999999999998643 234677888999999999999999887 99999999999999999999999999
Q ss_pred cccCCCCCCc--cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHh-cCCCCccccCCccHHHHHHHhCCCc
Q 041249 432 ARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR-KKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 432 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
++........ .......++..|+|||+.....++.++|||||||++|||++| ..||... +.....+......
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~~~~~~~~~~~ 219 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYLLQGR 219 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHhcCC
Confidence 9865433211 111233467789999999888999999999999999999995 5555421 1111111111000
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
.+. ....+...+.+++..|++.++.+||+...+...
T Consensus 220 -----~~~----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 220 -----RLL----------------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred -----CCC----------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000 000123356688999999999999999877443
No 233
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=99.97 E-value=1.2e-30 Score=275.96 Aligned_cols=268 Identities=24% Similarity=0.321 Sum_probs=202.1
Q ss_pred cCCCCCCcccccCCccEEEEEEcC----CceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDE----GRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
++|...+.||+|+||.||+|.+.. +++.||||.++..... ....+.+|++.++++.|+||+++++++.... .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~---~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG---G 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCC---C
Confidence 456777899999999999999753 3789999999765443 5678999999999999999999999876522 3
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
...++||||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~---------~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~ 148 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRH---------RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLV 148 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhC---------ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCE
Confidence 3689999999999999999654 235899999999999999999999988 9999999999999999999
Q ss_pred eeCcccccccCCCCCCcc-ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249 425 HVGDFGLARFLPPTHVQT-SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 503 (789)
|++|||.+.......... ......++..|+|||......++.++||||||+++|||++|+.|+......... ++..
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~ 225 (284)
T cd05038 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGI 225 (284)
T ss_pred EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---cccc
Confidence 999999999876443211 111233556799999998889999999999999999999999998643221100 0000
Q ss_pred hCCCc----hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 504 ALPDH----VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 504 ~~~~~----~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
..... ..+.+.... +......|..++.+++..|++.++.+||++..+...+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 226 AQGQMIVTRLLELLKEGE------------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred ccccccHHHHHHHHHcCC------------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 00000 001111000 01112234567888999999999999999987755443
No 234
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=99.97 E-value=3.3e-30 Score=267.32 Aligned_cols=243 Identities=26% Similarity=0.343 Sum_probs=189.3
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
++||+|+||.||+|... +++.||+|.++.... .....+.+|++.+++++||||+++++++.... ..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-----PIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-----ccEEEEECC
Confidence 47899999999999976 688999999865432 33456889999999999999999999987655 789999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
++|+|.+++... ...+++.++..++.|++.||.|+|..+ ++||||||+||++++++.+|++|||++..
T Consensus 75 ~~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 75 PGGDFLSFLRKK---------KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred CCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCcccee
Confidence 999999988543 235789999999999999999999888 99999999999999999999999999876
Q ss_pred CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhc
Q 041249 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIV 513 (789)
Q Consensus 435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (789)
....... ......++..|+|||+...+.++.++||||||+++||+++ |..||...... .....+.....
T Consensus 143 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~~------- 212 (250)
T cd05085 143 EDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGYR------- 212 (250)
T ss_pred ccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCC-------
Confidence 5433211 1112234568999999998999999999999999999998 99998632111 11111110000
Q ss_pred cCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 514 DSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 514 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
......+...+.+++.+|++.++.+||+...+.
T Consensus 213 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 245 (250)
T cd05085 213 -----------------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQ 245 (250)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 000112334567889999999999999988764
No 235
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=99.97 E-value=3e-30 Score=273.11 Aligned_cols=256 Identities=21% Similarity=0.265 Sum_probs=202.0
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||+|+||+||++.+..+++.||+|++.... ......+..|+++++.++||||+++++++.... ..+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-----NIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC-----EEE
Confidence 56778899999999999999999889999999986543 344578899999999999999999999988765 899
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeC
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
+|+||+++|+|.+++... ..+++.....++.+++.||.|||+ .+ ++||||+|+||++++++.++|+
T Consensus 80 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~ 146 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKG----------GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLC 146 (284)
T ss_pred EEEecCCCCCHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEc
Confidence 999999999999988543 458899999999999999999996 45 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCC------ccHHHHH
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGD------MNLHNFA 501 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~------~~~~~~~ 501 (789)
|||++....... .....|+..|+|||++.+..++.++|||||||++||+++|+.||+...... .....+.
T Consensus 147 d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd06620 147 DFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222 (284)
T ss_pred cCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH
Confidence 999987653322 123458899999999988899999999999999999999999997543210 1111222
Q ss_pred HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
+...... .+.+. ...+...+.+++..|.+.++..||+..++...+.
T Consensus 223 ~~~~~~~-----~~~~~---------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 223 QQIVQEP-----PPRLP---------------------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HHHhhcc-----CCCCC---------------------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 2111110 00000 0123445678888999999999999988765443
No 236
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=99.97 E-value=2.3e-30 Score=270.28 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=192.0
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
++|...+.||+|++|.||+|.+.. +..||+|.+.... ...+.+.+|++++++++|+|++++++++.. . ..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-E-----PIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-C-----CcEE
Confidence 568888999999999999999874 4569999876433 234678899999999999999999988642 2 5789
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+.+|+|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 78 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~df 146 (260)
T cd05069 78 VTEFMGKGSLLDFLKEG--------DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADF 146 (260)
T ss_pred EEEcCCCCCHHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCC
Confidence 99999999999999643 2345789999999999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
|.+......... ......++..|+|||......++.++|||||||++|||++ |+.||..... .....+.......
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~- 222 (260)
T cd05069 147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQVERGYRM- 222 (260)
T ss_pred ccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC-
Confidence 999876443211 1122346678999999988899999999999999999999 8999863211 1111111111100
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.. .......+.+++..|++.++..||+...+..
T Consensus 223 -------~~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -------PC----------------------PQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -------CC----------------------CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 0112345667888999999999998876543
No 237
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=99.97 E-value=1.4e-30 Score=274.57 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=196.2
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+..|++.+++++||||+++++.+.... ..++|
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv 80 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-----KLWII 80 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-----ceEEE
Confidence 455678999999999999998889999999987543 344567899999999999999999999987654 78999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 430 (789)
+||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.+|++|||
T Consensus 81 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06642 81 MEYLGGGSALDLLKP-----------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFG 146 (277)
T ss_pred EEccCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccc
Confidence 999999999998842 35788999999999999999999887 9999999999999999999999999
Q ss_pred ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchh
Q 041249 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVM 510 (789)
Q Consensus 431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 510 (789)
++........ ......++..|+|||++.+..++.++|||||||++|||++|+.|+...... ....+. ..
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~----~~--- 215 (277)
T cd06642 147 VAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--RVLFLI----PK--- 215 (277)
T ss_pred ccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--hHHhhh----hc---
Confidence 9987654321 112345788999999999888999999999999999999999998632211 000000 00
Q ss_pred hhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 511 DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 511 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
...+.+. ..+...+.+++..|++.++..||++..+..+
T Consensus 216 -~~~~~~~----------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 216 -NSPPTLE----------------------GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CCCCCCC----------------------cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011110 1233456688889999999999999877543
No 238
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=99.97 E-value=9.5e-31 Score=286.17 Aligned_cols=202 Identities=22% Similarity=0.264 Sum_probs=170.2
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND 345 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 345 (789)
.++|...+.||+|+||.||++....+++.||||.+... .......+.+|+.+++.++||||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46899999999999999999999888999999998643 23335677889999999999999999998765432 2233
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++||||+.+ ++.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+|
T Consensus 96 ~~~lv~e~~~~-~l~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~k 159 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh------------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEE
Confidence 57999999975 5666553 23788889999999999999999988 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 160 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 160 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred EeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999987544321 2234588999999999888899999999999999999999999963
No 239
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=99.97 E-value=3.5e-30 Score=268.07 Aligned_cols=250 Identities=20% Similarity=0.237 Sum_probs=198.7
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|+..+.||+|+||.||++....+++.||+|.+... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG-----NLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC-----eEE
Confidence 477889999999999999999989999999998644 2334567899999999999999999999987655 899
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+.+++|.+++... ....+++.++..++.|++.|++|||+.+ ++|+||+|+||+++.++.++++|
T Consensus 76 lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d 144 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQ--------RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGD 144 (256)
T ss_pred EEEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEee
Confidence 999999999999988643 2345788999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
||.+......... .....|+..|+|||...+..++.++|||||||++|+|++|+.||... .....+.......
T Consensus 145 ~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~~~ 217 (256)
T cd08218 145 FGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIRGS 217 (256)
T ss_pred ccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhcCC
Confidence 9999876543211 12245788999999998888999999999999999999999998631 1112211111110
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
... ........+.+++..|++.++..||++..+..
T Consensus 218 ~~~---------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 218 YPP---------------------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCC---------------------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 000 01122345668888999999999999987754
No 240
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=99.97 E-value=2.8e-30 Score=273.07 Aligned_cols=266 Identities=21% Similarity=0.227 Sum_probs=204.0
Q ss_pred cccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249 259 NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACS 337 (789)
Q Consensus 259 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 337 (789)
..+..++..+.+.|+..+.||+|+||.||+|....+++.||+|++.... .....+..|+.+++++ +|+||+++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 3466677778889999999999999999999998889999999986543 2345688899999999 7999999999986
Q ss_pred cCCC-CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCce
Q 041249 338 GVDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNI 416 (789)
Q Consensus 338 ~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Ni 416 (789)
.... ......+++|||+.+|+|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~ni 152 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--------KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNV 152 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHE
Confidence 4322 1234789999999999999998643 2345788889999999999999999988 99999999999
Q ss_pred ecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHhcCCCCccc
Q 041249 417 LLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIRKKPSDIMF 491 (789)
Q Consensus 417 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG~~P~~~~~ 491 (789)
++++++.++|+|||.+........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....
T Consensus 153 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 153 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred EECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 999999999999999886543221 122345888999999875 3468889999999999999999999996321
Q ss_pred cCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 492 EGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
.. ...... .....+.+. ...+...+.+++..|++.++.+||+..+..
T Consensus 231 ~~----~~~~~~------~~~~~~~~~---------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 231 PM----RALFLI------PRNPPPKLK---------------------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred HH----hhhhhH------hhCCCCCCc---------------------ccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 10 000000 000000000 012344567888899999999999987654
No 241
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=99.97 E-value=3.3e-30 Score=268.36 Aligned_cols=198 Identities=28% Similarity=0.380 Sum_probs=172.2
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-----chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
.|...+.||+|++|.||+|....+++.|++|.+.... .+..+.+..|++++++++|+||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED----- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC-----
Confidence 3667889999999999999998889999999986543 234567899999999999999999999987655
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++|+||+++++|.+++... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.+|
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY----------GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 789999999999999998543 35789999999999999999999888 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+|||.+....... ......|+..|+|||...... ++.++||||||+++|+|++|+.||..
T Consensus 143 l~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~ 204 (258)
T cd06632 143 LADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204 (258)
T ss_pred EccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 99999988764433 122355888999999987766 89999999999999999999999974
No 242
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=99.97 E-value=4e-30 Score=270.00 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=190.1
Q ss_pred CcccccCCccEEEEEEcCCce--EEEEEEecccc-chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRT--TVTVKVFNLHH-HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|+||.||+|....++. .+++|.++... ......+..|++++.++ +||||+++++++.... ..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----YLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-----CceEEE
Confidence 468999999999999986665 56888886433 34456788999999999 8999999999987655 689999
Q ss_pred eccCCCChhhhccCCCCCcc------ccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 352 EFMQNGSLEEWLYPVNREDE------VDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
||+++|+|.+++........ .......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEE
Confidence 99999999999875421110 1122346889999999999999999999887 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHh
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMA 504 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 504 (789)
++|||++....... .......+..|+|||+.....++.++|||||||++|||++ |..||... +.....+..
T Consensus 153 l~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~-----~~~~~~~~~ 224 (270)
T cd05047 153 IADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----TCAELYEKL 224 (270)
T ss_pred ECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc-----CHHHHHHHH
Confidence 99999986432111 1111223567999999988889999999999999999997 99998632 111111111
Q ss_pred CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
... .. ......+...+.+++..|++.++..||+...+...
T Consensus 225 ~~~---------~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 225 PQG---------YR------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred hCC---------CC------------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 000 00 00011233456788999999999999999877443
No 243
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=99.97 E-value=2.9e-30 Score=278.92 Aligned_cols=199 Identities=21% Similarity=0.197 Sum_probs=166.0
Q ss_pred CCccccc--CCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249 275 ANLIGTG--SFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 275 ~~~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
.++||+| +|++||++....+++.||+|.++... ......+.+|+++++.++||||+++++++...+ ..++|
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~lv 77 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-----ELWVV 77 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----EEEEE
Confidence 5689999 67899999999999999999997553 233467888999999999999999999998765 78999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 430 (789)
+||+.+|++.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+
T Consensus 78 ~e~~~~~~l~~~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~ 146 (327)
T cd08227 78 TSFMAYGSAKDLICTH--------FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLR 146 (327)
T ss_pred EeccCCCcHHHHHHhh--------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccc
Confidence 9999999999998643 2245889999999999999999999988 9999999999999999999999998
Q ss_pred ccccCCCCCC-----ccceeeecccccccCcccCCC--CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 431 LARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLG--SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 431 la~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
.+........ ........++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 6544322111 011122346778999999876 3589999999999999999999999974
No 244
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=99.97 E-value=1.1e-30 Score=282.73 Aligned_cols=192 Identities=26% Similarity=0.289 Sum_probs=160.8
Q ss_pred ccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC---CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI---RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
||+|+||+||+|....+++.||+|++.... .........|..++... .||||+++++++.... ..++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~-----~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS-----DLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-----eEEEEE
Confidence 699999999999999899999999986432 12233445566666655 6999999999887665 899999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 76 e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (330)
T cd05586 76 DYMSGGELFWHLQKE----------GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGL 142 (330)
T ss_pred cCCCCChHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCc
Confidence 999999999888543 46889999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++....... ......||..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 143 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 143 SKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred CcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 876433221 12345689999999998765 489999999999999999999999963
No 245
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=99.97 E-value=3e-30 Score=270.09 Aligned_cols=200 Identities=24% Similarity=0.400 Sum_probs=170.9
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc------hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH------RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
+|...+.||+|+||+||+|... +++.+|+|.++.... .....+.+|++.+++++|+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN---- 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC----
Confidence 4778899999999999999875 788999999864421 22356889999999999999999999987765
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+
T Consensus 76 -~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~ 141 (265)
T cd06631 76 -TISIFMEFVPGGSISSILNRF----------GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGII 141 (265)
T ss_pred -eEEEEEecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeE
Confidence 899999999999999998543 35788899999999999999999888 9999999999999999999
Q ss_pred eeCcccccccCCCCC----CccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 425 HVGDFGLARFLPPTH----VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 425 kl~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|++|||.+....... .........|+..|+|||+..+..++.++|||||||++|||++|+.||..
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 999999988654221 11112234588999999999988899999999999999999999999963
No 246
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=2e-31 Score=280.50 Aligned_cols=193 Identities=30% Similarity=0.399 Sum_probs=167.6
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
|...+.||.|+||.||-|.+..+.+.||||.+.-... +....+.+|+..+.+++|||++.+-|.|.-.. ..|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-----TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-----TAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-----hHH
Confidence 4556789999999999999999999999999865433 33567999999999999999999999876544 689
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|||||-+ +-.+++. .-.+++-+-++..|..+.+.||+|||+.+ .||||||+.|||+++.+.+||+|
T Consensus 103 LVMEYClG-SAsDlle---------VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaD 169 (948)
T KOG0577|consen 103 LVMEYCLG-SASDLLE---------VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLAD 169 (948)
T ss_pred HHHHHHhc-cHHHHHH---------HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeecc
Confidence 99999985 5555542 12467888999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
||.|....+.. .+.||+.|||||++. .|+|+-|+||||+|++..||.-+++|..
T Consensus 170 FGSAsi~~PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 170 FGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred ccchhhcCchh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 99999887765 356999999999864 5889999999999999999999999975
No 247
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=99.97 E-value=2.8e-30 Score=273.56 Aligned_cols=253 Identities=21% Similarity=0.226 Sum_probs=195.2
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||+|+||.||++.+..+++.||+|.++.. .......+.+|++++++++|+||+++++.+.... ..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-----AVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-----eEE
Confidence 4677889999999999999999988999999998654 2333467889999999999999999999887655 899
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCCCCceeeC
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
+|+||+++++|..++... .....+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+|++
T Consensus 76 lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~ 145 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGG-------VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLC 145 (286)
T ss_pred EEEeecCCCCHHHHHHhc-------cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEe
Confidence 999999999999988643 1234689999999999999999999963 5 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCC------CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS------EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~ 501 (789)
|||.+........ ....++..|+|||.+.+. .++.++|||||||++|||++|+.||..... .......
T Consensus 146 dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~ 219 (286)
T cd06622 146 DFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQL 219 (286)
T ss_pred ecCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHH
Confidence 9999886643321 223578899999988554 358899999999999999999999963211 1111111
Q ss_pred HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
+...... .+.+ ...+...+.+++.+|++.++..|++......
T Consensus 220 ~~~~~~~-----~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 220 SAIVDGD-----PPTL----------------------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHhhcC-----CCCC----------------------CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1000000 0000 1123345567888999999999999876644
No 248
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=99.97 E-value=1.5e-30 Score=285.50 Aligned_cols=202 Identities=22% Similarity=0.248 Sum_probs=170.7
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND 345 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 345 (789)
.++|...+.||+|+||.||++.....++.||||++... .......+.+|+.+++.++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999999888999999998643 23345678889999999999999999998765431 2223
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++||||+.+ ++.+.+. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 103 ~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH------------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence 57999999975 6666653 23678889999999999999999988 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 167 L~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred EEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 99999998764432 12234588999999999998999999999999999999999999963
No 249
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=99.97 E-value=3.1e-30 Score=274.05 Aligned_cols=203 Identities=23% Similarity=0.380 Sum_probs=170.2
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++++|...+.||+|+||.||+|....+++.||+|++..... .....+.+|+++++.++|+||+++.+++.... .
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE-----T 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-----e
Confidence 56889999999999999999999988899999999865533 23346788999999999999999999987655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++|+||+. +++.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l 144 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQH---------PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKL 144 (291)
T ss_pred EEEEEeccc-CCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEE
Confidence 899999996 6777766432 234678888999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
+|||+++........ .....++..|+|||...+. .++.++|||||||++|||++|+.||+..
T Consensus 145 ~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 145 ADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred eccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 999998765332211 1233478899999998764 4789999999999999999999999743
No 250
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=99.97 E-value=2.4e-30 Score=270.23 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=197.0
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
.-++|...+.||+|++|.||+|... +++.||||.+.... .....+.+|+..+++++|+||+++++++.... ..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 76 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE-----PI 76 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC-----ce
Confidence 4468889999999999999999986 56889999987543 23467899999999999999999999987654 68
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++||||+.+++|.+++... ....+++.++..++.|++.|++|||..+ ++|+||||+||++++++.+|++
T Consensus 77 ~~v~e~~~~~~L~~~i~~~--------~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~ 145 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSG--------EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIA 145 (261)
T ss_pred EEEEeccCCCCHHHHHhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999654 3356899999999999999999999888 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
|||.+......... ......++..|+|||...+..+++++||||||+++||+++ |+.||..... ....+.......
T Consensus 146 d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~~ 222 (261)
T cd05034 146 DFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQVERGYR 222 (261)
T ss_pred ccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC
Confidence 99999877543211 1112234568999999998889999999999999999999 9999863211 111111111000
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.. ....+...+.+++.+|.+.++..||+......
T Consensus 223 ~~------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 MP------------------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CC------------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00 00112345668888999999999998876543
No 251
>PHA03211 serine/threonine kinase US3; Provisional
Probab=99.97 E-value=2e-30 Score=289.15 Aligned_cols=196 Identities=26% Similarity=0.334 Sum_probs=169.4
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
..+|...+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++|+||+++++++.... ..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-----~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGG-----LTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC-----EEE
Confidence 457999999999999999999999899999999642 234578999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|||++. ++|.+++... ...+++.++..|+.|++.||+|||+.+ ||||||||+|||++.++.+||+|
T Consensus 237 lv~e~~~-~~L~~~l~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGAR---------LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred EEEEccC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcc
Confidence 9999995 6888887533 246899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 999987654332222234569999999999999999999999999999999999887664
No 252
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=99.97 E-value=2.4e-30 Score=272.23 Aligned_cols=235 Identities=22% Similarity=0.287 Sum_probs=180.4
Q ss_pred cccccCCccEEEEEEcCC------------------------ceEEEEEEeccccchhhHHHHHHHHHHhcCCCCcccee
Q 041249 277 LIGTGSFGSVYKGVLDEG------------------------RTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKV 332 (789)
Q Consensus 277 ~ig~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 332 (789)
.||+|+||.||+|.+..+ ...|++|++..........+.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999986321 24589999876655556778899999999999999999
Q ss_pred eeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCC
Q 041249 333 FTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK 412 (789)
Q Consensus 333 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk 412 (789)
+++|.... ..++||||+.+|+|..++... ...+++..++.++.|+++||+|||+.+ ++|||||
T Consensus 82 ~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlk 144 (274)
T cd05076 82 HGVCVRGS-----ENIMVEEFVEHGPLDVCLRKE---------KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVC 144 (274)
T ss_pred EEEEEeCC-----ceEEEEecCCCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCC
Confidence 99998765 789999999999999988542 246789999999999999999999887 9999999
Q ss_pred CCceecCCCC-------ceeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHH-Hh
Q 041249 413 PSNILLDEEM-------VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELI-IR 483 (789)
Q Consensus 413 ~~Nill~~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~ell-tG 483 (789)
|+||+++..+ .+|++|||.+....... ...++..|+|||.+.. ..++.++|||||||++||++ +|
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred cccEEEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999997643 47999999886543221 2346788999998865 56899999999999999995 68
Q ss_pred cCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccC
Q 041249 484 KKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLE 563 (789)
Q Consensus 484 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~ 563 (789)
+.||...... ....+..... .... .....+.+++..|++.++-+||
T Consensus 219 ~~p~~~~~~~--~~~~~~~~~~----------~~~~----------------------~~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 219 EVPLKERTPS--EKERFYEKKH----------RLPE----------------------PSCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred CCCccccChH--HHHHHHHhcc----------CCCC----------------------CCChHHHHHHHHHcccChhhCc
Confidence 9998632111 1111111100 0000 0112456788899999999999
Q ss_pred ccccc
Q 041249 564 SLKLA 568 (789)
Q Consensus 564 s~~~~ 568 (789)
++..+
T Consensus 265 s~~~i 269 (274)
T cd05076 265 SFRTI 269 (274)
T ss_pred CHHHH
Confidence 88765
No 253
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=99.97 E-value=3.7e-30 Score=269.02 Aligned_cols=236 Identities=21% Similarity=0.307 Sum_probs=181.8
Q ss_pred CcccccCCccEEEEEEcC------------CceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 276 NLIGTGSFGSVYKGVLDE------------GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
+.||+|+||.||+|.+.. ....|++|++..........+.+|+..++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~--- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV--- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 468999999999998642 23468999987666666678899999999999999999999987655
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV 423 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 423 (789)
..++||||+.+|+|..++... ...+++.++..++.|+++||+|||+.+ ++||||||+||+++.++.
T Consensus 78 --~~~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 78 --ENIMVEEFVEFGPLDLFMHRK---------SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGI 143 (262)
T ss_pred --CCEEEEecccCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCc
Confidence 679999999999999887532 245899999999999999999999887 999999999999986654
Q ss_pred -------eeeCcccccccCCCCCCccceeeecccccccCcccCC-CCCcCccccchhhHHHHHHHH-HhcCCCCccccCC
Q 041249 424 -------SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-GSEVSTNGDVYSYGILMLELI-IRKKPSDIMFEGD 494 (789)
Q Consensus 424 -------~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~sfGvvl~ell-tG~~P~~~~~~~~ 494 (789)
+|++|||.+....... ...++..|+|||.+. ...++.++|||||||++|||+ +|+.|+....
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--- 214 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT--- 214 (262)
T ss_pred cCCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc---
Confidence 8999999987653322 234778999999886 456899999999999999998 4888875321
Q ss_pred ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249 495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA 568 (789)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~ 568 (789)
.....+.. ... .... ......+.+++..|++.++.+||+....
T Consensus 215 --~~~~~~~~-~~~-~~~~---------------------------~~~~~~~~~li~~cl~~dp~~Rp~~~~i 257 (262)
T cd05077 215 --LAEKERFY-EGQ-CMLV---------------------------TPSCKELADLMTHCMNYDPNQRPFFRAI 257 (262)
T ss_pred --hhHHHHHH-hcC-ccCC---------------------------CCChHHHHHHHHHHcCCChhhCcCHHHH
Confidence 11110000 000 0000 0112345678889999999999998765
No 254
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=99.97 E-value=3e-30 Score=279.96 Aligned_cols=281 Identities=20% Similarity=0.227 Sum_probs=201.7
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
+++|...+.||+|++|.||+|.+..+++.||+|.++.. .......+.+|++++++++|+||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 57899999999999999999999989999999998643 23345668889999999999999999998876655455568
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++|+||+.+ ++...+.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred EEEehhccc-CHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence 999999984 77776642 35889999999999999999999988 9999999999999999999999
Q ss_pred cccccccCCCCCCc-cceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249 428 DFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505 (789)
Q Consensus 428 Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 505 (789)
|||++......... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .......+....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~--~~~~~~~~~~~~ 226 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD--YLHQLNLILGVL 226 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHc
Confidence 99999876543321 11223468889999998755 468999999999999999999999996321 111111111111
Q ss_pred CCc----hhhhccCCcccChhhHHHhhhhhhhhh-hhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 506 PDH----VMDIVDSTLLNDVEDLAIISNQRQRQI-RVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 506 ~~~----~~~~~d~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
... ...+.+........ ........ ..........++.+++..|++.++..|++......+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIK-----SLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHh-----hcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 11111111110000 00000000 000011224556788999999999999998876543
No 255
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=99.97 E-value=5.1e-30 Score=268.73 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=196.8
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc------hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH------RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
+|+..+.||+|++|.||+|....+++.||+|+++.... ...+.+..|++.+++++|+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS---- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC----
Confidence 47888999999999999999988999999999864331 23467899999999999999999999987665
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-c
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-V 423 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~ 423 (789)
..++|+||+.+++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .
T Consensus 77 -~~~~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~ 142 (268)
T cd06630 77 -HFNLFVEWMAGGSVSHLLSKY----------GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQR 142 (268)
T ss_pred -eEEEEEeccCCCcHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 889999999999999998643 45788999999999999999999998 99999999999998776 5
Q ss_pred eeeCcccccccCCCCCCc--cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249 424 SHVGDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~ 501 (789)
+||+|||.+......... .......++..|+|||...+..++.++||||+|+++|+|++|+.||...... ......
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~ 220 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALI 220 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHH
Confidence 899999999877654311 1122345888999999998888999999999999999999999998632111 111111
Q ss_pred HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
....... ..+.. .......+.++...|.+.++..|++......
T Consensus 221 ~~~~~~~----~~~~~----------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 FKIASAT----TAPSI----------------------PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHhccC----CCCCC----------------------chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1000000 00000 0112345567888999999999998876643
No 256
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=99.97 E-value=5.8e-30 Score=269.86 Aligned_cols=248 Identities=23% Similarity=0.286 Sum_probs=198.5
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+..|+++++++.|+||+++++++.... ..++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-----KLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----EEEE
Confidence 5677889999999999999998889999999987543 344567899999999999999999999987765 8999
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+++|+|.+++.. ..+++.+...++.|++.||+|+|+.+ ++|+||+|+||+++.++.++++||
T Consensus 80 v~e~~~~~~L~~~i~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~df 145 (277)
T cd06640 80 IMEYLGGGSALDLLRA-----------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred EEecCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccc
Confidence 9999999999998853 24788899999999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 509 (789)
|.+........ ......++..|+|||++.+..++.++|||||||++|||++|+.||...... ...... .
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~-~--- 214 (277)
T cd06640 146 GVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RVLFLI-P--- 214 (277)
T ss_pred ccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hHhhhh-h---
Confidence 99987654332 122345788999999998888999999999999999999999998632111 000000 0
Q ss_pred hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
....+.+ ...+...+.+++..|++.++..||+...+...
T Consensus 215 -~~~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 215 -KNNPPTL----------------------TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -cCCCCCC----------------------chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0000111 11344566788899999999999999877443
No 257
>PTZ00284 protein kinase; Provisional
Probab=99.97 E-value=3.1e-30 Score=292.04 Aligned_cols=203 Identities=23% Similarity=0.308 Sum_probs=165.6
Q ss_pred HHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCC------Cccceeeeee
Q 041249 263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH------RNLVKVFTAC 336 (789)
Q Consensus 263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~ 336 (789)
+++...+++|.+.+.||+|+||+||+|.+..+++.||||+++... ...+....|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 445567789999999999999999999998889999999986432 223445667777776654 4588888887
Q ss_pred ccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCc
Q 041249 337 SGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSN 415 (789)
Q Consensus 337 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~N 415 (789)
.... ...++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ .+ ||||||||+|
T Consensus 201 ~~~~----~~~~iv~~~~-g~~l~~~l~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~N 262 (467)
T PTZ00284 201 QNET----GHMCIVMPKY-GPCLLDWIMKH----------GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPEN 262 (467)
T ss_pred EcCC----ceEEEEEecc-CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHH
Confidence 6432 3689999988 56888887543 468999999999999999999997 47 9999999999
Q ss_pred eecCCCC----------------ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHH
Q 041249 416 ILLDEEM----------------VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLE 479 (789)
Q Consensus 416 ill~~~~----------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~e 479 (789)
||++.++ .+||+|||.+...... .....||..|+|||++.+..++.++|||||||++||
T Consensus 263 ILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e 337 (467)
T PTZ00284 263 ILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE 337 (467)
T ss_pred EEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence 9998665 4899999987643322 223568999999999999999999999999999999
Q ss_pred HHHhcCCCCc
Q 041249 480 LIIRKKPSDI 489 (789)
Q Consensus 480 lltG~~P~~~ 489 (789)
|++|+.||+.
T Consensus 338 lltG~~pf~~ 347 (467)
T PTZ00284 338 LYTGKLLYDT 347 (467)
T ss_pred HHhCCCCCCC
Confidence 9999999974
No 258
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=99.97 E-value=3e-30 Score=272.82 Aligned_cols=253 Identities=22% Similarity=0.235 Sum_probs=190.5
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHH-HhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRA-LRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++|.+.+.||+|+||.||+|.+..+++.||+|.++... ......+..|+.. ++...||||+++++++.... ..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-----~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-----DV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-----cE
Confidence 47888999999999999999999899999999987543 2233455556664 56668999999999987655 78
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCCCCceee
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
++|+||++ |+|.+++.... .....+++.++..++.|++.||+|||+. + ++||||||+||+++.++.+||
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl 145 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVY------DKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKL 145 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999997 68887775431 1235689999999999999999999986 6 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCC----CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHH
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG----SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~ 502 (789)
+|||.+........ .....++..|+|||.+.. ..++.++|||||||++|||++|+.||.........+.....
T Consensus 146 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 222 (283)
T cd06617 146 CDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222 (283)
T ss_pred eecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh
Confidence 99999987643321 123457889999998764 34689999999999999999999998632221111111111
Q ss_pred HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
. ..+.+. ...+...+.+++..|...++.+|++...+..
T Consensus 223 ~---------~~~~~~---------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 223 E---------PSPQLP---------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred c---------CCCCCC---------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 001110 0012334667888899999999999977644
No 259
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=99.97 E-value=3.7e-30 Score=274.80 Aligned_cols=200 Identities=25% Similarity=0.383 Sum_probs=169.9
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||.|+||.||+|....+++.||+|.++.... .....+.+|++.+++++||||+++++++.... ..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-----~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC-----eEE
Confidence 568889999999999999999998899999999875432 33456788999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+. ++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 81 lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d 147 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDC---------GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLAD 147 (301)
T ss_pred EEEeccc-cCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECc
Confidence 9999998 5888887543 245788999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||++......... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 148 fg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 148 FGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred CcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999865433211 1233468899999987654 478999999999999999999999974
No 260
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=99.97 E-value=6.2e-30 Score=267.77 Aligned_cols=204 Identities=23% Similarity=0.357 Sum_probs=172.4
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-----chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-----HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
++|...+.||+|+||.||.|....+++.||+|.+.... ......+..|++++++++||||+++++++.+.. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 57888999999999999999999889999999985432 123457888999999999999999999875532 1
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
...++|+||+++|+|.+++... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~ 145 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY----------GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNV 145 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCE
Confidence 2578999999999999998543 34788889999999999999999888 9999999999999999999
Q ss_pred eeCcccccccCCCCCC-ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 425 HVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+|||.++....... ........|+..|+|||...+..++.++|||||||++|||++|+.||..
T Consensus 146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 9999999986543221 1112234588999999999888899999999999999999999999863
No 261
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=99.97 E-value=3.8e-30 Score=269.96 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=190.9
Q ss_pred CcccccCCccEEEEEEcCCc------eEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 276 NLIGTGSFGSVYKGVLDEGR------TTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+.||+|+||.||+|++.... +.||+|.+.... ......+.+|++.+++++||||+++++++...+ ..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-----PQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-----CeE
Confidence 46899999999999986433 689999886443 234567899999999999999999999987655 689
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-----c
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-----V 423 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-----~ 423 (789)
+||||+++|+|.+++....... .....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVER---FGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcc---cCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcc
Confidence 9999999999999996531110 12345789999999999999999999887 99999999999999877 8
Q ss_pred eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249 424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR 502 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 502 (789)
+|++|||+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||.... .......+.
T Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~~~ 227 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHVT 227 (269)
T ss_pred eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHHHh
Confidence 99999999987654432222222345678999999999999999999999999999998 999986321 111111111
Q ss_pred HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
.. . .+ .....+...+.+++..|+..++..||+...+.
T Consensus 228 ~~---~-------~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 264 (269)
T cd05044 228 AG---G-------RL--------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQ 264 (269)
T ss_pred cC---C-------cc--------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 00 0 00 00012234566888899999999999988763
No 262
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=99.97 E-value=6.3e-30 Score=270.77 Aligned_cols=200 Identities=25% Similarity=0.333 Sum_probs=171.6
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++|+..+.||+|++|.||+|....+++.||+|++.... ....+.+.+|++++++++|+|++++++++.... ..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-----KL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-----EE
Confidence 46888899999999999999999889999999986442 223466889999999999999999999987655 78
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++|+||++++.+..+.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++++||+
T Consensus 76 ~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~ 142 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNP----------RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLC 142 (286)
T ss_pred EEEEeccCccHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEEC
Confidence 9999999998888876432 45899999999999999999999987 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 143 dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 143 DFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred ccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999877554321 123457789999999866 4579999999999999999999999964
No 263
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=99.97 E-value=9.8e-30 Score=269.60 Aligned_cols=263 Identities=22% Similarity=0.212 Sum_probs=202.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||.|++|.||++....+++.||+|.+..... .....+.+|++++++++||||++++++|.... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEE
Confidence 467888999999999999999988899999999875433 34567899999999999999999999986543 23579
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+++++|.+++... ......++...+..++.|++.||+|||+.+ ++|+||+|+||++++++.++++|
T Consensus 78 lv~e~~~~~~L~~~l~~~------~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKV------KKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred EEEEecCCCCHHHHHHHH------HhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEee
Confidence 999999999999887532 112356888999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcccc---CCccHHHHHHHhC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFE---GDMNLHNFARMAL 505 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~---~~~~~~~~~~~~~ 505 (789)
||++........ ....++..|+|||...+..++.++||||||+++|||++|+.||+.... .......+.....
T Consensus 149 fg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 149 FGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred cccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 999876543321 124577899999999988999999999999999999999999975422 1112222222111
Q ss_pred CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.....+..+. .......+.+++..|++.++..||+..++...+
T Consensus 225 ~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 225 NPELKDEPGN------------------------GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred chhhccCCCC------------------------CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 1001000000 001234566889999999999999998775544
No 264
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=99.97 E-value=8.5e-30 Score=266.75 Aligned_cols=259 Identities=22% Similarity=0.250 Sum_probs=202.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|+..+.||.|++|+||+|....++..||+|++.... ....+.+.+|++.++.++|+||+++++.+.... ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-----ELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-----EEE
Confidence 47889999999999999999998889999999986543 335678999999999999999999999887655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+|++.+++|.+++... .....+++.....++.|++.||+|||+.+ ++||||+|+||++++++.+|++|
T Consensus 76 iv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSS-------YPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred EEEeccCCCcHHHHHHHh-------cccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence 999999999999998643 11246889999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCcc--ceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249 429 FGLARFLPPTHVQT--SSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505 (789)
Q Consensus 429 fgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 505 (789)
||++.......... ......|+..|+|||++... .++.++|||||||++|||++|+.||...... ..+....+..
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~- 223 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQND- 223 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCC-
Confidence 99998776554221 22334588899999998877 7899999999999999999999999733111 1111111110
Q ss_pred CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
++.+.... ........+.++...|.+.++..||+......
T Consensus 224 --------~~~~~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 --------PPSLETGA-----------------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --------CCCcCCcc-----------------ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00010000 00123345668888999999999998876644
No 265
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=99.97 E-value=1.4e-29 Score=265.70 Aligned_cols=199 Identities=23% Similarity=0.358 Sum_probs=158.2
Q ss_pred CcccccCCccEEEEEEcCC--ceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 276 NLIGTGSFGSVYKGVLDEG--RTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
+.||+|+||.||+|....+ ...+++|.++... ....+.+.+|+..++.++||||+++++.|.... ..++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-----PYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-----ccEEEEe
Confidence 3699999999999986533 2356677765443 344678999999999999999999999987655 7899999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLA 432 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 432 (789)
|+.+|+|.+++.... ......++.....++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||++
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~ 146 (268)
T cd05086 76 YCELGDLKSYLSQEQ------WHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG 146 (268)
T ss_pred cCCCCcHHHHHHhhh------cccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccc
Confidence 999999999986531 11234677788899999999999999887 999999999999999999999999998
Q ss_pred ccCCCCCCccceeeecccccccCcccCCC-------CCcCccccchhhHHHHHHHHH-hcCCCC
Q 041249 433 RFLPPTHVQTSSIGVKGSIGYIAPEYGLG-------SEVSTNGDVYSYGILMLELII-RKKPSD 488 (789)
Q Consensus 433 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~sfGvvl~ellt-G~~P~~ 488 (789)
................++..|+|||+... ..++.++|||||||++|||++ |..||.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 65332221112223557889999998743 245789999999999999997 567775
No 266
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=99.97 E-value=3.6e-30 Score=270.33 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=195.6
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
-++|...+.||+|+||.||+|.+... ...||||...... ....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~----- 79 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN----- 79 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-----
Confidence 35678889999999999999998643 3568999986554 34456899999999999999999999988642
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..++||||+++|+|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~ 146 (270)
T cd05056 80 -PVWIVMELAPLGELRSYLQVN---------KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCV 146 (270)
T ss_pred -CcEEEEEcCCCCcHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCe
Confidence 468999999999999999643 235899999999999999999999888 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHH
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~ 503 (789)
|++|||+++......... .....++..|+|||.+....++.++||||||+++||+++ |+.||...... ........
T Consensus 147 ~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~ 223 (270)
T cd05056 147 KLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRIEN 223 (270)
T ss_pred EEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHc
Confidence 999999998765443211 112234568999999888889999999999999999996 99999633211 11111111
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.... .....+...+.+++.+|+..+|..||+.......+
T Consensus 224 ~~~~------------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l 262 (270)
T cd05056 224 GERL------------------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQL 262 (270)
T ss_pred CCcC------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0000 00113344667888899999999999887764433
No 267
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=99.97 E-value=5.8e-30 Score=267.48 Aligned_cols=258 Identities=21% Similarity=0.261 Sum_probs=200.3
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||.|+||.||++....+++.||+|.+... .....+.+..|++++++++|+||+++++++.... ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS---NQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC---CCEEE
Confidence 477788999999999999999989999999998643 2334567889999999999999999999875432 23679
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC--CCCceecCCCCCceecCCCCceee
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC--QPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
+++||+.+++|.+++... ......+++.++..++.|++.||+|||..+ ...++|+||+|+||++++++.+|+
T Consensus 78 ~~~e~~~~~~L~~~l~~~------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKC------KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred EEehhccCCCHHHHHHHH------hhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 999999999999998643 123457899999999999999999999333 334999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
+|||.+......... .....++..|+|||......++.++||||||+++|+|++|+.||.... ...+.+....
T Consensus 152 ~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~ 224 (265)
T cd08217 152 GDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASKIKE 224 (265)
T ss_pred ecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHHHhc
Confidence 999999987654421 223458899999999998889999999999999999999999997421 1122111110
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
... +.+. .+....+.+++..|.+.++.+||++..+..+
T Consensus 225 ~~~-----~~~~----------------------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKF-----RRIP----------------------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCC-----CCCc----------------------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 0010 1223456688889999999999998876543
No 268
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=99.97 E-value=1.7e-30 Score=270.88 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=196.4
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhh--HHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS--RSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
|...+.||+|+||+||++....+++.||+|.+........ .....|+..+++++||||+++++++.... ..++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN-----YLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS-----EEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc-----cccc
Confidence 3456789999999999999999999999999976644332 23456999999999999999999998755 8899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+.+++|.+++.. ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+||
T Consensus 76 v~~~~~~~~L~~~l~~----------~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Df 142 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQK----------NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDF 142 (260)
T ss_dssp EEEEETTEBHHHHHHH----------HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSG
T ss_pred cccccccccccccccc----------ccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 9999999999999962 256799999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCC-CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
|.+...... ........++..|+|||... ...++.++||||+|+++|+|++|+.||.... ..+............
T Consensus 143 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~ 218 (260)
T PF00069_consen 143 GSSVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILKRP 218 (260)
T ss_dssp TTTEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHHTH
T ss_pred ccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhccccc
Confidence 999865211 12233456889999999998 7889999999999999999999999998430 001111111110000
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
..............+.++...|.+.++-+||+......
T Consensus 219 ------------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 219 ------------------------LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ------------------------HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ------------------------ccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000001111256778888999999999999877644
No 269
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=99.97 E-value=5.2e-30 Score=267.55 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=193.9
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
-++|...+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|++++++++|+||+++.+.+.. . ..+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~-----~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E-----PIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C-----CeE
Confidence 467888999999999999999876 56779999886432 234678899999999999999999998765 3 679
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
++|||+.+|+|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+|++|
T Consensus 77 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05073 77 IITEFMAKGSLLDFLKSD--------EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 145 (260)
T ss_pred EEEEeCCCCcHHHHHHhC--------CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECC
Confidence 999999999999998653 2346788999999999999999999887 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
||.+......... ......++..|+|||++..+.++.++|||||||++|++++ |+.||.... ......+.......
T Consensus 146 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~~~ 222 (260)
T cd05073 146 FGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRM 222 (260)
T ss_pred CcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCCC
Confidence 9999876543321 1222345678999999988889999999999999999999 899986321 11122222111110
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
. . ......++.+++.+|++.++-.||+.....
T Consensus 223 ~--------~----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 223 P--------R----------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred C--------C----------------------cccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 0 0 001223466788899999999999877653
No 270
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=99.97 E-value=4.3e-30 Score=268.82 Aligned_cols=254 Identities=22% Similarity=0.252 Sum_probs=201.6
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|+..+.||.|++|.||++....+++.||+|.+.... ......+.+|++.+++++||||+++++.+.... ..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-----DIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC-----EEE
Confidence 46778889999999999999999889999999986553 344567889999999999999999999987665 899
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeC
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
+|+||+.+++|.+++... ...+++..+..++.|++.||+|+|+ .+ ++|+||||+||++++++.+||+
T Consensus 76 lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 76 ICMEYMDGGSLDKILKEV---------QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred EEEEecCCCcHHHHHHHc---------cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEe
Confidence 999999999999998643 1568889999999999999999998 77 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
|||.+......... ...++..|+|||...+..++.++||||||+++|+|++|+.||...........+..+.....
T Consensus 144 d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (265)
T cd06605 144 DFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE 219 (265)
T ss_pred ecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence 99998766433211 15688899999999888999999999999999999999999974432222333333222111
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.. +.+. .......+.+++..|+..++..||+......
T Consensus 220 ~~-----~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 220 PP-----PRLP---------------------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CC-----CCCC---------------------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 00 0000 0013345668888999999999999876643
No 271
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=99.97 E-value=9.5e-30 Score=264.69 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=196.5
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||+|++|.||++....+++.+|+|.+... .......+..|++++++++|||++++++.+.... ..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-----ALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC-----EEE
Confidence 477788999999999999999889999999998654 2334567899999999999999999999876554 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-CceeeC
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHVG 427 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~ 427 (789)
+|+||+++++|.+++... .+..+++..+..++.++++||+|||+.+ ++|+||+|+||+++++ +.+|++
T Consensus 76 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~ 144 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR--------CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIG 144 (256)
T ss_pred EEEecCCCCCHHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEc
Confidence 999999999999999653 2345889999999999999999999988 9999999999999865 467999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
|||.+........ .....++..|+|||......++.++||||||+++|+|++|+.||... +....+......
T Consensus 145 d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-----~~~~~~~~~~~~ 216 (256)
T cd08220 145 DFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-----NLPALVLKIMSG 216 (256)
T ss_pred cCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-----chHHHHHHHHhc
Confidence 9999987754432 12245788999999998888999999999999999999999998632 111111111100
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
....+. ..+...+.++...|++.++..||+......
T Consensus 217 ~~~~~~---------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 217 TFAPIS---------------------------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCC---------------------------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000000 012334567888999999999999887643
No 272
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=99.97 E-value=3.6e-30 Score=273.74 Aligned_cols=200 Identities=24% Similarity=0.365 Sum_probs=175.9
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.+.|...+.||+|+||.||+|....+++.||+|.+........+.+..|++++++++|||++++++++.... ..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-----ELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-----cEE
Confidence 367888999999999999999998889999999987665555677899999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|
T Consensus 93 lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~d 158 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD 158 (293)
T ss_pred EEEecCCCCcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEcc
Confidence 99999999999999853 24688899999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||++....+.... .....++..|+|||.+....++.++|||||||++||+++|+.||..
T Consensus 159 fg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~ 217 (293)
T cd06647 159 FGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (293)
T ss_pred Ccceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9998866544321 2234588899999999888899999999999999999999999963
No 273
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=99.97 E-value=6.7e-30 Score=265.14 Aligned_cols=244 Identities=27% Similarity=0.332 Sum_probs=190.5
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
+.||+|++|.||++.... ++.||+|.++..... ....+.+|+++++++.|+||+++++++.... ..++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-----PIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----CeEEEEEcC
Confidence 478999999999999986 999999998765443 4567999999999999999999999987665 789999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
.+++|.+++... ...+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||.+..
T Consensus 75 ~~~~l~~~l~~~---------~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 75 PGGSLLTFLRKK---------KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred CCCcHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccc
Confidence 999999998543 235788999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCchhhhc
Q 041249 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDHVMDIV 513 (789)
Q Consensus 435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (789)
..............++..|+|||...++.++.++|||||||++|||++ |..||...... ............
T Consensus 143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~~~------ 214 (251)
T cd05041 143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGYRM------ 214 (251)
T ss_pred ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCCCC------
Confidence 653222111112234567999999988899999999999999999999 88888632211 111111110000
Q ss_pred cCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 514 DSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 514 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
.....+...+.+++..|.+.++..||+.....
T Consensus 215 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell 246 (251)
T cd05041 215 ------------------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIY 246 (251)
T ss_pred ------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 00012234567888899999999999887653
No 274
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=99.97 E-value=9.1e-30 Score=272.33 Aligned_cols=249 Identities=21% Similarity=0.242 Sum_probs=193.6
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||.||++....+++.||+|.+.... ......+.+|+++++.++||||+++++.+.... .
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR-----H 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-----E
Confidence 47888999999999999999999899999999986543 233457889999999999999999999987655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+|+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNI----------GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred EEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEE
Confidence 89999999999999998543 45788999999999999999999887 999999999999999999999
Q ss_pred CcccccccCCCCCC-------------ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccC
Q 041249 427 GDFGLARFLPPTHV-------------QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEG 493 (789)
Q Consensus 427 ~Dfgla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~ 493 (789)
+|||.++....... ........++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--- 219 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--- 219 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---
Confidence 99999874221110 00111234778899999998888999999999999999999999998632
Q ss_pred CccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccc
Q 041249 494 DMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLK 566 (789)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~ 566 (789)
...++........ ...+.. ...+...+.+++.+|++.++..|++..
T Consensus 220 --~~~~~~~~~~~~~---~~~~~~----------------------~~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 220 --TPEELFGQVISDD---IEWPEG----------------------DEALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred --CHHHHHHHHHhcc---cCCCCc----------------------cccCCHHHHHHHHHHhccChhhccCcc
Confidence 1122222111110 000000 001234456888999999999999864
No 275
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=99.97 E-value=4.3e-30 Score=272.94 Aligned_cols=197 Identities=26% Similarity=0.355 Sum_probs=172.2
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
.|.....||+|+||.||++....+++.||||.+........+.+..|+..++.++|+||+++++.+...+ ..++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-----ELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-----eEEEE
Confidence 3444567999999999999998889999999987665566677899999999999999999999987655 78999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 430 (789)
|||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 98 ~e~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg 163 (292)
T cd06658 98 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG 163 (292)
T ss_pred EeCCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCc
Confidence 999999999998742 24788999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
++......... .....|+..|+|||+.....++.++|||||||++|||++|+.||.
T Consensus 164 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 164 FCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred chhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 98865443321 223458899999999988889999999999999999999999986
No 276
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=99.96 E-value=2.1e-30 Score=270.16 Aligned_cols=237 Identities=22% Similarity=0.307 Sum_probs=182.8
Q ss_pred CcccccCCccEEEEEEcCCce-------EEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 276 NLIGTGSFGSVYKGVLDEGRT-------TVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+.||+|+||.||+|.....+. .||+|.+........+.+.+|+.+++.+.|||++++++++.... ..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence 468999999999999865443 48889886555555678899999999999999999999988655 689
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc-----
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV----- 423 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~----- 423 (789)
+||||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~ 143 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKN---------KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGN 143 (258)
T ss_pred EEEecCCCCcHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCC
Confidence 999999999999999654 235789999999999999999999888 999999999999987765
Q ss_pred ---eeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhc-CCCCccccCCccHH
Q 041249 424 ---SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRK-KPSDIMFEGDMNLH 498 (789)
Q Consensus 424 ---~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~-~P~~~~~~~~~~~~ 498 (789)
+|++|||.+....... ...++..|+|||.+.+. .++.++|||||||++|||++|. .|+..... ....
T Consensus 144 ~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--~~~~ 215 (258)
T cd05078 144 PPFIKLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--QKKL 215 (258)
T ss_pred CceEEecccccccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--HHHH
Confidence 5899999887654322 24578899999999875 4799999999999999999985 55542110 0001
Q ss_pred HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 499 NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 499 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
...... ..+. .....++.+++..|++.++..||+.....
T Consensus 216 ~~~~~~----------~~~~----------------------~~~~~~~~~li~~~l~~~p~~Rps~~~il 254 (258)
T cd05078 216 QFYEDR----------HQLP----------------------APKWTELANLINQCMDYEPDFRPSFRAII 254 (258)
T ss_pred HHHHcc----------ccCC----------------------CCCcHHHHHHHHHHhccChhhCCCHHHHH
Confidence 110000 0000 01123456888899999999999988763
No 277
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=99.96 E-value=1.2e-29 Score=265.02 Aligned_cols=253 Identities=24% Similarity=0.287 Sum_probs=201.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||+|++|.||+|+...+++.|++|.+..... .....+..|++.+.+++|+|++++++.+.... ..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-----EIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-----eEE
Confidence 468888999999999999999998899999999876644 45678999999999999999999999987765 899
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCceeeC
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
+|+||+.+++|.+++... ..+++..+..++.|++.|++|||+ .+ ++||||+|+||+++.++.++|+
T Consensus 76 lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~ 142 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV----------GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIA 142 (264)
T ss_pred EEEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEc
Confidence 999999999999998643 568899999999999999999998 87 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
|||.+.......... ....++..|+|||...+..++.++||||||+++|||++|+.||..... ....+..+.....
T Consensus 143 df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~ 218 (264)
T cd06623 143 DFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDG 218 (264)
T ss_pred cCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcC
Confidence 999998775444221 234578899999999988999999999999999999999999974432 1111111111111
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
. .+.... ..+...+.++...|++.++..|++......
T Consensus 219 ~-----~~~~~~---------------------~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 219 P-----PPSLPA---------------------EEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred C-----CCCCCc---------------------ccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0 000000 002345667788899999999998876543
No 278
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=99.96 E-value=1.1e-30 Score=280.09 Aligned_cols=247 Identities=22% Similarity=0.286 Sum_probs=202.0
Q ss_pred CCCCcccccCCccEEEEEEcCC---ceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 273 SSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 273 ~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
...+.||+|.||.|++|.|... .-.||||.++..... ....|..|+.+|.+|+|+|++++||+..+. ...
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p~m 186 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------PAM 186 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------hhh
Confidence 3457899999999999999633 346899999877554 568899999999999999999999998752 578
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+|.++.|+|.+.+++. ....|-......++.|||.||+||..+. +||||+-++|+++...-.+||+|
T Consensus 187 MV~ELaplGSLldrLrka--------~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKA--------KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred HHhhhcccchHHHHHhhc--------cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeec
Confidence 999999999999999763 3456788889999999999999999887 99999999999999999999999
Q ss_pred ccccccCCCCCCcccee-eecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCC
Q 041249 429 FGLARFLPPTHVQTSSI-GVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
||+.+.++.....+.+. ...-.+.|+|||.+...+++-++|||+|||++|||+| |+.||-... -.+
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----g~q------- 323 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----GIQ------- 323 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----HHH-------
Confidence 99999988766443222 3344568999999999999999999999999999998 899986211 111
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA 568 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~ 568 (789)
+.+.+|..-+ ......|...+++++..||.-.+.||++....
T Consensus 324 --IL~~iD~~er------------------LpRPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 324 --ILKNIDAGER------------------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred --HHHhcccccc------------------CCCCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 2222331111 22345789999999999999999999998765
No 279
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=99.96 E-value=9.3e-30 Score=267.60 Aligned_cols=262 Identities=23% Similarity=0.255 Sum_probs=201.2
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCC-CCC
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDY-QGN 344 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~-~~~ 344 (789)
.++++|...+.||+|++|.||+|....+++.+++|++..... ..+.+..|+++++++ .|+||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 467899999999999999999999988899999999875543 346789999999999 79999999999876543 234
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
...++||||+.+++|.+++... ......+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~ 152 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGL------RKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEV 152 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHH------hhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeE
Confidence 4689999999999999988643 112356899999999999999999999888 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHH
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHN 499 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~ 499 (789)
|++|||.+........ ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...... ..+..
T Consensus 153 ~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~ 229 (275)
T cd06608 153 KLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFK 229 (275)
T ss_pred EECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHH
Confidence 9999999886643321 1223458889999998753 34788999999999999999999999632110 11111
Q ss_pred HHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 500 FARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 500 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
..+ . ..+.+. ........+.+++.+|...++..||+......
T Consensus 230 ~~~----~-----~~~~~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPR----N-----PPPTLK--------------------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhc----c-----CCCCCC--------------------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 100 0 000000 00112345667888999999999999877644
No 280
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=99.96 E-value=5.4e-30 Score=267.04 Aligned_cols=199 Identities=28% Similarity=0.394 Sum_probs=174.7
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
+|...+.||.|+||.||+|....+++.||+|++.... ....+.+.+|++++++++||||+++++.+.... ..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-----NM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC-----eE
Confidence 4777889999999999999998889999999996442 234578999999999999999999999886655 89
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++|+||+.+++|.+++... ..+++.++..++.|+++||.|||+.+ ++|+||+|+||++++++.++++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~ 142 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK----------VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHIT 142 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc----------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEe
Confidence 9999999999999998532 46889999999999999999999888 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
|||.+........ .....|+..|+|||......++.++||||||+++|+|++|+.||...
T Consensus 143 d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 202 (258)
T cd05578 143 DFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH 202 (258)
T ss_pred ecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCC
Confidence 9999887755431 22355888999999998888999999999999999999999999743
No 281
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=99.96 E-value=1.3e-29 Score=265.19 Aligned_cols=204 Identities=23% Similarity=0.367 Sum_probs=172.6
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-----cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-----HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
.+|...+.||+|++|.||+|....+++.||+|.+... .......+.+|++++++++|+||+++++++.... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 5788999999999999999999888999999987532 1233467889999999999999999999876532 2
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
...++|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~ 145 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY----------GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNV 145 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCE
Confidence 2578999999999999988543 34788899999999999999999888 9999999999999999999
Q ss_pred eeCcccccccCCCCCC-ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 425 HVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|+|||.++....... ........++..|+|||...+..++.++|||||||++|||++|+.||..
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 9999999986543211 1112234588999999999888899999999999999999999999963
No 282
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=99.96 E-value=6.5e-30 Score=274.97 Aligned_cols=204 Identities=25% Similarity=0.326 Sum_probs=174.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|++|.||+|....+++.||+|.+..... ...+.+..|++.++.++|+||+++++.+.... .
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET-----Y 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-----E
Confidence 368888999999999999999998899999999865432 24567889999999999999999999987655 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQ--------PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIML 144 (316)
T ss_pred EEEEEEecCCCCHHHHHHhC--------CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEE
Confidence 89999999999999998643 2356899999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCc---------------------------cceeeecccccccCcccCCCCCcCccccchhhHHHHHH
Q 041249 427 GDFGLARFLPPTHVQ---------------------------TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLE 479 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~e 479 (789)
+|||.+......... .......|+..|+|||+..+..++.++||||||+++|+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 999998866433211 01112357889999999998889999999999999999
Q ss_pred HHHhcCCCCc
Q 041249 480 LIIRKKPSDI 489 (789)
Q Consensus 480 lltG~~P~~~ 489 (789)
|++|+.||..
T Consensus 225 l~~g~~pf~~ 234 (316)
T cd05574 225 MLYGTTPFKG 234 (316)
T ss_pred HhhCCCCCCC
Confidence 9999999963
No 283
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=99.96 E-value=2e-29 Score=263.61 Aligned_cols=201 Identities=29% Similarity=0.441 Sum_probs=174.6
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.|...+.||+|++|.||+|....+++.|++|.++.... ...+.+..|++++++++|+||+++++.+...+ ..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-----KVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC-----EEE
Confidence 36778899999999999999988899999999876544 35678999999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+++++|.+++... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d 142 (264)
T cd06626 76 IFMEYCSGGTLEELLEHG----------RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGD 142 (264)
T ss_pred EEEecCCCCcHHHHHhhc----------CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcc
Confidence 999999999999998543 45788899999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccc--eeeecccccccCcccCCCCC---cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTS--SIGVKGSIGYIAPEYGLGSE---VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||.+........... .....++..|+|||++.... ++.++||||||+++||+++|+.||..
T Consensus 143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 999988765442211 12345788999999988766 89999999999999999999999963
No 284
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=99.96 E-value=1.1e-29 Score=278.22 Aligned_cols=202 Identities=23% Similarity=0.254 Sum_probs=169.4
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND 345 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 345 (789)
.++|...+.||+|+||.||++....+++.||+|.+... .......+.+|+.+++.++||||+++++++..... ....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 36889999999999999999999989999999998643 23345678899999999999999999998864431 1223
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++||||+.+ ++.+.+. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 100 ~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~k 163 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 163 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh------------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEE
Confidence 57999999985 5555542 23678889999999999999999988 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 164 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 164 ILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred EecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 99999997653322 12234588999999999998999999999999999999999999974
No 285
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=99.96 E-value=2e-29 Score=264.22 Aligned_cols=250 Identities=18% Similarity=0.240 Sum_probs=191.9
Q ss_pred cHHHHHHhhcCCCCCCcc--cccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249 261 SYQNLHNATDGFSSANLI--GTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACS 337 (789)
Q Consensus 261 ~~~~~~~~~~~f~~~~~i--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 337 (789)
+..+.....++|...+.+ |+|+||.||++....+++.+|+|.+........ |+.....+ +||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence 445556666788887877 999999999999998999999999864422211 22222222 7999999999987
Q ss_pred cCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417 (789)
Q Consensus 338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil 417 (789)
..+ ..++||||+++|+|.+++... ..+++.++..++.|+++||+|||+.+ ++||||||+||+
T Consensus 80 ~~~-----~~~iv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil 141 (267)
T PHA03390 80 TLK-----GHVLIMDYIKDGDLFDLLKKE----------GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVL 141 (267)
T ss_pred cCC-----eeEEEEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEE
Confidence 765 899999999999999999643 37899999999999999999999988 999999999999
Q ss_pred cCCCC-ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCcc
Q 041249 418 LDEEM-VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMN 496 (789)
Q Consensus 418 l~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~ 496 (789)
++.++ .++++|||.++...... ...++..|+|||++....++.++|||||||++|||++|+.||....++..+
T Consensus 142 ~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 215 (267)
T PHA03390 142 YDRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD 215 (267)
T ss_pred EeCCCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh
Confidence 99998 99999999988765332 235889999999999888999999999999999999999999854443333
Q ss_pred HHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcc-ccc
Q 041249 497 LHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESL-KLA 568 (789)
Q Consensus 497 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~-~~~ 568 (789)
...+.+.. .... .. .......+.++...|.+.++..|++. ...
T Consensus 216 ~~~~~~~~-~~~~-~~---------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 259 (267)
T PHA03390 216 LESLLKRQ-QKKL-PF---------------------------IKNVSKNANDFVQSMLKYNINYRLTNYNEI 259 (267)
T ss_pred HHHHHHhh-cccC-Cc---------------------------ccccCHHHHHHHHHHhccChhhCCchHHHH
Confidence 33333322 1000 00 00123345567778888888888753 443
No 286
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=99.96 E-value=1.1e-29 Score=269.77 Aligned_cols=200 Identities=25% Similarity=0.377 Sum_probs=169.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
++|...+.||.|++|.||+|..+.+++.||+|.+..... .....+.+|++++++++|+||+++++++...+ ..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-----TLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC-----eEE
Confidence 578889999999999999999988899999999865432 22355778999999999999999999987655 899
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+. ++|.+++... ...+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 80 lv~e~~~-~~L~~~~~~~---------~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 146 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDC---------GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLAD 146 (291)
T ss_pred EEEecCC-CCHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECc
Confidence 9999998 4899887543 236789999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+++........ .....++..|+|||+..+ ..++.++||||||+++|||++|+.||..
T Consensus 147 fg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 147 FGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred cccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9998765322211 122346788999998865 4589999999999999999999999964
No 287
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=99.96 E-value=1.2e-29 Score=264.10 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=197.3
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||+|+||.||+|..+.++..||+|.+.... ....+.+.+|++++++++|+||+++++.+.... ..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-----~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-----RLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC-----eEE
Confidence 4677889999999999999999899999999986542 234567889999999999999999999987655 889
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-ceeeC
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHVG 427 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~ 427 (789)
+|+||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++ .+|++
T Consensus 76 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~ 144 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ--------RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLG 144 (257)
T ss_pred EEEecCCCCcHHHHHHhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEec
Confidence 999999999999998643 2345789999999999999999999888 99999999999999885 56999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
|||.+......... .....|+..|+|||......++.++||||||+++|||++|+.||... ...+++......
T Consensus 145 d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~ 217 (257)
T cd08225 145 DFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQG 217 (257)
T ss_pred ccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcc
Confidence 99999876543321 12245888999999998888999999999999999999999998632 223333322211
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
..... .+ .....+.+++.+|++.++..||+...+..
T Consensus 218 ~~~~~-~~--------------------------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 218 YFAPI-SP--------------------------NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred cCCCC-CC--------------------------CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11111 11 11234557778899999999999877643
No 288
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=99.96 E-value=1.9e-29 Score=265.23 Aligned_cols=261 Identities=22% Similarity=0.336 Sum_probs=194.9
Q ss_pred CCCCCcccccCCccEEEEEEcC---CceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC-Cc
Q 041249 272 FSSANLIGTGSFGSVYKGVLDE---GRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG-ND 345 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~-~~ 345 (789)
|...+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|++.+++++||||+++++++......+ ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5667899999999999999753 46899999986542 334567889999999999999999999876543221 12
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++++||+.+|++.+++...... .....+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG----EEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEE
Confidence 357889999999999887533111 12245789999999999999999999888 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHh
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMA 504 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~ 504 (789)
++|||.++...............++..|++||......++.++||||||+++|||++ |+.||..... ..+..+....
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~ 231 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKG 231 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcC
Confidence 999999987654332212222345678999999988889999999999999999999 8888863211 1111111110
Q ss_pred CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
.. .. ....+...+.+++..|++.++-+||+...+...
T Consensus 232 ~~--------~~----------------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 232 NR--------LK----------------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred Cc--------CC----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 00 001233467788999999999999998876443
No 289
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=99.96 E-value=1e-29 Score=273.63 Aligned_cols=200 Identities=27% Similarity=0.362 Sum_probs=178.9
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch---hhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR---ASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~ 344 (789)
.+.|...+.||.|.||.||+++.+.+|+.+|+|++...... ......+|+++|+.+. |||||.+.+.+....
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~---- 109 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD---- 109 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC----
Confidence 45677889999999999999999999999999999766443 3468999999999997 999999999998876
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE--- 421 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~--- 421 (789)
..++|||++.+|.|.+.+... .+++.....++.|++.|+.|||+.+ +||||+||+|+|+...
T Consensus 110 -~~~lvmEL~~GGeLfd~i~~~-----------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~ 174 (382)
T KOG0032|consen 110 -SVYLVMELCEGGELFDRIVKK-----------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEG 174 (382)
T ss_pred -eEEEEEEecCCchHHHHHHHc-----------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCC
Confidence 899999999999999998532 3899999999999999999999988 9999999999999644
Q ss_pred -CceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 422 -MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 422 -~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
+.+|++|||++..... ........||+.|+|||.+....|+..+||||.||++|.|++|..||...
T Consensus 175 ~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~ 241 (382)
T KOG0032|consen 175 SGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE 241 (382)
T ss_pred CCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence 4799999999999877 23455678999999999999999999999999999999999999999854
No 290
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=99.96 E-value=1.8e-29 Score=262.79 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=195.7
Q ss_pred CCCCCcccccCCccEEEEEEcCCc----eEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGR----TTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
|...+.||.|+||.||++.+...+ ..||+|+++..... ..+.+..|++.+..++|+||+++++++.... .
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE-----P 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-----e
Confidence 356789999999999999998665 89999999765443 5678999999999999999999999987765 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.+++|||+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+++
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l 144 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKN--------RPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKI 144 (258)
T ss_pred eEEEEeccCCCCHHHHHHhh--------hhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEE
Confidence 89999999999999998654 1122899999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMAL 505 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 505 (789)
+|||.+............ ...++..|+|||......++.++||||+|+++|||++ |+.||... +.....+...
T Consensus 145 ~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~ 218 (258)
T smart00219 145 SDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEYLK 218 (258)
T ss_pred cccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHh
Confidence 999999887655322111 2336789999999988889999999999999999998 78887631 1111111111
Q ss_pred CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249 506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA 568 (789)
Q Consensus 506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~ 568 (789)
..... .....+...+.+++.+|.+.++..||+....
T Consensus 219 ~~~~~---------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (258)
T smart00219 219 KGYRL---------------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSEL 254 (258)
T ss_pred cCCCC---------------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence 10000 0011234456688889999999999987654
No 291
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=99.96 E-value=6e-30 Score=270.73 Aligned_cols=198 Identities=23% Similarity=0.372 Sum_probs=166.9
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.|...+.||+|++|.||+|.+..+++.||+|.++... ......+.+|++++++++|+||+++++++.+.. ..+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-----KLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC-----ceE
Confidence 3677789999999999999999899999999986542 223456788999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+. +++.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d 142 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSC---------NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLAD 142 (284)
T ss_pred EEEecCC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECc
Confidence 9999997 5787776532 245899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
||+++........ .....++..|+|||.+.+.. ++.++|||||||++|||++|+.|+.
T Consensus 143 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 143 FGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred cchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 9999865433211 12345788999999887654 7999999999999999999999975
No 292
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=99.96 E-value=1.9e-29 Score=264.65 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=194.5
Q ss_pred CCCCCCcccccCCccEEEEEEcC-CceEEEEEEecccc----------chhhHHHHHHHHHHhc-CCCCccceeeeeecc
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDE-GRTTVTVKVFNLHH----------HRASRSFIAECRALRS-IRHRNLVKVFTACSG 338 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 338 (789)
+|+..+.||+|+||.||+|.+.. +++.+|+|.+.... ......+..|++++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 57888999999999999999986 67899999885331 1223457788888875 699999999999876
Q ss_pred CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCcee
Q 041249 339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNIL 417 (789)
Q Consensus 339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nil 417 (789)
.. ..++||||+.+++|.+++... ......+++..+..++.|++.||.|||+ .+ ++|+||+|+||+
T Consensus 81 ~~-----~~~lv~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil 146 (269)
T cd08528 81 ND-----RLYIVMDLIEGAPLGEHFNSL------KEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIM 146 (269)
T ss_pred CC-----eEEEEEecCCCCcHHHHHHHH------HhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEE
Confidence 65 899999999999999887432 1223568999999999999999999996 55 999999999999
Q ss_pred cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccH
Q 041249 418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNL 497 (789)
Q Consensus 418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~ 497 (789)
++.++.+||+|||.+....... ......|+..|+|||......++.++||||||+++|||++|+.||... ..
T Consensus 147 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~ 218 (269)
T cd08528 147 LGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NM 218 (269)
T ss_pred ECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CH
Confidence 9999999999999998765443 223456888999999999888999999999999999999999998632 11
Q ss_pred HHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 498 HNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 498 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
................ ...+...+.+++.+|++.++..||+..++..
T Consensus 219 ~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 219 LSLATKIVEAVYEPLP--------------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred HHHHHHHhhccCCcCC--------------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 1111111110000000 0012234567888999999999999887654
No 293
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=99.96 E-value=8.1e-30 Score=271.51 Aligned_cols=196 Identities=25% Similarity=0.353 Sum_probs=171.4
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
|.....||+|+||.||+|....+++.||+|++..........+.+|+..++.+.|||++++++.+.... ..++|+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE-----ELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC-----eEEEEE
Confidence 334557999999999999998889999999997665555677889999999999999999999987655 789999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+++++|..++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 98 e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~ 163 (297)
T cd06659 98 EFLQGGALTDIVSQ-----------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGF 163 (297)
T ss_pred ecCCCCCHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechh
Confidence 99999999987742 35789999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
+......... .....|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 164 CAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred Hhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 8765443321 223558899999999988889999999999999999999999986
No 294
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=99.96 E-value=1.6e-29 Score=268.32 Aligned_cols=197 Identities=28% Similarity=0.352 Sum_probs=174.5
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|++|.||++.+..+++.||+|++.... ......+..|+++++++.||||+++++++.... .
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-----N 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----e
Confidence 46888899999999999999999889999999986432 233567889999999999999999999987665 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+++|.+++... ..++...+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl 142 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS----------GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKI 142 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEE
Confidence 89999999999999998643 56889999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||++....... ....++..|+|||...+...+.++||||||+++|+|++|+.||..
T Consensus 143 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 143 TDFGFAKRVKGRT-----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred eeCCCccccCCCC-----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999998765542 234588999999999888899999999999999999999999863
No 295
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=99.96 E-value=2.1e-29 Score=271.16 Aligned_cols=206 Identities=22% Similarity=0.321 Sum_probs=162.9
Q ss_pred CCcccccCCccEEEEEEcC--CceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 275 ANLIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
...||+|+||+||+|.... +++.||+|.++... ....+.+|++++++++||||+++++++.... ....++|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEe
Confidence 3589999999999999753 45789999986432 2346788999999999999999999885432 236799999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec----CCCCceeeCc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL----DEEMVSHVGD 428 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~D 428 (789)
|+.+ ++.+++....... .......+++..+..++.|++.||+|||+.+ ++||||||+||++ ++++++||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 81 YAEH-DLWHIIKFHRASK-ANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eeCC-cHHHHHHhhhccc-cCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 9885 7777664321111 1122346889999999999999999999988 9999999999999 5667999999
Q ss_pred ccccccCCCCCCc-cceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 429 FGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 429 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
||+++........ .......||..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9999877544321 122335688999999998764 5899999999999999999999999743
No 296
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=99.96 E-value=1.1e-29 Score=264.73 Aligned_cols=189 Identities=28% Similarity=0.452 Sum_probs=161.2
Q ss_pred CcccccCCccEEEEEEcCCc----------eEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 276 NLIGTGSFGSVYKGVLDEGR----------TTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
+.||+|+||.||+|.+..++ ..|++|.+...... ...+.+|++++++++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~----- 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D----- 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C-----
Confidence 46899999999999998665 45888887654433 6788999999999999999999999876 4
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC---
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM--- 422 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~--- 422 (789)
..++|+||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHRE---------KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCcccc
Confidence 579999999999999998654 226889999999999999999999887 99999999999999888
Q ss_pred ----ceeeCcccccccCCCCCCccceeeecccccccCcccCCCC--CcCccccchhhHHHHHHHHH-hcCCCCc
Q 041249 423 ----VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS--EVSTNGDVYSYGILMLELII-RKKPSDI 489 (789)
Q Consensus 423 ----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~sfGvvl~ellt-G~~P~~~ 489 (789)
.+|++|||.+....... ...++..|+|||++... .++.++||||||+++|||++ |..|+..
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~ 209 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209 (259)
T ss_pred CCceeEEeCCCCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence 79999999998764421 23466789999998876 78999999999999999999 5777753
No 297
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=99.96 E-value=6.2e-30 Score=270.86 Aligned_cols=199 Identities=25% Similarity=0.369 Sum_probs=170.0
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++|...+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+++++.++||||+++++++.... ..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK-----RL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC-----eE
Confidence 467888999999999999999988899999999854322 23567889999999999999999999987654 78
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++|+||+.++++.++.... ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+|++
T Consensus 76 ~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~ 142 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYP----------NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLC 142 (286)
T ss_pred EEEEecCCccHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEE
Confidence 9999999999888876432 34899999999999999999999887 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
|||++......... .....++..|+|||+..+ ..++.++||||||+++|||++|+.||.
T Consensus 143 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 143 DFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred eeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 99999876543311 223457889999998865 447889999999999999999999986
No 298
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=99.96 E-value=1.2e-29 Score=267.05 Aligned_cols=259 Identities=20% Similarity=0.309 Sum_probs=197.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcC-----CceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDE-----GRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
++|...+.||+|+||+||+|+... +.+.|++|.+...... ....+..|++++++++|+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE--- 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC---
Confidence 578889999999999999999753 3467999998655444 4577999999999999999999999987655
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV 423 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 423 (789)
..++||||+++|+|.+++....... .......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 82 --~~~lv~e~~~~~~L~~~i~~~~~~~-~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 82 --PHYMILEYTDLGDLKQFLRATKSKD-EKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQRE 155 (275)
T ss_pred --cceEEEEecCCCcHHHHHHhccccc-ccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCc
Confidence 7899999999999999997541110 0111236899999999999999999999988 999999999999999999
Q ss_pred eeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHH
Q 041249 424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFAR 502 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~ 502 (789)
++++|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+.....
T Consensus 156 ~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~~~~ 232 (275)
T cd05046 156 VKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNRLQ 232 (275)
T ss_pred EEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHHHHH
Confidence 99999999875543221 11223346778999999988889999999999999999999 7888853211 11111111
Q ss_pred HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
.. ... .. ....+...+.+++..|++.++..|++.....
T Consensus 233 ~~---~~~-~~-------------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l 270 (275)
T cd05046 233 AG---KLE-LP-------------------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270 (275)
T ss_pred cC---CcC-CC-------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 00 000 00 0012344677889999999999999887653
No 299
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=99.96 E-value=1.4e-29 Score=267.09 Aligned_cols=192 Identities=23% Similarity=0.306 Sum_probs=158.7
Q ss_pred cccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHh---cCCCCccceeeeeeccCCCCCCceEEEE
Q 041249 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALR---SIRHRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 277 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
.||+|+||.||++....+++.||+|.+..... .....+..|..++. ...|++|+.+++++...+ ..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-----KLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-----eEEEE
Confidence 48999999999999988899999999864421 22233444444333 347999999999887655 78999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 430 (789)
|||+.+|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+|++|||
T Consensus 76 ~e~~~~~~L~~~i~~~----------~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg 142 (279)
T cd05633 76 LDLMNGGDLHYHLSQH----------GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG 142 (279)
T ss_pred EecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCC
Confidence 9999999999988543 46899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
++........ ....|+..|+|||...+ ..++.++|||||||++|||++|+.||...
T Consensus 143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 143 LACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred cceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 9876543321 23458999999999875 45899999999999999999999999743
No 300
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=99.96 E-value=9.8e-30 Score=264.74 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=193.8
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
..+|+..+.||+|+||.||+|.+. .++.+|+|.++.... ....+.+|++++++++|||++++++++.... ..+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS-----PIC 75 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC-----ceE
Confidence 356788899999999999999986 467899998864322 3457899999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+.+|+|.+++... ...+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d 143 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQ---------RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSD 143 (256)
T ss_pred EEEEcCCCCcHHHHHHhC---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECC
Confidence 999999999999998643 235789999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPD 507 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 507 (789)
||.++........ ......++..|+|||....+.++.++||||||+++|||++ |+.||.... .....+.....
T Consensus 144 ~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~~ 217 (256)
T cd05112 144 FGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NSEVVETINAG 217 (256)
T ss_pred CcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHHhCC
Confidence 9998876543211 1112335578999999998899999999999999999998 999986321 11222111000
Q ss_pred chhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 508 HVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 508 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
....++.. ....+.+++..|++.++..||+...+.
T Consensus 218 --~~~~~~~~-------------------------~~~~~~~l~~~~l~~~p~~Rp~~~~~l 252 (256)
T cd05112 218 --FRLYKPRL-------------------------ASQSVYELMQHCWKERPEDRPSFSLLL 252 (256)
T ss_pred --CCCCCCCC-------------------------CCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 00011111 123566889999999999999987663
No 301
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=99.96 E-value=1.4e-29 Score=274.47 Aligned_cols=284 Identities=19% Similarity=0.227 Sum_probs=201.1
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
.++|...+.||+|++|.||+|....+++.||+|++.... ......+..|+.++++++||||+++.+++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 378999999999999999999999899999999986542 234567788999999999999999999876543 22336
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++|+||+. |+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD----------QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred EEEEEehhh-hhHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEe
Confidence 899999996 6898888543 45899999999999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCc--cceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249 427 GDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 503 (789)
+|||.+......... .......|+..|+|||.+.. ..++.++|||||||++|||++|+.||.... .......+..
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~--~~~~~~~~~~ 226 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN--YVHQLKLILS 226 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC--hHHHHHHHHH
Confidence 999999876443311 11123468889999998765 458999999999999999999999996321 1111112222
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhh-hchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIR-VNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.......+..+............ ........+ ..........+.+++..|.+.++.+|++...+..
T Consensus 227 ~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 227 VLGSPSEEVLNRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HhCCChhHhhhhhchhhHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11111111111100000000000 000000000 0001123566778999999999999999876543
No 302
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=99.96 E-value=3.1e-29 Score=265.46 Aligned_cols=248 Identities=20% Similarity=0.238 Sum_probs=196.4
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
.|...+.||+|++|.||++....+++.|++|.+........+.+.+|+.+++.++|||++++++++...+ ..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-----~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-----ELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC-----eEEEE
Confidence 5666789999999999999998889999999987655555667889999999999999999999987655 78999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 430 (789)
+||+.+++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||+|+||+++.++.++++|||
T Consensus 95 ~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g 160 (285)
T cd06648 95 MEFLEGGALTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFG 160 (285)
T ss_pred EeccCCCCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccc
Confidence 999999999998843 35788999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchh
Q 041249 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVM 510 (789)
Q Consensus 431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 510 (789)
.+......... .....|+..|+|||...+..++.++|||||||++|||++|+.||... +.....+.....
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~-----~~~~~~~~~~~~--- 230 (285)
T cd06648 161 FCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-----PPLQAMKRIRDN--- 230 (285)
T ss_pred cchhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC-----CHHHHHHHHHhc---
Confidence 88765443221 12345888999999998888999999999999999999999998631 111111111110
Q ss_pred hhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 511 DIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 511 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
..+.+. ........+.+++..|++.++-+||+.....
T Consensus 231 --~~~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 231 --LPPKLK--------------------NLHKVSPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred --CCCCCc--------------------ccccCCHHHHHHHHHHcccChhhCcCHHHHc
Confidence 000000 0011234566888899999999999887664
No 303
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=99.96 E-value=3.9e-29 Score=263.48 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=194.9
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCC---CCccceeeeeeccCCCCCCce
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIR---HRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~~~~ 346 (789)
.|+..+.||+|+||.||+|.+..+++.||+|.++... ......+.+|++++++++ |||++++++++.... .
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~-----~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP-----R 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-----E
Confidence 4677889999999999999998889999999986543 334567888999999996 999999999987655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+++
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l 142 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-----------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKL 142 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEE
Confidence 8999999999999998742 25789999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMAL 505 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~ 505 (789)
+|||.+......... .....|+..|+|||+..++. ++.++|||||||++|+|++|+.||..... ..+... .
T Consensus 143 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~-~ 214 (277)
T cd06917 143 CDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMML-I 214 (277)
T ss_pred ccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhc-c
Confidence 999999877654321 22345888999999987654 68999999999999999999999973211 111100 0
Q ss_pred CCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 506 PDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 506 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
. ....+.+..+ .....+.+++..|++.++..|++......
T Consensus 215 ~----~~~~~~~~~~---------------------~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 215 P----KSKPPRLEDN---------------------GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred c----cCCCCCCCcc---------------------cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0 0001111100 12345667888999999999999877643
No 304
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=99.96 E-value=2e-29 Score=262.11 Aligned_cols=242 Identities=25% Similarity=0.363 Sum_probs=189.4
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
++|...+.||+|+||.||+|.. .++.||+|.++... ....+.+|++++++++|||++++++++... ..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEE
Confidence 5688899999999999999975 57889999986432 346788999999999999999999987542 4689
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+.+|+|.+++... ....+++.++..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 76 v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Df 144 (254)
T cd05083 76 VMELMSKGNLVNFLRTR--------GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDF 144 (254)
T ss_pred EEECCCCCCHHHHHHhc--------CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCC
Confidence 99999999999998654 2345789999999999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCCccHHHHHHHhCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
|.+....... .....+..|+|||++..+.++.++|||||||++|||++ |+.||.... ...+..... ..
T Consensus 145 g~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~-~~ 213 (254)
T cd05083 145 GLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKECVE-KG 213 (254)
T ss_pred ccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHHh-CC
Confidence 9987653321 11234567999999988899999999999999999998 999986321 111111110 00
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
.+. .....+...+.+++..|++.++-.||+.....
T Consensus 214 --------~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 248 (254)
T cd05083 214 --------YRM------------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLR 248 (254)
T ss_pred --------CCC------------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 000 00012234566888899999999999887653
No 305
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=99.96 E-value=1.3e-29 Score=268.28 Aligned_cols=200 Identities=27% Similarity=0.384 Sum_probs=169.7
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|+..+.||.|++|.||+|....+++.||||.++... ......+.+|++++++++||||+++++++...+ ..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC-----cEE
Confidence 5788899999999999999998889999999986543 223457889999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+. +++.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+|++|
T Consensus 76 ~v~e~~~-~~l~~~~~~~--------~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~d 143 (284)
T cd07860 76 LVFEFLH-QDLKKFMDAS--------PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLAD 143 (284)
T ss_pred EEeeccc-cCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEee
Confidence 9999996 6888888543 2356899999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+++........ .....++..|+|||...+.. ++.++|||||||++|||+||+.||..
T Consensus 144 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 144 FGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred ccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9998866543211 12234678899999886654 68899999999999999999999963
No 306
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=99.96 E-value=1.5e-29 Score=268.14 Aligned_cols=201 Identities=25% Similarity=0.333 Sum_probs=172.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++|+..+.||+|++|.||+|.+..+++.||+|.++.. .......+.+|++++++++|+||+++++++...+ ..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-----RL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC-----EE
Confidence 3678889999999999999999988999999998654 2334577899999999999999999999987655 79
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++|+||+.++.+..+.... ..+++.++..++.|++.|++|||..+ ++|+||+|+||++++++.+||+
T Consensus 76 ~iv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~ 142 (288)
T cd07833 76 YLVFEYVERTLLELLEASP----------GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLC 142 (288)
T ss_pred EEEEecCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEE
Confidence 9999999987777655322 45789999999999999999999888 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||.+.......... .....++..|+|||+.... .++.++||||||+++|||++|+.||..
T Consensus 143 d~g~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 143 DFGFARALRARPASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred eeecccccCCCcccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999998776544211 1234578889999999888 789999999999999999999999874
No 307
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=99.96 E-value=2.5e-29 Score=265.09 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=195.9
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
-|+..+.||.|+||.||+|.+..+++.||+|.+.... ......+.+|++.+++++||||+++++++.... ..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-----eEEE
Confidence 3667889999999999999998889999999986443 233467889999999999999999999987665 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||+.+++|.+++.. ..+++..+..++.|++.|++|||..+ ++|+||+|+||+++.++.++++||
T Consensus 80 v~e~~~~~~l~~~i~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~df 145 (277)
T cd06641 80 IMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADF 145 (277)
T ss_pred EEEeCCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeec
Confidence 9999999999998842 35789999999999999999999888 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 509 (789)
|++........ ......++..|+|||...+..++.++|||||||++|+|++|..||..... ..+.... ....
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~-~~~~ 217 (277)
T cd06641 146 GVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFLI-PKNN 217 (277)
T ss_pred ccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHHH-hcCC
Confidence 99887644321 11224578899999999888899999999999999999999999863211 1111110 0000
Q ss_pred hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
.+.+. ..+...+.+++..|++.++..||++.....+
T Consensus 218 ----~~~~~----------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 ----PPTLE----------------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CCCCC----------------------cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 1123445678889999999999998876553
No 308
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.96 E-value=3.8e-30 Score=253.37 Aligned_cols=201 Identities=23% Similarity=0.293 Sum_probs=178.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|+..+++|+|.||.|-.++.+.+++.+|+|+++.. ..........|-+++...+||.+..+-..|+..+ .
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d-----r 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD-----R 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-----e
Confidence 6899999999999999999999999999999999765 2333445677999999999999999988888777 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.|+||||..+|.|.-++... +.+++.....+..+|..||.|||+.+ ||.||+|-+|.|+|.++++||
T Consensus 243 lCFVMeyanGGeLf~HLsre----------r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKi 309 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRE----------RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKI 309 (516)
T ss_pred EEEEEEEccCceEeeehhhh----------hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEe
Confidence 99999999999999988654 67888888899999999999999988 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
+|||+++.--... ..+...+||+.|.|||++.+..|+..+|.|..|||||||++|+.||...
T Consensus 310 tDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 310 TDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred eecccchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 9999998643332 2344578999999999999999999999999999999999999999743
No 309
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=99.96 E-value=3.9e-29 Score=269.05 Aligned_cols=206 Identities=22% Similarity=0.312 Sum_probs=163.6
Q ss_pred CCcccccCCccEEEEEEc--CCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 275 ANLIGTGSFGSVYKGVLD--EGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
.+.||+|+||+||+|... .+++.||+|.+.... ....+.+|++++++++||||+++++++.... ....++|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEe
Confidence 468999999999999975 356889999986432 2345788999999999999999999875432 236899999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec----CCCCceeeCc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL----DEEMVSHVGD 428 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~D 428 (789)
|+.+ ++.+++....... .......+++..+..++.|++.||+|||+.+ |+||||||+|||+ +..+.+||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 81 YAEH-DLWHIIKFHRASK-ANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred ccCC-CHHHHHHhccccc-ccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 9874 7877765331111 1122346899999999999999999999988 9999999999999 4567999999
Q ss_pred ccccccCCCCCCc-cceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 429 FGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 429 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
||+++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9999876544321 122345689999999998764 5899999999999999999999999743
No 310
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=99.96 E-value=2.1e-30 Score=292.24 Aligned_cols=208 Identities=24% Similarity=0.302 Sum_probs=185.4
Q ss_pred HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecc---ccchhhHHHHHHHHHHhcCCCCccceeeeeecc
Q 041249 262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNL---HHHRASRSFIAECRALRSIRHRNLVKVFTACSG 338 (789)
Q Consensus 262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 338 (789)
..++....+||.+.++||.|+||+|..++.+.+++.+|+|+++. -+.....-|+.|-++|..-..+=|+.+...|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 35666678999999999999999999999999999999999975 345556789999999999999999999888888
Q ss_pred CCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249 339 VDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418 (789)
Q Consensus 339 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill 418 (789)
.. +.|+|||||++|+|-.++... ..+++..+..++++|.-||.-+|..| +|||||||.|||+
T Consensus 147 ~~-----~LYlVMdY~pGGDlltLlSk~----------~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 147 ER-----YLYLVMDYMPGGDLLTLLSKF----------DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLL 208 (1317)
T ss_pred cc-----ceEEEEecccCchHHHHHhhc----------CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEe
Confidence 76 899999999999999999755 27899999999999999999999988 9999999999999
Q ss_pred CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
|..|++||+|||.+-.+..++.- ......||+-|++||++.. +.|++.+|.||+||++|||+.|..||+
T Consensus 209 d~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 209 DKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred cccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 99999999999999888755532 2345679999999998752 679999999999999999999999998
No 311
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=99.96 E-value=3.4e-29 Score=269.39 Aligned_cols=248 Identities=26% Similarity=0.272 Sum_probs=192.2
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
.|...+.||+|+||.||+|.+..+++.||+|.+.... ......+..|++++++++|+|++++++++.... ..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-----TA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----eE
Confidence 3667889999999999999998889999999986432 223456888999999999999999999987765 78
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++||||+. |++.+.+... ...+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+|++
T Consensus 101 ~lv~e~~~-g~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~ 167 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLA 167 (317)
T ss_pred EEEEeCCC-CCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEe
Confidence 99999997 5777766432 345899999999999999999999988 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 504 (789)
|||++....... ...|+..|+|||++. .+.++.++|||||||++|||++|+.||..... ......+....
T Consensus 168 dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~ 240 (317)
T cd06635 168 DFGSASIASPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNE 240 (317)
T ss_pred cCCCccccCCcc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhcc
Confidence 999987654332 235788999999874 45689999999999999999999999863210 00111111110
Q ss_pred CCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 505 LPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 505 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
.+ .. ........+.+++.+|++.++..|++...+...+-
T Consensus 241 ~~---------~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 241 SP---------TL---------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CC---------CC---------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00 00 00122334567888999999999999887755443
No 312
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=99.96 E-value=3.8e-29 Score=264.95 Aligned_cols=253 Identities=22% Similarity=0.248 Sum_probs=201.3
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
..+++|...+.||+|++|.||+|.+..+++.|++|++..... ....+..|++.+++++|+|++++++++.... .
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD-----E 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-----E
Confidence 356788899999999999999999988899999999976544 5567889999999999999999999987765 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++|+||+.+++|.+++... ...+++..+..++.|++.||+|||..+ ++|+||+|+||+++.++.+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l 157 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQN---------FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKL 157 (286)
T ss_pred EEEEEeccCCCcHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEE
Confidence 99999999999999999654 147899999999999999999999887 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
+|||.+........ ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+..
T Consensus 158 ~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~---- 230 (286)
T cd06614 158 ADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITT---- 230 (286)
T ss_pred Cccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh----
Confidence 99999876654321 112234778999999998888999999999999999999999998632110 00111100
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
....... ....+...+.+++..|++.++..|++...+.
T Consensus 231 ~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 231 KGIPPLK-------------------------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred cCCCCCc-------------------------chhhCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 0000000 0011334566888999999999999887664
No 313
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=99.96 E-value=4.6e-29 Score=267.16 Aligned_cols=247 Identities=26% Similarity=0.263 Sum_probs=192.1
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
..|...+.||+|+||+||+|....+++.||+|.+.... ....+.+.+|+++++.++||||+++.++|.... .
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-----T 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----e
Confidence 45888899999999999999998889999999986432 223456889999999999999999999998765 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++|+||+. |++.+++... ...+++.++..++.|++.||.|||+.+ ++||||+|+||++++++.+||
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~---------~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL 156 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVH---------KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKL 156 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEE
Confidence 899999997 5777766432 245899999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 503 (789)
+|||.+....... ...++..|+|||.+. ...++.++||||||+++|||++|+.||.... .......
T Consensus 157 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-----~~~~~~~ 225 (307)
T cd06607 157 ADFGSASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYH 225 (307)
T ss_pred eecCcceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-----HHHHHHH
Confidence 9999987664332 235778999999874 4568999999999999999999999986321 1111000
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
..... .+.+. ...+...+.++...|++.++-.||++..+...
T Consensus 226 ~~~~~-----~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 226 IAQND-----SPTLS---------------------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HhcCC-----CCCCC---------------------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00000 01233456788889999999999998877543
No 314
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=99.96 E-value=4.2e-29 Score=266.29 Aligned_cols=198 Identities=25% Similarity=0.381 Sum_probs=169.0
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-----hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-----ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
+|...+.||+|++|.||+|....+++.||||.++..... ....+..|++++++++|+||+++++++....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS----- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC-----
Confidence 367788999999999999999888999999999755332 3456778999999999999999999987754
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++||||+ .|+|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+|
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDK---------SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred EEEEEEccc-CCCHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEE
Confidence 889999999 89999998643 136899999999999999999999998 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
|+|||+++........ .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.
T Consensus 143 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 143 LADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred EccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 9999999877554321 122346778999998865 457899999999999999999977775
No 315
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=99.96 E-value=3.6e-29 Score=260.32 Aligned_cols=203 Identities=27% Similarity=0.415 Sum_probs=177.5
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||+|++|.||+|....+++.|++|++..... ...+.+.+|++.+++++|+||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 46778899999999999999998899999999865543 45678999999999999999999999987652 12789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+.+++|.+++... ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|
T Consensus 78 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d 144 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF----------GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLAD 144 (260)
T ss_pred EEEEecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcc
Confidence 999999999999998644 37899999999999999999999987 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||.+................++..|+|||......++.++||||||+++|+|++|+.||..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (260)
T cd06606 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE 205 (260)
T ss_pred cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999987765432122345688899999999888899999999999999999999999974
No 316
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=99.96 E-value=3.3e-29 Score=271.89 Aligned_cols=205 Identities=26% Similarity=0.310 Sum_probs=171.9
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
.+.|...+.||+|+||+||+|....+++.||||.++.. .......+..|+++++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35788899999999999999999989999999998643 2333456778999999999999999999886554333345
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----------QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence 899999997 6888887543 46899999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||++........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..
T Consensus 150 ~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 150 CDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred CcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 99999987654321 1223457889999998765 4689999999999999999999999963
No 317
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=99.96 E-value=4e-29 Score=263.51 Aligned_cols=193 Identities=25% Similarity=0.365 Sum_probs=166.5
Q ss_pred ccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
||+|+||+||++....+++.||+|.+.... ......+..|++++++++||||+++++++...+ ..++|+||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-----DLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC-----eEEEEEecC
Confidence 689999999999998889999999986432 223455678999999999999999999987655 789999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
++++|.+++... ....+++.++..++.|++.||.|||..+ ++||||+|+||++++++.+|++|||.+..
T Consensus 76 ~~~~L~~~l~~~--------~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 76 NGGDLKYHIYNV--------GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred CCCcHHHHHHHc--------CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 999999998654 2246899999999999999999999888 99999999999999999999999999887
Q ss_pred CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
..... ......++..|+|||...+..++.++|||||||++|+|++|+.||..
T Consensus 145 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 145 LKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred hccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 64422 12234577899999999888899999999999999999999999964
No 318
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=99.96 E-value=4.6e-29 Score=264.18 Aligned_cols=199 Identities=26% Similarity=0.330 Sum_probs=171.4
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||.|++|.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-----GFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC-----eeE
Confidence 4677889999999999999998889999999987553 334567999999999999999999999987655 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+ +++|.+++... ...+++.++..++.|+++||+|||+.+ ++|+||||+||+++.++.++++|
T Consensus 76 ~v~e~~-~~~L~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~d 142 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDE---------ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIAD 142 (286)
T ss_pred EEeccc-CCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEee
Confidence 999999 99999998643 256899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
||.+........ .......++..|+|||...+.+ ++.++||||+|+++|||++|+.||.
T Consensus 143 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 143 FGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred eeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 999987765432 1122345888999999986554 6899999999999999999977775
No 319
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=99.96 E-value=2.8e-29 Score=266.26 Aligned_cols=258 Identities=22% Similarity=0.210 Sum_probs=192.1
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++|...+.||+|+||+||++....+++.||+|.+.... ......+.+|+..+.++. |+||+++++++.... ..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-----~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-----DC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-----cE
Confidence 35666789999999999999999899999999986543 344567889999999996 999999999887654 78
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcC-CCCCceecCCCCCceecCCCCceee
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHD-CQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
+++|||+.. ++.++.... .......+++.....++.+++.||+|||+. + ++||||||+||+++.++.+||
T Consensus 79 ~~~~e~~~~-~l~~l~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl 149 (288)
T cd06616 79 WICMELMDI-SLDKFYKYV-----YEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKL 149 (288)
T ss_pred EEEEecccC-CHHHHHHHH-----HHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEE
Confidence 999999874 444432110 001235689999999999999999999974 6 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCC---CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS---EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 503 (789)
+|||+++....... .....|+..|+|||.+... .++.++|||||||++|||++|+.||.... ........
T Consensus 150 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~ 222 (288)
T cd06616 150 CDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQ 222 (288)
T ss_pred eecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhh
Confidence 99999976543321 1223578899999998776 68999999999999999999999986321 11111111
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
..... .+.+.. .....+...+.+++..|++.++.+||+...+...
T Consensus 223 ~~~~~-----~~~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 223 VVKGD-----PPILSN------------------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hcCCC-----CCcCCC------------------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11100 011110 0011244567788889999999999999876543
No 320
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]
Probab=99.96 E-value=2.1e-31 Score=295.02 Aligned_cols=227 Identities=22% Similarity=0.330 Sum_probs=166.6
Q ss_pred hhccccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCc-CCC
Q 041249 549 RIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLS-SCS 627 (789)
Q Consensus 549 ~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~-~l~ 627 (789)
+....|.+++.++...+.+ ...+..+...++|+.|++..|.++ -+|....+++.|++|||..|+|. .+|..|- -+.
T Consensus 258 ~wi~~~~nle~l~~n~N~l-~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~ 334 (1081)
T KOG0618|consen 258 EWIGACANLEALNANHNRL-VALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLN 334 (1081)
T ss_pred HHHHhcccceEecccchhH-HhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhh
Confidence 4456788888888888888 466777888899999999999998 46666788999999999999998 5555443 333
Q ss_pred C-CcEEEcccCCCCCCCCc-ccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeee
Q 041249 628 N-LIRIGLAKNQLMGKIPS-DFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILY 705 (789)
Q Consensus 628 ~-L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 705 (789)
. |..|+.+.|+++ ..|. .=..++.|+.|++.+|.++...-..+.+.++|+.|+|++|+|.......+.+++.|++|+
T Consensus 335 ~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~ 413 (1081)
T KOG0618|consen 335 ASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELN 413 (1081)
T ss_pred HHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHh
Confidence 2 677777778877 4442 112345688888888888777767777778888888888888733334567788888888
Q ss_pred ccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCc
Q 041249 706 LGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNK 783 (789)
Q Consensus 706 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 783 (789)
||+|+++ .+|.++..++.|++|...+|+|. ..| ++. .+++|+.+|||.|.|+...-..-...++|++|||++|.
T Consensus 414 LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~-~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 414 LSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELA-QLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhh-hcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 8888887 67788888888888888888887 777 444 67888888888888775433232334678888888875
No 321
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.96 E-value=1.7e-29 Score=265.46 Aligned_cols=253 Identities=18% Similarity=0.204 Sum_probs=198.9
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 345 (789)
..-|.+.+.||.||.+.||++... +.+.+|+|.+... +.+....|..|++.|.+| .|.+|+++++|-...+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~----- 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG----- 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc-----
Confidence 456888999999999999999987 4556666665433 445578899999999999 5999999999977655
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..||||||-.. +|..+++.. +...+...+..+..|++.|+.++|.++ |||.||||.|+|+.. |.+|
T Consensus 434 ~lYmvmE~Gd~-DL~kiL~k~---------~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LK 499 (677)
T KOG0596|consen 434 YLYMVMECGDI-DLNKILKKK---------KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLK 499 (677)
T ss_pred eEEEEeecccc-cHHHHHHhc---------cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEE
Confidence 89999998774 999999765 233343378899999999999999999 999999999999964 7899
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCC-----------CcCccccchhhHHHHHHHHHhcCCCCccccCC
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-----------EVSTNGDVYSYGILMLELIIRKKPSDIMFEGD 494 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~ 494 (789)
|+|||+|..++.+..........||+.||+||.+... +++.++||||+||+||+|+.|++||..
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~----- 574 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ----- 574 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-----
Confidence 9999999999999888888888999999999987542 367899999999999999999999972
Q ss_pred ccHH-HHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 495 MNLH-NFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 495 ~~~~-~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
+. .|.+ +..+.||.-.=.+++ + ..-+++++++-.|...++-.|++......+
T Consensus 575 --~~n~~aK------l~aI~~P~~~Iefp~-----------~------~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 575 --IINQIAK------LHAITDPNHEIEFPD-----------I------PENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHHHHH------HHhhcCCCccccccC-----------C------CCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 23 2222 234444422111110 0 011236788899999999999999876543
No 322
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=99.96 E-value=5.3e-29 Score=264.49 Aligned_cols=245 Identities=21% Similarity=0.261 Sum_probs=193.5
Q ss_pred CCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
...||+|+||.||++....+++.||||.+..........+..|+.+++.++|+|++++++++...+ ..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-----EEEEEEecC
Confidence 357999999999999998899999999987655556677999999999999999999999987765 899999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
++++|.+++.. ..+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++++|||.+..
T Consensus 100 ~~~~L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 100 EGGALTDIVTH-----------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred CCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEccccccee
Confidence 99999998742 24788999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhcc
Q 041249 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVD 514 (789)
Q Consensus 435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d 514 (789)
....... .....|+..|+|||......++.++|||||||++|||++|+.||... .........+...+.....
T Consensus 166 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~--- 238 (292)
T cd06657 166 VSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPKLKN--- 238 (292)
T ss_pred ccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhhCCcccCC---
Confidence 6543211 22345788999999998888999999999999999999999998631 1111112222111111000
Q ss_pred CCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 515 STLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.......+.++...|.+.++.+|++...+..
T Consensus 239 -------------------------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 -------------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -------------------------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0011223456777899999999999877643
No 323
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=99.96 E-value=5.2e-29 Score=260.25 Aligned_cols=192 Identities=26% Similarity=0.346 Sum_probs=168.4
Q ss_pred ccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
||.|++|.||++....+++.||+|++.... ....+.+.+|++++++++||||+++++.+.... ..++|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-----YIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC-----ccEEEEecC
Confidence 689999999999999889999999986442 234567999999999999999999999987655 789999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
++++|.+++... ..+++..+..++.|++.||+|+|+.+ ++|+||+|+||+++.++.+||+|||.+..
T Consensus 76 ~~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 76 LGGELWTILRDR----------GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred CCCcHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 999999999643 35889999999999999999999887 99999999999999999999999999987
Q ss_pred CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
..... ......++..|+|||......++.++||||||+++|||++|+.||...
T Consensus 143 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 195 (262)
T cd05572 143 LKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195 (262)
T ss_pred cCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence 76543 112345788999999998888999999999999999999999999743
No 324
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=99.96 E-value=4.4e-30 Score=258.89 Aligned_cols=272 Identities=20% Similarity=0.267 Sum_probs=222.5
Q ss_pred HHHHHHhhcCCCCCCcccccCCccEEEEEEcCC-----ceEEEEEEeccccchh-hHHHHHHHHHHhcCCCCccceeeee
Q 041249 262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEG-----RTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFTA 335 (789)
Q Consensus 262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~ 335 (789)
.+|+....+.++....+-+|.||+||.|.|++. .+.|-+|+++.+..+. ...+..|.-.+....|||+.++.|+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 467777778888889999999999999988633 4568888887665443 4678889999999999999999999
Q ss_pred eccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCc
Q 041249 336 CSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSN 415 (789)
Q Consensus 336 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~N 415 (789)
+.+.. ...+..+.++.-|+|..|+..++ .+.+...+.++..+...++.|++.||+|||.++ +||.||.++|
T Consensus 356 ~ie~~----~~P~V~y~~~~~gNLK~FL~~Cr--~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRN 426 (563)
T KOG1024|consen 356 SIEDY----ATPFVLYPATGVGNLKSFLQICR--GDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARN 426 (563)
T ss_pred Eeecc----CcceEEEeccCcchHHHHHHHhc--cCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhc
Confidence 87643 36788999999999999998664 334456778899999999999999999999998 9999999999
Q ss_pred eecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCCccccCC
Q 041249 416 ILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSDIMFEGD 494 (789)
Q Consensus 416 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~~~~~~~ 494 (789)
.+|++..++||+|=.+++.+.+.+......+......||+||.+.+..|+..+|||||||+||||+| |+.|+.+-...
T Consensus 427 CvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf- 505 (563)
T KOG1024|consen 427 CVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF- 505 (563)
T ss_pred ceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-
Confidence 9999999999999999999988887666667778889999999999999999999999999999998 99998732110
Q ss_pred ccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccccc
Q 041249 495 MNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPH 574 (789)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~ 574 (789)
.+..+.++. -|.....+|+.++..++.-||.+.+.+||+..+...-+..
T Consensus 506 -Em~~ylkdG------------------------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 506 -EMEHYLKDG------------------------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -HHHHHHhcc------------------------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 011111111 0133455899999999999999999999999877544433
No 325
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=99.96 E-value=1.3e-28 Score=254.97 Aligned_cols=198 Identities=30% Similarity=0.431 Sum_probs=177.2
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
+|...+.||+|++|.||++....+++.|++|++..........+.+|++.+++++|++++++++.+.... ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-----ELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eEEEE
Confidence 4777899999999999999998889999999997766556678999999999999999999999987655 78999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 430 (789)
+||+++++|.+++... ...+++..+..++.+++.|++|||..+ ++||||+|+||++++++.++|+|||
T Consensus 76 ~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 76 MEFCSGGSLKDLLKST---------NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred EecCCCCcHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecc
Confidence 9999999999998643 256899999999999999999999987 9999999999999999999999999
Q ss_pred ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
.+........ .....++..|+|||+.....++.++||||||+++|+|++|+.||.
T Consensus 144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 198 (253)
T cd05122 144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS 198 (253)
T ss_pred cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9988765542 234568889999999988889999999999999999999999986
No 326
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=99.96 E-value=3.4e-29 Score=271.88 Aligned_cols=203 Identities=26% Similarity=0.371 Sum_probs=169.3
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 345 (789)
.++|...+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+++++++ +|+||++++++|.... ..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~---~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN---DK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC---Cc
Confidence 46788899999999999999999888999999988532 223345677899999999 9999999999886533 23
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++|+||+. ++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~k 147 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRA-----------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVK 147 (337)
T ss_pred eEEEEecccc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEE
Confidence 5799999998 588888742 25788899999999999999999888 99999999999999999999
Q ss_pred eCcccccccCCCCCCc---cceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHVQ---TSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+|||.+......... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999877544321 12233458889999998765 4578999999999999999999999863
No 327
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=99.96 E-value=5.5e-29 Score=267.65 Aligned_cols=208 Identities=24% Similarity=0.331 Sum_probs=171.0
Q ss_pred CCCCCCcccccCCccEEEEEEcC--CceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDE--GRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
.|...+.||+|++|.||+|.... +++.||+|.+.... ......+.+|++++++++||||+++++++.... ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA---DK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC---Cc
Confidence 36778899999999999999987 78999999997643 334567788999999999999999999997652 23
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC----C
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE----E 421 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~----~ 421 (789)
..++||||+.+ ++.+++.... ......+++..+..++.|++.||+|||+.+ ++||||||+||+++. +
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHR-----QAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPER 148 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhc-----cCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCcc
Confidence 78999999985 6666664321 112246889999999999999999999888 999999999999999 9
Q ss_pred CceeeCcccccccCCCCCC-ccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 422 MVSHVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 422 ~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
+.+|++|||++........ ........++..|+|||...+. .++.++|||||||++|||++|+.||...
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9999999999987654432 1122345678899999987664 5799999999999999999999999754
No 328
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=99.96 E-value=4.5e-29 Score=265.37 Aligned_cols=202 Identities=25% Similarity=0.343 Sum_probs=170.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++|...+.||.|++|.||+|.+..+++.||+|.++.... .....+.+|++++.+++||||+++++++.... ....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 578889999999999999999998899999999975432 22345678999999999999999999886542 2378
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++|+||+. ++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+
T Consensus 82 ~lv~e~~~-~~L~~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETM---------KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred EEEehhcC-cCHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEe
Confidence 99999998 4898888543 236899999999999999999999988 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||.+......... .....++..|+|||...+.. ++.++||||||+++|||++|+.||..
T Consensus 149 d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 149 DFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred ecCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999877654211 12344778999999887644 68999999999999999999999974
No 329
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=99.96 E-value=3.6e-29 Score=271.15 Aligned_cols=195 Identities=29% Similarity=0.358 Sum_probs=169.8
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-C-----CccceeeeeeccCCCCCC
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-H-----RNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~~ 344 (789)
.|.+.++||+|+||.|.+|.+..+++.||||+++.... ..++...|+.+|+.++ | -|+|+++++|....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~---- 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN---- 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc----
Confidence 67889999999999999999999999999999976543 3456678999999986 4 57999999998766
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC--
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-- 422 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-- 422 (789)
+.|||+|.+.. +|.++++.+ .-..++...+..++.||+.||.+||..+ |||.||||+|||+.+..
T Consensus 262 -HlciVfELL~~-NLYellK~n--------~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 262 -HLCIVFELLST-NLYELLKNN--------KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRS 328 (586)
T ss_pred -ceeeeehhhhh-hHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcC
Confidence 99999999985 999999876 3456899999999999999999999888 99999999999998654
Q ss_pred ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
.+||+|||.|.+...... ...-+..|+|||++.+.+|+.+.||||||||+.||.+|.+-|.
T Consensus 329 ~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred ceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 779999999998765442 2235678999999999999999999999999999999966654
No 330
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=99.96 E-value=8.5e-29 Score=261.09 Aligned_cols=192 Identities=23% Similarity=0.304 Sum_probs=159.1
Q ss_pred cccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHH---HHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAEC---RALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 277 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
.||+|+||.||+|....+++.||+|.+..... .....+..|. +.++...||+|+++.+++...+ ..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-----KLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----EEEEE
Confidence 48999999999999988899999999864321 1122233443 3444567999999999887665 78999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 430 (789)
+||+.+|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 76 ~e~~~g~~L~~~l~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg 142 (278)
T cd05606 76 LDLMNGGDLHYHLSQH----------GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG 142 (278)
T ss_pred EecCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999988533 46899999999999999999999888 9999999999999999999999999
Q ss_pred ccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
++........ ....|+..|+|||...++ .++.++|||||||++|||++|+.||...
T Consensus 143 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 143 LACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 9876543321 224588999999998765 5899999999999999999999999743
No 331
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=99.96 E-value=6.9e-29 Score=262.50 Aligned_cols=199 Identities=27% Similarity=0.376 Sum_probs=168.4
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
|...+.||.|++|.||+|.+..+++.||+|++.... ......+.+|++.++.++|||++++++++...+ ..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~-----~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN-----KLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC-----eEEE
Confidence 567789999999999999998899999999987543 223456888999999999999999999987655 8999
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
++||+. ++|.+++... ....+++.++..++.|+++||+|||+.+ ++||||+|+||+++.++.+||+||
T Consensus 76 v~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df 143 (283)
T cd07835 76 VFEFLD-LDLKKYMDSS--------PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADF 143 (283)
T ss_pred EEeccC-cCHHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeec
Confidence 999995 6899988654 2246899999999999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|.+......... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 144 ~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 144 GLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred ccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999865433211 1223467899999987654 478999999999999999999999864
No 332
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=99.96 E-value=9.3e-29 Score=261.83 Aligned_cols=201 Identities=25% Similarity=0.364 Sum_probs=170.0
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
|...+.||.|++|.||+|.+..+++.||+|.+.... ......+..|+++++.++|+|++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 556788999999999999999889999999997653 334567889999999999999999999987651 237899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||+.+ ++.+++... ...+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+|++||
T Consensus 78 v~e~~~~-~l~~~~~~~---------~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~ 144 (287)
T cd07840 78 VFEYMDH-DLTGLLDSP---------EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADF 144 (287)
T ss_pred Eeccccc-cHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccc
Confidence 9999984 888887543 246899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|.+......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+.
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 145 GLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred cceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999877654321 1223456788999998765 4579999999999999999999999974
No 333
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=99.96 E-value=8.3e-29 Score=257.52 Aligned_cols=252 Identities=22% Similarity=0.245 Sum_probs=200.5
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|+..+.||+|++|.||++....+++.+|+|.+... .......+.+|++.+++++|+||+++.+++.... ..+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN-----KLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC-----EEE
Confidence 477889999999999999999888999999998654 2334567788999999999999999998887654 899
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+++++|.+++... ......+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+|++|
T Consensus 76 ~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 76 IVMEYAPFGDLSKAISKR------KKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred EEehhcCCCCHHHHHHHH------HhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEee
Confidence 999999999999998643 122356899999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
||.+....... .....++..|+|||...+..++.++||||||+++|||++|+.||.... ............
T Consensus 147 ~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~ 217 (256)
T cd08530 147 LGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQDLRYKVQRGK 217 (256)
T ss_pred ccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCC
Confidence 99998876552 123457889999999988889999999999999999999999997321 111111110000
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.... .......+.++...|.+.++.+||+.......|
T Consensus 218 ~~~~---------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 218 YPPI---------------------------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred CCCC---------------------------chhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 0000 012334567888899999999999988765443
No 334
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=99.96 E-value=8.1e-29 Score=265.53 Aligned_cols=207 Identities=23% Similarity=0.341 Sum_probs=169.6
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC---CC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ---GN 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---~~ 344 (789)
++|...+.||+|+||.||+|....+++.||||.+.... ......+.+|++++++++||||++++++|...... ..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57888999999999999999999899999999986442 22234567899999999999999999998765421 12
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
...++|+||+.+ ++.+.+... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK---------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGIL 158 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcE
Confidence 346999999974 777776432 246899999999999999999999988 9999999999999999999
Q ss_pred eeCcccccccCCCCCCc--cceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 425 HVGDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+|||.+......... .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999876543321 1122345778899999886654 78999999999999999999999864
No 335
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=99.96 E-value=9.3e-29 Score=261.59 Aligned_cols=202 Identities=24% Similarity=0.374 Sum_probs=170.7
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
+|+..+.||.|++|.||+|+...+++.||||.++.... .....+.+|++++++++|+||+++++++.... ..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-----KLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-----cEEE
Confidence 57888999999999999999998899999999876533 23466788999999999999999999988765 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||+.+ ++.+++... .....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|++||
T Consensus 76 v~e~~~~-~l~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~ 144 (284)
T cd07836 76 VFEYMDK-DLKKYMDTH-------GVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADF 144 (284)
T ss_pred EEecCCc-cHHHHHHhc-------CCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeec
Confidence 9999984 888887543 11246899999999999999999999888 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
|++........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 145 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 145 GLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred chhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99986543321 11223467899999987654 4789999999999999999999999743
No 336
>PHA02882 putative serine/threonine kinase; Provisional
Probab=99.96 E-value=5.4e-29 Score=264.80 Aligned_cols=261 Identities=20% Similarity=0.233 Sum_probs=182.5
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCC---ceEEEEEEeccccchhh-----------HHHHHHHHHHhcCCCCccceeee
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEG---RTTVTVKVFNLHHHRAS-----------RSFIAECRALRSIRHRNLVKVFT 334 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~ 334 (789)
.+.|...+.||+|+||.||+|.+..+ ...+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46789999999999999999999866 66778887543322111 11233445566778999999998
Q ss_pred eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS 414 (789)
Q Consensus 335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~ 414 (789)
.+.... ......++++|+... ++.+.+... ...++..+..|+.|++.||+|||+.+ ++||||||+
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~ 155 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKLVE-NTKEIFKRI----------KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPE 155 (294)
T ss_pred eeeEec-CCceEEEEEEehhcc-CHHHHHHhh----------ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 764432 111245778887654 555554322 23467788999999999999999887 999999999
Q ss_pred ceecCCCCceeeCcccccccCCCCCC-----ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 415 NILLDEEMVSHVGDFGLARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 415 Nill~~~~~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||++.++.+||+|||+|+....... ........||..|+|||...+..++.++|||||||++|||++|+.||..
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999987653321 1112234699999999999999999999999999999999999999974
Q ss_pred cccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 490 MFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
.... .......+..+.. .+..+.+ ...++...+.++...|+++++.+||+.....
T Consensus 236 ~~~~-~~~~~~~~~~~~~---~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 236 FGHN-GNLIHAAKCDFIK---RLHEGKI---------------------KIKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred cccc-hHHHHHhHHHHHH---Hhhhhhh---------------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 3211 1111111100000 0000000 1123445677888899999999999887653
No 337
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=99.96 E-value=4e-29 Score=288.31 Aligned_cols=271 Identities=22% Similarity=0.348 Sum_probs=210.5
Q ss_pred HHHHhhcCCCCCCcccccCCccEEEEEEcC-------CceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeee
Q 041249 264 NLHNATDGFSSANLIGTGSFGSVYKGVLDE-------GRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFT 334 (789)
Q Consensus 264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~ 334 (789)
.++...++....+.+|+|.||.|++|.... ....||||+++.... ...+.+..|+++|..+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 455666777777899999999999998641 256799999976543 4567899999999999 7999999999
Q ss_pred eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCC------CCCCHHHHHHHHHHHHHHHhhhhcCCCCCcee
Q 041249 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAP------RNLNLLQRLNIAIDVASALDYLHHDCQPITTH 408 (789)
Q Consensus 335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH 408 (789)
+|.... ..++|.||+..|+|.++++..+........+ ..++....+.++.|||.||+||++.. +||
T Consensus 370 ~~t~~~-----~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vH 441 (609)
T KOG0200|consen 370 ACTQDG-----PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVH 441 (609)
T ss_pred eeccCC-----ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccc
Confidence 998744 7899999999999999998874111111111 34899999999999999999999776 999
Q ss_pred cCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecc--cccccCcccCCCCCcCccccchhhHHHHHHHHH-hcC
Q 041249 409 CDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKG--SIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKK 485 (789)
Q Consensus 409 ~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~ 485 (789)
||+-++|||+.++..+|++|||+|+...+........ -.| ...|||||.+....|+.|+|||||||+|||++| |..
T Consensus 442 RDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 442 RDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhhhhhhEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 9999999999999999999999999876655332111 112 235999999999999999999999999999998 999
Q ss_pred CCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcc
Q 041249 486 PSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESL 565 (789)
Q Consensus 486 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~ 565 (789)
||.... ...++.++.+... |......|..++.+++..|++.++.+||+.
T Consensus 521 PYp~~~-~~~~l~~~l~~G~------------------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F 569 (609)
T KOG0200|consen 521 PYPGIP-PTEELLEFLKEGN------------------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTF 569 (609)
T ss_pred CCCCCC-cHHHHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence 986311 0111122222111 122334677888899999999999999999
Q ss_pred ccccccccc
Q 041249 566 KLAGSILPH 574 (789)
Q Consensus 566 ~~~~~~l~~ 574 (789)
.+.......
T Consensus 570 ~~~~~~~~~ 578 (609)
T KOG0200|consen 570 SECVEFFEK 578 (609)
T ss_pred HHHHHHHHH
Confidence 887654443
No 338
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.96 E-value=3.1e-29 Score=268.71 Aligned_cols=203 Identities=27% Similarity=0.359 Sum_probs=178.6
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCC
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~ 344 (789)
.-...|....+||+|.|++|..|....++..||||.++...- .....+.+|+++|..++|||||+++.+.....
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~---- 128 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA---- 128 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc----
Confidence 345689999999999999999999999999999999865532 22345889999999999999999999987766
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
..++||||..+|.+++++... .+..+.....++.|+..|++|||+++ |||||||++|||++.++++
T Consensus 129 -~lylV~eya~~ge~~~yl~~~----------gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 129 -TLYLVMEYASGGELFDYLVKH----------GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNI 194 (596)
T ss_pred -eeEEEEEeccCchhHHHHHhc----------ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccce
Confidence 899999999999999999765 34455778889999999999999998 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCCcc
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
||+|||++.++.... .....+|++.|.|||+..+.+| ++++|+||+|+++|-|+.|..||+..
T Consensus 195 kIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 195 KIADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred eeeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 999999999987554 2334679999999999998876 78899999999999999999999843
No 339
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=99.96 E-value=9.4e-29 Score=263.12 Aligned_cols=209 Identities=22% Similarity=0.313 Sum_probs=171.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||.|+||.||+|.+..+++.||+|.++.... .....+.+|+++++++. |+||+++++++...+..+...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468889999999999999999998999999999865432 23467888999999995 699999999987665434445
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCcee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSH 425 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~k 425 (789)
.++||||+.+ ++.+++....+ .....+++.++..++.||++||+|||+.+ ++||||+|+||+++. ++.+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGR-----GPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcc-----cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEE
Confidence 8999999985 88888764311 11346899999999999999999999888 999999999999998 88999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++|||.++........ .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 152 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 152 IADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred EeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999998865433211 122346788999998765 4579999999999999999999999863
No 340
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=99.96 E-value=1.4e-28 Score=267.51 Aligned_cols=208 Identities=22% Similarity=0.318 Sum_probs=170.8
Q ss_pred cHHHHHHhh----cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeee
Q 041249 261 SYQNLHNAT----DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFT 334 (789)
Q Consensus 261 ~~~~~~~~~----~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~ 334 (789)
+.+|+..++ ++|...+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|++++++++||||+++++
T Consensus 2 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 81 (342)
T cd07879 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81 (342)
T ss_pred chhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhh
Confidence 445555554 78999999999999999999998889999999986432 223456889999999999999999999
Q ss_pred eeccCCC-CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCC
Q 041249 335 ACSGVDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKP 413 (789)
Q Consensus 335 ~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~ 413 (789)
++..... ......++|+||+.. ++..+.. ..+++..+..++.|++.||+|||..+ ++||||||
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp 145 (342)
T cd07879 82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG------------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKP 145 (342)
T ss_pred eecccccCCCCceEEEEeccccc-CHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 8865431 122356899999974 6665542 34788999999999999999999988 99999999
Q ss_pred CceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 414 SNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 414 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+||+++.++.+||+|||+++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 146 ~NIll~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 146 GNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred HHEEECCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999988654322 23457888999999876 4689999999999999999999999973
No 341
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=99.96 E-value=1.5e-28 Score=256.48 Aligned_cols=238 Identities=20% Similarity=0.234 Sum_probs=182.5
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHH-hcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRAL-RSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.||+|++|.||+|....+++.||+|+++.... .....+..|...+ ....|+|++++++++...+ ..++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD-----YLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC-----eEEEEE
Confidence 468999999999999988899999999864321 2223344555544 4458999999999987655 899999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||.
T Consensus 77 e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 143 (260)
T cd05611 77 EYLNGGDCASLIKTL----------GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGL 143 (260)
T ss_pred eccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeeccc
Confidence 999999999998643 45788999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhh
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMD 511 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (789)
++..... ....++..|+|||...+..++.++||||||+++|||++|..||..... ............
T Consensus 144 ~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~-- 210 (260)
T cd05611 144 SRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRRI-- 210 (260)
T ss_pred ceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhccc--
Confidence 8765431 224578899999999888899999999999999999999999963211 111111100000
Q ss_pred hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccc
Q 041249 512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLK 566 (789)
Q Consensus 512 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~ 566 (789)
... ......+...+.+++..|++.++..|++..
T Consensus 211 ----~~~------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 211 ----NWP------------------EEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred ----CCC------------------CcccccCCHHHHHHHHHHccCCHHHccCCC
Confidence 000 000112345567888999999999999764
No 342
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=99.96 E-value=2.2e-28 Score=254.39 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=201.8
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||.|++|.||++.+..+++.|++|++..... .....+.+|+++++.++|+|++++.+.+...+ ..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~-----~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG-----KLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC-----EEE
Confidence 47778899999999999999998899999999976533 55677899999999999999999999887654 889
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+++++|.+++.... .....+++.++..++.+++.||+|||+.+ ++|+||+|+||++++++.++++|
T Consensus 76 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d 146 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQK------KEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGD 146 (258)
T ss_pred EEEEecCCCcHHHHHHHhh------ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECC
Confidence 9999999999999986531 12467899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
||.+........ ......|+..|+|||......++.++||||||+++|+|++|+.||+... ..+.........
T Consensus 147 ~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~ 219 (258)
T cd08215 147 FGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQ 219 (258)
T ss_pred ccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC
Confidence 999987765431 1223458889999999988889999999999999999999999986321 222222211111
Q ss_pred hhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
... +. ..+...+.+++..|++.++..||+......
T Consensus 220 ~~~-----~~----------------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 220 YPP-----IP----------------------SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCC-----CC----------------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00 022344567888999999999999877643
No 343
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=99.96 E-value=1.5e-28 Score=263.45 Aligned_cols=203 Identities=28% Similarity=0.370 Sum_probs=169.9
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
.++|...+.||.|+||.||+|.+..+++.||+|.++.... .....+.+|++++++++|+||+++++++.... ...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence 4689999999999999999999998899999999865432 22345678999999999999999999986532 225
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++|+||+.+ +|.+++... ...+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~---------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNM---------PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred EEEEEecCCC-CHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 7999999974 788887543 256899999999999999999999998 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||.+......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 150 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 150 ADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred CccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999877543211 122335778999999865 4579999999999999999999999963
No 344
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=99.96 E-value=1.1e-28 Score=262.80 Aligned_cols=253 Identities=19% Similarity=0.205 Sum_probs=190.7
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCce
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 346 (789)
-++|...+.||+|++|.||+|.+..+++.||||.++.... .....+..|++.+.+. .|+||++++++|.... .
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-----D 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-----e
Confidence 4678889999999999999999998899999999965432 3345566777777676 5999999999997765 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCceecCCCCCceecCCCCcee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
.++||||+. +++..++... ...+++..+..++.|+++||+|||+ .+ ++||||+|+||++++++.+|
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~k 155 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRI---------QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVK 155 (296)
T ss_pred EEEEeeccC-cCHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEE
Confidence 999999986 4676666432 2468999999999999999999997 46 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCC----cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE----VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~ 501 (789)
|+|||.+......... ....++..|+|||.+.... ++.++||||||+++|||++|+.||.....+ .+..
T Consensus 156 L~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~ 228 (296)
T cd06618 156 LCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVL 228 (296)
T ss_pred ECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHH
Confidence 9999999876543321 1234778999999987553 889999999999999999999998632111 1111
Q ss_pred HHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 502 RMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 502 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
.......... +.. ...+..++.+++..|.+.++..||+...+...
T Consensus 229 ~~~~~~~~~~-----~~~--------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 229 TKILQEEPPS-----LPP--------------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHhcCCCCC-----CCC--------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111110000 000 00123456678889999999999998776443
No 345
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=99.96 E-value=2e-28 Score=258.75 Aligned_cols=272 Identities=19% Similarity=0.178 Sum_probs=192.6
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
|...+.||+|+||.||+|....+++.||+|.++... ........+|+..+.++. |+|++++++++.+.. ....++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence 556788999999999999998889999999986542 223334567899999985 999999999987651 126899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||+. |++.+++... ...+++.++..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+||
T Consensus 78 v~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 78 VFELMD-MNLYELIKGR---------KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred EEecCC-ccHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEec
Confidence 999997 5888877543 246899999999999999999999888 999999999999999 99999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
|.++........ ....++..|+|||.... ..++.++|||||||++|||++|+.||.... ......+........
T Consensus 144 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~--~~~~~~~~~~~~~~~ 218 (282)
T cd07831 144 GSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN--ELDQIAKIHDVLGTP 218 (282)
T ss_pred ccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC--HHHHHHHHHHHcCCC
Confidence 999876543321 12347889999997654 557899999999999999999999996421 112222222222111
Q ss_pred hhh---hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 509 VMD---IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 509 ~~~---~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
..+ ...+.-.... ..... ....+ ..........+.+++.+|.+.+|..|++...+..
T Consensus 219 ~~~~~~~~~~~~~~~~---~~~~~-~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 219 DAEVLKKFRKSRHMNY---NFPSK-KGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CHHHHHhhcccccccc---cCccc-ccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000 0000000000 00000 00000 0001234567789999999999999999876643
No 346
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=99.96 E-value=2.3e-30 Score=295.53 Aligned_cols=203 Identities=27% Similarity=0.397 Sum_probs=175.9
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
-++....+||.|.||.||.|...++|...|+|.++.... ...+...+|+.++..++|||+|++||+-.+.+ ..
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----kv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----KV 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----HH
Confidence 367788899999999999999999999999999976643 33467889999999999999999999976655 67
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
+|.||||.+|+|.+.+.. ++..++.....+..|++.|++|||.+| ||||||||.||+++.++.+|++
T Consensus 1310 ~IFMEyC~~GsLa~ll~~----------gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH----------GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred HHHHHHhccCcHHHHHHh----------cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEee
Confidence 899999999999999853 356777778889999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCC--CccceeeecccccccCcccCCCCC---cCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 428 DFGLARFLPPTH--VQTSSIGVKGSIGYIAPEYGLGSE---VSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 428 Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
|||.|..+.... .........||+.|||||.+.+.. -..++||||+|||+.||+||+.||...
T Consensus 1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 999999887553 223344567999999999988754 356799999999999999999999844
No 347
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=99.96 E-value=1.6e-28 Score=265.82 Aligned_cols=205 Identities=25% Similarity=0.313 Sum_probs=174.8
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||.|++|.||+|....+++.||||.+.... ....+.+.+|+++++.++|+||+++.+++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999998889999999986543 34457799999999999999999999998765433344689
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+. +++.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|
T Consensus 81 lv~e~~~-~~l~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----------QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred EEecchh-hhHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 9999998 4888888543 37899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCc-cceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 429 FGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 429 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||.+......... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~ 209 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence 9999987655311 112234578899999999887 789999999999999999999999964
No 348
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=99.96 E-value=4.5e-29 Score=245.55 Aligned_cols=207 Identities=23% Similarity=0.326 Sum_probs=175.3
Q ss_pred cHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccC
Q 041249 261 SYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGV 339 (789)
Q Consensus 261 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 339 (789)
+|.|+-+-| .+.+|+|+|+.|..+..-.+++++|||++.........+..+|++++... .|+||++++.+|.+.
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 355665555 36899999999999999999999999999877666677888999999999 599999999999877
Q ss_pred CCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249 340 DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD 419 (789)
Q Consensus 340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~ 419 (789)
. ..|+|||-|.+|.|..++.+. +-+++.+...+..+||.||.|||+.| |.|||+||+|||..
T Consensus 149 ~-----~FYLVfEKm~GGplLshI~~~----------~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 149 T-----RFYLVFEKMRGGPLLSHIQKR----------KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCE 210 (463)
T ss_pred c-----eEEEEEecccCchHHHHHHHh----------hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeec
Confidence 6 899999999999999999765 67899999999999999999999998 99999999999997
Q ss_pred CCC---ceeeCcccccccCCCCC-----CccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCC
Q 041249 420 EEM---VSHVGDFGLARFLPPTH-----VQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKP 486 (789)
Q Consensus 420 ~~~---~~kl~Dfgla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P 486 (789)
... -+||+||.+..-+.... .........|+..|||||+..- -.|+.++|.||+|||+|-|++|..|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 655 45999998877554222 1222334668999999997542 3489999999999999999999999
Q ss_pred CCcc
Q 041249 487 SDIM 490 (789)
Q Consensus 487 ~~~~ 490 (789)
|-..
T Consensus 291 FvG~ 294 (463)
T KOG0607|consen 291 FVGH 294 (463)
T ss_pred ccCc
Confidence 9643
No 349
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.96 E-value=5.8e-29 Score=258.14 Aligned_cols=201 Identities=23% Similarity=0.351 Sum_probs=175.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
.=|+.++.||+|-|..|-.|++--+|..||||++...+- .....+.+|++.|+-++|||||++|.+..... ..
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-----Kl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-----KL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc-----eE
Confidence 347788999999999999999999999999999965532 33567889999999999999999999876554 79
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC-Cceee
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-MVSHV 426 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl 426 (789)
|+|+|.-.+|+|.+|+.+. ...+++.-..+++.||+.|+.|+|... +|||||||+||.+.+. +-+||
T Consensus 93 yLiLELGD~GDl~DyImKH---------e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKL 160 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKH---------EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKL 160 (864)
T ss_pred EEEEEecCCchHHHHHHhh---------hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEe
Confidence 9999999999999999754 356888899999999999999999665 9999999999988765 68899
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcC-ccccchhhHHHHHHHHHhcCCCCcc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVS-TNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
.|||++..+.++.. ....+|+..|-|||++.+..|+ +.+||||+||+||-|++|+.||...
T Consensus 161 TDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA 222 (864)
T KOG4717|consen 161 TDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA 222 (864)
T ss_pred eeccccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence 99999998877763 2345799999999999999985 6799999999999999999999744
No 350
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=99.96 E-value=1.2e-28 Score=269.34 Aligned_cols=202 Identities=22% Similarity=0.255 Sum_probs=170.2
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCCc
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGND 345 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~~ 345 (789)
.++|...+.||+|+||.||+|....+++.||+|.+... .......+.+|+.++++++|+||+++++++..... ....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46799999999999999999999989999999998533 23334567789999999999999999998764432 2223
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++|+||+. +++.+.+.. .++..++..++.|++.||+|||..+ ++||||||+||+++.++.+|
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~------------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM------------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEE
Confidence 5799999997 478777632 2788889999999999999999988 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+|||.++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 159 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 159 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred EccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 999999987654321 2234578899999999988999999999999999999999999963
No 351
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=99.96 E-value=3e-28 Score=257.94 Aligned_cols=203 Identities=27% Similarity=0.367 Sum_probs=168.7
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcC---CCCccceeeeeeccCCCCCCce
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSI---RHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~~~~ 346 (789)
|+..+.||+|++|.||+|.+..+++.||+|+++.... .....+.+|++++.++ +|+|++++++++...+..+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999988899999999974422 2234566787776655 6999999999998776434445
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.+++|||+.+ ++.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~--------~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC--------PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eEEEehhccc-CHHHHHHHc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEE
Confidence 8999999984 888887543 2235899999999999999999999888 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||.+........ .....++..|+|||......++.++|||||||++|||++|+.||..
T Consensus 149 ~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 149 ADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred eccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 99999987754432 1223478899999999988999999999999999999999999874
No 352
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=99.96 E-value=1.7e-28 Score=264.99 Aligned_cols=202 Identities=25% Similarity=0.318 Sum_probs=170.1
Q ss_pred HHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249 264 NLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY 341 (789)
Q Consensus 264 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 341 (789)
++...+++|...+.||.|+||.||+|....+++.||+|.+... .....+.+..|++++.+++||||+++.+++....
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 82 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL- 82 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-
Confidence 4455788999999999999999999999989999999987543 2233567889999999999999999999875422
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE 421 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~ 421 (789)
...++|+||+. ++|.+++.. ..+++.....++.|+++||+|||+.+ ++||||+|+||+++++
T Consensus 83 ---~~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~ 144 (328)
T cd07856 83 ---EDIYFVTELLG-TDLHRLLTS-----------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINEN 144 (328)
T ss_pred ---CcEEEEeehhc-cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCC
Confidence 26789999985 688887743 24678888899999999999999988 9999999999999999
Q ss_pred CceeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 422 MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 422 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+.+|++|||.+....... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 145 ~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 145 CDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred CCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999988654322 12346788999998766 5689999999999999999999999964
No 353
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=99.96 E-value=2.2e-28 Score=255.60 Aligned_cols=193 Identities=26% Similarity=0.385 Sum_probs=167.2
Q ss_pred ccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
||+|+||.||++.+..+++.|++|.+..... .....+.+|++.+++++|+||+++++.+.... ..++|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK-----NLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc-----EEEEEEecC
Confidence 6899999999999998899999999865433 34567889999999999999999998876554 789999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
.+++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+|++|||++..
T Consensus 76 ~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 76 PGGDLASLLENV----------GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred CCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 999999998643 36899999999999999999999888 99999999999999999999999999886
Q ss_pred CCCCCC------ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 435 LPPTHV------QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 435 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
...... ........++..|+|||......++.++||||||+++||+++|+.||.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 554321 112233457889999999988889999999999999999999999996
No 354
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=99.95 E-value=3.2e-28 Score=257.22 Aligned_cols=275 Identities=22% Similarity=0.204 Sum_probs=198.7
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
|...+.||.|++|.||+|....+++.+++|.++.... .....+..|++++++++|+||+++++++.... ..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG-----DLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC-----CEEE
Confidence 5567889999999999999988899999999865533 34567889999999999999999999987655 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||+.+ ++.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+|++||
T Consensus 76 v~e~~~~-~l~~~l~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df 142 (283)
T cd05118 76 VFEFMDT-DLYKLIKDR---------QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADF 142 (283)
T ss_pred EEeccCC-CHHHHHHhh---------cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeee
Confidence 9999985 888877543 246899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDH 508 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 508 (789)
|.+........ ......++..|+|||...+. .++.++||||||+++|+|++|+.||..... .....-........
T Consensus 143 ~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~ 218 (283)
T cd05118 143 GLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTP 218 (283)
T ss_pred eeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCC
Confidence 99987765431 11224577889999998776 689999999999999999999999863211 11111111111111
Q ss_pred hhhhccCCcccChhhHHHhhhhhhh-hhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 509 VMDIVDSTLLNDVEDLAIISNQRQR-QIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 509 ~~~~~d~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
..+.......... .......... ........+....+.+++..|++.++..||+......
T Consensus 219 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 219 DPEVWPKFTSLAR--NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chHhcccchhhhh--hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000000000 0000000000 0000111245667889999999999999999887643
No 355
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=99.95 E-value=1.7e-28 Score=258.73 Aligned_cols=202 Identities=25% Similarity=0.424 Sum_probs=175.3
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCc
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 345 (789)
++|...+.||+|++|.||+|....+++.||+|++... .....+.+..|++++.++. |+||+++++.+...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~----- 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE----- 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc-----
Confidence 4688889999999999999999989999999998643 2333567889999999998 999999999887655
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~ 142 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKY----------GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIK 142 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEE
Confidence 789999999999999998643 36899999999999999999999988 99999999999999999999
Q ss_pred eCcccccccCCCCCCc------------------cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCC
Q 041249 426 VGDFGLARFLPPTHVQ------------------TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS 487 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~ 487 (789)
++|||++......... .......++..|+|||......++.++||||||++++++++|+.||
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 9999999876544321 1222345788999999998888999999999999999999999999
Q ss_pred Cc
Q 041249 488 DI 489 (789)
Q Consensus 488 ~~ 489 (789)
..
T Consensus 223 ~~ 224 (280)
T cd05581 223 RG 224 (280)
T ss_pred CC
Confidence 73
No 356
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=99.95 E-value=3.9e-28 Score=259.32 Aligned_cols=210 Identities=26% Similarity=0.349 Sum_probs=172.0
Q ss_pred HHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCC---
Q 041249 266 HNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVD--- 340 (789)
Q Consensus 266 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 340 (789)
+.+.++|+..+.||+|++|.||+|....+++.||+|.++... ......+..|++++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999999889999999997543 223456788999999999999999999886543
Q ss_pred --CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249 341 --YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418 (789)
Q Consensus 341 --~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill 418 (789)
.......++|+||+.+ ++...+... ...+++..+..++.|++.||+|||+.+ ++||||||+||++
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili 149 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG---------LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILL 149 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 1122368999999986 666666432 246899999999999999999999888 9999999999999
Q ss_pred CCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 419 DEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 419 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++++.+||+|||.+......... ......++..|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 150 NNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred CCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999876544321 11223457789999987654 478999999999999999999999973
No 357
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=99.95 E-value=3.3e-28 Score=264.77 Aligned_cols=209 Identities=22% Similarity=0.308 Sum_probs=173.2
Q ss_pred cHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeecc
Q 041249 261 SYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSG 338 (789)
Q Consensus 261 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 338 (789)
.-.++...+++|...+.||+|+||.||+|....+++.||+|.+.... ....+.+.+|++++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34567778899999999999999999999998889999999986432 2234567889999999999999999998764
Q ss_pred CCC-CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249 339 VDY-QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417 (789)
Q Consensus 339 ~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil 417 (789)
... ......+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ ++||||||+||+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl 152 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLA 152 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEE
Confidence 332 1222467888876 6788887742 35789999999999999999999988 999999999999
Q ss_pred cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+++++.+||+|||++....... ....++..|+|||...+ ..++.++|||||||++|||++|+.||..
T Consensus 153 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 153 VNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred EcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999988654322 23457889999998766 4688999999999999999999999863
No 358
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=99.95 E-value=1.7e-28 Score=262.86 Aligned_cols=248 Identities=26% Similarity=0.283 Sum_probs=191.0
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
+.|+..+.||+|++|.||+|....+++.||+|.+... .......+.+|+++++.++|+|++++++++.... .
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----e
Confidence 4477788999999999999999888999999998643 2233456788999999999999999999987655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++|+||+. |++.+.+... ...+++.++..++.|++.|+.|||+.+ ++||||+|+||+++.++.+|+
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~---------~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl 156 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVH---------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKL 156 (308)
T ss_pred eEEEEEccC-CCHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEE
Confidence 899999997 6887776432 245789999999999999999999887 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHH
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARM 503 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~ 503 (789)
+|||++....... ...++..|+|||.+. .+.++.++|||||||++|||++|+.||...... .....+.+.
T Consensus 157 ~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~ 229 (308)
T cd06634 157 GDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN 229 (308)
T ss_pred CCcccceeecCcc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhc
Confidence 9999988764322 245788999999874 356899999999999999999999998632100 000111110
Q ss_pred hCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 504 ALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 504 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
.. +.. ....+...+.+++.+|++..+..||+...+...+
T Consensus 230 ~~---------~~~---------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 230 ES---------PAL---------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CC---------CCc---------------------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00 000 0012234456788899999999999988765443
No 359
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=99.95 E-value=2.6e-28 Score=259.69 Aligned_cols=201 Identities=26% Similarity=0.344 Sum_probs=166.8
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++|...+.||.|++|+||+|....+++.||+|.+..... ...+.+..|++++++++|+||+++++++.... ..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-----RL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-----eE
Confidence 468888999999999999999988899999999865432 23467889999999999999999999987655 89
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCceee
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSHV 426 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl 426 (789)
++||||+. +++.+++... ....+++.....++.|++.||+|||+.+ ++|+||+|+||+++. ++.+|+
T Consensus 77 ~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl 144 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSS--------PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKL 144 (294)
T ss_pred EEEEeccc-ccHHHHHHhC--------CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEE
Confidence 99999996 5787777543 2234577888899999999999999887 999999999999985 557899
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|||++......... .....++..|+|||.+.+. .++.++|||||||++|+|+||+.||..
T Consensus 145 ~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 145 ADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred cccccccccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999866443211 1223467899999988664 579999999999999999999999964
No 360
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=99.95 E-value=4.3e-28 Score=251.76 Aligned_cols=198 Identities=30% Similarity=0.427 Sum_probs=174.8
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|...+.||+|++|.||++....+++.|++|.+..... .....+.+|++++++++|+|++++++++.... ..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-----SLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----EEE
Confidence 46778899999999999999988899999999976543 45578999999999999999999999987654 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+.+++|.+++... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.+||+|
T Consensus 76 ~v~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d 142 (254)
T cd06627 76 IILEYAENGSLRQIIKKF----------GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLAD 142 (254)
T ss_pred EEEecCCCCcHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEec
Confidence 999999999999998543 46899999999999999999999888 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
||.+......... .....++..|+|||......++.++||||||+++|+|++|+.||.
T Consensus 143 ~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~ 200 (254)
T cd06627 143 FGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY 200 (254)
T ss_pred cccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 9999987654432 223458889999999888789999999999999999999999986
No 361
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=99.95 E-value=4.1e-28 Score=257.56 Aligned_cols=199 Identities=24% Similarity=0.323 Sum_probs=167.8
Q ss_pred CCCCCCcccccCCccEEEEEEc---CCceEEEEEEecccc----chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249 271 GFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHH----HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 342 (789)
+|...+.||+|+||.||.+... .+++.||+|+++... ....+.+..|++++.++ .|+||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT-- 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--
Confidence 4677889999999999999874 368999999986432 23346788899999999 5999999998876654
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM 422 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~ 422 (789)
..++|+||+++++|.+++... ..+++.++..++.|++.||.|||..+ ++||||+|+||+++.++
T Consensus 79 ---~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 79 ---KLHLILDYINGGELFTHLSQR----------ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNG 142 (290)
T ss_pred ---eEEEEEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCC
Confidence 789999999999999998643 45788899999999999999999888 99999999999999999
Q ss_pred ceeeCcccccccCCCCCCccceeeecccccccCcccCCCC--CcCccccchhhHHHHHHHHHhcCCCC
Q 041249 423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS--EVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
++||+|||+++........ ......|+..|+|||..... .++.++||||||+++|+|++|+.||.
T Consensus 143 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred CEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 9999999999876543321 11234588899999998753 47889999999999999999999986
No 362
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.95 E-value=1.5e-29 Score=267.70 Aligned_cols=199 Identities=25% Similarity=0.361 Sum_probs=174.9
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
-|.+...||.|+||.||+|..++++...|-|++.....+....|.-||++++...||+||++++.|.... ..||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-----kLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-----KLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-----ceEEE
Confidence 3455677999999999999999888889999998888888899999999999999999999999887655 89999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 430 (789)
.|||.+|-....+..- ++.+++.++.-+++|++.||.|||+.. |+|||||+.|||++-+|.++|+|||
T Consensus 108 iEFC~GGAVDaimlEL---------~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFG 175 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLEL---------GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFG 175 (1187)
T ss_pred EeecCCchHhHHHHHh---------ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccc
Confidence 9999999998887643 578999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCccceeeecccccccCcccCCC-----CCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-----SEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
.+...... ......+.||+.|||||+... .+|+.++||||||++|.||..+.+|..
T Consensus 176 VSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh 236 (1187)
T KOG0579|consen 176 VSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH 236 (1187)
T ss_pred ccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence 87654321 122345779999999998654 469999999999999999999999976
No 363
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=99.95 E-value=3.5e-28 Score=263.29 Aligned_cols=204 Identities=23% Similarity=0.283 Sum_probs=166.6
Q ss_pred CCCCCCcccccCCccEEEEEEcCC--ceEEEEEEeccc--cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEG--RTTVTVKVFNLH--HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 345 (789)
+|...+.||+|+||.||++....+ ++.||+|.+... .....+.+.+|++++.++ .||||+++++.+.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 467788999999999999999877 889999998643 222346678899999999 5999999998754321 1223
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++++||+. ++|.+++... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSG----------QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEE
Confidence 5788889887 6898888533 56889999999999999999999988 99999999999999999999
Q ss_pred eCcccccccCCCCCCc--cceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 426 VGDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|+|||.++........ .......|+..|+|||...+ ..++.++|||||||++|+|++|+.||..
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 9999999876543321 11223458899999998765 4689999999999999999999999863
No 364
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=99.95 E-value=3.3e-28 Score=263.00 Aligned_cols=199 Identities=23% Similarity=0.283 Sum_probs=162.9
Q ss_pred Cccccc--CCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEe
Q 041249 276 NLIGTG--SFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 276 ~~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
..||.| +||+||++.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-----WLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-----ceEEEE
Confidence 356776 88999999998899999999987543 233467889999999999999999999998765 789999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+..|++.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+|++||+.
T Consensus 79 e~~~~~~l~~~l~~~--------~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~ 147 (328)
T cd08226 79 PFMAYGSANSLLKTY--------FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSH 147 (328)
T ss_pred ecccCCCHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHH
Confidence 999999999988654 2345889999999999999999999887 99999999999999999999999986
Q ss_pred cccCCCCCCc-----cceeeecccccccCcccCCCC--CcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 432 ARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGS--EVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 432 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
+......... .......++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 5433221110 011112355679999998764 4789999999999999999999999743
No 365
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=99.95 E-value=4.3e-28 Score=256.33 Aligned_cols=198 Identities=26% Similarity=0.336 Sum_probs=167.6
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
|...+.||.|++|+||+|....+++.|+||.+..... .......+|++.+.+++ |+|++++++++.... ..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~-----~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND-----ELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC-----cEEE
Confidence 5667899999999999999988899999999865432 22334567999999998 999999999987754 8899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
||||+ +|++.+++... .+..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 76 v~e~~-~~~l~~~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~ 143 (283)
T cd07830 76 VFEYM-EGNLYQLMKDR--------KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADF 143 (283)
T ss_pred EEecC-CCCHHHHHHhc--------ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeec
Confidence 99999 78999888654 2356899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|.+......... ....++..|+|||.... ..++.++||||||+++|||++|+.||..
T Consensus 144 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 144 GLAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred ccceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 999876543321 12347889999998754 4589999999999999999999999864
No 366
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=99.95 E-value=4.3e-28 Score=260.54 Aligned_cols=192 Identities=23% Similarity=0.215 Sum_probs=159.4
Q ss_pred CCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCCh
Q 041249 282 SFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSL 359 (789)
Q Consensus 282 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L 359 (789)
+++.||.++...+++.||+|+++.. .....+.+..|++.+++++|+||+++++++.... ..+++|||+.+|++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-----~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-----ELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-----eEEEEEeccCCCCH
Confidence 4556666666668999999998754 3445678999999999999999999999987655 78999999999999
Q ss_pred hhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCC
Q 041249 360 EEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439 (789)
Q Consensus 360 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 439 (789)
.+++... ....+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+|++|||.+.......
T Consensus 87 ~~~l~~~--------~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 87 EDLLKTH--------FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred HHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 9998643 2345788999999999999999999988 9999999999999999999999999887654322
Q ss_pred C-----ccceeeecccccccCcccCCCC--CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 440 V-----QTSSIGVKGSIGYIAPEYGLGS--EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 440 ~-----~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
. ........++..|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1 1122234577889999998763 588999999999999999999999974
No 367
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=99.95 E-value=9.1e-28 Score=257.75 Aligned_cols=193 Identities=30% Similarity=0.373 Sum_probs=164.3
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
|...+.||+|+||+||+|....+++.|++|.+..... .....+..|+++++.++|||++++++++.+.. ..+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-----TAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEE
Confidence 5556789999999999999988899999999864322 23356788999999999999999999988765 789
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+. |++.+++... ...+++.++..++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|
T Consensus 98 lv~e~~~-~~l~~~l~~~---------~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~d 164 (313)
T cd06633 98 LVMEYCL-GSASDLLEVH---------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLAD 164 (313)
T ss_pred EEEecCC-CCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEee
Confidence 9999996 5777776432 345899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
||.+...... ....|+..|+|||++. .+.++.++|||||||++|||++|..||.
T Consensus 165 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 165 FGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred cCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9998654322 2345788999999974 4568999999999999999999999986
No 368
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=99.95 E-value=3.7e-28 Score=264.16 Aligned_cols=205 Identities=23% Similarity=0.339 Sum_probs=168.5
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC-------
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ------- 342 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------- 342 (789)
.+|...+.||.|+||.||+|....+++.||+|.+........+.+.+|++++++++||||+++++.+......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788899999999999999999989999999999776666667889999999999999999999876543211
Q ss_pred --CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC
Q 041249 343 --GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE 420 (789)
Q Consensus 343 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~ 420 (789)
.....++|+||+. ++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~ 149 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT 149 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence 1125789999998 588887742 35788999999999999999999988 999999999999984
Q ss_pred -CCceeeCcccccccCCCCCCc-cceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 421 -EMVSHVGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 421 -~~~~kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++.+|++|||.++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 567899999999866433211 11122357889999997654 4588999999999999999999999963
No 369
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=99.95 E-value=9.5e-29 Score=229.50 Aligned_cols=221 Identities=24% Similarity=0.286 Sum_probs=179.6
Q ss_pred HHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249 265 LHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 265 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 342 (789)
++...++......||.|++|.|-+-++..+|+..|+|.++.. ..+.+++...|+++..+- .+|.+|.+||......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-- 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG-- 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--
Confidence 556667777788999999999999999999999999999755 345567778888877666 7999999999865544
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM 422 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~ 422 (789)
..|+.||.|.. ++..+-.+. ...+..+++.-.-+||..|..||.|||++- .++|||+||+|||++.++
T Consensus 119 ---dvwIcME~M~t-Sldkfy~~v------~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~G 186 (282)
T KOG0984|consen 119 ---DVWICMELMDT-SLDKFYRKV------LKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDG 186 (282)
T ss_pred ---cEEEeHHHhhh-hHHHHHHHH------HhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCC
Confidence 79999999985 666655322 234677888999999999999999999864 599999999999999999
Q ss_pred ceeeCcccccccCCCCCCccceeeecccccccCcccCCC----CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHH
Q 041249 423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG----SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLH 498 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~ 498 (789)
++|++|||.+..+.++.. .+...|-..|||||.+.. ..|+.|+||||+|+++.||.+++.||+.......-+.
T Consensus 187 qVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk 263 (282)
T KOG0984|consen 187 QVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK 263 (282)
T ss_pred cEEEcccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence 999999999988876542 233458889999998764 3589999999999999999999999986544444444
Q ss_pred HHHH
Q 041249 499 NFAR 502 (789)
Q Consensus 499 ~~~~ 502 (789)
+.+.
T Consensus 264 qvVe 267 (282)
T KOG0984|consen 264 QVVE 267 (282)
T ss_pred HHhc
Confidence 4433
No 370
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=99.95 E-value=6.9e-28 Score=261.45 Aligned_cols=201 Identities=23% Similarity=0.313 Sum_probs=166.3
Q ss_pred cCCC-CCCcccccCCccEEEEEEcCCceEEEEEEeccccchh--------------hHHHHHHHHHHhcCCCCccceeee
Q 041249 270 DGFS-SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--------------SRSFIAECRALRSIRHRNLVKVFT 334 (789)
Q Consensus 270 ~~f~-~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~ 334 (789)
+.|. ..+.||.|+||+||+|....+++.||||.++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 3577999999999999998889999999986442221 125778999999999999999999
Q ss_pred eeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCC
Q 041249 335 ACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPS 414 (789)
Q Consensus 335 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~ 414 (789)
++.... ..++||||+. |++.+++... ..+++.....++.|++.||+|||..+ ++|+||+|+
T Consensus 88 ~~~~~~-----~~~lv~e~~~-~~l~~~l~~~----------~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~ 148 (335)
T PTZ00024 88 VYVEGD-----FINLVMDIMA-SDLKKVVDRK----------IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPA 148 (335)
T ss_pred EEecCC-----cEEEEEeccc-cCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHH
Confidence 987655 7899999997 6899888543 45889999999999999999999888 999999999
Q ss_pred ceecCCCCceeeCcccccccCCCCCC------------ccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHH
Q 041249 415 NILLDEEMVSHVGDFGLARFLPPTHV------------QTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELI 481 (789)
Q Consensus 415 Nill~~~~~~kl~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~ell 481 (789)
||+++.++.+|++|||.+.....+.. ........++..|+|||.+.+. .++.++|||||||++|||+
T Consensus 149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 228 (335)
T PTZ00024 149 NIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228 (335)
T ss_pred HeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999987652210 0111223467889999998764 4799999999999999999
Q ss_pred HhcCCCCc
Q 041249 482 IRKKPSDI 489 (789)
Q Consensus 482 tG~~P~~~ 489 (789)
+|+.||..
T Consensus 229 tg~~p~~~ 236 (335)
T PTZ00024 229 TGKPLFPG 236 (335)
T ss_pred hCCCCCCC
Confidence 99999974
No 371
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=99.95 E-value=6.7e-29 Score=243.66 Aligned_cols=207 Identities=25% Similarity=0.330 Sum_probs=174.7
Q ss_pred cCCCCCCcccccCCccEEEEEEcCC----ceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEG----RTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
..|.....||.|.||.||+|.-.++ .+.+|||.++..++ ......-+|++.++.++|||++.+..++...+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d--- 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD--- 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC---
Confidence 4678888999999999999976533 34789999976643 23566788999999999999999999987643
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC--
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-- 421 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-- 421 (789)
...++++||.+. +|.+.++-.+. ...+.++......|+.||+.|+.|||++. |+||||||+|||+..+
T Consensus 101 -~~v~l~fdYAEh-DL~~II~fHr~-----~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgp 170 (438)
T KOG0666|consen 101 -KKVWLLFDYAEH-DLWHIIKFHRA-----SKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGP 170 (438)
T ss_pred -ceEEEEehhhhh-hHHHHHHHhcc-----chhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCC
Confidence 378999999997 78888765422 23467899999999999999999999999 9999999999999877
Q ss_pred --CceeeCcccccccCCCCCC-ccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 422 --MVSHVGDFGLARFLPPTHV-QTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 422 --~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|.+||+|+|+++.+...-. -.....+.-|+.|+|||.+.+.+ ||...||||.||+..||+|-++-|..
T Consensus 171 erG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 171 ERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 8999999999999876653 33455677899999999999876 99999999999999999999988864
No 372
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=99.95 E-value=6.2e-28 Score=255.95 Aligned_cols=199 Identities=25% Similarity=0.339 Sum_probs=167.4
Q ss_pred CCCCCCcccccCCccEEEEEEc---CCceEEEEEEecccc----chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249 271 GFSSANLIGTGSFGSVYKGVLD---EGRTTVTVKVFNLHH----HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 342 (789)
+|...+.||+|++|.||++... .+++.||||+++... ....+.+..|++++.++ .|+||+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~-- 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT-- 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--
Confidence 4677889999999999999864 356889999986432 23346688999999999 5999999998876655
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM 422 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~ 422 (789)
..++||||+.+|+|.+++... ..+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++
T Consensus 79 ---~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 79 ---KLHLILDYVNGGELFTHLYQR----------EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEG 142 (288)
T ss_pred ---EEEEEEecCCCCcHHHHHhhc----------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCC
Confidence 789999999999999988543 45788999999999999999999887 99999999999999999
Q ss_pred ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC--cCccccchhhHHHHHHHHHhcCCCC
Q 041249 423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE--VSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
.++++|||+++........ ......|+..|+|||...+.. .+.++||||||+++|||++|..||.
T Consensus 143 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred CEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 9999999998876543321 122345888999999987665 7899999999999999999999986
No 373
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=99.95 E-value=9.9e-29 Score=257.02 Aligned_cols=194 Identities=26% Similarity=0.381 Sum_probs=171.1
Q ss_pred CCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEee
Q 041249 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYE 352 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 352 (789)
.+++|+|-||+||-|.++.+|+.||||++... .......+++|++++.++.||.||.+-.-|...+ ..+.|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-----rvFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-----RVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-----eEEEEeh
Confidence 68999999999999999999999999999644 2334578999999999999999999988887666 8899999
Q ss_pred ccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC---CCceeeCcc
Q 041249 353 FMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE---EMVSHVGDF 429 (789)
Q Consensus 353 ~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df 429 (789)
-+.+.-|+-.+.. ...++++.....++.||+.||.|||..+ |||.||||+|||+.. -..+||+||
T Consensus 644 Kl~GDMLEMILSs---------EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 644 KLHGDMLEMILSS---------EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred hhcchHHHHHHHh---------hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccc
Confidence 9986555555543 4577999999999999999999999998 999999999999953 358899999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
|.|++++.... ...+.||+.|.|||++.+..|...-|+||.||++|.-++|.-||.
T Consensus 712 GfARiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 712 GFARIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred cceeecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 99999987763 345789999999999999999999999999999999999999996
No 374
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=99.95 E-value=6.5e-28 Score=258.66 Aligned_cols=208 Identities=23% Similarity=0.329 Sum_probs=169.4
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc--hhhHHHHHHHHHHhcCCCCccceeeeeeccCCC---CC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH--RASRSFIAECRALRSIRHRNLVKVFTACSGVDY---QG 343 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---~~ 343 (789)
.++|...+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++|+||+++++.+..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4789999999999999999999998899999999865432 223467789999999999999999988755431 11
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV 423 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 423 (789)
....++|+||+.. ++...+... ...+++.++..++.|+++||+|||+.+ ++|+||||+||++++++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---------~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---------SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGI 153 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 2357999999885 666666432 346899999999999999999999988 999999999999999999
Q ss_pred eeeCcccccccCCCCCCc---------cceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 424 SHVGDFGLARFLPPTHVQ---------TSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|++|||+++........ .......++..|+|||..... .++.++|||||||++|||++|+.||..
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 999999999876543311 111234567889999987654 589999999999999999999999864
No 375
>PHA03210 serine/threonine kinase US3; Provisional
Probab=99.95 E-value=4.8e-28 Score=275.27 Aligned_cols=204 Identities=20% Similarity=0.259 Sum_probs=158.1
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCce-EEEEEE--------------ec---cccchhhHHHHHHHHHHhcCCCCccc
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRT-TVTVKV--------------FN---LHHHRASRSFIAECRALRSIRHRNLV 330 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~-~vavK~--------------~~---~~~~~~~~~~~~e~~~l~~l~h~niv 330 (789)
.++|...+.||+|+||+||++.++.... .+++|. +. .........+.+|++++++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999988753322 122221 10 01122345688999999999999999
Q ss_pred eeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecC
Q 041249 331 KVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCD 410 (789)
Q Consensus 331 ~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~d 410 (789)
++++++...+ ..++|+|++. +++.+++..... .........+...|+.|++.||+|||+.+ |||||
T Consensus 227 ~l~~~~~~~~-----~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrD 292 (501)
T PHA03210 227 KIEEILRSEA-----NTYMITQKYD-FDLYSFMYDEAF-----DWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRD 292 (501)
T ss_pred cEeEEEEECC-----eeEEEEeccc-cCHHHHHhhccc-----cccccccHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9999987765 7899999886 577777653311 11122345667889999999999999988 99999
Q ss_pred CCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCC
Q 041249 411 LKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPS 487 (789)
Q Consensus 411 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~ 487 (789)
|||+|||++.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 293 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 293 IKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999877543321 122356899999999999989999999999999999999987543
No 376
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=99.95 E-value=7.3e-28 Score=261.94 Aligned_cols=202 Identities=24% Similarity=0.320 Sum_probs=169.7
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QGN 344 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~~ 344 (789)
.+++|...+.||+|++|.||+|....+++.||+|++... .......+.+|++++++++|+|++++.+++...+. ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 357899999999999999999999988999999998643 22334567789999999999999999987765442 222
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
...++|+||+. ++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 93 ~~~~lv~e~~~-~~L~~~~~~-----------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 93 QDVYLVTHLMG-ADLNNIVKC-----------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred ccEEEEEecCC-CCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence 34899999984 689888843 35899999999999999999999988 9999999999999999999
Q ss_pred eeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 425 HVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+|||.+....... ....++..|+|||.... ..++.++|||||||++||+++|+.||..
T Consensus 158 kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 158 KILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred EEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999998764331 22357888999998765 3678999999999999999999999963
No 377
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=99.95 E-value=1.4e-27 Score=249.15 Aligned_cols=250 Identities=19% Similarity=0.216 Sum_probs=190.4
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-----cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-----HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
|...+.||+|+||.||++.+...+..+++|+++.. .......+..|+.++++++||||+++++++.... .
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 76 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-----A 76 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-----c
Confidence 67788999999999999999877777777776432 2223445778999999999999999999987655 7
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++|+||+.+++|.+++... ......+++.++..++.|++.|+.|||+.+ ++|+||+|+||++++ ..+|+
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l 146 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEEL------KHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKI 146 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHH------hhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEee
Confidence 89999999999999888542 112356899999999999999999999888 999999999999976 56999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
+|||.++....... ......|+..|+|||......++.++||||||+++|+|++|..||... ...........
T Consensus 147 ~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~~~~ 219 (260)
T cd08222 147 GDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLRIVE 219 (260)
T ss_pred cccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHHc
Confidence 99999887644321 122345788999999988888899999999999999999999998632 11122111111
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
. ..+.. ...+..++.+++.+|++.++-.||+......
T Consensus 220 ~-----~~~~~----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 G-----PTPSL----------------------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C-----CCCCC----------------------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0 01111 0123345667888999999999998876643
No 378
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=99.95 E-value=1.6e-27 Score=251.72 Aligned_cols=198 Identities=28% Similarity=0.380 Sum_probs=170.2
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
|+..+.||.|++|.||+|+...+++.||+|++.... ....+.+..|++++++++|+|++++++++.... ..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER-----KLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC-----ceEE
Confidence 456788999999999999999889999999997653 334567888999999999999999999987654 7899
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
|+||+. ++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+||
T Consensus 76 v~e~~~-~~l~~~i~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~ 142 (282)
T cd07829 76 VFEYCD-MDLKKYLDKR---------PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADF 142 (282)
T ss_pred EecCcC-cCHHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecC
Confidence 999998 5899998643 146899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|.++........ .....++..|+|||..... .++.++|||||||++||+++|+.||..
T Consensus 143 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 143 GLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred CcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999876544321 1223456789999998776 789999999999999999999999863
No 379
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=99.95 E-value=2.1e-27 Score=258.19 Aligned_cols=203 Identities=23% Similarity=0.302 Sum_probs=169.8
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCC-CC
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDY-QG 343 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~ 343 (789)
...++|...+.||+|+||.||+|....+++.||||.+.... ......+..|++++++++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999998899999999985432 2234568899999999999999999998865431 12
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV 423 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 423 (789)
....++|+||+ ++++.+++.. ..+++.++..++.|++.||+|||..+ |+||||||+||+++.++.
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~ 156 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCE 156 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence 23468999998 5688887742 35789999999999999999999888 999999999999999999
Q ss_pred eeeCcccccccCCCCCCccceeeecccccccCcccCCC-CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 424 SHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG-SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+|++|||.+....... ....++..|+|||.+.+ ..++.++||||||+++|++++|+.||..
T Consensus 157 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 157 LKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred EEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998654332 23457889999998876 4589999999999999999999999973
No 380
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=99.95 E-value=2.7e-27 Score=245.33 Aligned_cols=192 Identities=29% Similarity=0.360 Sum_probs=167.6
Q ss_pred ccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
||.|++|.||++....+++.+|+|.++.... .....+..|++++++++|+||+++++.+.... ..++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE-----KLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC-----eeEEEEecC
Confidence 6899999999999988899999999865432 24567899999999999999999999887655 899999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
.+++|.+++... ..+++.....++.|++.|+.|+|+.+ ++|+||+|+||+++.++.++++|||.+..
T Consensus 76 ~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 76 PGGELFSHLSKE----------GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred CCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCccee
Confidence 999999998643 35899999999999999999999887 99999999999999999999999999987
Q ss_pred CCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
...... ......++..|+|||.......+.++||||||+++||+++|+.||..
T Consensus 143 ~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 143 LSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred cccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 654321 12345578899999999888899999999999999999999999963
No 381
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=99.95 E-value=2.3e-28 Score=235.91 Aligned_cols=250 Identities=19% Similarity=0.188 Sum_probs=189.9
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccc-cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH-HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
......||.|.-|.|++++++.+++..|||..... ..+..+++...++++.+- ..|.||+-+|+|.... ..++
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~I 168 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVFI 168 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHHH
Confidence 34456799999999999999999999999998644 445566777777777666 4899999999997655 6788
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
.||.|.. =++.++.. ..+.+++.-.-++..-+.+||.||.+.. .|+|||+||+|||+|+.+++|++||
T Consensus 169 cMelMs~-C~ekLlkr---------ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKR---------IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred HHHHHHH-HHHHHHHH---------hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecc
Confidence 8998863 23333321 2355788888899999999999998865 4999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
|++..+-++.. .+...|-+.|||||-+.- .+|+.++||||||++++||.||+.||....-+...+..... ..
T Consensus 237 GIsGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~e- 311 (391)
T KOG0983|consen 237 GISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EE- 311 (391)
T ss_pred cccceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cC-
Confidence 99988766553 344568899999998864 46999999999999999999999999753323222222222 11
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGS 570 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~ 570 (789)
.|.+++.. .+.....+....|...+.-+||.......
T Consensus 312 -------PP~L~~~~--------------------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 312 -------PPLLPGHM--------------------GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -------CCCCCccc--------------------CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 13333211 23445667788999999999998876644
No 382
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=99.95 E-value=3.4e-28 Score=237.77 Aligned_cols=203 Identities=23% Similarity=0.283 Sum_probs=171.8
Q ss_pred hhcCCCCC-CcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249 268 ATDGFSSA-NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 268 ~~~~f~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 345 (789)
-|++|++. ++||-|-.|.|-.+..+.+++.+|+|++.+. ...++|++..=.. .|||||.+++++... +.+..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence 36777764 5899999999999999999999999998644 3456777766555 699999999998654 34555
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---C
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---M 422 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~---~ 422 (789)
-..+|||.|++|.|...+.+. ..+.+++.+...|..||+.|+.|||+.+ |+||||||+|+|.... -
T Consensus 133 cLLiVmE~meGGeLfsriq~~--------g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR--------GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred eeEeeeecccchHHHHHHHHc--------ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCc
Confidence 678999999999999999765 5678999999999999999999999998 9999999999999643 4
Q ss_pred ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
..||+|||.|+...... .....+=|+.|.|||++-..+|+..+|+||+||++|-|++|.+||+..
T Consensus 202 ~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred ceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 67999999999865432 223355688999999999999999999999999999999999999743
No 383
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=99.95 E-value=1.7e-29 Score=242.97 Aligned_cols=253 Identities=23% Similarity=0.246 Sum_probs=188.0
Q ss_pred CCCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEEEe
Q 041249 274 SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 274 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
....||.|.||+|++-.++..|+..|||.++.... ..++++..|.+...+- +.||||++||.+..+. ..|+.|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-----dcWiCM 142 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-----DCWICM 142 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-----ceeeeH
Confidence 34579999999999999999999999999986644 5567788888865555 7999999999987766 899999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
|.|.- ++..+-+.. -......+++.-.-+|..-...||.||...- .|+|||+||+|||++..|.+||+|||+
T Consensus 143 ELMd~-SlDklYk~v-----y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRV-----YSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred HHHhh-hHHHHHHHH-----HHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccc
Confidence 99985 544433211 0012346778878888888999999997643 599999999999999999999999999
Q ss_pred cccCCCCCCccceeeecccccccCcccCCCC--CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCch
Q 041249 432 ARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS--EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHV 509 (789)
Q Consensus 432 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 509 (789)
+..+..+. ..+...|-.+|||||-+... .|+.++||||+|++|||+.||+-|+..... .+.+..+-.
T Consensus 215 cGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv----- 283 (361)
T KOG1006|consen 215 CGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVV----- 283 (361)
T ss_pred hHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHH-----
Confidence 88765543 23445688999999988653 399999999999999999999999863211 112221111
Q ss_pred hhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249 510 MDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA 568 (789)
Q Consensus 510 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~ 568 (789)
.-||.+... ..+-.+....+...+..|.-.+.-+||.....
T Consensus 284 --~gdpp~l~~----------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~L 324 (361)
T KOG1006|consen 284 --IGDPPILLF----------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDL 324 (361)
T ss_pred --cCCCCeecC----------------cccccccCHHHHHHHHHHhhcccccCcchhhh
Confidence 112211111 11112345667788889999999898887654
No 384
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]
Probab=99.95 E-value=2e-30 Score=287.31 Aligned_cols=224 Identities=25% Similarity=0.359 Sum_probs=187.1
Q ss_pred ceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEc
Q 041249 555 QKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGL 634 (789)
Q Consensus 555 ~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l 634 (789)
.++..+++..+...... +.+..+.+|+.|+..+|+++ .+|..+....+|+.|++.+|.++ -+|....+++.|++|+|
T Consensus 241 ~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 34556666666666544 78888999999999999997 78888889999999999999998 77888888999999999
Q ss_pred ccCCCCCCCCccc-CCCC-CCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcccc
Q 041249 635 AKNQLMGKIPSDF-GSLS-KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLS 712 (789)
Q Consensus 635 ~~N~l~~~~~~~~-~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 712 (789)
..|+|. ..|+.| .-+. .|..|+.+.|++.......=..++.|+.|++.+|.++...-..+.+.++|++|+|++|+|.
T Consensus 318 ~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 318 QSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred hhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 999998 566544 3333 3888888999887333212234678999999999999887778999999999999999999
Q ss_pred ccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249 713 GIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786 (789)
Q Consensus 713 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 786 (789)
......+.++..|++|+||+|+++ .+|..+. +++.|+.|...+|+|. ..| .+..++.|+.+|++.|.++-
T Consensus 397 ~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva-~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 397 SFPASKLRKLEELEELNLSGNKLT-TLPDTVA-NLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred cCCHHHHhchHHhHHHhcccchhh-hhhHHHH-hhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence 555567789999999999999999 9998887 8999999999999999 567 88999999999999999874
No 385
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=99.94 E-value=2e-27 Score=215.59 Aligned_cols=198 Identities=24% Similarity=0.370 Sum_probs=169.6
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+|+..++||+|.||+||+|+..++++.||+|.++... ........+|+.+++.++|+|||++++...+.. ...
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk-----klt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc-----eeE
Confidence 4666789999999999999999999999999997653 344677899999999999999999999877655 889
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+|+||+.. +|..+.... ...++......++.|+++|+.|+|++. +.|||+||.|.+|+.+++.|++|
T Consensus 78 lvfe~cdq-dlkkyfdsl---------ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelklad 144 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSL---------NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLAD 144 (292)
T ss_pred EeHHHhhH-HHHHHHHhc---------CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecc
Confidence 99999985 788887644 356788889999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHH-hcCCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELII-RKKPSD 488 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~ellt-G~~P~~ 488 (789)
||+++..+-+.. ......-|..|.+|+.+.+.+ |++..|+||-||++.|+.- |++-|.
T Consensus 145 fglarafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 145 FGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred cchhhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 999998765431 122345788999999999876 8999999999999999997 554443
No 386
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=99.94 E-value=2.9e-27 Score=261.31 Aligned_cols=270 Identities=21% Similarity=0.209 Sum_probs=212.7
Q ss_pred cccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeec
Q 041249 259 NLSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACS 337 (789)
Q Consensus 259 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 337 (789)
.+.++.+..-++.|.+.++||+|.+|.||+++...+++.+|+|+..... ....+.+.|..++..+ .|||++.++|++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 4445556667889999999999999999999999999999999986554 3346788899999998 6999999999998
Q ss_pred cCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249 338 GVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417 (789)
Q Consensus 338 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil 417 (789)
-.+....+..|+|||||.+|+..++++.. .+.++.|..+.-|+++++.|+.|||... ++|||+|=.|||
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~--------~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiL 155 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNT--------KGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVL 155 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhh--------cccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEE
Confidence 88877788899999999999999999876 2678999999999999999999999887 999999999999
Q ss_pred cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC-----CcCccccchhhHHHHHHHHHhcCCCCcccc
Q 041249 418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS-----EVSTNGDVYSYGILMLELIIRKKPSDIMFE 492 (789)
Q Consensus 418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DV~sfGvvl~elltG~~P~~~~~~ 492 (789)
+++++.+|+.|||.+.-....- ....-..||+.|||||++... .|+.++|+||+|++..||.-|.+|+.+...
T Consensus 156 LT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 156 LTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred EeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 9999999999999988654322 112234599999999998764 478899999999999999999999974322
Q ss_pred CCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCccccccccc
Q 041249 493 GDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSIL 572 (789)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l 572 (789)
- ...+. +...-.|.+. ....-..++.+.+..|...+...||.......++
T Consensus 234 m----raLF~------IpRNPPPkLk--------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 234 M----RALFL------IPRNPPPKLK--------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred h----hhhcc------CCCCCCcccc--------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 1 01100 0011111111 1112234556777888888888888887665543
No 387
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=99.94 E-value=7.6e-28 Score=273.97 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=188.9
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCC---
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQ--- 342 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--- 342 (789)
+.-++|...+.||+||||.||+++.+-+|+.+|||.+.... ........+|+..+++++|||||+|+....+....
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45578889999999999999999999999999999997664 33346688899999999999999998764332200
Q ss_pred ----------------------------------------------------------C---------------------
Q 041249 343 ----------------------------------------------------------G--------------------- 343 (789)
Q Consensus 343 ----------------------------------------------------------~--------------------- 343 (789)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ------------------------C--------ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHH
Q 041249 344 ------------------------N--------DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDV 391 (789)
Q Consensus 344 ------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~i 391 (789)
. ...||=||||+.-++++++..++... ......+++++|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---------~~d~~wrLFreI 706 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---------QRDEAWRLFREI 706 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---------hhHHHHHHHHHH
Confidence 0 12466678888877777776552111 244567899999
Q ss_pred HHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCC-----------CC-----CCccceeeecccccccC
Q 041249 392 ASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP-----------PT-----HVQTSSIGVKGSIGYIA 455 (789)
Q Consensus 392 a~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~-----------~~-----~~~~~~~~~~gt~~y~a 455 (789)
++||+|+|++| ||||||||.|||++++..+||+|||+|.... +. ......+...||..|+|
T Consensus 707 lEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 707 LEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 99999999998 9999999999999999999999999999821 00 01223456779999999
Q ss_pred cccCCCC---CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhh
Q 041249 456 PEYGLGS---EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQ 532 (789)
Q Consensus 456 PE~~~~~---~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 532 (789)
||.+.+. +|+.|+|+||+|||++||+. ||...++....+.+..+..+|.. .+..|+...
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~~-------------- 845 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPEHP-------------- 845 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccccch--------------
Confidence 9998764 49999999999999999985 46655554444444433333332 222333222
Q ss_pred hhhhhchhHHHHHHHHhhccccceeeEeccCccccc
Q 041249 533 RQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLA 568 (789)
Q Consensus 533 ~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~ 568 (789)
.-..++.+..+-+|-+||+..+.
T Consensus 846 -------------~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 846 -------------EEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred -------------HHHHHHHHHhcCCCccCCCHHHH
Confidence 11244556667788888887654
No 388
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=99.94 E-value=4.8e-27 Score=275.31 Aligned_cols=146 Identities=28% Similarity=0.397 Sum_probs=130.4
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
++|...+.||+|+||+||+|.+..+++.||||+++... ......+..|+++++.++|+||+++++.+.... .
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-----~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN-----N 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-----E
Confidence 57888999999999999999999899999999986442 223467889999999999999999998887655 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.++||||+.+++|.+++... ..+++..+..|+.||+.||+|||..+ ||||||||+|||++.++++||
T Consensus 79 ~~lVmEy~~g~~L~~li~~~----------~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL 145 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIY----------GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKL 145 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEE
Confidence 99999999999999998643 35788889999999999999999987 999999999999999999999
Q ss_pred Ccccccc
Q 041249 427 GDFGLAR 433 (789)
Q Consensus 427 ~Dfgla~ 433 (789)
+|||+++
T Consensus 146 ~DFGls~ 152 (669)
T cd05610 146 TDFGLSK 152 (669)
T ss_pred EeCCCCc
Confidence 9999986
No 389
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.94 E-value=6.6e-28 Score=244.32 Aligned_cols=203 Identities=23% Similarity=0.294 Sum_probs=172.2
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCC
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 342 (789)
+...+|....+||+|+||.|-.|.-+.+.+.+|||+++..- ..+.+-...|-++++-- +-|.++++-..++..+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD-- 423 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD-- 423 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh--
Confidence 34458999999999999999999999889999999997552 22222344566677666 5677888777777766
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM 422 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~ 422 (789)
..++||||+.+|+|--.++.. ..+.+..+..+|++||-||-+||+.+ |++||||-.|||++.++
T Consensus 424 ---RLyFVMEyvnGGDLMyhiQQ~----------GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eG 487 (683)
T KOG0696|consen 424 ---RLYFVMEYVNGGDLMYHIQQV----------GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEG 487 (683)
T ss_pred ---heeeEEEEecCchhhhHHHHh----------cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCC
Confidence 899999999999999988765 45677889999999999999999998 99999999999999999
Q ss_pred ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 423 VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 423 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
++||+|||+++.--.+. ..+...+||+-|+|||++...+|+..+|.|||||+||||+.|++||+.
T Consensus 488 HiKi~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 488 HIKIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred ceEeeecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999998654333 234457899999999999999999999999999999999999999984
No 390
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.94 E-value=2e-27 Score=256.26 Aligned_cols=243 Identities=21% Similarity=0.182 Sum_probs=192.4
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++.|.....+|.|+|+.|..+....+++..++|++... .....+|+.++... .||||+++.+.+.+.. +.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~-----~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGK-----EI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCc-----ee
Confidence 56788888899999999999999999999999999655 23345677676666 7999999999987766 89
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec-CCCCceee
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL-DEEMVSHV 426 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl 426 (789)
++|||.+.+|-+.+.+... +.+. .++..|+.+++.|+.|||.+| +||||+||+|||+ +..++++|
T Consensus 392 ~~v~e~l~g~ell~ri~~~----------~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrl 457 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSK----------PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRL 457 (612)
T ss_pred eeeehhccccHHHHHHHhc----------chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEE
Confidence 9999999999887777543 2233 778899999999999999998 9999999999999 69999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCC
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALP 506 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~ 506 (789)
+|||.++....+ ....+=|..|.|||.+....|++.+||||||++||+|++|+.||.....+ .+.......
T Consensus 458 tyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~ 528 (612)
T KOG0603|consen 458 TYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQM 528 (612)
T ss_pred EEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcC
Confidence 999999988766 22344678999999999889999999999999999999999999743332 111111111
Q ss_pred CchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 507 DHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 507 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
..+.+ .-.....++...+.+++|..|+++.....++-
T Consensus 529 ~~~s~------------------------------~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 529 PKFSE------------------------------CVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred Ccccc------------------------------ccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 11111 11223346677899999999999998866543
No 391
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=99.94 E-value=9e-27 Score=239.53 Aligned_cols=180 Identities=23% Similarity=0.201 Sum_probs=154.1
Q ss_pred cCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChh
Q 041249 281 GSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLE 360 (789)
Q Consensus 281 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 360 (789)
|.+|.||++....+++.||+|.++... .+..|...+....||||+++++++...+ ..++||||+.+|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED-----SVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC-----eEEEEEecCCCCCHH
Confidence 889999999999999999999986543 2334555555667999999999987655 889999999999999
Q ss_pred hhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCC
Q 041249 361 EWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440 (789)
Q Consensus 361 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 440 (789)
+++... ..+++..+..++.|++.||+|||..+ ++||||||+||+++.++.++++|||.+.......
T Consensus 74 ~~l~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~- 139 (237)
T cd05576 74 SHISKF----------LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC- 139 (237)
T ss_pred HHHHHh----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-
Confidence 998543 35899999999999999999999887 9999999999999999999999999876654322
Q ss_pred ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 441 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
....++..|+|||......++.++||||+|+++|||++|+.|+.
T Consensus 140 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 140 ----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred ----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 12345678999999988889999999999999999999998875
No 392
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=99.94 E-value=2.3e-27 Score=242.20 Aligned_cols=204 Identities=25% Similarity=0.392 Sum_probs=170.7
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccc-------hhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-------RASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
.|-...++|.|||++||+|.+-...+.||||+....+. ...+..-+|.++.+.+.||.||++|+++.-..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt--- 540 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT--- 540 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc---
Confidence 34446689999999999999988889999999754321 11344667899999999999999999986432
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC--
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE-- 421 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~-- 421 (789)
...|-|+||+++.+|.-|++.. +.+++.+...|+.||+.||.||... .+||+|-||||.|||+...
T Consensus 541 -dsFCTVLEYceGNDLDFYLKQh----------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 541 -DSFCTVLEYCEGNDLDFYLKQH----------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred -ccceeeeeecCCCchhHHHHhh----------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence 3579999999999999999765 6789999999999999999999887 6889999999999999654
Q ss_pred -CceeeCcccccccCCCCCCc-----cceeeecccccccCcccCCCC----CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 422 -MVSHVGDFGLARFLPPTHVQ-----TSSIGVKGSIGYIAPEYGLGS----EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 422 -~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+.+||.|||+++.+.++... ..+....||..|.+||.+.-+ +++.|+||||.||+.|+.+.|+.||..
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 68899999999999866522 233346799999999987654 478999999999999999999999974
No 393
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=99.94 E-value=1.1e-27 Score=263.51 Aligned_cols=269 Identities=21% Similarity=0.257 Sum_probs=204.0
Q ss_pred CCCCCcccccCCc-cEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEEE
Q 041249 272 FSSANLIGTGSFG-SVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKAL 349 (789)
Q Consensus 272 f~~~~~ig~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l 349 (789)
|...+++|+|..| .||+|.+. +++||||++-.. ......+|++.+..- +|||||++++.-.+.. +.|+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q-----F~YI 580 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQ-----FLYI 580 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCc-----eEEE
Confidence 4456789999987 68999996 889999998433 234567899999888 7999999998866555 8999
Q ss_pred EeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC---C--Cce
Q 041249 350 VYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE---E--MVS 424 (789)
Q Consensus 350 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~ 424 (789)
..|.|.. +|.+++.....+.+ .........+..|+++||+|||+.+ ||||||||.||||+. + .+|
T Consensus 581 alELC~~-sL~dlie~~~~d~~------~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra 650 (903)
T KOG1027|consen 581 ALELCAC-SLQDLIESSGLDVE------MQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRA 650 (903)
T ss_pred EehHhhh-hHHHHHhccccchh------hcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeE
Confidence 9999986 99999976411111 1111456778899999999999987 999999999999976 2 588
Q ss_pred eeCcccccccCCCCCCc-cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHh-cCCCCccccCCccHHHHHH
Q 041249 425 HVGDFGLARFLPPTHVQ-TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR-KKPSDIMFEGDMNLHNFAR 502 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG-~~P~~~~~~~~~~~~~~~~ 502 (789)
+|+|||+++.++.+..+ .......||-+|+|||++....-+..+||||+|||+|+.++| .+||.+..+.+.++..-
T Consensus 651 ~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~-- 728 (903)
T KOG1027|consen 651 KISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG-- 728 (903)
T ss_pred EecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC--
Confidence 99999999999877633 234567899999999999998888999999999999999995 99998543332221110
Q ss_pred HhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccccccCccccc
Q 041249 503 MALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLK 582 (789)
Q Consensus 503 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~ 582 (789)
+.-..- .....+| ...+++..+.+.+|..||+...+..+|-.+..-..|+
T Consensus 729 ----~~~L~~------------------------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~ 778 (903)
T KOG1027|consen 729 ----NYTLVH------------------------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLS 778 (903)
T ss_pred ----ccceee------------------------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHH
Confidence 000000 0011122 4557888999999999999999998888777777777
Q ss_pred hhcccCCccc
Q 041249 583 ILNLENNSFT 592 (789)
Q Consensus 583 ~L~L~~N~l~ 592 (789)
.|.=..+++.
T Consensus 779 Fl~dvSDRvE 788 (903)
T KOG1027|consen 779 FLRDVSDRVE 788 (903)
T ss_pred HHHhhhhhhh
Confidence 7755555554
No 394
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.94 E-value=6.1e-27 Score=248.57 Aligned_cols=213 Identities=21% Similarity=0.279 Sum_probs=177.5
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc---chhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH---HRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
.-|...+.||-|+||+|..+.-..+...+|.|.++..+ .......+.|.++|+.-..+=||++|..|++.+ .
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-----n 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----N 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-----c
Confidence 45778899999999999999988888899999997552 222345778999999999999999999999887 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.|+||+|+++|++-.+|-+. ..|++.-...+++++.+|+++.|..| +|||||||.|||||.+|++||
T Consensus 704 LYFVMdYIPGGDmMSLLIrm----------gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRM----------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred eEEEEeccCCccHHHHHHHh----------ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceee
Confidence 99999999999998888543 67888888999999999999999999 999999999999999999999
Q ss_pred CcccccccCCCCCC----------------------------------------ccceeeecccccccCcccCCCCCcCc
Q 041249 427 GDFGLARFLPPTHV----------------------------------------QTSSIGVKGSIGYIAPEYGLGSEVST 466 (789)
Q Consensus 427 ~Dfgla~~~~~~~~----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 466 (789)
+|||++.-+...+. ....-...||..|+|||++....|+.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 99999875432110 00001234999999999999999999
Q ss_pred cccchhhHHHHHHHHHhcCCCCcccc--CCccHHHH
Q 041249 467 NGDVYSYGILMLELIIRKKPSDIMFE--GDMNLHNF 500 (789)
Q Consensus 467 k~DV~sfGvvl~elltG~~P~~~~~~--~~~~~~~~ 500 (789)
-+|.||.|||||||+.|+.||.+... ....+.+|
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence 99999999999999999999976533 23344455
No 395
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=99.93 E-value=9e-27 Score=245.71 Aligned_cols=197 Identities=21% Similarity=0.334 Sum_probs=171.6
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc--------chhhHHHHHHHHHHhcCC---CCccceeeeeecc
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH--------HRASRSFIAECRALRSIR---HRNLVKVFTACSG 338 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 338 (789)
.+|+..+.+|.|+||.|+.|.++.+...|+||++...+ ........-||++|+.++ |+||++++.+|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 47899999999999999999999999999999986542 111234667999999997 9999999999988
Q ss_pred CCCCCCceEEEEeeccCC-CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249 339 VDYQGNDFKALVYEFMQN-GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417 (789)
Q Consensus 339 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil 417 (789)
.+ ..++++|-... .+|.+++.. ..++++.+..-|+.||+.|+++||+++ |||||||-+||.
T Consensus 641 dd-----~yyl~te~hg~gIDLFd~IE~----------kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvi 702 (772)
T KOG1152|consen 641 DD-----YYYLETEVHGEGIDLFDFIEF----------KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVI 702 (772)
T ss_pred CC-----eeEEEecCCCCCcchhhhhhc----------cCccchHHHHHHHHHHHhccccccccC---ceecccccccEE
Confidence 77 88999986554 489999853 477899999999999999999999999 999999999999
Q ss_pred cCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCc-CccccchhhHHHHHHHHHhcCCCC
Q 041249 418 LDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEV-STNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 418 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
++.+|-+||+|||.|.+...+. .....||..|.|||.+.+.+| ...-|||++|++||-++..+.||+
T Consensus 703 vd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 703 VDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999999998876554 334679999999999999887 566999999999999999999986
No 396
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=99.93 E-value=1.7e-25 Score=249.03 Aligned_cols=217 Identities=18% Similarity=0.246 Sum_probs=158.7
Q ss_pred hhcCCCCCCcccccCCccEEEEEEc----------------CCceEEEEEEeccccchhhHHH--------------HHH
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLD----------------EGRTTVTVKVFNLHHHRASRSF--------------IAE 317 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e 317 (789)
..++|+..++||+|+||+||+|.+. ..++.||||.+........+.| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4679999999999999999999752 2356799999876544333333 346
Q ss_pred HHHHhcCCCCcc-----ceeeeeeccCCCC---CCceEEEEeeccCCCChhhhccCCCCC--------------ccccCC
Q 041249 318 CRALRSIRHRNL-----VKVFTACSGVDYQ---GNDFKALVYEFMQNGSLEEWLYPVNRE--------------DEVDKA 375 (789)
Q Consensus 318 ~~~l~~l~h~ni-----v~l~~~~~~~~~~---~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~~~~ 375 (789)
+.++.+++|.++ ++++++|.....+ .....++||||+.+|+|.++++..... ......
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 6778887643211 123579999999999999998753110 000011
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccC
Q 041249 376 PRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIA 455 (789)
Q Consensus 376 ~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 455 (789)
...+++..+..++.|++.||.|+|..+ |+||||||+||+++.++.+||+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 234678889999999999999999887 999999999999999999999999999765433211 1112234789999
Q ss_pred cccCCCCCc----------------------CccccchhhHHHHHHHHHhcC-CCC
Q 041249 456 PEYGLGSEV----------------------STNGDVYSYGILMLELIIRKK-PSD 488 (789)
Q Consensus 456 PE~~~~~~~----------------------~~k~DV~sfGvvl~elltG~~-P~~ 488 (789)
||.+..... ..+.||||+||++|||++|.. |+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 998754321 235799999999999999875 765
No 397
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=99.93 E-value=7.3e-26 Score=258.75 Aligned_cols=213 Identities=22% Similarity=0.198 Sum_probs=145.4
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCC----ceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCC-CC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEG----RTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVD-YQ 342 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~ 342 (789)
+.++|...+.||+|+||.||+|.+..+ +..||+|.+...... .....| .+....+.++..++..+.... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 568999999999999999999999888 899999987533211 111111 112222333333332221111 12
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCc----cc------cCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCC
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNRED----EV------DKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLK 412 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk 412 (789)
.....++|+||+.+++|.+++....... .. ...........+..++.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 2346899999999999999986431100 00 000111223446689999999999999887 9999999
Q ss_pred CCceecCC-CCceeeCcccccccCCCCCCccceeeecccccccCcccCCCC----------------------CcCcccc
Q 041249 413 PSNILLDE-EMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGS----------------------EVSTNGD 469 (789)
Q Consensus 413 ~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~D 469 (789)
|+|||+++ ++.+||+|||+|+........ ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 579999999999866433221 12234688999999964322 2345679
Q ss_pred chhhHHHHHHHHHhcCCCC
Q 041249 470 VYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 470 V~sfGvvl~elltG~~P~~ 488 (789)
||||||++|||+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999877754
No 398
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=99.93 E-value=4e-27 Score=244.67 Aligned_cols=200 Identities=22% Similarity=0.323 Sum_probs=175.1
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
.++.....+|-||||.|=....+.....+|+|.++.. ....+.....|-.+|-..+.|.||++|..|.+.+ .
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k-----y 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK-----Y 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch-----h
Confidence 4666777899999999999999855555888888644 3344556778999999999999999999987766 8
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
.|+.||-|-+|.+...+..+ ..++..+...++..+.+|++|||..+ ||+|||||+|.+++.++-+||
T Consensus 495 vYmLmEaClGGElWTiLrdR----------g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KL 561 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDR----------GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKL 561 (732)
T ss_pred hhhhHHhhcCchhhhhhhhc----------CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEE
Confidence 99999999999999999654 67888899999999999999999998 999999999999999999999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
.|||.|+.+..... +-..+||+.|.|||++.+...+..+|.||+|+++|||++|++||...
T Consensus 562 VDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 562 VDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred eehhhHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999877652 23477999999999999999999999999999999999999999743
No 399
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=99.93 E-value=1.2e-25 Score=231.18 Aligned_cols=238 Identities=28% Similarity=0.314 Sum_probs=189.1
Q ss_pred CCccEEEEEEcCCceEEEEEEeccccchh-hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChh
Q 041249 282 SFGSVYKGVLDEGRTTVTVKVFNLHHHRA-SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLE 360 (789)
Q Consensus 282 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 360 (789)
+||.||+|.+..+++.||+|++....... .+.+.+|++.+++++|+|++++++.+.... ..++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED-----KLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC-----EEEEEEeCCCCCCHH
Confidence 58999999999889999999997665444 688999999999999999999999987655 789999999999999
Q ss_pred hhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCC
Q 041249 361 EWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHV 440 (789)
Q Consensus 361 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 440 (789)
+++... ..+++..+..++.+++.|+.|||..+ ++|+||+|+||++++++.++++|||.+.......
T Consensus 76 ~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~- 141 (244)
T smart00220 76 DLLKKR----------GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG- 141 (244)
T ss_pred HHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence 998644 22789999999999999999999987 9999999999999999999999999999876543
Q ss_pred ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCCcccC
Q 041249 441 QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDSTLLND 520 (789)
Q Consensus 441 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 520 (789)
......++..|+|||......++.++||||||+++|++++|..||+... +.....++....... ...
T Consensus 142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~----~~~------ 208 (244)
T smart00220 142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPP----FPP------ 208 (244)
T ss_pred --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCC----Ccc------
Confidence 1223457889999999988889999999999999999999999987321 111111111110000 000
Q ss_pred hhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccc
Q 041249 521 VEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAG 569 (789)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~ 569 (789)
........+.+++..|...++.+||+.....
T Consensus 209 ------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~ 239 (244)
T smart00220 209 ------------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEAL 239 (244)
T ss_pred ------------------ccccCCHHHHHHHHHHccCCchhccCHHHHh
Confidence 0000234566888899999999999887654
No 400
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.93 E-value=2.6e-27 Score=225.98 Aligned_cols=207 Identities=22% Similarity=0.357 Sum_probs=171.5
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCC---C
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQG---N 344 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~---~ 344 (789)
..|....+||+|.||+||+|+..++++.||+|.+-.. +........+|++++..++|+|++.++..|....-.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3556677899999999999999999999999876432 3333456788999999999999999999997654222 2
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCce
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVS 424 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 424 (789)
...++||.+++. +|..++.. ...+++..++.+++.++..||.|+|... |+|||+||+|+||+.++..
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn---------~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN---------RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGIL 163 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC---------ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceE
Confidence 247999999997 78777743 3477999999999999999999999887 9999999999999999999
Q ss_pred eeCcccccccCCCCCC--ccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 425 HVGDFGLARFLPPTHV--QTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 425 kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
||+|||+++.+..+.. ....+...-|..|.+||.+.+. +|+++.|||+-|||+.||.||.+-+..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 9999999987765542 1222344468999999998875 599999999999999999999988863
No 401
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=99.93 E-value=2.6e-26 Score=216.35 Aligned_cols=207 Identities=22% Similarity=0.394 Sum_probs=172.3
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCce
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 346 (789)
..++|.+.+.+|.|.+++||.|..-.+.++++||+++..+ .+.+.+|+.++..++ ||||++++++..+.. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccC
Confidence 3578999999999999999999988789999999997554 456789999999996 999999999987654 335
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-cee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSH 425 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~k 425 (789)
..+++||..+.++..+- +.++...+.-+..++++||.|+|++| |+|||+||.|++||... ..+
T Consensus 110 paLiFE~v~n~Dfk~ly-------------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLr 173 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY-------------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLR 173 (338)
T ss_pred chhHhhhhccccHHHHh-------------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceee
Confidence 78999999998877665 34677788899999999999999999 99999999999999765 679
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHH
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFAR 502 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~ 502 (789)
++|+|+|.++.+.... .-...+.-|.-||.+.+-+ |+..-|+|||||++..|+..+.||. .+..++.+.++
T Consensus 174 lIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF---hG~dN~DQLVk 245 (338)
T KOG0668|consen 174 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF---HGHDNYDQLVK 245 (338)
T ss_pred eeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc---CCCCCHHHHHH
Confidence 9999999999877632 1223455678899987754 8999999999999999999999985 34445555543
No 402
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.93 E-value=7.2e-26 Score=223.89 Aligned_cols=212 Identities=24% Similarity=0.314 Sum_probs=180.0
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc---cchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCc
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH---HHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 345 (789)
.+|+..++||.|+|+.|..+.+..+.+.+|+|+++.. ..++.+-...|-.+...- +||.+|.+-..++..+
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes----- 324 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES----- 324 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc-----
Confidence 5899999999999999999999999999999998754 334444455666666665 7999999988887766
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++|.||.++|+|--+++.. +.++++.+..+..+|+-||.|||+.| |++||+|-.|||+|.++++|
T Consensus 325 rlffvieyv~ggdlmfhmqrq----------rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghik 391 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIK 391 (593)
T ss_pred eEEEEEEEecCcceeeehhhh----------hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCcee
Confidence 899999999999998888654 67899999999999999999999998 99999999999999999999
Q ss_pred eCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc--ccCCccHHHHH
Q 041249 426 VGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM--FEGDMNLHNFA 501 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~--~~~~~~~~~~~ 501 (789)
++|+|+++.--.+. ..+...+||+.|+|||++.+..|...+|.|++||+|+||+.|+.||+.. ...+++..++.
T Consensus 392 ltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl 467 (593)
T KOG0695|consen 392 LTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL 467 (593)
T ss_pred ecccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence 99999998654333 2344578999999999999999999999999999999999999999864 22344444443
No 403
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.92 E-value=6.4e-25 Score=223.22 Aligned_cols=199 Identities=30% Similarity=0.448 Sum_probs=172.8
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
|+..+.||.|++|.||++....+++.+++|.+...... ..+.+.+|++.+++++|+|++++++++.... ..+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE-----PLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC-----ceEEE
Confidence 45678899999999999999977899999999766554 6678999999999999999999999987655 78999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCC-CCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRN-LNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDF 429 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 429 (789)
+|++.+++|.+++... .. +++.....++.+++.++.|||..+ ++|+|++|+||+++.++.++++||
T Consensus 76 ~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~ 142 (225)
T smart00221 76 MEYCEGGDLFDYLRKK----------GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADF 142 (225)
T ss_pred EeccCCCCHHHHHHhc----------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeC
Confidence 9999999999998654 22 788999999999999999999887 999999999999999999999999
Q ss_pred cccccCCCCCCccceeeecccccccCcccC-CCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 430 GLARFLPPTHVQTSSIGVKGSIGYIAPEYG-LGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 430 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|.+......... ......++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 143 g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 143 GLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999987655311 12334577889999998 556688899999999999999999999963
No 404
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.92 E-value=1.9e-26 Score=222.24 Aligned_cols=203 Identities=24% Similarity=0.319 Sum_probs=170.4
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
|....+.||.|.||.||-.++..+|+.||.|.+... .-...+.+-+|++++..++|.|++..+++.+....+-..+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 566789999999999999999999999999987433 233457788999999999999999999987765543334567
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
.+.|.|.. +|...+- .++.++...+.-+++||++||.|||+.+ |.||||||.|.|++.+-..||+|
T Consensus 134 V~TELmQS-DLHKIIV----------SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIV----------SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred HHHHHHHh-hhhheec----------cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecc
Confidence 78888875 6777663 4577888888899999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCCCCC-cCccccchhhHHHHHHHHHhcCCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-VSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
||+++....+.... ++...-|..|.|||++.+.+ |+...||||.||+..|++-++.-|.
T Consensus 200 FGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 200 FGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred cccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 99999887665332 33344677899999999865 9999999999999999999988875
No 405
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=99.91 E-value=3.4e-25 Score=224.50 Aligned_cols=199 Identities=25% Similarity=0.317 Sum_probs=166.9
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-C-Cc----cceeeeeeccCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-H-RN----LVKVFTACSGVDYQ 342 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~n----iv~l~~~~~~~~~~ 342 (789)
++.|.+...+|+|.||.|-.+.++.++..||||+++... ...++...|++++.++. + |+ ++.+.+++....
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg-- 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG-- 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC--
Confidence 678999999999999999999999899999999997543 23456778999999993 2 22 556655554333
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC---
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD--- 419 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~--- 419 (789)
+.|+|+|.+.. ++.+++..+ .-.+++...+..|+.|++++++|||+.+ ++|.||||+||++.
T Consensus 165 ---hiCivfellG~-S~~dFlk~N--------~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 165 ---HICIVFELLGL-STFDFLKEN--------NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSE 229 (415)
T ss_pred ---ceEEEEeccCh-hHHHHhccC--------CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccc
Confidence 78999998864 899999765 4467899999999999999999999988 99999999999993
Q ss_pred -----------------CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH
Q 041249 420 -----------------EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII 482 (789)
Q Consensus 420 -----------------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt 482 (789)
....+|++|||.|.+....+ .....|.-|.|||++.+-.++.++||||+||||+|+.|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 13467999999999876554 33567889999999999999999999999999999999
Q ss_pred hcCCCCcc
Q 041249 483 RKKPSDIM 490 (789)
Q Consensus 483 G~~P~~~~ 490 (789)
|..-|...
T Consensus 305 G~~LFqtH 312 (415)
T KOG0671|consen 305 GETLFQTH 312 (415)
T ss_pred cceecccC
Confidence 99988643
No 406
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.90 E-value=1.4e-24 Score=209.81 Aligned_cols=209 Identities=21% Similarity=0.312 Sum_probs=167.1
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
+.|++.+.+|+|.||.+-.+.++.+.+.+++|-+... ....++|.+|.-.---+ .|.||+.-|....+.. +..+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d~Yv 98 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----DAYV 98 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC----ceEE
Confidence 5799999999999999999999999999999987433 23456788887665556 5999999887754433 2678
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC--CCCceee
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD--EEMVSHV 426 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl 426 (789)
+++||++.|+|.+.+... .+-+.....++.|++.|+.|||+.. +||||||.+|||+. +..++|+
T Consensus 99 F~qE~aP~gdL~snv~~~-----------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA-----------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred EeeccCccchhhhhcCcc-----------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEe
Confidence 899999999999988543 4556677889999999999999988 99999999999994 4469999
Q ss_pred CcccccccCCCCCCccceeeecccccccCcccCCC---C--CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249 427 GDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG---S--EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~ 501 (789)
+|||+++..+.- .....-+..|.|||.... + ++.+.+|||.||++++..+||+.||....-.+..+.+|.
T Consensus 165 cDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~ 239 (378)
T KOG1345|consen 165 CDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE 239 (378)
T ss_pred eecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence 999998865432 123445678999997654 2 358899999999999999999999985555566666665
Q ss_pred H
Q 041249 502 R 502 (789)
Q Consensus 502 ~ 502 (789)
+
T Consensus 240 ~ 240 (378)
T KOG1345|consen 240 Q 240 (378)
T ss_pred H
Confidence 4
No 407
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=99.89 E-value=2.9e-24 Score=230.63 Aligned_cols=199 Identities=27% Similarity=0.364 Sum_probs=174.6
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.++|.....+|.|.||.||++++..+++.+|+|+++.....+.....+|+-+++..+|+||+.++|.+...+ ..|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcE
Confidence 368899999999999999999999999999999999998888888899999999999999999999987655 899
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+.|||+.+|+|++.-+- ...+++.++....++..+|++|||+.+ -+|||||=.||++++.+.+|+.|
T Consensus 89 icMEycgggslQdiy~~----------TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaD 155 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHV----------TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLAD 155 (829)
T ss_pred EEEEecCCCcccceeee----------cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecc
Confidence 99999999999987653 478999999999999999999999998 99999999999999999999999
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCC---CCCcCccccchhhHHHHHHHHHhcCCC
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL---GSEVSTNGDVYSYGILMLELIIRKKPS 487 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~sfGvvl~elltG~~P~ 487 (789)
||.+..+..-.. ......||+.|||||+.. .+.|.+++|||+.|++..|+---+.|.
T Consensus 156 fgvsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 156 FGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred cCchhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 998876654321 123467999999999754 567999999999999999985444443
No 408
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]
Probab=99.88 E-value=1.7e-24 Score=219.46 Aligned_cols=198 Identities=23% Similarity=0.248 Sum_probs=156.8
Q ss_pred ccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCc
Q 041249 575 IGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIE 654 (789)
Q Consensus 575 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 654 (789)
|..|++|++|+|++|+|+.+-+.+|.++.+++.|.|..|+|..+....|.++..|++|+|.+|+|+...|.+|..+..|.
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~ 349 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS 349 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence 88999999999999999999999999999999999999999977788999999999999999999999999999999999
Q ss_pred EEEccCCCCC------------------ccCCcCCCCCCCCCEEEccCCcCCc---cCCccc---------cCCCCCC-e
Q 041249 655 VLSLGFNNLI------------------GSIPPPLGNLSSLRKISLAINNLAG---SIPFTL---------SKLKNLV-I 703 (789)
Q Consensus 655 ~L~L~~N~l~------------------~~~~~~~~~l~~L~~L~L~~N~l~~---~~~~~~---------~~l~~L~-~ 703 (789)
+|+|-.|.+. |..| -++-..++.+.++++.+.. ..|+.. ..++.+. +
T Consensus 350 ~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tV 427 (498)
T KOG4237|consen 350 TLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTV 427 (498)
T ss_pred eeehccCcccCccchHHHHHHHhhCCCCCCCC--CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhh
Confidence 9999988761 1111 1223356677777766542 122222 1233343 3
Q ss_pred eeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCC
Q 041249 704 LYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNN 782 (789)
Q Consensus 704 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 782 (789)
...|++.++ .+|..+.. ..++|++.+|.++ .+|.+. +.+| .+||++|+|.......|.++++|.+|-++.|
T Consensus 428 vRcSnk~lk-~lp~~iP~--d~telyl~gn~~~-~vp~~~---~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 428 VRCSNKLLK-LLPRGIPV--DVTELYLDGNAIT-SVPDEL---LRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred Hhhcccchh-hcCCCCCc--hhHHHhcccchhc-ccCHHH---Hhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 445666665 66655432 5789999999999 999984 5677 8999999999888888999999999998876
No 409
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=99.88 E-value=4.8e-22 Score=199.15 Aligned_cols=184 Identities=30% Similarity=0.520 Sum_probs=160.0
Q ss_pred ccccCCccEEEEEEcCCceEEEEEEeccccch-hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCC
Q 041249 278 IGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQN 356 (789)
Q Consensus 278 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~ 356 (789)
||+|.+|.||++....+++.+++|++...... ....+.+|++.++.++|++++++++++.... ..++++||+.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN-----HLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-----eEEEEEecCCC
Confidence 68999999999999878999999999765433 3567999999999999999999999987654 78999999999
Q ss_pred CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-CCceeeCcccccccC
Q 041249 357 GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-EMVSHVGDFGLARFL 435 (789)
Q Consensus 357 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgla~~~ 435 (789)
++|.+++... ...+++..+..++.+++++++|||..+ ++|+||+|.||++++ +..++++|||.+...
T Consensus 76 ~~l~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 76 GSLKDLLKEN---------EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred CcHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 9999998543 145789999999999999999999988 999999999999999 899999999999877
Q ss_pred CCCCCccceeeecccccccCcccCCCC-CcCccccchhhHHHHHHH
Q 041249 436 PPTHVQTSSIGVKGSIGYIAPEYGLGS-EVSTNGDVYSYGILMLEL 480 (789)
Q Consensus 436 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~sfGvvl~el 480 (789)
..... ......+...|++||..... .++.++|+|++|++++++
T Consensus 144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 65432 12234577899999998877 789999999999999999
No 410
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=99.87 E-value=5.1e-23 Score=204.03 Aligned_cols=210 Identities=22% Similarity=0.286 Sum_probs=171.9
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCC-CCCCceE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVD-YQGNDFK 347 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~ 347 (789)
.|.-...+|.|.. .|..+.+.-.++.||+|..... .....++...|...+..++|+||++++.++.... .......
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555677888888 7888888778999999987433 3344577888999999999999999999986543 2223357
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++|||+|.. ++.+.+.- .++-.++..|..|+++|++|||+.+ |+||||||+||++..+..+|+.
T Consensus 97 y~v~e~m~~-nl~~vi~~------------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~ 160 (369)
T KOG0665|consen 97 YLVMELMDA-NLCQVILM------------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKIL 160 (369)
T ss_pred HHHHHhhhh-HHHHHHHH------------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeec
Confidence 999999985 77777652 3567788999999999999999998 9999999999999999999999
Q ss_pred cccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHh
Q 041249 428 DFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMA 504 (789)
Q Consensus 428 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~ 504 (789)
|||+|+..... ...+....|..|.|||.+.+..+.+.+||||.||++.||++|+.-|. ++..+.+|.+..
T Consensus 161 dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~ 230 (369)
T KOG0665|consen 161 DFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKII 230 (369)
T ss_pred cchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHH
Confidence 99999976655 23444567889999999999889999999999999999999998775 556677776544
No 411
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.87 E-value=3.7e-22 Score=207.67 Aligned_cols=136 Identities=25% Similarity=0.415 Sum_probs=116.1
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC-----C---CccceeeeeeccCCC
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR-----H---RNLVKVFTACSGVDY 341 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~~~ 341 (789)
..|-..++||+|-|++||.+.+..+.+.||+|+.+.. +...+....||.++++++ | ..||+++++|....+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 4677889999999999999999999999999998643 334567788999999883 2 469999999987775
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL 418 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill 418 (789)
.|. +.|||+|++.. +|..++... .-+.++...+.+|+.||+.||.|||..+ .|+|.||||+|||+
T Consensus 157 NG~-HVCMVfEvLGd-nLLklI~~s--------~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQ-HVCMVFEVLGD-NLLKLIKYS--------NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCc-EEEEEehhhhh-HHHHHHHHh--------CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 554 89999999976 777777544 4567899999999999999999999987 69999999999999
No 412
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=99.87 E-value=2.8e-22 Score=206.41 Aligned_cols=210 Identities=26% Similarity=0.368 Sum_probs=171.4
Q ss_pred hcCCCCCCcccccCCccEEEEEEcC---CceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDE---GRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGN 344 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~ 344 (789)
.+.|...++||.|.|+.||++++.. ..+.||+|.+.... .......|++++..+ .+.||+++.+.+...+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd---- 108 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND---- 108 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC----
Confidence 4678899999999999999999987 78899999986442 335688999999999 5999999999877666
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-c
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-V 423 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~ 423 (789)
..++|+||++.-...++.. .++...+..+++.+.+||+++|..| ||||||||+|++.+... .
T Consensus 109 -~v~ivlp~~~H~~f~~l~~-------------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 109 -QVAIVLPYFEHDRFRDLYR-------------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred -eeEEEecccCccCHHHHHh-------------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCC
Confidence 8999999999999988874 3578889999999999999999999 99999999999998764 5
Q ss_pred eeeCcccccccC-----------------CC-CC------------------------CccceeeecccccccCcccCCC
Q 041249 424 SHVGDFGLARFL-----------------PP-TH------------------------VQTSSIGVKGSIGYIAPEYGLG 461 (789)
Q Consensus 424 ~kl~Dfgla~~~-----------------~~-~~------------------------~~~~~~~~~gt~~y~aPE~~~~ 461 (789)
-.|.|||+|... .+ .. .........||++|.|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 589999999821 11 00 0001112459999999999876
Q ss_pred -CCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHH
Q 041249 462 -SEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFA 501 (789)
Q Consensus 462 -~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~ 501 (789)
+..+++.||||-||++.-+++++.||.....+...+...+
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~ 292 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIA 292 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHH
Confidence 4579999999999999999999999976555544444443
No 413
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.87 E-value=8.6e-21 Score=235.09 Aligned_cols=172 Identities=23% Similarity=0.293 Sum_probs=138.2
Q ss_pred cccchhcccCCcccccCcccccCccceeeecccCCCCc-------cCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCC
Q 041249 579 SFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIG-------GEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLS 651 (789)
Q Consensus 579 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~-------~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 651 (789)
++|++|+|++|.++ .+|..+ .+++|++|++.++... ...+..+...++|+.|+|++|.....+|..+.+++
T Consensus 725 ~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~ 802 (1153)
T PLN03210 725 TNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLH 802 (1153)
T ss_pred CCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCC
Confidence 45778889999988 566654 6888999999875432 12222334457899999999987778999999999
Q ss_pred CCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEcc
Q 041249 652 KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVG 731 (789)
Q Consensus 652 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 731 (789)
+|+.|++++|..-+.+|..+ ++++|++|+|++|..-..+|.. .++|+.|+|++|.|+ .+|.++..+++|+.|+|+
T Consensus 803 ~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~ 877 (1153)
T PLN03210 803 KLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMN 877 (1153)
T ss_pred CCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECC
Confidence 99999999976444777766 7899999999998654466653 358999999999998 789999999999999999
Q ss_pred C-CcccccCCcccccCCCCccEEEccCCc
Q 041249 732 E-NKIQGNIPLDYGFTLQNLQYFSIGTNR 759 (789)
Q Consensus 732 ~-N~l~~~ip~~~~~~l~~L~~L~L~~N~ 759 (789)
+ |++. .+|..+. .+++|+.|+++++.
T Consensus 878 ~C~~L~-~l~~~~~-~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 878 GCNNLQ-RVSLNIS-KLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCcC-ccCcccc-cccCCCeeecCCCc
Confidence 8 5666 7888876 79999999999986
No 414
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.86 E-value=3.9e-21 Score=221.35 Aligned_cols=123 Identities=24% Similarity=0.255 Sum_probs=82.9
Q ss_pred ccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEcc
Q 041249 580 FLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLG 659 (789)
Q Consensus 580 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 659 (789)
+|++|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+ .+|.. .++|+.|+++
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS 410 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVS 410 (788)
T ss_pred ccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCc---ccCCCEEEcc
Confidence 46778888888884 4543 245777788888887 35543 246777888888877 35533 2467777777
Q ss_pred CCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccc
Q 041249 660 FNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSI 719 (789)
Q Consensus 660 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 719 (789)
+|+|++ +|..+ .+|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..+
T Consensus 411 ~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 411 GNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 777773 45432 35667777777777 567777777777777777777776666655
No 415
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.85 E-value=3.1e-21 Score=206.16 Aligned_cols=176 Identities=22% Similarity=0.180 Sum_probs=136.3
Q ss_pred hhcCCCCCCcccccCCccEEEEEEcC-CceEEEEEEeccc-----cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCC
Q 041249 268 ATDGFSSANLIGTGSFGSVYKGVLDE-GRTTVTVKVFNLH-----HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDY 341 (789)
Q Consensus 268 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 341 (789)
..++|...+.||+|+||+||+|.+.. +++.||||++... .......+.+|++++++++|+|+++.+..+ .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~- 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G- 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C-
Confidence 45789999999999999999999875 6778899987533 122356799999999999999998643221 1
Q ss_pred CCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC-CCCceecCC
Q 041249 342 QGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL-KPSNILLDE 420 (789)
Q Consensus 342 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl-k~~Nill~~ 420 (789)
..++||||+.+++|... ... . ...++.++++||+|||+.+ |+|||| ||+|||++.
T Consensus 92 ----~~~LVmE~~~G~~L~~~-~~~----------~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~ 147 (365)
T PRK09188 92 ----KDGLVRGWTEGVPLHLA-RPH----------G------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGP 147 (365)
T ss_pred ----CcEEEEEccCCCCHHHh-Ccc----------c------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcC
Confidence 46999999999999632 111 0 1467889999999999988 999999 999999999
Q ss_pred CCceeeCcccccccCCCCCCccc------eeeecccccccCcccCCCCC------cCccccch
Q 041249 421 EMVSHVGDFGLARFLPPTHVQTS------SIGVKGSIGYIAPEYGLGSE------VSTNGDVY 471 (789)
Q Consensus 421 ~~~~kl~Dfgla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~k~DV~ 471 (789)
++.+||+|||+|+.......... .....+++.|+|||++...+ .+..+|-|
T Consensus 148 ~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 148 DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99999999999998876552211 13456888999999987643 23446766
No 416
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.85 E-value=6.5e-21 Score=219.53 Aligned_cols=140 Identities=24% Similarity=0.313 Sum_probs=105.8
Q ss_pred hhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCC
Q 041249 583 ILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNN 662 (789)
Q Consensus 583 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 662 (789)
.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|.. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+
T Consensus 326 ~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~ 393 (788)
T PRK15387 326 KLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNR 393 (788)
T ss_pred ccccccCcccc-cccc---ccccceEecCCCccC-CCCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCc
Confidence 34455666663 4431 247899999999999 45543 357888999999998 46653 3578999999999
Q ss_pred CCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcc
Q 041249 663 LIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLD 742 (789)
Q Consensus 663 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~ 742 (789)
|++ +|.. .++|+.|++++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..|..+++|+.|+|++|+|++.++..
T Consensus 394 Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~ 464 (788)
T PRK15387 394 LTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA 464 (788)
T ss_pred ccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHH
Confidence 984 5543 357899999999998 466543 46788999999998 78888999999999999999998776664
Q ss_pred c
Q 041249 743 Y 743 (789)
Q Consensus 743 ~ 743 (789)
+
T Consensus 465 L 465 (788)
T PRK15387 465 L 465 (788)
T ss_pred H
Confidence 4
No 417
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=99.85 E-value=3.8e-20 Score=229.38 Aligned_cols=131 Identities=17% Similarity=0.244 Sum_probs=111.7
Q ss_pred ccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCC
Q 041249 599 IGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLR 678 (789)
Q Consensus 599 ~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 678 (789)
+...++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|+|++|..-...|.. ..+|+
T Consensus 774 ~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~ 849 (1153)
T PLN03210 774 TMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNIS 849 (1153)
T ss_pred hhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccC
Confidence 3445789999999998887899999999999999999985444777765 7899999999998655455543 36899
Q ss_pred EEEccCCcCCccCCccccCCCCCCeeeccC-ccccccCCccccCCCCccEEEccCCcc
Q 041249 679 KISLAINNLAGSIPFTLSKLKNLVILYLGV-NRLSGIVPSSIFNISSIAEFDVGENKI 735 (789)
Q Consensus 679 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l 735 (789)
.|+|++|.|+ .+|..+..+++|+.|+|++ |+++ .+|..+..+++|+.|++++|.-
T Consensus 850 ~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~~ 905 (1153)
T PLN03210 850 DLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCGA 905 (1153)
T ss_pred EeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCcc
Confidence 9999999998 7899999999999999999 5666 6788889999999999999863
No 418
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=99.84 E-value=6.1e-22 Score=206.82 Aligned_cols=200 Identities=23% Similarity=0.267 Sum_probs=167.4
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC------CCccceeeeeeccCCCC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR------HRNLVKVFTACSGVDYQ 342 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~ 342 (789)
.+.|.+.-..|+|-|++|..|.+...++.||||+++... ...+.=.+|+++|++|. .-|.++++..|....
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn-- 507 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN-- 507 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc--
Confidence 456777788899999999999999889999999997442 22345577999999995 367899988887655
Q ss_pred CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC
Q 041249 343 GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM 422 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~ 422 (789)
+.|+|||-+.. +|.+.++.. ...-.|....+..++.|+.-||..|...+ |+|.||||.|||+++..
T Consensus 508 ---HLClVFE~Lsl-NLRevLKKy-------G~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 508 ---HLCLVFEPLSL-NLREVLKKY-------GRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred ---eeEEEehhhhc-hHHHHHHHh-------CcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 99999998875 899999876 23345778889999999999999999888 99999999999999875
Q ss_pred -ceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 423 -VSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 423 -~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
..||||||.|......... ..--+..|.|||++.+-.|+...|+||.||+||||.||+.-|..
T Consensus 574 ~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred ceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 5599999999887665421 11234689999999999999999999999999999999998864
No 419
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]
Probab=99.83 E-value=1e-22 Score=206.67 Aligned_cols=230 Identities=20% Similarity=0.216 Sum_probs=206.0
Q ss_pred eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccC-CCCccCCCccCcCCCCCcEEEc
Q 041249 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNN-NSIGGEIPVNLSSCSNLIRIGL 634 (789)
Q Consensus 556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~i~~~~p~~~~~l~~L~~L~l 634 (789)
..+.+++..|.+....+..|+.+++|+.|||++|+|+.+.|++|.++++|..|-+.+ |+|+.+....|+++..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 356788889999999999999999999999999999999999999999988776655 9999777789999999999999
Q ss_pred ccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCC--------------------------
Q 041249 635 AKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA-------------------------- 688 (789)
Q Consensus 635 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------- 688 (789)
.-|++.-+..++|..+++|..|.+.+|.+..+....|..+..++.+.++.|.+.
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 999999888889999999999999999998555558999999999988888720
Q ss_pred -----------------------------------ccC-CccccCCCCCCeeeccCccccccCCccccCCCCccEEEccC
Q 041249 689 -----------------------------------GSI-PFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE 732 (789)
Q Consensus 689 -----------------------------------~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 732 (789)
++. ...|..|++|+.|+|++|+|+.+-+.+|.++..+++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 011 13467899999999999999999999999999999999999
Q ss_pred CcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249 733 NKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786 (789)
Q Consensus 733 N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 786 (789)
|+|. .+...+|.++.+|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|++..
T Consensus 308 N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 308 NKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred chHH-HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence 9999 9999999999999999999999999999999999999999999999864
No 420
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.82 E-value=7.7e-21 Score=228.67 Aligned_cols=153 Identities=18% Similarity=0.290 Sum_probs=115.1
Q ss_pred cCCC-CccceeeeeeccCCCCC--CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhh
Q 041249 323 SIRH-RNLVKVFTACSGVDYQG--NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH 399 (789)
Q Consensus 323 ~l~h-~niv~l~~~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH 399 (789)
.++| +||++++++|......+ ....+.++||+ .++|.+++... ...+++.+++.++.||+.||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---------DRSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---------cccccHHHHHHHHHHHHHHHHHHH
Confidence 4556 68888888874333222 12456678887 45999999532 355899999999999999999999
Q ss_pred cCCCCCceecCCCCCceecCC-------------------CCceeeCcccccccCCCCCC--------------ccceee
Q 041249 400 HDCQPITTHCDLKPSNILLDE-------------------EMVSHVGDFGLARFLPPTHV--------------QTSSIG 446 (789)
Q Consensus 400 ~~~~~~ivH~dlk~~Nill~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~ 446 (789)
+.+ ||||||||+|||++. ++.+|++|||+++....... ......
T Consensus 98 ~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 98 SQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred hCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 988 999999999999954 45567777777764321100 000111
Q ss_pred ecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 447 VKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 447 ~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
..||+.|||||++.+..++.++|||||||+||||++|..|+.
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 347888999999999999999999999999999999988865
No 421
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]
Probab=99.81 E-value=3.8e-22 Score=180.24 Aligned_cols=164 Identities=28% Similarity=0.547 Sum_probs=100.0
Q ss_pred CccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEE
Q 041249 601 RLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKI 680 (789)
Q Consensus 601 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 680 (789)
.+.+++.|.||+|+++ .+|..++.+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. +.|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4455555566666665 55555666666666666666665 45555666666666666666665 556666666666666
Q ss_pred EccCCcCCc-cCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCc
Q 041249 681 SLAINNLAG-SIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNR 759 (789)
Q Consensus 681 ~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~ 759 (789)
||+.|++.. .+|+.|..|+.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|.++. .+.+|++|++.+|+
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig-~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIG-DLTRLRELHIQGNR 184 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHH-HHHHHHHHhcccce
Confidence 666665542 35666666666666666666666 56666666666666666666666 6666665 56666666666666
Q ss_pred ccccCcccccCC
Q 041249 760 ITGAIPPSISNA 771 (789)
Q Consensus 760 l~~~~~~~~~~l 771 (789)
++ .+|..++++
T Consensus 185 l~-vlppel~~l 195 (264)
T KOG0617|consen 185 LT-VLPPELANL 195 (264)
T ss_pred ee-ecChhhhhh
Confidence 66 455555443
No 422
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.81 E-value=3.2e-20 Score=181.36 Aligned_cols=165 Identities=21% Similarity=0.159 Sum_probs=120.3
Q ss_pred CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCC
Q 041249 357 GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436 (789)
Q Consensus 357 g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 436 (789)
|+|.+++... +..+++.++..|+.|++.||+|||+.+ ||+||++++++.+|+ ||.++...
T Consensus 1 GsL~~~l~~~---------~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~ 60 (176)
T smart00750 1 VSLADILEVR---------GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKT 60 (176)
T ss_pred CcHHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeec
Confidence 6788888532 356999999999999999999999876 999999999999999 99998765
Q ss_pred CCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhhhccCC
Q 041249 437 PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMDIVDST 516 (789)
Q Consensus 437 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 516 (789)
... ..|+..|+|||++.+..++.|+|||||||++|||++|+.||.....-...+..+.....+.. +.
T Consensus 61 ~~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~ 127 (176)
T smart00750 61 PEQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------PR 127 (176)
T ss_pred ccc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------cc
Confidence 432 24889999999999999999999999999999999999999643222222222222111110 00
Q ss_pred cccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccc
Q 041249 517 LLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSI 571 (789)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~ 571 (789)
-+... ........+.+++..|++.++..||+......+
T Consensus 128 ~~~~~-----------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~ 165 (176)
T smart00750 128 DRSNL-----------------ESVSAARSFADFMRVCASRLPQRREAANHYLAH 165 (176)
T ss_pred ccccH-----------------HHHHhhhhHHHHHHHHHhcccccccCHHHHHHH
Confidence 00000 000011246788889999999999998876443
No 423
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.79 E-value=4e-19 Score=190.83 Aligned_cols=202 Identities=24% Similarity=0.307 Sum_probs=164.2
Q ss_pred CCCCCCcccccCCccEEEEEEcCCc-eEEEEEEeccccchhhHHHHHHHHHHhcCCC----Cccceeeeeec-cCCCCCC
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGR-TTVTVKVFNLHHHRASRSFIAECRALRSIRH----RNLVKVFTACS-GVDYQGN 344 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~~-~~~~~~~ 344 (789)
.|...+.||+|+||.||.+....++ ..+|+|............+..|+.++..+.. +++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~----- 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE----- 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC-----
Confidence 7999999999999999999987553 6899999866544433378889999999863 57888877763 33
Q ss_pred ceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---
Q 041249 345 DFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE--- 421 (789)
Q Consensus 345 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~--- 421 (789)
...++||+.... +|.++.... ..+.++..+.+.|+.|+..+|+++|+.| ++||||||+|++++..
T Consensus 94 ~~~~iVM~l~G~-sL~dl~~~~--------~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~ 161 (322)
T KOG1164|consen 94 DFNFIVMSLLGP-SLEDLRKRN--------PPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRS 161 (322)
T ss_pred ceeEEEEeccCc-cHHHHHHhC--------CCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCc
Confidence 378999987764 898877544 2578999999999999999999999999 9999999999999865
Q ss_pred --CceeeCcccccccCC--CCCCc------cceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 422 --MVSHVGDFGLARFLP--PTHVQ------TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 422 --~~~kl~Dfgla~~~~--~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
..+.+.|||+++... ..... .......||..|+++..+.+.+.+.+.|+||++.++.|+..|..||..
T Consensus 162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~ 239 (322)
T KOG1164|consen 162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEA 239 (322)
T ss_pred ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcc
Confidence 468999999999332 22210 112234599999999999999999999999999999999999999963
No 424
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]
Probab=99.78 E-value=5.2e-21 Score=172.94 Aligned_cols=183 Identities=33% Similarity=0.518 Sum_probs=162.6
Q ss_pred cccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCC
Q 041249 572 LPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLS 651 (789)
Q Consensus 572 l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 651 (789)
...+.+++..+.|.|++|+++ .+|..+..+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. +.|..|+.++
T Consensus 26 ~~gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p 102 (264)
T KOG0617|consen 26 LPGLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFP 102 (264)
T ss_pred cccccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCc
Confidence 345667888999999999999 67777999999999999999999 88999999999999999999998 8999999999
Q ss_pred CCcEEEccCCCCC-ccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEc
Q 041249 652 KIEVLSLGFNNLI-GSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDV 730 (789)
Q Consensus 652 ~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 730 (789)
-|+.|||.+|++. ...|+.|..|..|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|.+
T Consensus 103 ~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhi 180 (264)
T KOG0617|consen 103 ALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHI 180 (264)
T ss_pred hhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhc
Confidence 9999999999996 457899999999999999999998 88989999999999999999998 89999999999999999
Q ss_pred cCCcccccCCcccccCCC---CccEEEccCCccc
Q 041249 731 GENKIQGNIPLDYGFTLQ---NLQYFSIGTNRIT 761 (789)
Q Consensus 731 s~N~l~~~ip~~~~~~l~---~L~~L~L~~N~l~ 761 (789)
.+|+++ .+|.++. .+. +=+.+.+.+|...
T Consensus 181 qgnrl~-vlppel~-~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 181 QGNRLT-VLPPELA-NLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred ccceee-ecChhhh-hhhhhhhHHHHhhhhCCCC
Confidence 999999 9998876 321 1223455555543
No 425
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.77 E-value=3.5e-19 Score=169.76 Aligned_cols=202 Identities=22% Similarity=0.322 Sum_probs=167.6
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCC-CccceeeeeeccCCCCCCceE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH-RNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~ 347 (789)
...|...+.||.|+||.+|.|..-..|.+||||+-+... ...++.-|..+...++| ..|..+..+..+.. ..
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~-----yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKD-----YN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccc-----cc
Confidence 457899999999999999999999899999999975443 33567778888888865 55666665555444 67
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---Cce
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE---MVS 424 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~ 424 (789)
.+||+.... +|++++.-+ .+.++..+.+-++-|+..-++|+|..+ ++||||||+|.|.+-+ ..+
T Consensus 87 vlVMdLLGP-sLEdLfnfC---------~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl 153 (341)
T KOG1163|consen 87 VLVMDLLGP-SLEDLFNFC---------SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKL 153 (341)
T ss_pred eeeeeccCc-cHHHHHHHH---------hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceE
Confidence 899998864 888888655 467899999999999999999999998 9999999999999754 466
Q ss_pred eeCcccccccCCCCC-----CccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 425 HVGDFGLARFLPPTH-----VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 425 kl~Dfgla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
.++|||+|+.+.+.. +........||.+|.+--.+.+.+.+.+-|.=|.|.+|.+.-.|..||...
T Consensus 154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 899999999887654 223334567999999998888888899999999999999999999999743
No 426
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.77 E-value=1.2e-18 Score=173.68 Aligned_cols=200 Identities=21% Similarity=0.320 Sum_probs=171.2
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCCCceEE
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
-.|.+.++||+|.||+++.|+.--+++.||||.-... ....+++.|.+..+.| ..++|..+|.+-++.. +..
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~-----~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK-----YNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccc-----hhh
Confidence 4899999999999999999999889999999986433 3346788899999988 4689988887766555 678
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-----CCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE-----EMV 423 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~-----~~~ 423 (789)
+|+|.+.. +|+++..-+ ++.|+..+...+|.|+..-++|+|++. +|.|||||+|+||+. ...
T Consensus 101 LVidLLGP-SLEDLFD~C---------gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 101 LVIDLLGP-SLEDLFDLC---------GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred hhhhhhCc-CHHHHHHHh---------cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCce
Confidence 99998864 888887543 688999999999999999999999998 999999999999973 346
Q ss_pred eeeCcccccccCCCCCC-----ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 424 SHVGDFGLARFLPPTHV-----QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+.++|||+|+.+.+... ........||.+||+--++.+.+-+.+-|.=|+|-|..+.+-|..||..
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 79999999999987662 2233345699999999999999999999999999999999999999974
No 427
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.76 E-value=1.5e-19 Score=174.82 Aligned_cols=243 Identities=20% Similarity=0.297 Sum_probs=177.8
Q ss_pred cccccCCccEEEEEEcCCceEEEEEEeccc--cchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeecc
Q 041249 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLH--HHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFM 354 (789)
Q Consensus 277 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 354 (789)
+|.+.-.|+.|+|+|. |..++.|+++.. .....+.|.+|.-.++-+.||||.+++|.|.... ...++..||
T Consensus 197 kl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv~isq~m 269 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLVIISQYM 269 (448)
T ss_pred hhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----CceEeeeec
Confidence 5677888999999997 666777776533 4455678999999999999999999999998765 889999999
Q ss_pred CCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccccccc
Q 041249 355 QNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARF 434 (789)
Q Consensus 355 ~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 434 (789)
+-|+|...+++. ..-..+..+..+++.++|+|++|||+.. +.|----+.+..|++|++.+++|+= +-+++
T Consensus 270 p~gslynvlhe~--------t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf 339 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ--------TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF 339 (448)
T ss_pred cchHHHHHHhcC--------ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee
Confidence 999999999865 3345677889999999999999999985 3344457899999999999998741 11111
Q ss_pred CCCCCCccceeeecccccccCcccCCCCCc---CccccchhhHHHHHHHHHhcCCCCccccCCccHHHHHHHhCCCchhh
Q 041249 435 LPPTHVQTSSIGVKGSIGYIAPEYGLGSEV---STNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNFARMALPDHVMD 511 (789)
Q Consensus 435 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (789)
+...-+..-.+.||+||.+...+- -..+|+|||.+++||+.|++.||.+...-+..+.-. .+++..
T Consensus 340 ------sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-----leglrv 408 (448)
T KOG0195|consen 340 ------SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-----LEGLRV 408 (448)
T ss_pred ------eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----hccccc
Confidence 111112334578999999987654 356999999999999999999998542211111000 011112
Q ss_pred hccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhccccceeeEeccCcccccccccc
Q 041249 512 IVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIGSKAQKVTILDLESLKLAGSILP 573 (789)
Q Consensus 512 ~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~ 573 (789)
-+.|.+ ...+..++.-|.+-++-.||..+.+..+++
T Consensus 409 ~ippgi--------------------------s~hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 409 HIPPGI--------------------------SRHMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred cCCCCc--------------------------cHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 222222 334557778899999999999987765443
No 428
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.76 E-value=8.3e-19 Score=174.22 Aligned_cols=174 Identities=11% Similarity=0.115 Sum_probs=133.6
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHH---------HHHHHHHHhcCCCCccceeeeeeccC
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRS---------FIAECRALRSIRHRNLVKVFTACSGV 339 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~~~~~~~ 339 (789)
.+.|...+++|.|+||.||.... ++..+|||+++......... +.+|++.+.++.|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57899999999999999999655 46689999997654333332 78999999999999999998875543
Q ss_pred CCC---CCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCce
Q 041249 340 DYQ---GNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNI 416 (789)
Q Consensus 340 ~~~---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Ni 416 (789)
... .....++||||+++.+|.++.. ++. ....+++.++..+|..+ ++|||++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Ni 166 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNF 166 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHE
Confidence 211 1235799999999999987631 111 34669999999999998 99999999999
Q ss_pred ecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHH
Q 041249 417 LLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLEL 480 (789)
Q Consensus 417 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~el 480 (789)
++++++ ++++|||.......+.... .+.....+..++||||||+++...
T Consensus 167 li~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHH
Confidence 999988 9999999887664332110 122333467899999999997655
No 429
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.75 E-value=3.9e-18 Score=167.80 Aligned_cols=142 Identities=15% Similarity=0.111 Sum_probs=108.9
Q ss_pred CCcccccCCccEEEEEEcCCceEEEEEEeccccch--h-------h-----------------HHHHHHHHHHhcCCCCc
Q 041249 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--A-------S-----------------RSFIAECRALRSIRHRN 328 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~n 328 (789)
...||+|++|.||+|... +|+.||||+++..... . . .....|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999754221 1 0 12245999999998877
Q ss_pred cceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhh-hcCCCCCce
Q 041249 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYL-HHDCQPITT 407 (789)
Q Consensus 329 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~iv 407 (789)
+.....+.. . ..++||||++++++...... ...++..+...++.|++.+|.|+ |..+ |+
T Consensus 81 v~~p~~~~~--~-----~~~iVmE~i~g~~l~~~~~~----------~~~~~~~~~~~i~~qi~~~L~~l~H~~g---ii 140 (190)
T cd05147 81 IPCPEPILL--K-----SHVLVMEFIGDDGWAAPRLK----------DAPLSESKARELYLQVIQIMRILYQDCR---LV 140 (190)
T ss_pred CCCCcEEEe--c-----CCEEEEEEeCCCCCcchhhh----------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 643222211 1 34899999998776544321 23578889999999999999999 6777 99
Q ss_pred ecCCCCCceecCCCCceeeCcccccccCCCC
Q 041249 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPT 438 (789)
Q Consensus 408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 438 (789)
||||||+||+++ ++.++++|||+|.....+
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccCCCc
Confidence 999999999998 478999999999865443
No 430
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.74 E-value=1.5e-17 Score=178.85 Aligned_cols=200 Identities=34% Similarity=0.510 Sum_probs=167.6
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch---hhHHHHHHHHHHhcCCCC-ccceeeeeeccCCCCCCceE
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR---ASRSFIAECRALRSIRHR-NLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~~~~~ 347 (789)
|...+.||.|+|+.||++... ..+++|.+...... ....+.+|+..++.+.|+ ++++++..+.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-----SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-----EE
Confidence 556778999999999999987 88999998655333 367899999999999988 7999999985433 47
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC-ceee
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM-VSHV 426 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl 426 (789)
+++++++.++++.+++.... ....++......+..|++.+++|+|..+ ++|||+||+||+++... .+++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l 143 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIG-------RKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKL 143 (384)
T ss_pred EEEEecCCCCcHHHHHHhcc-------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEE
Confidence 99999999999997765430 0036888999999999999999999998 99999999999999988 7999
Q ss_pred CcccccccCCCCCCcc----ceeeecccccccCcccCCC---CCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 427 GDFGLARFLPPTHVQT----SSIGVKGSIGYIAPEYGLG---SEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
.|||.++......... ......|+..|+|||.... ..++...|+||+|++++++++|..||..
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999998665544221 2355679999999999987 5789999999999999999999999663
No 431
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.72 E-value=3.3e-17 Score=161.85 Aligned_cols=142 Identities=18% Similarity=0.108 Sum_probs=110.3
Q ss_pred CCcccccCCccEEEEEEcCCceEEEEEEeccccchh--------------------------hHHHHHHHHHHhcCCCCc
Q 041249 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--------------------------SRSFIAECRALRSIRHRN 328 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~n 328 (789)
...||+|++|.||+|... +|+.||||+++...... ...+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 89999999987552110 122467899999999988
Q ss_pred cceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCce
Q 041249 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITT 407 (789)
Q Consensus 329 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~iv 407 (789)
+.....+... ..++||||++++++...... ...++..+...++.+++.++.++|+ .+ |+
T Consensus 81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~----------~~~~~~~~~~~i~~~l~~~l~~lH~~~g---iv 140 (190)
T cd05145 81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLK----------DVPLEEEEAEELYEQVVEQMRRLYQEAG---LV 140 (190)
T ss_pred CCCceEEEec-------CCEEEEEEecCCCchhhhhh----------hccCCHHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 7433322211 24899999998754433211 1346778899999999999999999 88 99
Q ss_pred ecCCCCCceecCCCCceeeCcccccccCCCC
Q 041249 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPT 438 (789)
Q Consensus 408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 438 (789)
||||||+||+++ ++.++++|||++...+..
T Consensus 141 HrDlkP~NIll~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 141 HGDLSEYNILYH-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred cCCCChhhEEEE-CCCEEEEEcccceecCCC
Confidence 999999999999 889999999999877654
No 432
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.71 E-value=3.4e-17 Score=190.23 Aligned_cols=202 Identities=24% Similarity=0.429 Sum_probs=109.9
Q ss_pred eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcc
Q 041249 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA 635 (789)
Q Consensus 556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~ 635 (789)
+...+++....+.. .|..+ .+.|+.|+|++|+|+ .+|..+. ++|++|++++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~I--p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACI--PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCccc--ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 34556665555442 23323 246777777777777 3454443 46777777777777 4455443 357777777
Q ss_pred cCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccC
Q 041249 636 KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIV 715 (789)
Q Consensus 636 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 715 (789)
+|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|++++|+++ .+
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-AL 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cC
Confidence 77776 4555443 36777777777776 3455443 36777777777776 3444332 24555555555555 23
Q ss_pred CccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCc
Q 041249 716 PSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLT 785 (789)
Q Consensus 716 p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 785 (789)
|..+. ++|+.|++++|.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+|+
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt 380 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALT-SLPASLP---PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT 380 (754)
T ss_pred Ccccc--ccceeccccCCccc-cCChhhc---CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC
Confidence 33222 34555555555554 4444332 34555555555554 2333332 34555555555544
No 433
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.71 E-value=1.4e-17 Score=193.46 Aligned_cols=206 Identities=24% Similarity=0.385 Sum_probs=117.6
Q ss_pred eeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcc
Q 041249 556 KVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLA 635 (789)
Q Consensus 556 ~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~ 635 (789)
.++.+++..+.+... +..+ .++|++|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+++
T Consensus 200 ~L~~L~Ls~N~LtsL-P~~l--~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 200 QITTLILDNNELKSL-PENL--QGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred CCcEEEecCCCCCcC-Chhh--ccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 456666767666532 3322 246777777777777 3454443 35777777777776 5555543 467777777
Q ss_pred cCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCC-------------------CCCCCCEEEccCCcCCccCCcccc
Q 041249 636 KNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLG-------------------NLSSLRKISLAINNLAGSIPFTLS 696 (789)
Q Consensus 636 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-------------------~l~~L~~L~L~~N~l~~~~~~~~~ 696 (789)
+|+|+ .+|+.+. ++|+.|+|++|+|++ +|..+. -.++|+.|++++|.++ .+|..+.
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt-~LP~~l~ 345 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLTALPETLPPGLKTLEAGENALT-SLPASLP 345 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCcccc-CcccchhhHHHHHhcCCccccCCccccccceeccccCCccc-cCChhhc
Confidence 77776 4555442 366777777776663 333221 0134555555555555 2444332
Q ss_pred CCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccc----cCCC
Q 041249 697 KLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI----SNAS 772 (789)
Q Consensus 697 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~ 772 (789)
++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+ ..++
T Consensus 346 --~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~---~sL~~LdLs~N~L~-~LP~sl~~~~~~~~ 415 (754)
T PRK15370 346 --PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP---AALQIMQASRNNLV-RLPESLPHFRGEGP 415 (754)
T ss_pred --CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH---HHHHHHhhccCCcc-cCchhHHHHhhcCC
Confidence 45666666666665 4454442 45666666666666 5665543 24666666666666 334333 2345
Q ss_pred CCCeeeccCCcCc
Q 041249 773 KLEVFQALNNKLT 785 (789)
Q Consensus 773 ~L~~L~l~~N~l~ 785 (789)
++..|++.+|+|+
T Consensus 416 ~l~~L~L~~Npls 428 (754)
T PRK15370 416 QPTRIIVEYNPFS 428 (754)
T ss_pred CccEEEeeCCCcc
Confidence 6667777777765
No 434
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.70 E-value=7e-17 Score=156.82 Aligned_cols=190 Identities=16% Similarity=0.052 Sum_probs=138.4
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch----hhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCce
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR----ASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~ 346 (789)
+.....|+.|+||+||.+.. .+.+++.+.+.....- ....+.+|+++++++. |+++.+++++. .
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~ 72 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------G 72 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------C
Confidence 34577899999999996655 5788888887655331 1235889999999995 58899888761 5
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC-CCCceecCCCCcee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL-KPSNILLDEEMVSH 425 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl-k~~Nill~~~~~~k 425 (789)
.+++|||+.+.+|.+.... ....+..|++.+|+++|..| |||||| ||+||+++.++.++
T Consensus 73 ~~lvmeyI~G~~L~~~~~~-----------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~ 132 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPPR-----------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPA 132 (218)
T ss_pred EEEEEeeecCccHHhhhhh-----------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEE
Confidence 6899999998888654311 12357789999999999998 999999 79999999999999
Q ss_pred eCcccccccCCCCCCc----c-------ceeeecccccccCcccCCC-CCcC-ccccchhhHHHHHHHHHhcCCCCcccc
Q 041249 426 VGDFGLARFLPPTHVQ----T-------SSIGVKGSIGYIAPEYGLG-SEVS-TNGDVYSYGILMLELIIRKKPSDIMFE 492 (789)
Q Consensus 426 l~Dfgla~~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~-~~~~-~k~DV~sfGvvl~elltG~~P~~~~~~ 492 (789)
|+|||+|....+.... . .......+..|++|+...- ...+ ...+.++-|.-+|.++||+.|.....+
T Consensus 133 LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 133 VIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred EEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 9999999976554420 0 0001223445555543221 1223 557888999999999999999864433
No 435
>PRK10345 hypothetical protein; Provisional
Probab=99.67 E-value=3.3e-16 Score=155.43 Aligned_cols=142 Identities=18% Similarity=0.288 Sum_probs=109.6
Q ss_pred CCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-----CCCccceeeeeeccCCCCCCce
Q 041249 272 FSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-----RHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 272 f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~~~~~~~ 346 (789)
.+..+.||+|++|.||. +++++.. +||++........+.+.+|+++++.+ .||||++++|++.... +...
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence 45578999999999996 6556555 69988766555667899999999999 5799999999987643 1123
Q ss_pred -EEEEeec--cCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHH-hhhhcCCCCCceecCCCCCceecCC--
Q 041249 347 -KALVYEF--MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASAL-DYLHHDCQPITTHCDLKPSNILLDE-- 420 (789)
Q Consensus 347 -~~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL-~~LH~~~~~~ivH~dlk~~Nill~~-- 420 (789)
..+|+|| +..|+|.+++... .+++. ..++.+++.++ +|||+.+ ||||||||+||+++.
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-----------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~ 142 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-----------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRIS 142 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-----------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccC
Confidence 3478999 5589999999532 23433 35678888887 9999998 999999999999974
Q ss_pred --CCceeeCc-cccccc
Q 041249 421 --EMVSHVGD-FGLARF 434 (789)
Q Consensus 421 --~~~~kl~D-fgla~~ 434 (789)
+..++|+| ||....
T Consensus 143 ~~~~~~~LiDg~G~~~~ 159 (210)
T PRK10345 143 ESEVIPVVCDNIGESTF 159 (210)
T ss_pred CCCCcEEEEECCCCcce
Confidence 34899999 555444
No 436
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.67 E-value=3.1e-18 Score=184.35 Aligned_cols=230 Identities=23% Similarity=0.264 Sum_probs=157.1
Q ss_pred eeEeccCccccccc----ccccccCccccchhcccCCcccc------cCcccccCccceeeecccCCCCccCCCccCcCC
Q 041249 557 VTILDLESLKLAGS----ILPHIGNLSFLKILNLENNSFTH------EIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSC 626 (789)
Q Consensus 557 l~~l~l~s~~~~~~----~l~~l~~l~~L~~L~L~~N~l~~------~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l 626 (789)
++.+++..+.+... ....+...+.|++|+++++.+.+ .++..|..+++|+.|++++|.+.+..+..+..+
T Consensus 25 L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l 104 (319)
T cd00116 25 LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESL 104 (319)
T ss_pred ccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHH
Confidence 66666666665322 23445567778888888887762 234556677888888888888876666655555
Q ss_pred CC---CcEEEcccCCCCC----CCCcccCCC-CCCcEEEccCCCCCcc----CCcCCCCCCCCCEEEccCCcCCcc----
Q 041249 627 SN---LIRIGLAKNQLMG----KIPSDFGSL-SKIEVLSLGFNNLIGS----IPPPLGNLSSLRKISLAINNLAGS---- 690 (789)
Q Consensus 627 ~~---L~~L~l~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~---- 690 (789)
.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+..+++|++|+|++|.+++.
T Consensus 105 ~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 184 (319)
T cd00116 105 LRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRA 184 (319)
T ss_pred hccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHH
Confidence 54 8888888888873 223344556 7888888888888732 334466677888888888888742
Q ss_pred CCccccCCCCCCeeeccCcccccc----CCccccCCCCccEEEccCCcccccCCcccccC----CCCccEEEccCCcccc
Q 041249 691 IPFTLSKLKNLVILYLGVNRLSGI----VPSSIFNISSIAEFDVGENKIQGNIPLDYGFT----LQNLQYFSIGTNRITG 762 (789)
Q Consensus 691 ~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~----l~~L~~L~L~~N~l~~ 762 (789)
++..+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++.....+... .+.|++|++++|.+++
T Consensus 185 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~ 264 (319)
T cd00116 185 LAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITD 264 (319)
T ss_pred HHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCc
Confidence 333455667888888888888643 33456677888888888888874322222222 3688888888888862
Q ss_pred ----cCcccccCCCCCCeeeccCCcCcc
Q 041249 763 ----AIPPSISNASKLEVFQALNNKLTG 786 (789)
Q Consensus 763 ----~~~~~~~~l~~L~~L~l~~N~l~~ 786 (789)
.+...+..+++|+.+++++|.++.
T Consensus 265 ~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 265 DGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 233455666788888888888875
No 437
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.65 E-value=4e-17 Score=186.30 Aligned_cols=202 Identities=24% Similarity=0.330 Sum_probs=161.7
Q ss_pred CCCCcccccCCccEEEEEEcCCceEEEEEEecc-----ccchh-hHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCce
Q 041249 273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNL-----HHHRA-SRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDF 346 (789)
Q Consensus 273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~-----~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 346 (789)
...+.+|.|.+|.|+........+..+.|.++. ..... ...+..|..+-.+++|+|++..+..+.+.+ .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----G 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----c
Confidence 457789999999888777764555555554431 11111 122566777788899999999888877665 3
Q ss_pred EEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceee
Q 041249 347 KALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHV 426 (789)
Q Consensus 347 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 426 (789)
..-+|||++. +|..++... ..+...++-.+..|+..|+.|+|+.| +.|||+|++|++++.++.+|+
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~----------~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki 461 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSN----------GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKI 461 (601)
T ss_pred chhhhhcccH-HHHHHHhcc----------cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEE
Confidence 3334999999 999998643 46788889999999999999999999 999999999999999999999
Q ss_pred CcccccccCCCCCCc--cceeeecccccccCcccCCCCCcCcc-ccchhhHHHHHHHHHhcCCCCccccC
Q 041249 427 GDFGLARFLPPTHVQ--TSSIGVKGSIGYIAPEYGLGSEVSTN-GDVYSYGILMLELIIRKKPSDIMFEG 493 (789)
Q Consensus 427 ~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k-~DV~sfGvvl~elltG~~P~~~~~~~ 493 (789)
+|||.+.....+... ....+..|+-+|+|||.....+|++. .||||.|+++..|++|+.||......
T Consensus 462 ~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 462 IDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred eecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 999999987655543 45567889999999999999999876 99999999999999999999765443
No 438
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.65 E-value=2e-16 Score=183.66 Aligned_cols=202 Identities=18% Similarity=0.192 Sum_probs=161.6
Q ss_pred HHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCC---CCccceeeeeeccC
Q 041249 263 QNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIR---HRNLVKVFTACSGV 339 (789)
Q Consensus 263 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 339 (789)
.+.+...+.|.+...||+|+||.||+|...+ ++.||+|+-+....- +|..-.+++.+|+ -+.|+.+.......
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3555567889999999999999999999985 999999997654332 3333344444554 34455554444333
Q ss_pred CCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecC
Q 041249 340 DYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLD 419 (789)
Q Consensus 340 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~ 419 (789)
+ ...+|+||.+-|+|.+++... +.++|.-.+.++.|++.-+++||..+ ||||||||.|.+|.
T Consensus 767 ~-----~S~lv~ey~~~Gtlld~~N~~----------~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~ 828 (974)
T KOG1166|consen 767 N-----ASVLVSEYSPYGTLLDLINTN----------KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLR 828 (974)
T ss_pred C-----cceeeeeccccccHHHhhccC----------CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEee
Confidence 3 568999999999999999744 67889999999999999999999999 99999999999994
Q ss_pred -------CCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCC
Q 041249 420 -------EEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486 (789)
Q Consensus 420 -------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P 486 (789)
+...++|+|||.+.-+..-.......++++|-.+-++|+..+..++..+|.|.+..+++-|+.|+.-
T Consensus 829 ~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 829 REICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 3346799999999866533333456678899999999999999999999999999999999999743
No 439
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=99.64 E-value=1.5e-17 Score=179.13 Aligned_cols=235 Identities=21% Similarity=0.252 Sum_probs=175.7
Q ss_pred hhccccceeeEeccCccccc------ccccccccCccccchhcccCCcccccCcccccCccc---eeeecccCCCCcc--
Q 041249 549 RIGSKAQKVTILDLESLKLA------GSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRR---LQVPDLNNNSIGG-- 617 (789)
Q Consensus 549 ~i~~~c~~l~~l~l~s~~~~------~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~i~~-- 617 (789)
+....+..++.+++..+... ......+..+++|+.|++++|.+.+..+..|..+.+ |+.|++++|++++
T Consensus 45 ~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~ 124 (319)
T cd00116 45 SALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRG 124 (319)
T ss_pred HHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHH
Confidence 33344555666666665544 223356677899999999999998777777777666 9999999999983
Q ss_pred --CCCccCcCC-CCCcEEEcccCCCCCC----CCcccCCCCCCcEEEccCCCCCcc----CCcCCCCCCCCCEEEccCCc
Q 041249 618 --EIPVNLSSC-SNLIRIGLAKNQLMGK----IPSDFGSLSKIEVLSLGFNNLIGS----IPPPLGNLSSLRKISLAINN 686 (789)
Q Consensus 618 --~~p~~~~~l-~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~ 686 (789)
.+...+..+ ++|+.|++++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|++|+|++|.
T Consensus 125 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~ 204 (319)
T cd00116 125 LRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG 204 (319)
T ss_pred HHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCc
Confidence 233455667 8999999999999843 344567788999999999999842 33445566899999999999
Q ss_pred CCcc----CCccccCCCCCCeeeccCccccccCCcccc-----CCCCccEEEccCCcccc----cCCcccccCCCCccEE
Q 041249 687 LAGS----IPFTLSKLKNLVILYLGVNRLSGIVPSSIF-----NISSIAEFDVGENKIQG----NIPLDYGFTLQNLQYF 753 (789)
Q Consensus 687 l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~ip~~~~~~l~~L~~L 753 (789)
+++. +...+..+++|++|++++|.+++.....+. ..++|+.|++++|.+++ .+...+. .+++|++|
T Consensus 205 i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~-~~~~L~~l 283 (319)
T cd00116 205 LTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLA-EKESLLEL 283 (319)
T ss_pred cChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHh-cCCCccEE
Confidence 9744 344567889999999999999863333332 24799999999999961 2333333 56899999
Q ss_pred EccCCccccc----CcccccCC-CCCCeeeccCCcC
Q 041249 754 SIGTNRITGA----IPPSISNA-SKLEVFQALNNKL 784 (789)
Q Consensus 754 ~L~~N~l~~~----~~~~~~~l-~~L~~L~l~~N~l 784 (789)
++++|.++.. ....+... +.|++|++.+|++
T Consensus 284 ~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 284 DLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred ECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 9999999965 44445555 6899999999975
No 440
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.64 E-value=3.6e-16 Score=170.10 Aligned_cols=216 Identities=25% Similarity=0.331 Sum_probs=159.1
Q ss_pred HhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc
Q 041249 321 LRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH 400 (789)
Q Consensus 321 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~ 400 (789)
|+.+.|.|+.+++|.+.... ..+.|.+|+..|+|.+.+.. ....++|.-...+.+++++||+|+|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~-----~~~~i~~~c~rGsl~D~i~~---------~~~~~d~~F~~s~~rdi~~Gl~ylh~ 66 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP-----EMIVIWEYCSRGSLLDILSN---------EDIKLDYFFILSFIRDISKGLAYLHN 66 (484)
T ss_pred CcccchhhhhhheeeEecCC-----ceEEEEeeecCccHHhHHhc---------cccCccHHHHHHHHHHHHHHHHHHhc
Confidence 35678999999999998775 88999999999999999964 35678999999999999999999997
Q ss_pred CCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCCCC-------cCccccchhh
Q 041249 401 DCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSE-------VSTNGDVYSY 473 (789)
Q Consensus 401 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~k~DV~sf 473 (789)
.. ...|+.++++|.+++..|.+|++|||+....................-|.|||.+.... .+.++|||||
T Consensus 67 s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 67 SP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred Cc--ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 54 23999999999999999999999999998875421111111223456799999987641 4778999999
Q ss_pred HHHHHHHHHhcCCCCccccCCc--cHHHHHHHhCCCchhhhccCCcccChhhHHHhhhhhhhhhhhchhHHHHHHHHhhc
Q 041249 474 GILMLELIIRKKPSDIMFEGDM--NLHNFARMALPDHVMDIVDSTLLNDVEDLAIISNQRQRQIRVNNIIECLISMLRIG 551 (789)
Q Consensus 474 Gvvl~elltG~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~ 551 (789)
|++++|+++.+.||+....... .+...++.... ....|.+. ...+....+..++
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~----~~~rP~i~--------------------~~~e~~~~l~~l~ 200 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGS----NPFRPSIE--------------------LLNELPPELLLLV 200 (484)
T ss_pred HHHHHHHHhccCccccccccCChHHHHHHHHhcCC----CCcCcchh--------------------hhhhcchHHHHHH
Confidence 9999999999999986433222 23333332000 11111111 0012333677888
Q ss_pred cccceeeEeccCccccccccccccc
Q 041249 552 SKAQKVTILDLESLKLAGSILPHIG 576 (789)
Q Consensus 552 ~~c~~l~~l~l~s~~~~~~~l~~l~ 576 (789)
..|+.-.|..||+...+......+.
T Consensus 201 ~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 201 ARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred HHhcccChhhCccHHHHHhhhhhhc
Confidence 9999999999999988766554443
No 441
>smart00090 RIO RIO-like kinase.
Probab=99.60 E-value=3.8e-15 Score=151.70 Aligned_cols=146 Identities=18% Similarity=0.137 Sum_probs=112.3
Q ss_pred CCCCCCcccccCCccEEEEE-EcCCceEEEEEEeccccch------------------------hhHHHHHHHHHHhcCC
Q 041249 271 GFSSANLIGTGSFGSVYKGV-LDEGRTTVTVKVFNLHHHR------------------------ASRSFIAECRALRSIR 325 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 325 (789)
.|...+.||+|++|.||+|. ...+++.||+|+++..... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57788999999999999998 5558999999998754210 1123678999999997
Q ss_pred CC--ccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCC
Q 041249 326 HR--NLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQ 403 (789)
Q Consensus 326 h~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~ 403 (789)
+. .+.+++++. ..++||||+.++++....... ..+...+...++.|++.++++||..+
T Consensus 109 ~~~i~~p~~~~~~---------~~~lV~E~~~g~~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~g- 168 (237)
T smart00090 109 EAGVPVPKPIAWR---------RNVLVMEFIGGDGLPAPRLKD----------VEPEEEEEFELYDDILEEMRKLYKEG- 168 (237)
T ss_pred hcCCCCCeeeEec---------CceEEEEEecCCccccccccc----------CCcchHHHHHHHHHHHHHHHHHHhcC-
Confidence 53 344444321 348999999998887654222 23455667899999999999999775
Q ss_pred CCceecCCCCCceecCCCCceeeCcccccccCCCC
Q 041249 404 PITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT 438 (789)
Q Consensus 404 ~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 438 (789)
.++||||||+||+++ +++++++|||.+......
T Consensus 169 -~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 169 -ELVHGDLSEYNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred -CEEeCCCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence 499999999999999 889999999998865543
No 442
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.59 E-value=6.9e-15 Score=146.52 Aligned_cols=149 Identities=18% Similarity=0.134 Sum_probs=114.9
Q ss_pred HHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccch----------------------hhHHHHHHHH
Q 041249 262 YQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR----------------------ASRSFIAECR 319 (789)
Q Consensus 262 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~ 319 (789)
.+++.+....|...+.||+|+||.||++... +++.||||+++..... ....+..|..
T Consensus 7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 85 (198)
T cd05144 7 LHTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA 85 (198)
T ss_pred HHHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence 3455556656888999999999999999986 7999999997643211 1123677888
Q ss_pred HHhcCCCCc--cceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 041249 320 ALRSIRHRN--LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY 397 (789)
Q Consensus 320 ~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~ 397 (789)
.+.++.|++ +.+.++. ...++||||+.++++...... .....++.+++.++.+
T Consensus 86 ~l~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~ 140 (198)
T cd05144 86 ALKALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVK 140 (198)
T ss_pred HHHHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHH
Confidence 898887774 4444432 145899999999988765420 2346788999999999
Q ss_pred hhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCC
Q 041249 398 LHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439 (789)
Q Consensus 398 LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 439 (789)
+|..+ ++||||||+||++++++.++|+|||.+.......
T Consensus 141 lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 141 AYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred HHHCC---CCcCCCCcccEEEcCCCcEEEEECCccccCCCcc
Confidence 99987 9999999999999999999999999997655443
No 443
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.59 E-value=3.5e-16 Score=169.71 Aligned_cols=187 Identities=25% Similarity=0.263 Sum_probs=153.9
Q ss_pred cccccCCccEEEEEE---cCCceEEEEEEeccccch--hhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCceEEEE
Q 041249 277 LIGTGSFGSVYKGVL---DEGRTTVTVKVFNLHHHR--ASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGNDFKALV 350 (789)
Q Consensus 277 ~ig~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv 350 (789)
++|+|.||.|+.+.- ...++.+|.|+.+..... .......|..++...+ ||.++++-..++... ..+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-----kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-----KLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-----chhHh
Confidence 368899998886543 334677888887654222 2235667888888886 999999977776655 78999
Q ss_pred eeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCccc
Q 041249 351 YEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFG 430 (789)
Q Consensus 351 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 430 (789)
+++..+|.+...+... ..++......+...+|-|++++|..+ ++|||+|++||+++.+|++++.|||
T Consensus 76 ld~~rgg~lft~l~~~----------~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfg 142 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKE----------VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFG 142 (612)
T ss_pred hhhcccchhhhccccC----------CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCch
Confidence 9999999999888654 55677788889999999999999888 9999999999999999999999999
Q ss_pred ccccCCCCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCc
Q 041249 431 LARFLPPTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 431 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
+++..-..... +||..|||||+.. .....+|-||||++++||+||-.||..
T Consensus 143 lske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 143 LSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 99976544322 7899999999987 567889999999999999999999974
No 444
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.58 E-value=7e-16 Score=175.16 Aligned_cols=197 Identities=22% Similarity=0.248 Sum_probs=144.2
Q ss_pred CCCCCCcccccCCccEEEEEEcCCceEEEEEEecccc-chhhHHHHHHHHH--HhcCCCCccceeeeeeccCCCCCCceE
Q 041249 271 GFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHH-HRASRSFIAECRA--LRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 271 ~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
++.-.+.+|.+.|=.|.+|++++ |. |+||++-... ....+.|+++++. ...++|||.+++.-...... ..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~k-----AA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDK-----AA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhH-----HH
Confidence 56667889999999999999983 44 9999985443 3334444444333 44558999999865533222 44
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++|=+|..+ +|.+.+.- ...+...+...|+.|+.+|+..+|..+ |+|||||.+|||++.-.=+.|+
T Consensus 97 ylvRqyvkh-nLyDRlST----------RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~Lt 162 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLST----------RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLT 162 (1431)
T ss_pred HHHHHHHhh-hhhhhhcc----------chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhh
Confidence 566677765 78887743 356788899999999999999999998 9999999999999988888999
Q ss_pred cccccc--cCCCCCCccceee---ecccccccCcccCCC----------CC-cCccccchhhHHHHHHHHH-hcCCCC
Q 041249 428 DFGLAR--FLPPTHVQTSSIG---VKGSIGYIAPEYGLG----------SE-VSTNGDVYSYGILMLELII-RKKPSD 488 (789)
Q Consensus 428 Dfgla~--~~~~~~~~~~~~~---~~gt~~y~aPE~~~~----------~~-~~~k~DV~sfGvvl~ellt-G~~P~~ 488 (789)
||..=+ +++.+.+...+-. -..-..|+|||-+.. .. .+++.||||.|||+.||++ |++||+
T Consensus 163 DFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 163 DFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred cccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 996544 2333333222221 122346999996543 12 6789999999999999998 899997
No 445
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]
Probab=99.58 E-value=1.1e-16 Score=170.04 Aligned_cols=184 Identities=27% Similarity=0.456 Sum_probs=166.3
Q ss_pred CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEE
Q 041249 577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL 656 (789)
Q Consensus 577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 656 (789)
.++.-...||+.|++. ++|..+..+..|+.|.|.+|.|. .+|..+.++..|++|||+.|+++ .+|..+..|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 4666678999999999 89999999999999999999999 88999999999999999999999 7887777765 9999
Q ss_pred EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCccc
Q 041249 657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQ 736 (789)
Q Consensus 657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 736 (789)
-+++|+++ .+|..++.++.|..|+.+.|.|. .+|..++++.+|+.|.+..|++. .+|..+..| .|..||+|.|+|+
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 99999998 88889999999999999999998 78889999999999999999999 678888765 6999999999999
Q ss_pred ccCCcccccCCCCccEEEccCCcccccCcccccCC
Q 041249 737 GNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNA 771 (789)
Q Consensus 737 ~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 771 (789)
.||..+- +|..|++|-|.+|.++ ..|..++..
T Consensus 225 -~iPv~fr-~m~~Lq~l~LenNPLq-SPPAqIC~k 256 (722)
T KOG0532|consen 225 -YLPVDFR-KMRHLQVLQLENNPLQ-SPPAQICEK 256 (722)
T ss_pred -ecchhhh-hhhhheeeeeccCCCC-CChHHHHhc
Confidence 9999987 8999999999999999 566666543
No 446
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.57 E-value=2.5e-15 Score=153.93 Aligned_cols=206 Identities=21% Similarity=0.249 Sum_probs=131.3
Q ss_pred CCCCcccccCCccEEEEEEcCCceEEEEEEeccccc---hhhHHHHHHHHHHhcCCC-----------Cccceeeeeecc
Q 041249 273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH---RASRSFIAECRALRSIRH-----------RNLVKVFTACSG 338 (789)
Q Consensus 273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-----------~niv~l~~~~~~ 338 (789)
...+.||.|+++.||.+++.++++++|+|++..... ...+.+++|.-....+.+ .-++++--.-..
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 346789999999999999999999999999854432 234566666655555432 222222111111
Q ss_pred CCC-----C-CCc-----eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCce
Q 041249 339 VDY-----Q-GND-----FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITT 407 (789)
Q Consensus 339 ~~~-----~-~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iv 407 (789)
.+. . +.. ..+++|+-+. ++|.+++..-. ........+....++.+..|+.+.+++||+.| +|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~---~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALF---SRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHH---HHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHh---hcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 110 0 001 2356777664 57777753210 00011233455667888899999999999999 99
Q ss_pred ecCCCCCceecCCCCceeeCcccccccCCCCCCccceeeecccccccCcccCCC--------CCcCccccchhhHHHHHH
Q 041249 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGVKGSIGYIAPEYGLG--------SEVSTNGDVYSYGILMLE 479 (789)
Q Consensus 408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DV~sfGvvl~e 479 (789)
|+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999887765432211 234467899997543 247999999999999999
Q ss_pred HHHhcCCCCcc
Q 041249 480 LIIRKKPSDIM 490 (789)
Q Consensus 480 lltG~~P~~~~ 490 (789)
|.+|+.||+..
T Consensus 243 lWC~~lPf~~~ 253 (288)
T PF14531_consen 243 LWCGRLPFGLS 253 (288)
T ss_dssp HHHSS-STCCC
T ss_pred HHHccCCCCCC
Confidence 99999999854
No 447
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.56 E-value=1.6e-14 Score=165.78 Aligned_cols=147 Identities=20% Similarity=0.241 Sum_probs=114.3
Q ss_pred ccHHHHHHhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEe--ccccc------hhhHHHHHHHHHHhcCCCCccce
Q 041249 260 LSYQNLHNATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVF--NLHHH------RASRSFIAECRALRSIRHRNLVK 331 (789)
Q Consensus 260 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~--~~~~~------~~~~~~~~e~~~l~~l~h~niv~ 331 (789)
.++.........|...+.||+|+||+||+|.+... .+++|+. +.... .....+..|+++++.++|++++.
T Consensus 323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 400 (535)
T PRK09605 323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT 400 (535)
T ss_pred eeeccccccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence 34444444455667789999999999999998633 3444432 11111 12356889999999999999988
Q ss_pred eeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL 411 (789)
Q Consensus 332 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl 411 (789)
...++.... ..++||||+++++|.+++. ....++.+++.+|.|||..+ ++|||+
T Consensus 401 p~~~~~~~~-----~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH~~g---iiHrDl 454 (535)
T PRK09605 401 PVIYDVDPE-----EKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLHKAG---IVHGDL 454 (535)
T ss_pred eEEEEEeCC-----CCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHHhCC---CccCCC
Confidence 766665433 5689999999999998773 35678999999999999988 999999
Q ss_pred CCCceecCCCCceeeCcccccccC
Q 041249 412 KPSNILLDEEMVSHVGDFGLARFL 435 (789)
Q Consensus 412 k~~Nill~~~~~~kl~Dfgla~~~ 435 (789)
||+||++ +++.++++|||+++..
T Consensus 455 kp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 455 TTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999 6789999999999864
No 448
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.56 E-value=1.6e-14 Score=145.52 Aligned_cols=135 Identities=21% Similarity=0.265 Sum_probs=110.2
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEeccccch--------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceE
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFK 347 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 347 (789)
+.||+|++|.||+|.+ .+..|++|........ ....+..|++.+..+.|+++.....++.... ..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence 5799999999999988 4778999986543211 1245788999999999998876655554333 57
Q ss_pred EEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeC
Q 041249 348 ALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVG 427 (789)
Q Consensus 348 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 427 (789)
++||||+++++|.+++... .+ ++..++.+++.+|.++|..+ ++|||++|.||+++ ++.++++
T Consensus 75 ~lv~e~~~G~~L~~~~~~~-------------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~li 136 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSN-------------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLI 136 (211)
T ss_pred EEEEEEeCCcCHHHHHHhc-------------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEE
Confidence 8999999999999988532 12 78899999999999999888 99999999999999 7889999
Q ss_pred cccccccC
Q 041249 428 DFGLARFL 435 (789)
Q Consensus 428 Dfgla~~~ 435 (789)
|||.+...
T Consensus 137 Df~~a~~~ 144 (211)
T PRK14879 137 DFGLAEFS 144 (211)
T ss_pred ECCcccCC
Confidence 99998763
No 449
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]
Probab=99.53 E-value=2.6e-16 Score=167.28 Aligned_cols=194 Identities=24% Similarity=0.373 Sum_probs=172.8
Q ss_pred hhcccCCcccccCcc-cc-cCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccC
Q 041249 583 ILNLENNSFTHEIPS-EI-GRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGF 660 (789)
Q Consensus 583 ~L~L~~N~l~~~~~~-~~-~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 660 (789)
.|.|++-++.. .|. ++ ..+..-...||+.|++. ++|..+..+..|+.|.|.+|.|. .+|..+.++..|++|||+.
T Consensus 54 ~l~Ls~rrlk~-fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLKE-FPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhhc-CCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 45566666663 332 22 35667788999999999 89999999999999999999998 8999999999999999999
Q ss_pred CCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCC
Q 041249 661 NNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIP 740 (789)
Q Consensus 661 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip 740 (789)
|+++ ..|..++.|+ |+.|-+++|+++ .+|+.++.+..|..||.+.|.|. .+|..+..+.+|+.|.+..|.+. .+|
T Consensus 131 NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp 205 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLP 205 (722)
T ss_pred chhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCC
Confidence 9998 7888888887 999999999999 89999999999999999999999 78999999999999999999999 999
Q ss_pred cccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCccc
Q 041249 741 LDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGE 787 (789)
Q Consensus 741 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 787 (789)
.++. . -.|..||+|.|+|+ .+|..|.+|+.|++|-|.+|++...
T Consensus 206 ~El~-~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 206 EELC-S-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred HHHh-C-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC
Confidence 9986 4 46899999999999 7899999999999999999999763
No 450
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.52 E-value=4.2e-14 Score=141.06 Aligned_cols=131 Identities=21% Similarity=0.255 Sum_probs=103.1
Q ss_pred cccccCCccEEEEEEcCCceEEEEEEeccccch--------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 277 LIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 277 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.||+|++|.||+|.+ ++..|++|........ ....+..|++++..+.|+++.....++.... ..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence 489999999999996 4788999986433211 1255778999999998876544333333322 468
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
+||||+++++|.+++... . ..++.+++.+|.++|..+ ++|||++|.||+++ ++.++++|
T Consensus 74 lv~e~~~g~~l~~~~~~~----------~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liD 132 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEG----------N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLID 132 (199)
T ss_pred EEEEEECCccHHHHHhhc----------H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEE
Confidence 999999999999887432 0 078999999999999888 99999999999999 88999999
Q ss_pred ccccccC
Q 041249 429 FGLARFL 435 (789)
Q Consensus 429 fgla~~~ 435 (789)
||.+...
T Consensus 133 fg~a~~~ 139 (199)
T TIGR03724 133 FGLGKYS 139 (199)
T ss_pred CCCCcCC
Confidence 9998763
No 451
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.50 E-value=5.4e-14 Score=143.64 Aligned_cols=150 Identities=25% Similarity=0.282 Sum_probs=111.9
Q ss_pred CCCccceeeeeeccCC----------------------CCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHH
Q 041249 325 RHRNLVKVFTACSGVD----------------------YQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLL 382 (789)
Q Consensus 325 ~h~niv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~ 382 (789)
+|||||++.+.|.++- +.+....|+||.-... +|++++... ..+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----------~~s~r 341 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----------HRSYR 341 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----------CCchH
Confidence 5999999999876542 1234457888876664 899988643 34666
Q ss_pred HHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceec--CCCC--ceeeCcccccccCCCCC---Ccccee-eeccccccc
Q 041249 383 QRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILL--DEEM--VSHVGDFGLARFLPPTH---VQTSSI-GVKGSIGYI 454 (789)
Q Consensus 383 ~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfgla~~~~~~~---~~~~~~-~~~gt~~y~ 454 (789)
...-|+.|+++|+.|||.+| |.|||+|+.|||+ +++. ...++|||.+-.-..-. ...... ...|...-|
T Consensus 342 ~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm 418 (598)
T KOG4158|consen 342 TGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM 418 (598)
T ss_pred HHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence 77889999999999999999 9999999999999 3443 55889999876433211 111111 233666789
Q ss_pred CcccCCCC--C----cCccccchhhHHHHHHHHHhcCCCCc
Q 041249 455 APEYGLGS--E----VSTNGDVYSYGILMLELIIRKKPSDI 489 (789)
Q Consensus 455 aPE~~~~~--~----~~~k~DV~sfGvvl~elltG~~P~~~ 489 (789)
|||+.... + --.|+|.|+.|.+.||++....||+.
T Consensus 419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 99987652 2 24789999999999999999999985
No 452
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=99.49 E-value=2.5e-14 Score=158.74 Aligned_cols=196 Identities=28% Similarity=0.455 Sum_probs=125.4
Q ss_pred hhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCC-CCcEEEcccCCCCCCCCcccCCCCCCcEEEccCC
Q 041249 583 ILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCS-NLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN 661 (789)
Q Consensus 583 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 661 (789)
.+++..|.+.. ....+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 46666666642 3333455566777777777777 5555555553 7777777777776 45455666777777777777
Q ss_pred CCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCc
Q 041249 662 NLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL 741 (789)
Q Consensus 662 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~ 741 (789)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|++++|++. ..+..+..+.++..|.+++|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 776 44444446667777777777776 55555455556777777777544 45566667777777777777776 4444
Q ss_pred ccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcCcccC
Q 041249 742 DYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTGEV 788 (789)
Q Consensus 742 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 788 (789)
.+. .+++++.|++++|.++...+ +..+.+++.|++++|.++...
T Consensus 250 ~~~-~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~ 293 (394)
T COG4886 250 SIG-NLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNAL 293 (394)
T ss_pred hhc-cccccceecccccccccccc--ccccCccCEEeccCccccccc
Confidence 444 56667777777777774332 666777777777777666543
No 453
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.46 E-value=2e-14 Score=153.28 Aligned_cols=130 Identities=28% Similarity=0.478 Sum_probs=111.4
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
..++.|+++...+|.+++... .....-++.....++.|++.|+.| ++ .+|+|+||.||+...+...|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-------~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-------RTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-------CcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhh
Confidence 468999999999999999755 234566888999999999999999 55 89999999999999999999
Q ss_pred eCcccccccCCCCC----CccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHH-hcCCCC
Q 041249 426 VGDFGLARFLPPTH----VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELII-RKKPSD 488 (789)
Q Consensus 426 l~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~ellt-G~~P~~ 488 (789)
|+|||+........ .....+...||..||+||.+.+..|+.|+||||+|++++|+++ =..+++
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e 464 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE 464 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH
Confidence 99999998876555 2334445669999999999999999999999999999999988 455543
No 454
>PLN03150 hypothetical protein; Provisional
Probab=99.45 E-value=2.3e-13 Score=157.88 Aligned_cols=111 Identities=38% Similarity=0.632 Sum_probs=64.9
Q ss_pred CCEEEccCCcCCCCCcccccCCCCCCEEeccCCCCCCcCCccccCCcccccccccCCCCCccceeecCCcccCCCchhhh
Q 041249 71 LVALDLSRNQFRGSFPTEVGNLINLETLTVSGNILQGEIPSTLGSCIKLEILEMQGNVFQGLTILDLSRNKLSGEIPEFL 150 (789)
Q Consensus 71 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~l~~l~ls~N~l~~~~p~~~ 150 (789)
++.|+|++|.|+|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+. |||++|+++|.+|+.+
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~-------------LdLs~N~lsg~iP~~l 486 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV-------------LDLSYNSFNGSIPESL 486 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE-------------EECCCCCCCCCCchHH
Confidence 556666666666666666666666666666666666666666655555443 3333444555666666
Q ss_pred cCcccccEEecccCCCCCCCCCc--ccccCCccccccCCCccccCC
Q 041249 151 VGLKVIENLNLSYNDLEGMVPTE--GVFKNASAISVLGNNKLCGGI 194 (789)
Q Consensus 151 ~~~~~l~~l~ls~N~~~~~~~~~--~~~~~~~~~~~~~n~~~~~~~ 194 (789)
..+++|+.|+|++|+++|.+|.. ........+.+.+|+.+|+.+
T Consensus 487 ~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 487 GQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred hcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 66666666666666666666543 112233445666777778643
No 455
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.44 E-value=5.8e-14 Score=159.83 Aligned_cols=167 Identities=27% Similarity=0.364 Sum_probs=122.8
Q ss_pred hcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEE
Q 041249 269 TDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKA 348 (789)
Q Consensus 269 ~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 348 (789)
.+||..+++|..|+||.||...++.+.+.+|+|+=+ +. .. -+||..+.+ ..+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~----li------------lRnilt~a~-----------npf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN----LI------------LRNILTFAG-----------NPF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc----hh------------hhccccccC-----------Ccc
Confidence 369999999999999999999999889999995421 11 00 012332222 112
Q ss_pred EEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 349 LVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 349 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
.| |+-...++.. ..++ .+++.+++|+|+.+ |||||+||+|.+|+.-+++|++|
T Consensus 134 vv------gDc~tllk~~----------g~lP--------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTD 186 (1205)
T KOG0606|consen 134 VV------GDCATLLKNI----------GPLP--------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTD 186 (1205)
T ss_pred ee------chhhhhcccC----------CCCc--------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccc
Confidence 22 3333333221 1111 22378999999888 99999999999999999999999
Q ss_pred ccccccCCCCC------------C-ccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCCcc
Q 041249 429 FGLARFLPPTH------------V-QTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSDIM 490 (789)
Q Consensus 429 fgla~~~~~~~------------~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~~~ 490 (789)
||+++...... . +.....+.||+.|+|||++....|...+|.|++|+++||.+.|+.||+..
T Consensus 187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 99988653221 1 11222457999999999999999999999999999999999999999743
No 456
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.42 E-value=5.9e-13 Score=131.36 Aligned_cols=138 Identities=20% Similarity=0.176 Sum_probs=97.2
Q ss_pred CCcccccCCccEEEEEEcCCceEEEEEEeccccchh--hHH----------------------HHHHHHHHhcCCCCc--
Q 041249 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--SRS----------------------FIAECRALRSIRHRN-- 328 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n-- 328 (789)
.+.||+|+||.||+|... +++.||||+++...... ... ...|.+.+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 78999999986542211 111 134555555553332
Q ss_pred cceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhc-CCCCCce
Q 041249 329 LVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHH-DCQPITT 407 (789)
Q Consensus 329 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~iv 407 (789)
+.+.++.. ..++||||++++++....... . . ...+...++.+++.++.++|. .+ ++
T Consensus 81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~--------~--~-~~~~~~~~~~~~~~~l~~lh~~~~---iv 137 (187)
T cd05119 81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKD--------V--R-LLEDPEELYDQILELMRKLYREAG---LV 137 (187)
T ss_pred CCceEecC---------CCEEEEEEeCCCCccChhhhh--------h--h-hcccHHHHHHHHHHHHHHHhhccC---cC
Confidence 33333321 358999999996543221110 0 0 015578899999999999998 77 99
Q ss_pred ecCCCCCceecCCCCceeeCcccccccCCC
Q 041249 408 HCDLKPSNILLDEEMVSHVGDFGLARFLPP 437 (789)
Q Consensus 408 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 437 (789)
|+||||+||+++ ++.++++|||.+.....
T Consensus 138 H~Dl~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 138 HGDLSEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred cCCCChhhEEEE-CCcEEEEECcccccccC
Confidence 999999999999 89999999999976544
No 457
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.41 E-value=1.4e-12 Score=123.44 Aligned_cols=136 Identities=22% Similarity=0.253 Sum_probs=112.0
Q ss_pred CCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCC--CccceeeeeeccCCCCCCceEEEEe
Q 041249 274 SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRH--RNLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 274 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
+.+.||+|.++.||++... ++.+++|....... ...+..|++.+..++| ..+.+++++..... ..++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~-----~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDG-----WSYLLM 72 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-----ccEEEE
Confidence 3567999999999999986 37899999865433 4678999999999976 58888888765433 689999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccc
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
||+.++.+..+ +......++.+++.+++++|.....+++|+|++|+||++++.+.+++.|||.
T Consensus 73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 99998655432 4556788899999999999987556699999999999999989999999999
Q ss_pred cccC
Q 041249 432 ARFL 435 (789)
Q Consensus 432 a~~~ 435 (789)
+...
T Consensus 136 ~~~~ 139 (155)
T cd05120 136 AGYG 139 (155)
T ss_pred ccCC
Confidence 8754
No 458
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=99.41 E-value=1.2e-13 Score=153.35 Aligned_cols=186 Identities=34% Similarity=0.518 Sum_probs=150.8
Q ss_pred cccCccccchhcccCCcccccCcccccCcc-ceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCC
Q 041249 574 HIGNLSFLKILNLENNSFTHEIPSEIGRLR-RLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSK 652 (789)
Q Consensus 574 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 652 (789)
.+..++.++.|++.+|.++ .++.....++ +|+.|++++|.|. .+|..+..+++|+.|++++|++. .+|.....+++
T Consensus 111 ~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~ 187 (394)
T COG4886 111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN 187 (394)
T ss_pred hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhh
Confidence 4445578899999999999 4566566664 8999999999998 66677889999999999999998 56655557889
Q ss_pred CcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccC
Q 041249 653 IEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGE 732 (789)
Q Consensus 653 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 732 (789)
|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+.+++++..|.+++|++. .++..+..+++++.|++++
T Consensus 188 L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~ 264 (394)
T COG4886 188 LNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSN 264 (394)
T ss_pred hhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccc
Confidence 999999999998 66665555667999999999654 56777888999999999999998 5578888888999999999
Q ss_pred CcccccCCcccccCCCCccEEEccCCcccccCcccc
Q 041249 733 NKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSI 768 (789)
Q Consensus 733 N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 768 (789)
|.++ .++. +. .+.+|+.|++++|.+....|...
T Consensus 265 n~i~-~i~~-~~-~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 265 NQIS-SISS-LG-SLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred cccc-cccc-cc-ccCccCEEeccCccccccchhhh
Confidence 9998 7777 44 78999999999998876554443
No 459
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.35 E-value=5.7e-12 Score=128.69 Aligned_cols=141 Identities=17% Similarity=0.126 Sum_probs=106.0
Q ss_pred CCccc-ccCCccEEEEEEcCCceEEEEEEecccc-------------chhhHHHHHHHHHHhcCCCCcc--ceeeeeecc
Q 041249 275 ANLIG-TGSFGSVYKGVLDEGRTTVTVKVFNLHH-------------HRASRSFIAECRALRSIRHRNL--VKVFTACSG 338 (789)
Q Consensus 275 ~~~ig-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~ 338 (789)
...|| .||.|+||..... +..++||.+.... ......+.+|++++.++.|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45787 8999999999885 7789998874311 1223567889999999998885 566666433
Q ss_pred CCCCCCceEEEEeeccCC-CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCcee
Q 041249 339 VDYQGNDFKALVYEFMQN-GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNIL 417 (789)
Q Consensus 339 ~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nil 417 (789)
.. ......++|+|++++ .+|.+++... .++.. .+.+++.++.+||..| |+||||||.|||
T Consensus 114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~~-----------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NIL 174 (239)
T PRK01723 114 RH-GLFYRADILIERIEGARDLVALLQEA-----------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNIL 174 (239)
T ss_pred ec-CcceeeeEEEEecCCCCCHHHHHhcC-----------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEE
Confidence 21 111124699999997 6888887432 23332 3578999999999998 999999999999
Q ss_pred cCCCCceeeCcccccccCC
Q 041249 418 LDEEMVSHVGDFGLARFLP 436 (789)
Q Consensus 418 l~~~~~~kl~Dfgla~~~~ 436 (789)
++.++.++++|||.+....
T Consensus 175 v~~~~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 175 LDPDGKFWLIDFDRGELRT 193 (239)
T ss_pred EcCCCCEEEEECCCcccCC
Confidence 9998999999999988754
No 460
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.35 E-value=2.9e-13 Score=154.84 Aligned_cols=218 Identities=25% Similarity=0.281 Sum_probs=172.2
Q ss_pred cCCCCCCcccccCCccEEEEEEcC-CceEEEEEEecccc--chhhHHHHHHHHHHhcCC-CCccceeeeeeccCCCCCCc
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDE-GRTTVTVKVFNLHH--HRASRSFIAECRALRSIR-HRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~~~ 345 (789)
..|...+.||+|.|+.|-...... ....+|+|.+.... .........|..+=..+. |+|++.+++......
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~----- 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR----- 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-----
Confidence 356667789999999999888742 34456666664443 223344555777777775 999999998866555
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhh-cCCCCCceecCCCCCceecCCCC-c
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLH-HDCQPITTHCDLKPSNILLDEEM-V 423 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivH~dlk~~Nill~~~~-~ 423 (789)
..+++.||..+|++.+.+... .....+....-.+..|+..|+.|+| ..+ ++|+|+||+|.+++..+ .
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~--------~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~ 163 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHP--------DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSA 163 (601)
T ss_pred ccccccCcccccccccccccC--------CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCc
Confidence 789999999999998877311 1224566677889999999999999 777 99999999999999999 9
Q ss_pred eeeCcccccccCCC-CCCccceeeecc-cccccCcccCCCC-CcCccccchhhHHHHHHHHHhcCCCCccccCCccHHHH
Q 041249 424 SHVGDFGLARFLPP-THVQTSSIGVKG-SIGYIAPEYGLGS-EVSTNGDVYSYGILMLELIIRKKPSDIMFEGDMNLHNF 500 (789)
Q Consensus 424 ~kl~Dfgla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~DV~sfGvvl~elltG~~P~~~~~~~~~~~~~~ 500 (789)
.|++|||+|..+.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........+..|
T Consensus 164 l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~ 243 (601)
T KOG0590|consen 164 LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW 243 (601)
T ss_pred ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee
Confidence 99999999999988 565555666778 9999999998884 56888999999999999999999999776666666666
Q ss_pred HHH
Q 041249 501 ARM 503 (789)
Q Consensus 501 ~~~ 503 (789)
...
T Consensus 244 ~~~ 246 (601)
T KOG0590|consen 244 KSN 246 (601)
T ss_pred ccc
Confidence 554
No 461
>PLN03150 hypothetical protein; Provisional
Probab=99.31 E-value=3.4e-12 Score=148.22 Aligned_cols=107 Identities=35% Similarity=0.573 Sum_probs=97.0
Q ss_pred cCCeEecCCCcCCCCCCccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEEccCCcCCCCCcccccCCCCCCEEecc
Q 041249 22 KLVEPYVSDNFLKGSIPSSLGLCESLTTIGLFNNNLSGTIPPQLMGLTSLVALDLSRNQFRGSFPTEVGNLINLETLTVS 101 (789)
Q Consensus 22 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 101 (789)
.++.|+|++|.+.|.+|+.++.+++|++|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..++.+++|++|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 58889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCCccccCC-cccccccccCCC
Q 041249 102 GNILQGEIPSTLGSC-IKLEILEMQGNV 128 (789)
Q Consensus 102 ~N~l~~~~p~~~~~l-~~L~~l~l~~N~ 128 (789)
+|+++|.+|..+..+ .++..+++++|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCc
Confidence 999999999988764 244455555553
No 462
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]
Probab=99.29 E-value=4.3e-13 Score=132.27 Aligned_cols=132 Identities=23% Similarity=0.319 Sum_probs=102.1
Q ss_pred CCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEE
Q 041249 649 SLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEF 728 (789)
Q Consensus 649 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 728 (789)
...-|++|||++|.|+ .+.++..-+|.++.|++|+|.|+ .+. .++.+++|..||||+|.++ .+.++-..+.+++.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 3456888888888887 66677777888888888888887 333 3888888888888888888 666777788888888
Q ss_pred EccCCcccccCCcccccCCCCccEEEccCCccccc-CcccccCCCCCCeeeccCCcCccc
Q 041249 729 DVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGA-IPPSISNASKLEVFQALNNKLTGE 787 (789)
Q Consensus 729 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~ 787 (789)
.|++|.|. .+. ++. .+-+|..||+++|+|... .-..+++++.|+.+.|.+|++.+.
T Consensus 358 ~La~N~iE-~LS-GL~-KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 358 KLAQNKIE-TLS-GLR-KLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred ehhhhhHh-hhh-hhH-hhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 88888886 332 233 577788888988888743 235678888889999999988764
No 463
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.26 E-value=2.9e-12 Score=122.27 Aligned_cols=137 Identities=26% Similarity=0.357 Sum_probs=37.8
Q ss_pred ccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccC-CCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCC
Q 041249 610 LNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFG-SLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA 688 (789)
Q Consensus 610 Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 688 (789)
|..+.|. .. ..+.+..++++|+|++|+|+. +. .+. .+.+|+.|+|++|.|+.+ +.+..++.|++|++++|+|+
T Consensus 4 lt~~~i~-~~-~~~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIE-QI-AQYNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---
T ss_pred ccccccc-cc-ccccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC
Confidence 4445555 22 234445566777777777763 32 343 466777777777777633 24666777777777777776
Q ss_pred ccCCccc-cCCCCCCeeeccCccccccC-CccccCCCCccEEEccCCcccccCCc---ccccCCCCccEEE
Q 041249 689 GSIPFTL-SKLKNLVILYLGVNRLSGIV-PSSIFNISSIAEFDVGENKIQGNIPL---DYGFTLQNLQYFS 754 (789)
Q Consensus 689 ~~~~~~~-~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~ip~---~~~~~l~~L~~L~ 754 (789)
. +.+.+ ..+++|++|+|++|+|...- -..+..+++|+.|+|.+|+++ ..+. .+...+|+|+.||
T Consensus 78 ~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~-~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 78 S-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC-EKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG-GSTTHHHHHHHH-TT-SEET
T ss_pred c-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc-chhhHHHHHHHHcChhheeC
Confidence 3 33333 35667777777777776321 134455666666666666666 3222 1222456666554
No 464
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.26 E-value=3.9e-12 Score=121.42 Aligned_cols=121 Identities=25% Similarity=0.322 Sum_probs=30.3
Q ss_pred ceeeecccCCCCccCCCccCc-CCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCC-CCCCCCCEEE
Q 041249 604 RLQVPDLNNNSIGGEIPVNLS-SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPL-GNLSSLRKIS 681 (789)
Q Consensus 604 ~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~ 681 (789)
++++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+. ++ .+..++.|++|++++|+|+.+ .+.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEE
Confidence 455555555555522 2333 34555555555555552 22 244555555555555555522 2222 2345555555
Q ss_pred ccCCcCCccCC-ccccCCCCCCeeeccCccccccC---CccccCCCCccEEE
Q 041249 682 LAINNLAGSIP-FTLSKLKNLVILYLGVNRLSGIV---PSSIFNISSIAEFD 729 (789)
Q Consensus 682 L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 729 (789)
|++|+|..... ..+..+++|+.|+|.+|.++... ...+..+|+|+.||
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 55555542111 23444555555555555555221 01334455555554
No 465
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]
Probab=99.20 E-value=2e-12 Score=143.68 Aligned_cols=197 Identities=28% Similarity=0.365 Sum_probs=100.9
Q ss_pred cccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249 574 HIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI 653 (789)
Q Consensus 574 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 653 (789)
.+..+++|+.|++.+|+|..+ ...+..+.+|++|+|++|.|+.+ ..+..++.|+.|++++|.|+. +. .|..++.|
T Consensus 90 ~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~-~~-~~~~l~~L 164 (414)
T KOG0531|consen 90 HLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISD-IS-GLESLKSL 164 (414)
T ss_pred ccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhheeccCcchh-cc-CCccchhh
Confidence 345556666666666666632 22245556666666666666543 334455556666666666652 22 34445566
Q ss_pred cEEEccCCCCCccCC-cCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCC--ccEEEc
Q 041249 654 EVLSLGFNNLIGSIP-PPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISS--IAEFDV 730 (789)
Q Consensus 654 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L 730 (789)
+.+++++|+++.+.+ . ...+.+|+.+++.+|.+. ....+..+..+..+++..|+++..-+ +..+.. |+.+++
T Consensus 165 ~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l 239 (414)
T KOG0531|consen 165 KLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYL 239 (414)
T ss_pred hcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhc
Confidence 666666666653333 1 344555666666666655 22234444455555666666652211 122222 566666
Q ss_pred cCCcccccCCcccccCCCCccEEEccCCcccccCcccccCCCCCCeeeccCCcC
Q 041249 731 GENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISNASKLEVFQALNNKL 784 (789)
Q Consensus 731 s~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 784 (789)
++|.+. .++..+. .+.++..|++.+|++... ..+.....+..+.+..|++
T Consensus 240 ~~n~i~-~~~~~~~-~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~ 289 (414)
T KOG0531|consen 240 SGNRIS-RSPEGLE-NLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKL 289 (414)
T ss_pred ccCccc-ccccccc-ccccccccchhhcccccc--ccccccchHHHhccCcchh
Confidence 666665 4433332 455566666666665533 2233344444455554444
No 466
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]
Probab=99.18 E-value=2.4e-12 Score=126.99 Aligned_cols=131 Identities=24% Similarity=0.314 Sum_probs=110.1
Q ss_pred CCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCee
Q 041249 625 SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVIL 704 (789)
Q Consensus 625 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 704 (789)
....|++||||+|.|+ .+.+...-+++++.|++++|.|+.+ ..+..+++|+.||||+|.++ .+.+.=..+-+++.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 3567999999999998 6777888889999999999999833 34888999999999999998 666666778899999
Q ss_pred eccCccccccCCccccCCCCccEEEccCCcccccCCc--ccccCCCCccEEEccCCccccc
Q 041249 705 YLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPL--DYGFTLQNLQYFSIGTNRITGA 763 (789)
Q Consensus 705 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~--~~~~~l~~L~~L~L~~N~l~~~ 763 (789)
.|+.|.|... ..+..+-+|..||+++|+|. .+.. .++ ++|-|+.|.|.+|+|.+.
T Consensus 358 ~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG-~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 358 KLAQNKIETL--SGLRKLYSLVNLDLSSNQIE-ELDEVNHIG-NLPCLETLRLTGNPLAGS 414 (490)
T ss_pred ehhhhhHhhh--hhhHhhhhheeccccccchh-hHHHhcccc-cccHHHHHhhcCCCcccc
Confidence 9999999833 45788889999999999998 5433 355 799999999999999854
No 467
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]
Probab=99.15 E-value=4e-12 Score=132.05 Aligned_cols=186 Identities=23% Similarity=0.260 Sum_probs=116.8
Q ss_pred cccCccccchhcccCCccccc--CcccccCccceeeecccCCCCccCCCccC-cCCCCCcEEEcccCCCCCC-CCcccCC
Q 041249 574 HIGNLSFLKILNLENNSFTHE--IPSEIGRLRRLQVPDLNNNSIGGEIPVNL-SSCSNLIRIGLAKNQLMGK-IPSDFGS 649 (789)
Q Consensus 574 ~l~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~-~~l~~L~~L~l~~N~l~~~-~~~~~~~ 649 (789)
....|++++.|||+.|-+..- +-+...+|++|+.|+|+.|++.--..... ..++.|+.|.|+.|.++-- +......
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~ 220 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT 220 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence 455677788888888876633 23345677888888888888762221111 2456778888888877621 1222445
Q ss_pred CCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCC--ccccCCCCCCeeeccCcccccc-CCcc-----ccC
Q 041249 650 LSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIP--FTLSKLKNLVILYLGVNRLSGI-VPSS-----IFN 721 (789)
Q Consensus 650 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~-~p~~-----~~~ 721 (789)
+++|+.|+|+.|+...+-.....-+..|+.|+|++|++- ..+ ...+.++.|+.|+++.+.|+.+ .|+. -..
T Consensus 221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~ 299 (505)
T KOG3207|consen 221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHT 299 (505)
T ss_pred CCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcc
Confidence 677888888888533333334445667888888888775 333 3456777778888888877743 2332 245
Q ss_pred CCCccEEEccCCcccccCCc--ccccCCCCccEEEccCCcccc
Q 041249 722 ISSIAEFDVGENKIQGNIPL--DYGFTLQNLQYFSIGTNRITG 762 (789)
Q Consensus 722 l~~L~~L~Ls~N~l~~~ip~--~~~~~l~~L~~L~L~~N~l~~ 762 (789)
+++|+.|+++.|+|. ..+. .+. .+++|+.|....|.|+.
T Consensus 300 f~kL~~L~i~~N~I~-~w~sl~~l~-~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 300 FPKLEYLNISENNIR-DWRSLNHLR-TLENLKHLRITLNYLNK 340 (505)
T ss_pred cccceeeecccCccc-cccccchhh-ccchhhhhhcccccccc
Confidence 677888888888875 3332 222 46677777777777764
No 468
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.15 E-value=4.9e-11 Score=119.68 Aligned_cols=161 Identities=24% Similarity=0.362 Sum_probs=125.7
Q ss_pred HHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 041249 319 RALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYL 398 (789)
Q Consensus 319 ~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L 398 (789)
..+-.+-|.||+++-.|..+.++.+.....++.|||..|++..++++. ......+......+|+-||..||.||
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt------~~~~~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRT------KKNQKALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHH------HHhhhhhhHHHHHHHHHHHHhhhhhh
Confidence 344455799999998888877776777889999999999999999754 34456788888899999999999999
Q ss_pred hcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCC--CccceeeecccccccCcccCCCCCcCccccchhhHHH
Q 041249 399 HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH--VQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGIL 476 (789)
Q Consensus 399 H~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvv 476 (789)
|+. .|+|+|+++...-|++..++-+|++--.-....+.-. .........+-++|.|||+-..-..+..+|||+||+.
T Consensus 193 hs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 193 HSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC 271 (458)
T ss_pred hcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence 987 7899999999999999999988875432222111111 1111222335678999999888888999999999999
Q ss_pred HHHHHHhcCC
Q 041249 477 MLELIIRKKP 486 (789)
Q Consensus 477 l~elltG~~P 486 (789)
..||..|..-
T Consensus 272 AlemailEiq 281 (458)
T KOG1266|consen 272 ALEMAILEIQ 281 (458)
T ss_pred HHHHHHheec
Confidence 9999888654
No 469
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.14 E-value=1.2e-10 Score=129.39 Aligned_cols=144 Identities=20% Similarity=0.193 Sum_probs=101.0
Q ss_pred CCcccccCCccEEEEEEcCCceEEEEEEeccccchhh----------------------------------------HHH
Q 041249 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRAS----------------------------------------RSF 314 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 314 (789)
.+.||.|++|.||+|+.+ +|+.||||+.+....... -.|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 468999999999999997 789999999865421110 024
Q ss_pred HHHHHHHhcC----CCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHH
Q 041249 315 IAECRALRSI----RHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAID 390 (789)
Q Consensus 315 ~~e~~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ 390 (789)
..|++.+.++ +|.+-+.+-..+.+.. ...++||||++++++.++.... .... .+..++..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~---------~~~~---~~~~ia~~ 264 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALD---------EAGL---DRKALAEN 264 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHH---------hcCC---CHHHHHHH
Confidence 4455555555 2333334333333221 2469999999999998875321 0011 24456666
Q ss_pred HHH-HHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCC
Q 041249 391 VAS-ALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPT 438 (789)
Q Consensus 391 ia~-gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 438 (789)
++. .+..+|..| ++|+|++|.||++++++++++.|||++..+++.
T Consensus 265 ~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 265 LARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred HHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence 666 477889888 999999999999999999999999999877543
No 470
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]
Probab=99.12 E-value=3.8e-12 Score=141.51 Aligned_cols=197 Identities=26% Similarity=0.302 Sum_probs=110.0
Q ss_pred CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEE
Q 041249 577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVL 656 (789)
Q Consensus 577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 656 (789)
.+..++.+++..|.|.. .-..+..+++|+.|++.+|+|+++ ...+..+++|++|++++|+|+.+.+ +..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence 34555555566666652 233355566666666666666633 2225566666666666666664332 4455556666
Q ss_pred EccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCcc-ccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcc
Q 041249 657 SLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFT-LSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKI 735 (789)
Q Consensus 657 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 735 (789)
++++|.|+.+ ..|..++.|+.+++++|+++...+ . ...+.+|+.+++++|.+. ....+..+..+..+++..|.+
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccc
Confidence 6666666532 334456666666666666663322 1 355566666666666665 223344445555556666666
Q ss_pred cccCCcccccCCCC--ccEEEccCCcccccCcccccCCCCCCeeeccCCcCcc
Q 041249 736 QGNIPLDYGFTLQN--LQYFSIGTNRITGAIPPSISNASKLEVFQALNNKLTG 786 (789)
Q Consensus 736 ~~~ip~~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 786 (789)
+ .+..-. .+.. |+.+++++|++. ..+..+..+.++..|++.+|+++.
T Consensus 221 ~-~~~~l~--~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 221 S-KLEGLN--ELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred e-eccCcc--cchhHHHHHHhcccCccc-cccccccccccccccchhhccccc
Confidence 5 332211 1222 666666666666 333455566666666666666554
No 471
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]
Probab=99.06 E-value=1.5e-11 Score=124.75 Aligned_cols=244 Identities=20% Similarity=0.229 Sum_probs=177.9
Q ss_pred HHHHHHHHhhccccceeeEeccCccccccccc----ccccCccccchhcccCC---cccccCccc-------ccCcccee
Q 041249 541 IECLISMLRIGSKAQKVTILDLESLKLAGSIL----PHIGNLSFLKILNLENN---SFTHEIPSE-------IGRLRRLQ 606 (789)
Q Consensus 541 ~~~~~~l~~i~~~c~~l~~l~l~s~~~~~~~l----~~l~~l~~L~~L~L~~N---~l~~~~~~~-------~~~l~~L~ 606 (789)
.+....+.+.......++.++++++..-.... ..+.+.++|+..++++- ++...+|++ +...++|+
T Consensus 16 ~ed~~~v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~ 95 (382)
T KOG1909|consen 16 EEDEKDVEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQ 95 (382)
T ss_pred HhhhhhHHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCcee
Confidence 34455666777788888899999987655433 34456678888887763 333445554 34456899
Q ss_pred eecccCCCCccCCCccC----cCCCCCcEEEcccCCCCCCCC-------------cccCCCCCCcEEEccCCCCCccC--
Q 041249 607 VPDLNNNSIGGEIPVNL----SSCSNLIRIGLAKNQLMGKIP-------------SDFGSLSKIEVLSLGFNNLIGSI-- 667 (789)
Q Consensus 607 ~L~Ls~N~i~~~~p~~~----~~l~~L~~L~l~~N~l~~~~~-------------~~~~~l~~L~~L~L~~N~l~~~~-- 667 (789)
+||||+|.|.-..+..| ..+..|++|.|.+|.+...-- .....-++|+.+..+.|++....
T Consensus 96 ~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~ 175 (382)
T KOG1909|consen 96 KLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGAT 175 (382)
T ss_pred EeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHH
Confidence 99999999975444443 567899999999999873211 11234568999999999986332
Q ss_pred --CcCCCCCCCCCEEEccCCcCCcc----CCccccCCCCCCeeeccCccccc----cCCccccCCCCccEEEccCCcccc
Q 041249 668 --PPPLGNLSSLRKISLAINNLAGS----IPFTLSKLKNLVILYLGVNRLSG----IVPSSIFNISSIAEFDVGENKIQG 737 (789)
Q Consensus 668 --~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~ 737 (789)
...|...+.|+.+.++.|.|... +...|..+++|++|||.+|.++. .+...+..+++|++|+++++.+..
T Consensus 176 ~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~ 255 (382)
T KOG1909|consen 176 ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLEN 255 (382)
T ss_pred HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccc
Confidence 23467789999999999998622 23457899999999999999984 245667788999999999999973
Q ss_pred c----CCcccccCCCCccEEEccCCccccc----CcccccCCCCCCeeeccCCcC
Q 041249 738 N----IPLDYGFTLQNLQYFSIGTNRITGA----IPPSISNASKLEVFQALNNKL 784 (789)
Q Consensus 738 ~----ip~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l 784 (789)
. +-..+-...++|+.|.|.+|.|+.. +.......+.|..|+|++|++
T Consensus 256 ~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 256 EGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred ccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 2 2223334578999999999999843 233345688999999999998
No 472
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]
Probab=99.04 E-value=2.2e-11 Score=126.68 Aligned_cols=209 Identities=22% Similarity=0.192 Sum_probs=157.1
Q ss_pred cCccccchhcccCCcccccCc--ccccCccceeeecccCCCCccCCC--ccCcCCCCCcEEEcccCCCCCCCCcc-cCCC
Q 041249 576 GNLSFLKILNLENNSFTHEIP--SEIGRLRRLQVPDLNNNSIGGEIP--VNLSSCSNLIRIGLAKNQLMGKIPSD-FGSL 650 (789)
Q Consensus 576 ~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~i~~~~p--~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l 650 (789)
.++.+|+.+.|.+..+. ..+ +....+++++.||||+|-+....| .-...+++|+.|+|+.|++....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 57889999999999988 334 357789999999999999875433 34568999999999999998433222 2357
Q ss_pred CCCcEEEccCCCCCcc-CCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCC--ccccCCCCccE
Q 041249 651 SKIEVLSLGFNNLIGS-IPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVP--SSIFNISSIAE 727 (789)
Q Consensus 651 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~ 727 (789)
+.|+.|.|+.|.|+-. +-.....+|+|+.|+|..|....+.......+..|+.|||++|.+- ..+ ...+.++.|+.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence 7999999999999722 1122346799999999999643355555677789999999999998 455 56788999999
Q ss_pred EEccCCcccccC--Ccc----cccCCCCccEEEccCCccccc-CcccccCCCCCCeeeccCCcCccc
Q 041249 728 FDVGENKIQGNI--PLD----YGFTLQNLQYFSIGTNRITGA-IPPSISNASKLEVFQALNNKLTGE 787 (789)
Q Consensus 728 L~Ls~N~l~~~i--p~~----~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~ 787 (789)
|+++.+.|. .| |+. ....+++|++|+++.|+|..- .-..+..+++|+.|....|+|+-+
T Consensus 276 Lnls~tgi~-si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 276 LNLSSTGIA-SIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred hhccccCcc-hhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 999999998 43 222 123678999999999999632 112334567788888888888753
No 473
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.04 E-value=9e-10 Score=106.64 Aligned_cols=131 Identities=17% Similarity=0.150 Sum_probs=96.5
Q ss_pred CCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccce-eeeeeccCCCCCCceEEEEeec
Q 041249 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVK-VFTACSGVDYQGNDFKALVYEF 353 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~~~~~~lv~e~ 353 (789)
.+.++.|.++.||++... ++.|++|+...... ....+..|++.+..+.+.++++ +++... . ..++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~-----~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--E-----TGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--C-----CCeEEEEe
Confidence 356888999999999875 78899999754432 2235688999999886555544 444321 1 34799999
Q ss_pred cCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC--CCCceecCCCCCceecCCCCceeeCcccc
Q 041249 354 MQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC--QPITTHCDLKPSNILLDEEMVSHVGDFGL 431 (789)
Q Consensus 354 ~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 431 (789)
+++.++...- .....++.+++++++.||..+ ...++|+|++|.||+++ ++.++++||+.
T Consensus 73 i~G~~l~~~~------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 73 IEGSELLTED------------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred cCCCcccccc------------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 9997765420 012345689999999999886 23369999999999999 66899999998
Q ss_pred ccc
Q 041249 432 ARF 434 (789)
Q Consensus 432 a~~ 434 (789)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 764
No 474
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=98.96 E-value=1.5e-09 Score=122.00 Aligned_cols=148 Identities=18% Similarity=0.172 Sum_probs=96.5
Q ss_pred cCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh----------------------------------hH---
Q 041249 270 DGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA----------------------------------SR--- 312 (789)
Q Consensus 270 ~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~--- 312 (789)
..|+. +.||+|++|.||+|+.+.+|+.||||+.+...... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 46776 79999999999999999779999999997542110 11
Q ss_pred ---HHHHHHHHHhcCC----CCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhc--cCCCCCccccCCCCCCCHHH
Q 041249 313 ---SFIAECRALRSIR----HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWL--YPVNREDEVDKAPRNLNLLQ 383 (789)
Q Consensus 313 ---~~~~e~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~l~~~~ 383 (789)
.+..|++.+.+++ +...+.+-.++++. ....++||||+.++.+.+.- ... +...+.+....
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~------g~d~~~la~~~ 268 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAA------GTDMKLLAERG 268 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhc------CCCHHHHHHHH
Confidence 2444555555542 33333333333221 12578999999999987642 111 00111222222
Q ss_pred HHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCC----ceeeCcccccccCCCC
Q 041249 384 RLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEM----VSHVGDFGLARFLPPT 438 (789)
Q Consensus 384 ~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgla~~~~~~ 438 (789)
...++.| +...| ++|+|++|.||+++.++ ++++.|||++..++..
T Consensus 269 v~~~~~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 269 VEVFFTQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3333333 34466 99999999999999888 9999999999988655
No 475
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=98.96 E-value=3.6e-09 Score=116.70 Aligned_cols=170 Identities=19% Similarity=0.198 Sum_probs=126.5
Q ss_pred EEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCCCChhhhccCCC
Q 041249 288 KGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVN 367 (789)
Q Consensus 288 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 367 (789)
.|.-+.++.+|.|...+...........+-+..++.++||+|++|+....... ..|+|.|-+. .|..++...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-----~~ylvTErV~--Pl~~~lk~l- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-----TLYLVTERVR--PLETVLKEL- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-----ceEEEeeccc--cHHHHHHHh-
Confidence 56777789999999987666655566788889999999999999998876655 7899999876 355555432
Q ss_pred CCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCCCccceeee
Q 041249 368 REDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTHVQTSSIGV 447 (789)
Q Consensus 368 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 447 (789)
......--+.||++||.|||+.+ .++|+++.-..|++++.++-||++|.++.....-.. .....
T Consensus 102 ------------~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~ 165 (690)
T KOG1243|consen 102 ------------GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSL 165 (690)
T ss_pred ------------HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccc
Confidence 34556667899999999999765 599999999999999999999999988765432221 00011
Q ss_pred cccccccCcccCCCCCcCccccchhhHHHHHHHHHh
Q 041249 448 KGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIR 483 (789)
Q Consensus 448 ~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG 483 (789)
.--..|..|+.+.... -..|-|-||+++||++.|
T Consensus 166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 1112355565443322 236999999999999998
No 476
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]
Probab=98.95 E-value=5.8e-11 Score=120.45 Aligned_cols=217 Identities=18% Similarity=0.226 Sum_probs=162.3
Q ss_pred ccccccccCccccchhcccCCcccccC----cccccCccceeeecccC---CCCccCCCc-------cCcCCCCCcEEEc
Q 041249 569 GSILPHIGNLSFLKILNLENNSFTHEI----PSEIGRLRRLQVPDLNN---NSIGGEIPV-------NLSSCSNLIRIGL 634 (789)
Q Consensus 569 ~~~l~~l~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~---N~i~~~~p~-------~~~~l~~L~~L~l 634 (789)
....+.+..+..++.|+|++|.+...- .+.+...++|+.-++|+ -+....+|. ++..+++|++|||
T Consensus 20 ~~v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldL 99 (382)
T KOG1909|consen 20 KDVEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDL 99 (382)
T ss_pred hhHHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeec
Confidence 334455667889999999999998653 34466778899888887 344445554 3456789999999
Q ss_pred ccCCCCCCCCcc----cCCCCCCcEEEccCCCCCccCC-------------cCCCCCCCCCEEEccCCcCCccC----Cc
Q 041249 635 AKNQLMGKIPSD----FGSLSKIEVLSLGFNNLIGSIP-------------PPLGNLSSLRKISLAINNLAGSI----PF 693 (789)
Q Consensus 635 ~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~-------------~~~~~l~~L~~L~L~~N~l~~~~----~~ 693 (789)
|+|.+...-+.. +..++.|++|.|.+|.+.-..- +....-++|+++..++|++.... ..
T Consensus 100 SDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~ 179 (382)
T KOG1909|consen 100 SDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAE 179 (382)
T ss_pred cccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHH
Confidence 999998444333 4568899999999998852221 12345678999999999997332 33
Q ss_pred cccCCCCCCeeeccCccccc----cCCccccCCCCccEEEccCCccccc----CCcccccCCCCccEEEccCCcccccCc
Q 041249 694 TLSKLKNLVILYLGVNRLSG----IVPSSIFNISSIAEFDVGENKIQGN----IPLDYGFTLQNLQYFSIGTNRITGAIP 765 (789)
Q Consensus 694 ~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----ip~~~~~~l~~L~~L~L~~N~l~~~~~ 765 (789)
.|...+.|+.+.++.|.|.. .+...|..++.|+.|||.+|-++.. +...+ +.+++|++|+++++.+.....
T Consensus 180 ~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL-~s~~~L~El~l~dcll~~~Ga 258 (382)
T KOG1909|consen 180 AFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKAL-SSWPHLRELNLGDCLLENEGA 258 (382)
T ss_pred HHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHh-cccchheeecccccccccccH
Confidence 56778899999999999972 2345688999999999999999722 22223 368899999999999987655
Q ss_pred ccc-----cCCCCCCeeeccCCcCcc
Q 041249 766 PSI-----SNASKLEVFQALNNKLTG 786 (789)
Q Consensus 766 ~~~-----~~l~~L~~L~l~~N~l~~ 786 (789)
.+| ...++|+.|.|.+|.++-
T Consensus 259 ~a~~~al~~~~p~L~vl~l~gNeIt~ 284 (382)
T KOG1909|consen 259 IAFVDALKESAPSLEVLELAGNEITR 284 (382)
T ss_pred HHHHHHHhccCCCCceeccCcchhHH
Confidence 444 236899999999998873
No 477
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.92 E-value=8.3e-10 Score=86.72 Aligned_cols=57 Identities=32% Similarity=0.448 Sum_probs=22.2
Q ss_pred CCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCC
Q 041249 677 LRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGEN 733 (789)
Q Consensus 677 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 733 (789)
|++|+|++|+|+...++.|.++++|++|++++|+|+...|.+|.++++|++|++++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 333444444443333333333444444444444443333333334444444444433
No 478
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=98.91 E-value=1.8e-09 Score=118.08 Aligned_cols=199 Identities=26% Similarity=0.290 Sum_probs=149.7
Q ss_pred CCCCCCcccc--cCCccEEEEEE--cCCceEEEEEEeccccc--hhhHHHHHHHHHHhcC-CCCccceeeeeeccCCCCC
Q 041249 271 GFSSANLIGT--GSFGSVYKGVL--DEGRTTVTVKVFNLHHH--RASRSFIAECRALRSI-RHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 271 ~f~~~~~ig~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 343 (789)
.|.+...+|. |.+|.||.+.. .+++..+|+|.-+.... .....=.+|.....+. .|++.++..... .+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----cc
Confidence 4556778899 99999999999 88899999998543322 3333334566666666 589988844443 33
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHH----HHhhhhcCCCCCceecCCCCCceecC
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVAS----ALDYLHHDCQPITTHCDLKPSNILLD 419 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~----gL~~LH~~~~~~ivH~dlk~~Nill~ 419 (789)
....++-.|.+. .++..+.... ...++......+..+... |+.++|+.. ++|-|+||.||+..
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~---------~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~ 256 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTP---------CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTT 256 (524)
T ss_pred CCcceeeecccc-chhHHhhhcc---------cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecc
Confidence 446777788877 6888877543 233566667777777777 999999887 99999999999999
Q ss_pred CC-CceeeCcccccccCCCCCCcc---ceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCCCC
Q 041249 420 EE-MVSHVGDFGLARFLPPTHVQT---SSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKPSD 488 (789)
Q Consensus 420 ~~-~~~kl~Dfgla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P~~ 488 (789)
.+ ...+++|||+...+.+..... ......|...|++||.. .+-++...|||++|.|..+..+|-.+..
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhccccc
Confidence 99 788999999999988776221 11123688899999975 4567899999999999999999866553
No 479
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.90 E-value=1.2e-09 Score=85.90 Aligned_cols=59 Identities=36% Similarity=0.434 Sum_probs=29.8
Q ss_pred CCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCcc
Q 041249 652 KIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNR 710 (789)
Q Consensus 652 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 710 (789)
+|++|++++|+|+.+.+.+|.++++|++|+|++|+|+...|+.|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555554444445555555555555555554444455555555555555554
No 480
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=98.86 E-value=1.7e-08 Score=98.44 Aligned_cols=141 Identities=20% Similarity=0.142 Sum_probs=99.6
Q ss_pred CCcccccCCccEEEEEEcC------CceEEEEEEeccccc----------------------hhhHHHH----HHHHHHh
Q 041249 275 ANLIGTGSFGSVYKGVLDE------GRTTVTVKVFNLHHH----------------------RASRSFI----AECRALR 322 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~----------------------~~~~~~~----~e~~~l~ 322 (789)
...||.|.=+.||.|.... .+..+|||+++.... ...+.+. +|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3478999999999998653 257999999753210 0012233 7999999
Q ss_pred cCC--CCccceeeeeeccCCCCCCceEEEEeeccCCCChhh-hccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhh-
Q 041249 323 SIR--HRNLVKVFTACSGVDYQGNDFKALVYEFMQNGSLEE-WLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYL- 398 (789)
Q Consensus 323 ~l~--h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L- 398 (789)
++. .-++...+++. ..++||||+.++.+.. .+.. ..++..+...+..+++.+|..+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd-----------~~~~~~~~~~i~~~i~~~l~~l~ 141 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKD-----------AKLNDEEMKNAYYQVLSMMKQLY 141 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhc-----------cccCHHHHHHHHHHHHHHHHHHH
Confidence 884 34555555541 4689999998653321 1211 1234456677889999999999
Q ss_pred hcCCCCCceecCCCCCceecCCCCceeeCcccccccCCCCC
Q 041249 399 HHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLPPTH 439 (789)
Q Consensus 399 H~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 439 (789)
|..+ +||||+++.||+++ ++.+.++|||-+-...++.
T Consensus 142 H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~hp~ 178 (197)
T cd05146 142 KECN---LVHADLSEYNMLWH-DGKVWFIDVSQSVEPTHPH 178 (197)
T ss_pred HhCC---eecCCCCHHHEEEE-CCcEEEEECCCceeCCCCC
Confidence 7777 99999999999997 4679999999887765543
No 481
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]
Probab=98.76 E-value=8.3e-11 Score=128.86 Aligned_cols=206 Identities=20% Similarity=0.254 Sum_probs=124.0
Q ss_pred HHHHHhhccccceeeEeccCcccccccccccccCccccchhcccCCcccccCcccccCc-cceeeecccCCCCccCCCcc
Q 041249 544 LISMLRIGSKAQKVTILDLESLKLAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRL-RRLQVPDLNNNSIGGEIPVN 622 (789)
Q Consensus 544 ~~~l~~i~~~c~~l~~l~l~s~~~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~i~~~~p~~ 622 (789)
+..+.++.-+...+..+..|.-.-+. +-.+.....|+.|.|.++.|.. ...+..+ ..|++|..+ |.+. .+...
T Consensus 76 Lq~i~d~lqkt~~lkl~~~pa~~pt~--pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~-Al~~v 149 (1096)
T KOG1859|consen 76 LQRILDFLQKTKVLKLLPSPARDPTE--PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLD-ALRHV 149 (1096)
T ss_pred HHHHHHHHhhheeeeecccCCCCCCC--CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHH-HHHHH
Confidence 44455666666666666666555443 4556677788888888888773 2223333 235555433 3322 11111
Q ss_pred C-------c---CCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCC
Q 041249 623 L-------S---SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIP 692 (789)
Q Consensus 623 ~-------~---~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 692 (789)
| . ...+|.+.+.++|++. ....++.-++.|+.|+|++|+++.. ..+..|+.|++|||+.|+++.+.-
T Consensus 150 ~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~ 226 (1096)
T KOG1859|consen 150 FASCGGDISNSPVWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQ 226 (1096)
T ss_pred HHHhccccccchhhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccc
Confidence 1 1 1235677777777776 5555666677777777777777633 256677777777777777773222
Q ss_pred ccccCCCCCCeeeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccc
Q 041249 693 FTLSKLKNLVILYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRIT 761 (789)
Q Consensus 693 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~ 761 (789)
-....++ |..|.+++|.++.. ..+.+|.+|+.|||++|-|.+.-.......|..|+.|+|.+|++.
T Consensus 227 l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 227 LSMVGCK-LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cchhhhh-heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 2334443 77777777777732 346677777777777777765443333334666777777777776
No 482
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=98.76 E-value=4.2e-09 Score=115.29 Aligned_cols=208 Identities=22% Similarity=0.204 Sum_probs=151.7
Q ss_pred cccccHHH-HHHhhcCCCCCCcccccCCccEEEEEEc-CCceEEEEEEeccccch--hhHHHHHHHHHHhcC-CCCccce
Q 041249 257 LLNLSYQN-LHNATDGFSSANLIGTGSFGSVYKGVLD-EGRTTVTVKVFNLHHHR--ASRSFIAECRALRSI-RHRNLVK 331 (789)
Q Consensus 257 ~~~~~~~~-~~~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~ 331 (789)
...|.-.+ ....+.+|.....||.|.|+.|++...+ .++..+++|........ ....-..|+.+...+ .|.++++
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 33444444 4556679999999999999999998876 77889999987544322 222334566666666 5888887
Q ss_pred eeeeeccCCCCCCceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCC
Q 041249 332 VFTACSGVDYQGNDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDL 411 (789)
Q Consensus 332 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dl 411 (789)
++..... .+..++-.||+.+++...... -...++...++.+..|++.++.++|... ++|+|+
T Consensus 331 ~~~~W~~-----~r~~~ip~e~~~~~s~~l~~~----------~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~ 392 (524)
T KOG0601|consen 331 KNSSWSQ-----LRQGYIPLEFCEGGSSSLRSV----------TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDV 392 (524)
T ss_pred CCCCccc-----cccccCchhhhcCcchhhhhH----------HHHhcCcchhhhhHHHHHhccccccchh---hhcccc
Confidence 6554333 336678889999988766542 2345677788999999999999999777 999999
Q ss_pred CCCceecCCC-CceeeCcccccccCCCCCCccceeeecccccc-cCcccCCCCCcCccccchhhHHHHHHHHHhcCC
Q 041249 412 KPSNILLDEE-MVSHVGDFGLARFLPPTHVQTSSIGVKGSIGY-IAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486 (789)
Q Consensus 412 k~~Nill~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P 486 (789)
||+||++..+ +..+++|||.+..+.-.. .....++..| .+++......+..++|+||||..+.|.++|..-
T Consensus 393 ~psni~i~~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 393 KPSNILISNDGFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccceeeccchhhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 9999999886 788999999987532221 1112233344 356666677789999999999999999998654
No 483
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]
Probab=98.75 E-value=2e-10 Score=101.15 Aligned_cols=137 Identities=20% Similarity=0.248 Sum_probs=96.5
Q ss_pred CCcEEEcccCCCCCCCCccc---CCCCCCcEEEccCCCCCccCCcCC-CCCCCCCEEEccCCcCCccCCccccCCCCCCe
Q 041249 628 NLIRIGLAKNQLMGKIPSDF---GSLSKIEVLSLGFNNLIGSIPPPL-GNLSSLRKISLAINNLAGSIPFTLSKLKNLVI 703 (789)
Q Consensus 628 ~L~~L~l~~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 703 (789)
.+..+||+.++|. .+++.. .....|+..+|++|.+. ..|+.| ...+.++.|+|++|+|+ .+|..+..|+.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4556677777665 444443 33445677788888887 444444 34567888888888888 67777888888888
Q ss_pred eeccCccccccCCccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccccCcccccC
Q 041249 704 LYLGVNRLSGIVPSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPSISN 770 (789)
Q Consensus 704 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 770 (789)
|+++.|.+. ..|..|..+.++..||..+|.+. .||.+++ --.++-..++.++.+.+.-+..+..
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~-~s~~~al~~lgnepl~~~~~~klqa 168 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLF-YSSLPALIKLGNEPLGDETKKKLQA 168 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHh-ccccHHHHHhcCCcccccCcccccc
Confidence 888888888 77888888888888888888888 8888866 2333444566777777655544433
No 484
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=98.73 E-value=5e-08 Score=91.76 Aligned_cols=130 Identities=25% Similarity=0.276 Sum_probs=96.7
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEeccccchh--------hHHHHHHHHHHhcCCC--CccceeeeeeccCCCCCCc
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA--------SRSFIAECRALRSIRH--RNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~~~ 345 (789)
..+++|+=+.+|.+.|. |..+++|.--.+.... ......|++++++++- -+..-++.+.. +
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~----- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--D----- 72 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--C-----
Confidence 35788999999999885 5557777753332221 3457789999998853 23333343322 2
Q ss_pred eEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCcee
Q 041249 346 FKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSH 425 (789)
Q Consensus 346 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 425 (789)
...++|||.++-.+.+.+... ...++..+-.-+.-||..+ ||||||.++||.+..+. +.
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-----------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~ 131 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-----------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IY 131 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-----------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EE
Confidence 457999999998888888432 3567778888888899999 99999999999998776 89
Q ss_pred eCcccccccC
Q 041249 426 VGDFGLARFL 435 (789)
Q Consensus 426 l~Dfgla~~~ 435 (789)
++|||++...
T Consensus 132 ~IDfGLg~~s 141 (204)
T COG3642 132 FIDFGLGEFS 141 (204)
T ss_pred EEECCccccc
Confidence 9999998864
No 485
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]
Probab=98.70 E-value=1.4e-10 Score=127.21 Aligned_cols=197 Identities=21% Similarity=0.254 Sum_probs=135.2
Q ss_pred CccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCC-CCCcEEEcccCCCC----------CCCCc
Q 041249 577 NLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSC-SNLIRIGLAKNQLM----------GKIPS 645 (789)
Q Consensus 577 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l-~~L~~L~l~~N~l~----------~~~~~ 645 (789)
..+.|+.+..-.-.-++ |-.+..+.+|++|.|.++.|.. ...+..+ ..|++| +.+|.+. +.+-+
T Consensus 85 kt~~lkl~~~pa~~pt~--pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~L-IC~~Sl~Al~~v~ascggd~~n 159 (1096)
T KOG1859|consen 85 KTKVLKLLPSPARDPTE--PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKL-ICHNSLDALRHVFASCGGDISN 159 (1096)
T ss_pred hheeeeecccCCCCCCC--CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhh-hhhccHHHHHHHHHHhcccccc
Confidence 33444444444433332 5667888899999999998873 2333332 456666 4445443 11222
Q ss_pred ccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCCCeeeccCccccccCCccccCCCCc
Q 041249 646 DFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNLVILYLGVNRLSGIVPSSIFNISSI 725 (789)
Q Consensus 646 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 725 (789)
.+. ..+|.+.+.++|.++ .+..++.-++.|+.|+|++|+++... .+..|++|++|||++|.+..+.--....+ +|
T Consensus 160 s~~-Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L 234 (1096)
T KOG1859|consen 160 SPV-WNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KL 234 (1096)
T ss_pred chh-hhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhh-hh
Confidence 221 346888999999998 77788888899999999999998443 78889999999999999984333333344 49
Q ss_pred cEEEccCCcccccCCcccccCCCCccEEEccCCcccccCccc-ccCCCCCCeeeccCCcCcc
Q 041249 726 AEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGAIPPS-ISNASKLEVFQALNNKLTG 786 (789)
Q Consensus 726 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~ 786 (789)
+.|.|++|.++ ++-. +- +|.+|+.|||++|-|.+...-. +..+..|..|+|.+|++..
T Consensus 235 ~~L~lrnN~l~-tL~g-ie-~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 235 QLLNLRNNALT-TLRG-IE-NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred eeeeecccHHH-hhhh-HH-hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 99999999998 4432 22 7889999999999888652211 3346678889999999875
No 486
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=98.68 E-value=1.6e-07 Score=95.13 Aligned_cols=146 Identities=21% Similarity=0.228 Sum_probs=107.8
Q ss_pred CCcccccCCccEEEEEEcCCceEEEEEEeccccc-hhhHHHHHHHHHHhcCCCC--ccceeeeeeccCCCCCCceEEEEe
Q 041249 275 ANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHH-RASRSFIAECRALRSIRHR--NLVKVFTACSGVDYQGNDFKALVY 351 (789)
Q Consensus 275 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~ 351 (789)
.+.|+.|..+.||++... +|+.+++|....... .....+..|+++++.+++. .+.+++++...... ....++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~--~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV--LGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc--cCCceEEE
Confidence 356899999999999886 368899999754432 2356789999999999753 45667776544221 11458999
Q ss_pred eccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCC-----------------------------
Q 041249 352 EFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDC----------------------------- 402 (789)
Q Consensus 352 e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~----------------------------- 402 (789)
||++++++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 80 e~i~G~~l~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (223)
T cd05154 80 ERVDGRVLRDRLLR-----------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA 148 (223)
T ss_pred EEeCCEecCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence 99999877765421 23566777788888888888888531
Q ss_pred ------------------------CCCceecCCCCCceecCC--CCceeeCccccccc
Q 041249 403 ------------------------QPITTHCDLKPSNILLDE--EMVSHVGDFGLARF 434 (789)
Q Consensus 403 ------------------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~ 434 (789)
...++|+|+.+.||++++ +..+.++||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 244799999999999998 66789999988765
No 487
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=98.66 E-value=9.8e-08 Score=89.20 Aligned_cols=144 Identities=20% Similarity=0.233 Sum_probs=100.7
Q ss_pred CCCcccccCCccEEEEEEcCCceEEEEEEeccccch--------hhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCc
Q 041249 274 SANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR--------ASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGND 345 (789)
Q Consensus 274 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~ 345 (789)
....+.+|+=+.|+++.+. |+..+||.-..+... ..++..+|++.+.+++--.|.--.=++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 5678999999999999996 788788775333221 2467888999999985333221111121111
Q ss_pred eEEEEeeccCC-CChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCC---
Q 041249 346 FKALVYEFMQN-GSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEE--- 421 (789)
Q Consensus 346 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~--- 421 (789)
..+++|||.++ -++.+++... .............+..|-..+.-||..+ ++||||..+||++..+
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~--------~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILST--------MEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHH--------ccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCc
Confidence 45799999986 3677777543 1112223334678889999999999998 9999999999998654
Q ss_pred CceeeCcccccccC
Q 041249 422 MVSHVGDFGLARFL 435 (789)
Q Consensus 422 ~~~kl~Dfgla~~~ 435 (789)
..+.++|||++...
T Consensus 153 ~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 153 ITPILIDFGLSSVS 166 (229)
T ss_pred CceEEEeecchhcc
Confidence 45689999998754
No 488
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=98.64 E-value=2.4e-07 Score=99.24 Aligned_cols=181 Identities=15% Similarity=0.166 Sum_probs=140.9
Q ss_pred CccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcCCCCccceeeeeeccCCCCCCceEEEEeeccCC-CChhh
Q 041249 283 FGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSIRHRNLVKVFTACSGVDYQGNDFKALVYEFMQN-GSLEE 361 (789)
Q Consensus 283 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~ 361 (789)
-.+.|+++...+|..+++|++...+.......-.-+++++++.|.|+|++-.++.... -+..-.++||+|.+. ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHH
Confidence 3689999999999999999996665555555667788999999999999988877333 222358899999886 57777
Q ss_pred hccCCCCCc-----cccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCcccccccCC
Q 041249 362 WLYPVNRED-----EVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGDFGLARFLP 436 (789)
Q Consensus 362 ~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 436 (789)
+-....... .....+...++...+.++.|+..||.++|+.| +.-+-+.+.+|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 765543333 23445667888999999999999999999999 8889999999999999999999988877765
Q ss_pred CCCCccceeeecccccccCcccCCCCCcCccccchhhHHHHHHHHHhcCC
Q 041249 437 PTHVQTSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYGILMLELIIRKKP 486 (789)
Q Consensus 437 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfGvvl~elltG~~P 486 (789)
.+... | -+--++-|.-.||.++..|.||..-
T Consensus 445 ~d~~~--------------~-----le~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTE--------------P-----LESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCc--------------c-----hhHHhhhhHHHHHHHHHHHhhcccc
Confidence 44311 0 0113467899999999999999543
No 489
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=98.46 E-value=7.7e-08 Score=110.85 Aligned_cols=206 Identities=22% Similarity=0.288 Sum_probs=142.7
Q ss_pred HhhcCCCCCCcccccCCccEEEEEEcCCceEEEEEEeccccchh---hHHHHHHHHHHhcCCCCccceeeeeeccCCCCC
Q 041249 267 NATDGFSSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRA---SRSFIAECRALRSIRHRNLVKVFTACSGVDYQG 343 (789)
Q Consensus 267 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 343 (789)
...++|.+.+-+..|.++.++.+.-...+...++|+......-. .+....+-...-..++|-++.....+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~----- 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC----- 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC-----
Confidence 45678888888999999999988877677666666653221111 1111122222222233444444333222
Q ss_pred CceEEEEeeccCCCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCc
Q 041249 344 NDFKALVYEFMQNGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMV 423 (789)
Q Consensus 344 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 423 (789)
.....+|++|..+++|...++... ..+..........+..+.+|||... ++|+|++|.+.++..+++
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~----------~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh 942 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG----------CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGH 942 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC----------CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCC
Confidence 226789999999999999887652 2233334456677888999999776 899999999999999999
Q ss_pred eeeCcccccccCCCC---------------------C----Cc----cceeeecccccccCcccCCCCCcCccccchhhH
Q 041249 424 SHVGDFGLARFLPPT---------------------H----VQ----TSSIGVKGSIGYIAPEYGLGSEVSTNGDVYSYG 474 (789)
Q Consensus 424 ~kl~Dfgla~~~~~~---------------------~----~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~sfG 474 (789)
.++.||+........ . .. ...-...||..|.|||...+......+|.|++|
T Consensus 943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen 943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence 999999833322110 0 00 111234589999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCcc
Q 041249 475 ILMLELIIRKKPSDIM 490 (789)
Q Consensus 475 vvl~elltG~~P~~~~ 490 (789)
++++|.++|..||...
T Consensus 1023 ~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1023 VCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred hhhhhhhcCCCCCCCc
Confidence 9999999999999854
No 490
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=98.45 E-value=8.7e-07 Score=86.25 Aligned_cols=128 Identities=22% Similarity=0.252 Sum_probs=82.5
Q ss_pred cEEEEEEcCCceEEEEEEeccccc-------------h-------------hhHHHHHHHHHHhcCCCC--ccceeeeee
Q 041249 285 SVYKGVLDEGRTTVTVKVFNLHHH-------------R-------------ASRSFIAECRALRSIRHR--NLVKVFTAC 336 (789)
Q Consensus 285 ~Vy~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~--niv~l~~~~ 336 (789)
.||.|... ++..||+|..+.... . ......+|.+.|.++... ++.+.+.+-
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38999886 688999999753310 0 023477899999999755 455555442
Q ss_pred ccCCCCCCceEEEEeeccC--CCChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhh-hhcCCCCCceecCCCC
Q 041249 337 SGVDYQGNDFKALVYEFMQ--NGSLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDY-LHHDCQPITTHCDLKP 413 (789)
Q Consensus 337 ~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~-LH~~~~~~ivH~dlk~ 413 (789)
..++||||++ +..+..+.. . .++......++.++...+.. +|..| +||||+.+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~-~-----------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~ 135 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKD-V-----------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSE 135 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHH-C-----------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-ST
T ss_pred ---------CCEEEEEecCCCccchhhHHh-c-----------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCCh
Confidence 3479999999 434433321 1 11133456677788886666 46887 99999999
Q ss_pred CceecCCCCceeeCcccccccCCCC
Q 041249 414 SNILLDEEMVSHVGDFGLARFLPPT 438 (789)
Q Consensus 414 ~Nill~~~~~~kl~Dfgla~~~~~~ 438 (789)
.||+++++ .+.++|||.+....++
T Consensus 136 ~NIlv~~~-~~~iIDf~qav~~~~p 159 (188)
T PF01163_consen 136 YNILVDDG-KVYIIDFGQAVDSSHP 159 (188)
T ss_dssp TSEEEETT-CEEE--GTTEEETTST
T ss_pred hhEEeecc-eEEEEecCcceecCCc
Confidence 99999988 9999999988765543
No 491
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=98.45 E-value=2.1e-06 Score=88.82 Aligned_cols=146 Identities=14% Similarity=0.028 Sum_probs=98.8
Q ss_pred CcccccCCccEEEEEEcCCceEEEEEEeccccch-----------hhHHHHHHHHHHhcCCCCc--cceeeeeeccCCCC
Q 041249 276 NLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHR-----------ASRSFIAECRALRSIRHRN--LVKVFTACSGVDYQ 342 (789)
Q Consensus 276 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~ 342 (789)
+.+-......|++..+ +|+.+.||........ ....+..|.+.+.++...+ ..+.+++.......
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 3444444455677666 4788999977433211 1124778888888884322 33334443221111
Q ss_pred CCceEEEEeeccCCC-ChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCC-
Q 041249 343 GNDFKALVYEFMQNG-SLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDE- 420 (789)
Q Consensus 343 ~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~- 420 (789)
.....++|+|++++- +|.+++... .....+...+..++.+++..+.-||..| |+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~--------~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~ 174 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADW--------ATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLP 174 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEecc
Confidence 122468999999976 788887532 0123345677889999999999999999 999999999999975
Q ss_pred ------CCceeeCccccccc
Q 041249 421 ------EMVSHVGDFGLARF 434 (789)
Q Consensus 421 ------~~~~kl~Dfgla~~ 434 (789)
++.+.++||+.++.
T Consensus 175 ~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 175 FPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccCCCCCceEEEEECCcccc
Confidence 57889999998864
No 492
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]
Probab=98.45 E-value=3.7e-09 Score=93.21 Aligned_cols=105 Identities=21% Similarity=0.347 Sum_probs=48.9
Q ss_pred ccchhcccCCcccccCccc---ccCccceeeecccCCCCccCCCccCc-CCCCCcEEEcccCCCCCCCCcccCCCCCCcE
Q 041249 580 FLKILNLENNSFTHEIPSE---IGRLRRLQVPDLNNNSIGGEIPVNLS-SCSNLIRIGLAKNQLMGKIPSDFGSLSKIEV 655 (789)
Q Consensus 580 ~L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 655 (789)
.+..+||++++|. -+++. +.+...|+..+|++|.++ .+|..|. ..+.+++|+|++|+|+ .+|..+..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4556667777665 23333 233334444555555555 3333332 2234445555555554 34444444444555
Q ss_pred EEccCCCCCccCCcCCCCCCCCCEEEccCCcCC
Q 041249 656 LSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA 688 (789)
Q Consensus 656 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 688 (789)
|+++.|.+. ..|..|..+.+|..|+..+|.+.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 555444444 33333333444444444444443
No 493
>KOG2982 consensus Uncharacterized conserved protein [Function unknown]
Probab=98.42 E-value=4.6e-08 Score=97.29 Aligned_cols=63 Identities=14% Similarity=0.171 Sum_probs=29.8
Q ss_pred CCCeeeccCccccccC-CccccCCCCccEEEccCCcccccCCcccccCCCCccEEEccCCcccc
Q 041249 700 NLVILYLGVNRLSGIV-PSSIFNISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITG 762 (789)
Q Consensus 700 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~ 762 (789)
++..+-+..|.|.... -..+..++.+.-|+|+.|+|...-.-+...++++|..|.+++|++..
T Consensus 200 nv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 200 NVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred cchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 4444455555444221 12334444555556666655422222222355666666666666543
No 494
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]
Probab=98.41 E-value=1.3e-07 Score=112.67 Aligned_cols=109 Identities=28% Similarity=0.387 Sum_probs=66.7
Q ss_pred cccceeeEeccCccc--ccccccccccCccccchhcccCCcccccCcccccCccceeeecccCCCCccCCCccCcCCCCC
Q 041249 552 SKAQKVTILDLESLK--LAGSILPHIGNLSFLKILNLENNSFTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNL 629 (789)
Q Consensus 552 ~~c~~l~~l~l~s~~--~~~~~l~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L 629 (789)
..|.+++.+-+..+. ........|..++.|+.|||++|.=-+.+|+.++.|-+|++|+|++..|+ .+|..+.++++|
T Consensus 542 ~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L 620 (889)
T KOG4658|consen 542 SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKL 620 (889)
T ss_pred CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhh
Confidence 345555555555554 23222333556677777777766554566777777777777777777776 666677777777
Q ss_pred cEEEcccCCCCCCCCcccCCCCCCcEEEccCC
Q 041249 630 IRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFN 661 (789)
Q Consensus 630 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 661 (789)
.+|++..+.-...+|.....+++|++|.+..-
T Consensus 621 ~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 621 IYLNLEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred heeccccccccccccchhhhcccccEEEeecc
Confidence 77777766544445555555667776666544
No 495
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]
Probab=98.26 E-value=3.2e-07 Score=109.35 Aligned_cols=129 Identities=28% Similarity=0.329 Sum_probs=92.2
Q ss_pred CccccchhcccCCc--ccccCcccccCccceeeecccCCCCccCCCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCCc
Q 041249 577 NLSFLKILNLENNS--FTHEIPSEIGRLRRLQVPDLNNNSIGGEIPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIE 654 (789)
Q Consensus 577 ~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 654 (789)
+.+.|++|-+..|. +..+..+.|..++.|.+|||++|.=-+.+|..++.+-+|++|+|++..|+ .+|..+.++.+|.
T Consensus 543 ~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~ 621 (889)
T KOG4658|consen 543 ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLI 621 (889)
T ss_pred CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhh
Confidence 34568888888886 55455556777888888888887766678888888888888888888887 7888888888888
Q ss_pred EEEccCCCCCccCCcCCCCCCCCCEEEccCCcCC--ccCCccccCCCCCCeeec
Q 041249 655 VLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLA--GSIPFTLSKLKNLVILYL 706 (789)
Q Consensus 655 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L 706 (789)
+|++..+.-...+|.....|++|++|.+..-... ...-..+.++++|+.+..
T Consensus 622 ~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 622 YLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred eeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 8888887765566666667888888888665422 222223344555554444
No 496
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=98.23 E-value=2.9e-07 Score=90.53 Aligned_cols=185 Identities=21% Similarity=0.199 Sum_probs=92.4
Q ss_pred cCccceeeecccCCCCccCCCccC----cCCCCCcEEEcccCCCCCCCCcc-------------cCCCCCCcEEEccCCC
Q 041249 600 GRLRRLQVPDLNNNSIGGEIPVNL----SSCSNLIRIGLAKNQLMGKIPSD-------------FGSLSKIEVLSLGFNN 662 (789)
Q Consensus 600 ~~l~~L~~L~Ls~N~i~~~~p~~~----~~l~~L~~L~l~~N~l~~~~~~~-------------~~~l~~L~~L~L~~N~ 662 (789)
..+++|++.+||+|.+....|..+ +.-+.|++|.|++|.+...--.- ..+-+.|+......|+
T Consensus 89 lkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNR 168 (388)
T COG5238 89 LKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNR 168 (388)
T ss_pred hcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccch
Confidence 445666666666666655444332 34456666666666654211111 1234556666666666
Q ss_pred CCccCCcC-----CCCCCCCCEEEccCCcCCccC-----CccccCCCCCCeeeccCcccccc----CCccccCCCCccEE
Q 041249 663 LIGSIPPP-----LGNLSSLRKISLAINNLAGSI-----PFTLSKLKNLVILYLGVNRLSGI----VPSSIFNISSIAEF 728 (789)
Q Consensus 663 l~~~~~~~-----~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L 728 (789)
+. ..+.. |..-.+|+++.+..|.|.-.- ...+..+++|++|||.+|.++.. +..++..++.|++|
T Consensus 169 le-ngs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL 247 (388)
T COG5238 169 LE-NGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLREL 247 (388)
T ss_pred hc-cCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhc
Confidence 64 22211 222245666666666665110 11223456667777777766632 22344455566666
Q ss_pred EccCCcccccCCcccc-----cCCCCccEEEccCCcccccCccc-----c--cCCCCCCeeeccCCcCc
Q 041249 729 DVGENKIQGNIPLDYG-----FTLQNLQYFSIGTNRITGAIPPS-----I--SNASKLEVFQALNNKLT 785 (789)
Q Consensus 729 ~Ls~N~l~~~ip~~~~-----~~l~~L~~L~L~~N~l~~~~~~~-----~--~~l~~L~~L~l~~N~l~ 785 (789)
.+.+|-++..-...++ ...++|..|...+|.+.+-+-.. + ..++-|..|.+.+|+|.
T Consensus 248 ~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~ 316 (388)
T COG5238 248 RLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK 316 (388)
T ss_pred cccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcch
Confidence 6666666522111111 12456666666666654321111 1 23455555556666654
No 497
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=98.20 E-value=1.8e-05 Score=83.11 Aligned_cols=202 Identities=15% Similarity=0.169 Sum_probs=128.4
Q ss_pred CCCCcccccCCccEEEEEEcCCceEEEEEEeccccchhhHHHHHHHHHHhcC-CCCccceeeeeeccC--CCCCCceEEE
Q 041249 273 SSANLIGTGSFGSVYKGVLDEGRTTVTVKVFNLHHHRASRSFIAECRALRSI-RHRNLVKVFTACSGV--DYQGNDFKAL 349 (789)
Q Consensus 273 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~~~~~~l 349 (789)
...+.+|+|+-+.+|..-.- + ..+-|++.......+. +.++.|.+. .||-+..-+.+=+.- ..++.....+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh--h-chhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 44678999999999975432 2 2334555433322222 233444444 566543311110000 1122223566
Q ss_pred EeeccCCC-ChhhhccCCCCCccccCCCCCCCHHHHHHHHHHHHHHHhhhhcCCCCCceecCCCCCceecCCCCceeeCc
Q 041249 350 VYEFMQNG-SLEEWLYPVNREDEVDKAPRNLNLLQRLNIAIDVASALDYLHHDCQPITTHCDLKPSNILLDEEMVSHVGD 428 (789)
Q Consensus 350 v~e~~~~g-~L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 428 (789)
.|..+.+. -...+.....++ ..-....|.-.+..++.+|.+.+.||..| .+-||+.++|+|++++..+.|.|
T Consensus 88 lmP~v~g~~pI~~~y~p~tRR----qs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRR----QSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ecccCCCccchhhhcCchhhc----ccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence 67666654 233333332111 12345789999999999999999999999 88999999999999999999987
Q ss_pred ccccccCCCCCCccceeeecccccccCcccCC-----CCCcCccccchhhHHHHHHHHHh-cCCCCcc
Q 041249 429 FGLARFLPPTHVQTSSIGVKGSIGYIAPEYGL-----GSEVSTNGDVYSYGILMLELIIR-KKPSDIM 490 (789)
Q Consensus 429 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~sfGvvl~elltG-~~P~~~~ 490 (789)
-..-.....+ .......|...|.+||... +...++..|-|.+||++++++.| ++||..-
T Consensus 161 sDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 161 SDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 4322221111 1223455888999999765 34568899999999999999986 9999753
No 498
>KOG2982 consensus Uncharacterized conserved protein [Function unknown]
Probab=98.18 E-value=4.4e-07 Score=90.48 Aligned_cols=202 Identities=22% Similarity=0.228 Sum_probs=132.2
Q ss_pred ccccchhcccCCcccccCcc-ccc-CccceeeecccCCCCccC--CCccCcCCCCCcEEEcccCCCCCCCCcccCCCCCC
Q 041249 578 LSFLKILNLENNSFTHEIPS-EIG-RLRRLQVPDLNNNSIGGE--IPVNLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKI 653 (789)
Q Consensus 578 l~~L~~L~L~~N~l~~~~~~-~~~-~l~~L~~L~Ls~N~i~~~--~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 653 (789)
+..++.|-+.++.|..+-.. .|+ ..+.++.|||.+|.|+.. +-.-+.+++.|++|+|+.|++...+...-..+.+|
T Consensus 44 ~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl 123 (418)
T KOG2982|consen 44 LRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNL 123 (418)
T ss_pred ccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccce
Confidence 33555666666666533221 233 246788888888888742 23345678888888888888875443322456788
Q ss_pred cEEEccCCCCCc-cCCcCCCCCCCCCEEEccCCcCCc--cCCcc----------ccCCCCCCeeeccCccccccCCcccc
Q 041249 654 EVLSLGFNNLIG-SIPPPLGNLSSLRKISLAINNLAG--SIPFT----------LSKLKNLVILYLGVNRLSGIVPSSIF 720 (789)
Q Consensus 654 ~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~----------~~~l~~L~~L~Ls~N~l~~~~p~~~~ 720 (789)
+.|-|.+..+.= .....+..+|.++.|.||.|.+.- ...+. +..++.+..+.++-|++...
T Consensus 124 ~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~------ 197 (418)
T KOG2982|consen 124 RVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI------ 197 (418)
T ss_pred EEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh------
Confidence 888888777641 233445667888888888884331 11112 22334455555566666533
Q ss_pred CCCCccEEEccCCcccccCCcccccCCCCccEEEccCCccccc-CcccccCCCCCCeeeccCCcCcc
Q 041249 721 NISSIAEFDVGENKIQGNIPLDYGFTLQNLQYFSIGTNRITGA-IPPSISNASKLEVFQALNNKLTG 786 (789)
Q Consensus 721 ~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~ 786 (789)
++++..+.+..|+|...-...-+..++.+.-|+|+.|+|..- .-+++..+++|..|.+++|++..
T Consensus 198 -Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 198 -FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred -cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 457888899999987444444444678888999999999742 23456789999999999999875
No 499
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]
Probab=98.08 E-value=6.1e-06 Score=78.28 Aligned_cols=102 Identities=21% Similarity=0.208 Sum_probs=43.8
Q ss_pred CcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccC-CccccCCCCCCeeecc
Q 041249 629 LIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSI-PFTLSKLKNLVILYLG 707 (789)
Q Consensus 629 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls 707 (789)
...+||++|.|. .+ +.|..++.|.+|.|++|+|+.+.|.--.-+++|..|.|.+|.|.... -.-+..|++|++|.+-
T Consensus 44 ~d~iDLtdNdl~-~l-~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltll 121 (233)
T KOG1644|consen 44 FDAIDLTDNDLR-KL-DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTLL 121 (233)
T ss_pred cceecccccchh-hc-ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeeec
Confidence 344444444443 11 13444444555555555554333333333344555555555443110 0123444555555555
Q ss_pred CccccccCC---ccccCCCCccEEEccC
Q 041249 708 VNRLSGIVP---SSIFNISSIAEFDVGE 732 (789)
Q Consensus 708 ~N~l~~~~p---~~~~~l~~L~~L~Ls~ 732 (789)
+|.++..-- -.+..+++|+.||++.
T Consensus 122 ~Npv~~k~~YR~yvl~klp~l~~LDF~k 149 (233)
T KOG1644|consen 122 GNPVEHKKNYRLYVLYKLPSLRTLDFQK 149 (233)
T ss_pred CCchhcccCceeEEEEecCcceEeehhh
Confidence 555542111 2234455555555544
No 500
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=98.04 E-value=1.3e-05 Score=73.54 Aligned_cols=105 Identities=22% Similarity=0.251 Sum_probs=34.8
Q ss_pred cCcCCCCCcEEEcccCCCCCCCCcccCCCCCCcEEEccCCCCCccCCcCCCCCCCCCEEEccCCcCCccCCccccCCCCC
Q 041249 622 NLSSCSNLIRIGLAKNQLMGKIPSDFGSLSKIEVLSLGFNNLIGSIPPPLGNLSSLRKISLAINNLAGSIPFTLSKLKNL 701 (789)
Q Consensus 622 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 701 (789)
+|.++++|+.+.+.. .+..+....|.++++|+.+.+.++ +..+...+|.++++|+.+.+.+ .+.......|..+++|
T Consensus 7 ~F~~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l 83 (129)
T PF13306_consen 7 AFYNCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNL 83 (129)
T ss_dssp TTTT-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTE
T ss_pred HHhCCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccc
Confidence 344444444444442 233333334444444444444432 3334444444444444444433 2222233334444444
Q ss_pred CeeeccCccccccCCccccCCCCccEEEcc
Q 041249 702 VILYLGVNRLSGIVPSSIFNISSIAEFDVG 731 (789)
Q Consensus 702 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 731 (789)
+.+++..| +.......|.+. +|+.+.+.
T Consensus 84 ~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~ 111 (129)
T PF13306_consen 84 KNIDIPSN-ITEIGSSSFSNC-NLKEINIP 111 (129)
T ss_dssp CEEEETTT--BEEHTTTTTT--T--EEE-T
T ss_pred cccccCcc-ccEEchhhhcCC-CceEEEEC
Confidence 44444333 332333333333 44444443
Done!